40-F

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 40-F

(Check One)

☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

OR

☒ ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended: December 31, 2022 Commission File Number: 001-40688

Draganfly Inc.

(Exact name of Registrant as specified in its charter)

Not Applicable

(Translation of Registrant’s name into English (if applicable))

British Columbia, Canada

(Province or other jurisdiction of incorporation or organization)

3721

(Primary Standard Industrial Classification Code Number (if applicable))

Not Applicable

(I.R.S. Employer Identification Number (if applicable))

2108 St. George Avenue

Saskatoon, Saskatchewan, S7M 0K7

Canada

(800) 979-9794

(Address and telephone number of Registrant’s principal executive offices)

C T Corporation System

1015 15^th Street, N.W.,Suite 1000

Washington, DC 20005

(202) 572-3111

(Name, address (including zip code) and telephone number (including area code) of agent for service in the United States)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

Title of each class	Ticker Symbol(s)	Name of each exchange on which registered
Common Shares	DRPO	The Nasdaq Stock Market LLC

Securities registered or to be registered pursuant to Section 12(g) of the Act:

None

(Title of Class)

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:

None

(Title of Class)

For annual reports, indicate by check mark the information filed with this Form:

☒ Annual information form ☒ Audited annual financial statements

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 34,270,579

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

YES ☒ NO ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

YES ☒ NO ☐

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.

Emerging growth company ☒

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

† The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b).

EXPLANATORY NOTE

Draganfly Inc. (the “Registrant”) is a Canadian corporation eligible to file its Annual Report pursuant to Section 13(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on Form 40-F. The Registrant is a “foreign private issuer” as defined in Rule 3b-4 under the Exchange Act. Equity securities of the Registrant are accordingly exempt from Sections 14(a), 14(b), 14(c), 14(f) and 16 of the Exchange Act pursuant to Rule 3a12-3 thereunder.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Certain statements in this Annual Report on Form 40-F are forward-looking statements within the meaning of Section 21E of the Exchange Act and Section 27A of the Securities Act of 1933, as amended (the “Securities Act”). Additionally, the safe harbor provided in Section 21E of the Exchange Act and Section 27A of the Securities Act applies to any forward-looking information provided pursuant to “Off-Balance Sheet Arrangements” and “Disclosure of Contractual Obligations” in this Annual Report on Form 40-F. Please see “Cautionary Statement Regarding Forward-Looking Statements” beginning on page 2 of the Management’s Discussion and Analysis for the fiscal year ended December 31, 2022 of the Registrant, attached as Exhibit 99.3 to this Annual Report on Form 40-F, and “Cautionary Note Regarding Forward-Looking Information” beginning on page 1 of the Annual Information Form for the fiscal year ended December 31, 2022 of the Registrant, attached as Exhibit 99.1 to this Annual Report on Form 40-F.

DIFFERENCES IN UNITED STATES AND CANADIAN REPORTING PRACTICES

The Registrant is permitted, under a multijurisdictional disclosure system adopted by the United States, to prepare this Annual Report on Form 40-F in accordance with Canadian disclosure requirements, which are different from those of the United States.

The Registrant prepares its consolidated financial statements, which are filed with this Annual Report on Form 40-F, in accordance with International Financial Reporting Standards, as issued by the International Accounting Standards Board (“IFRS”). Such financial statements may not be comparable to financial statements prepared in accordance with United States generally accepted accounting principles.

2

Unless otherwise indicated, all dollar amounts in this Annual Report on Form 40-F are in Canadian dollars. The exchange rate of United States dollars into Canadian dollars, on December 30, 2022, based upon historical rates published by the Bank of Canada, was U.S.$1.00 = C$1.3544.

Purchasing, holding, or disposing of securities of the Registrant may have tax consequences under the laws of the United States and Canada that are not described in this Annual Report on Form 40-F.

PRINCIPAL DOCUMENTS

Annual Information Form

The Registrant’s Annual Information Form for the fiscal year ended December 31, 2022 is filed as Exhibit 99.1 and incorporated by reference in this Annual Report on Form 40-F.

Audited Annual Financial Statements

The audited consolidated financial statements of the Registrant for the fiscal year ended December 31, 2022 and 2021, including the Independent Auditor’s Report with respect thereto, are filed as Exhibit 99.2 and incorporated by reference in this Annual Report on Form 40-F.

Management’s Discussion and Analysis

The Registrant’s Management’s Discussion and Analysis for the fiscal year ended December 31, 2022 is filed as Exhibit 99.3 and incorporated by reference in this Annual Report on Form 40-F.

CONTROLS AND PROCEDURES

Certifications

The required certifications are included in Exhibits 99.4, 99.5, 99.6 and 99.7 of this Annual Report on Form 40-F.

3

Disclosure Controls and Procedures

At the end of the period covered by this report, an evaluation of the effectiveness of the design and operation of the Registrant’s “disclosure controls and procedures” (as such term is defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act) was carried out by the Registrant’s principal executive officer (the “CEO”) and principal financial officer (the “CFO”). Based upon that evaluation, the Registrant’s CEO and CFO have concluded that, as of the end of the period covered by this report, the design and operation of the Registrant’s disclosure controls and procedures are effective to ensure that (i) information required to be disclosed in reports that the Registrant files or submits to regulatory authorities is recorded, processed, summarized and reported within the time periods specified by regulation, and (ii) is accumulated and communicated to management, including the Registrant’s CEO and CFO, to allow timely decisions regarding required disclosure.

It should be noted that while the Registrant’s CEO and CFO believe that the Registrant’s disclosure controls and procedures provide a reasonable level of assurance that they are effective, they do not expect that the Registrant’s disclosure controls and procedures will prevent all errors and fraud. A control system, no matter how well conceived or operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.

Management Report on Internal Control Over Financial Reporting & Auditor Attestation

Management is responsible for establishing and maintaining adequate internal control over financial reporting (as such term is defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) and has designed such internal control over financial reporting to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with IFRS.

In designing and evaluating the Company’s internal control over financial reporting, the Company’s management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its reasonable judgment in evaluating the cost-benefit relationship of possible controls and procedures. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate.

Management conducted an evaluation of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2022. In making this assessment, management used the criteria set forth in “Internal Control - Integrated Framework (2013)” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this evaluation, management concluded that the Company’s internal control over financial reporting was effective as of December 31, 2022, based on those criteria.

In accordance with the JOBS Act enacted on April 5, 2012, the Company qualifies as an “emerging growth company,” which entitles the Company to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not EGCs. Specifically, the JOBS Act defers the requirement to have the Company’s independent auditor assess the Company’s internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act. As such, the Company is exempted from the requirement to include an auditor attestation report in this Annual Report for so long as the Company remains an EGC, which may be for as long as five years following its initial registration in the United States.

4

Changes in Internal Control over Financial Reporting

During the year ended December 31, 2022, there were no changes in the Registrant’s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

NOTICES PURSUANT TO REGULATION BTR

There were no notices required by Rule 104 of Regulation BTR that the Registrant sent during the year ended December 31, 2022 concerning any equity security subject to a blackout period under Rule 101 of Regulation BTR.

AUDIT COMMITTEE AND AUDIT COMMITTEE FINANCIAL EXPERT

Audit Committee

The Board of Directors has a separately-designated standing Audit Committee established in accordance with Section 3(a)(58)(A) of the Exchange Act for the purpose of overseeing the accounting and financial reporting processes of the Registrant and audits of the Registrant’s annual financial statements. As of the date of this Annual Report on Form 40-F, the members of the Audit Committee are Olen Aasen, Julie Myers Wood and John M. ‎Mitnick.

The Board of Directors of the Registrant has determined that all members of the Audit Committee are “independent,” as such term is defined under the rules of The Nasdaq Stock Market LLC (“Nasdaq”). Further, the Registrant has determined that all members of the Audit Committee are financially literate, meaning that they must be able to read and understand fundamental financial statements.

Audit Committee Financial Expert

The Board of Directors of the Registrant has determined that the Chair of the Audit Committee, Olen Aasen is an “audit committee financial expert,” as defined in General Instruction B(8)(b) of Form 40-F. The U.S. Securities and Exchange Commission (the “Commission”) has indicated that the designation of Olen Aasen, as an audit committee financial expert does not make him an “expert” for any purpose, impose any duties, obligations or liability on him that are greater than those imposed on members of the audit committee and board of directors who do not carry this designation or affect the duties, obligations or liability of any other member of the audit committee.

5

CODE OF ETHICS

The Registrant has adopted a written code of ethics for its directors, officers and employees entitled “Code of Business Conduct and Ethics” (the “Code”) that complies with Section 406 of the Sarbanes-Oxley Act of 2002 and with Nasdaq Listing Rule 5610. The Code includes, among other things, written standards for the Registrant’s CEO, CFO and principal accounting officer or controller, or persons performing similar functions, which are required by the Commission for a code of ethics applicable to such officers. A copy of the Code is posted on the Registrant’s website at https://investor.draganfly.com/governance-documents/ under “Code of Ethics”.

No substantive amendments to the Code were adopted during the year ended December 31, 2022. No “waiver” or “implicit waiver,” as such terms are defined in Note 6 to General Instruction B(9) of Form 40-F, was granted relating to any provision of the Code during the year ended December 31, 2022.

PRINCIPAL ACCOUNTANT FEES AND SERVICES

Dale Matheson Carr-Hilton Labonte LLP serves as the Registrant’s auditing firm. Aggregate fees billed to the Registrant for professional services rendered by Dale Matheson Carr-Hilton Labonte LLP and its affiliates during the fiscal years ended December 31, 2022 and December 31, 2021 are detailed below.

	Year Ended December 31,
Services	2022		2021
Audit Fees(1)	$	250,000	$	227,500
Audit-Related Fees(2)		63,900		24,000
Tax Fees(3)	$	11,000	$	11,000
Other Fees(4)		-		-

(1)	“Audit fees” means the aggregate fees billed for professional services rendered by our principal accounting firm for the audit of the Company’s annual financial statements and the review of its comparative interim financial statements.
(2)	“Audit-related fees” means the aggregate fees billed for professional services rendered by the Company’s principal accounting firm for the assurance and related services, which mainly included the audit and review of financial statements and are not reported under “Audit fees” above.
(3)	“Tax fees” means the aggregate fees billed for professional services rendered by the Company’s principal accounting firm for tax compliance, tax advice and tax planning.
(4)	“Other fees” means the aggregate fees incurred in each of the fiscal years listed for the professional tax services rendered by the Company’s principal accounting firm other than services reported under “Audit fees,” “Audit-related fees” and “Tax fees.”

6

Pre-Approval Policies and Procedures

The policy of the Company’s Audit Committee is to pre-approve all audit and non-audit services provided by Dale Matheson Carr-Hilton Labonte LLP, its independent registered public accounting firm, including audit services, audit-related services, tax services, and other services as described above. For the fiscal year ended December 31, 2022, all audit and non-audit services performed by the Registrant’s auditor were pre-approved by the Audit Committee of the Registrant, pursuant to Rule 2-01(c)(7)(i) of Regulation S-X.

OFF-BALANCE SHEET ARRANGEMENTS

As of December 31, 2022, the Registrant does not have any “off-balance sheet arrangements” (as that term is defined in paragraph 11(ii) of General Instruction B to Form 40-F) that have or are reasonably likely to have a current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

DISCLOSURE OF CONTRACTUAL OBLIGATIONS

The following table lists, as of December 31, 2022, information with respect to the Registrant’s known contractual obligations:

	1 year		1 – 5 years		More than 5 years
Trade payables and accrued liabilities		2,816,676		-		-
Customer deposits		194,758		-		-
Deferred income		63,690		-		-
Loans payable		81,512		5,059		-
Derivative liability		57,314		-		-
Lease liability		133,962		244,681		-
	$	3,347,912	$	249,740	$	-

7

MINE SAFETY DISCLOSURE

Not applicable.

DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not applicable.

RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION

Not applicable.

CORPORATE GOVERNANCE

The Registrant is a “foreign private issuer” as defined in Rule 3b-4 under the Exchange Act and its common shares are listed on Nasdaq. Nasdaq Marketplace Rule 5615(a)(3) permits a foreign private issuer to follow its home country practices in lieu of certain requirements in the Nasdaq Listing Rules. A foreign private issuer that follows home country practices in lieu of certain corporate governance provisions of the Nasdaq Listing Rules must disclose each Nasdaq corporate governance requirement that it does not follow and include a brief statement of the home country practice the issuer follows in lieu of the Nasdaq corporate governance requirement(s), either on its website or in its annual filings with the Commission. A description of the significant ways in which the Registrant’s corporate governance practices differ from those followed by domestic companies pursuant to the applicable Nasdaq Listing Rules is disclosed on the Registrant’s website at https://investor.draganfly.com/governance-documents/ under “Nasdaq Home Country Practice”.

UNDERTAKING

The Registrant undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to: the securities registered pursuant to Form 40-F; the securities in relation to which the obligation to file an Annual Report on Form 40-F arises; or transactions in said securities.

CONSENT TO SERVICE OF PROCESS

The Registrant filed an Appointment of Agent for Service of Process and Undertaking on Form F-X with the Commission on July 21, 2021 with respect to the class of securities in relation to which the obligation to file this Annual Report on Form 40-F arises.

Any change to the name or address of the Registrant’s agent for service of process shall be communicated promptly to the Commission by an amendment to the Form F-X referencing the file number of the Registrant.

8

EXHIBIT INDEX

Exhibit No.	Title of Exhibit
99.1	Annual Information Form of the Registrant for the year ended December 31, 2022
99.2	Audited Consolidated Financial Statements of the Registrant for the years ended December 31, 2022 and 2021, together with the Auditors’ Report thereon
99.3	Management’s Discussion and Analysis of the Registrant for the year ended December 31, 2022
99.4	Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the United States Securities Exchange Act of 1934
99.5	Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the United States Securities Exchange Act of 1934
99.6	Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the United States Sarbanes Oxley Act of 2002
99.7	Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the United States Sarbanes Oxley Act of 2002
99.8	Consent of Independent Registered Public Accounting Firm – Dale Matheson Carr-Hilton Labonte LLP (PCAOB ID: 1173)
101	The following materials from the Company’s Annual Report on Form 40-F for the fiscal year ended December 31, 2022, formatted in eXtensible Business Reporting Language (XBRL):
	(i)	Consolidated Balance Sheets as of December 31, 2022 and 2021;
	(ii)	Consolidated Statements of Operations for the years ended December 31, 2022 and 2021;
	(iii)	Consolidated Statements of Comprehensive Loss for the years ended December 31, 2022 and 2021;
	(iv)	Consolidated Statements of Changes in Stockholders’ Equity for the years ended December 31, 2022 and 2021;
	(v)	Consolidated Statements of Cash Flows for the years ended December 31, 2022 and 2021; and
	(vi)	Notes to Consolidated Financial Statements
104	Cover Page Interactive Data File (formatted as Inline eXtensible Business Reporting Language (iXBRL) and contained in Exhibit 101)

9

SIGNATURES

Pursuant to the requirements of the Exchange Act, the Registrant certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Draganfly Inc.
	By:	/s/ Paul Sun
	Name:	Paul Sun
	Title:	Chief Financial Officer
Date: March 27, 2023

10

EX-99.1

Exhibit 99.1

ANNUAL INFORMATION FORM

FOR THE FINANCIAL YEAR ENDED

DECEMBER 31, 2022

March 27, 2023

TABLE OF CONTENTS

ADVISORIES	1
GLOSSARY OF TERMS	4
CORPORATE STRUCTURE	6
GENERAL DEVELOPMENT OF THE BUSINESS OF THE COMPANY	7
THE ONGOING BUSINESS OF THE COMPANY	12
RISK FACTORS	21
DESCRIPTION OF CAPITAL STRUCTURE	38
MARKET FOR SECURITIES	39
ESCROWED SECURITIES	40
DIVIDENDS	41
DIRECTORS AND OFFICERS	41
AUDIT COMMITTEE	44
LEGAL PROCEEDINGS AND REGULATORY ACTIONS	45
INTERESTS OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS	46
AUDITOR, TRANSFER AGENT AND REGISTRAR	46
MATERIAL CONTRACTS	46
INTERESTS OF EXPERTS	46
ADDITIONAL INFORMATION	46
SCHEDULE
A – AUDIT COMMITTEE CHARTER

ADVISORIES

In this Annual Information Form (“AIF”), unless otherwise specified or if the context otherwise requires, references to “we”, “us”, “our”, “its”, “the Company” or “Draganfly” mean Draganfly Inc. The information in this AIF is stated as at December 31, 2022 unless otherwise indicated. For additional information and details, readers are referred to the audited consolidated financial statements for the year ended December 31, 2022 and notes that follow, as well as the accompanying annual Management’s Discussion and Analysis (“MD&A”), which are available on the Canadian Securities Administrator’s SEDAR System at www.sedar.com and on the SEC’s EDGAR system at www.sec.gov.

Cautionary Statement Regarding Forward-Looking Information and Statements

This AIF contains forward-looking information and statements (collectively, “forward-looking statements”). These forward-looking statements relate to Draganfly’s current expectations, estimates and projections as to future events or Draganfly’s future performance and are provided to allow readers a better understanding of Draganfly’s business and prospects and may not be suitable for other purposes. All statements, other than statements of historical fact, may be considered forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “plan”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “predict”, “potential”, “targeting”, “intend”, “could”, “might”, “should”, “believe” and similar expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in, or suggested by, such forward-looking statements. Draganfly believes the expectations reflected in the forward-looking statements included in this AIF are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements should not be unduly relied upon. These statements speak only as of the date of this AIF and are expressly qualified, in their entirety, by this cautionary statement. Draganfly assumes no obligation to revise or update these statements except as required pursuant to applicable securities laws.

In particular, this AIF contains forward-looking statements pertaining to the following:

● the intentions, plans and future actions of the Company;

● statements relating to the business and future activities of the ‎Company;

● anticipated developments in operations of the Company;

● market position, ability to compete and future ‎financial or operating performance of the Company;

● the timing and amount of funding required to execute the ‎Company’s business plans;

● capital expenditures;

● the effect on the Company of any changes to existing or new ‎legislation or policy or government regulation;

● ‎the availability of labour;

● requirements for additional capital;

● goals, strategies and future ‎growth;

● the adequacy of financial resources;

● expectations regarding revenues, ‎expenses and anticipated cash needs‎; and

● ‎the impact of the COVID-19 pandemic on the business and operations of the Company.

With respect to forward-looking statements contained in this AIF, the Company has made assumptions regarding, among other things:

● the Company’s ability to implement its growth strategies;

● the Company’s competitive advantages;

● the development of new products and services;

● the Company’s ability to obtain and maintain financing on acceptable terms;

● the impact of competition;

● changes in laws, rules and regulations;

● the Company’s ability to maintain and renew required licences;

Draganfly Inc. | Annual Information Form          Page 1

● the Company’s ability to maintain good business relationships with its customers, distributors, suppliers and other strategic partners;

● the Company’s ability to protect intellectual property;

● the Company’s ability to manage and integrate acquisitions;

● the Company’s ability to retain key personnel; and

● the absence of material adverse changes in the industry or Canadian or global economy, including as a result of the COVID-19 pandemic.

The Company’s actual results could differ materially from those anticipated in the forward-looking statements as a result of the risk factors set forth below and elsewhere in this AIF:

● a history of losses;

● dilution as a result of future sale of Common Shares;‎

● increased research and development costs and reduced profitability as a result;‎

● lack of outside funding available for research and development;‎

● adoption of new business models could fail to produce any financial returns;‎

● operational risks;

● evolving market and difficulty of evaluation future prospects;‎

● competition in the industry;

● rapid technological change in the industry‎; ‎

● failure to obtain or maintain required regulatory approvals‎;

● shipping products outside of Canada and approvals required for exporting;‎

● regulatory regime the Company operates in;‎

● risk associated with acquisitions;‎

● reliance on management and key employees;‎

● growth in the number of personnel straining resources;‎

● uncertainty and adverse changes in the economy;‎‎

● market-based financial risks associated with its operations;‎

● risks related to COVID-19‎ pandemic;‎

● the conflict between Russia and Ukraine;

● negative macroeconomic and geopolitical trends;

● risks associated with foreign operations in other countries‎;

● Canadian tax risks;‎

● supply chain risks;‎

● weather-related risks on products;‎

● products may be subject to the recall or return;‎

● having defective products‎;‎‎

● negative consumer perception;

● failure to adequately market products;

● electronic communication security risks;‎

● ‎‎possibility of data breaches and inadequacy of consumer protection and data privacy policies;‎

● reliance on business partners‎;

● failure to protect and maintain and the consequential loss of intellectual property rights‎;

● obtaining and maintaining the Company’s patent protection;

● potential litigation;‎

● intellectual property rights protection;‎

● failure to adhere to financial reporting obligations and other public company ‎requirements;‎

● limited operating experience as a publicly traded company in the U.S;‎

● goodwill and other intangible assets comprising of significant portion of value; ‎

● directors and officers conflicts of interest;‎

● high level of price and volume volatility in the capital markets‎;

● lack of active trading market on ‎‎the CSE and/or the Nasdaq;

● no dividends for the foreseeable future‎;‎

Draganfly Inc. | Annual Information Form          Page 2

● United States investors may not be able to obtain enforcement of civil liabilities against us;‎

● emerging growth company making Company ‎less attractive to ‎investors;

● increased costs as a result of operating as a public company in the United States;‎

● limited publicly available information relative to U.S. domestic issuers given classification as a foreign private issuer; and

● the other factors considered under “Risk Factors” in this AIF and other filings made by the Company with Canadian and U.S. securities authorities.

The Company has included the above summary of assumptions and risks related to forward-looking statements contained in this AIF in order to provide investors with a more complete perspective on the Company’s current and future operations and such information may not be appropriate for other purposes.

Additional information on these and other factors is available in the reports filed by the Company with Canadian securities regulators and available on SEDAR (as defined herein) and with the U.S. Securities and Exchange Commission (the “SEC”) and available on EDGAR (as defined herein). The forward-looking statements and information contained in this AIF are made as of the date hereof.

Readers are cautioned that the preparation of financial statements in accordance with generally accepted accounting principles in Canada requires management to make certain judgments and estimates that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates may change, having either a negative or positive effect on net earnings as further information becomes available and as the economic environment changes. The information contained in this AIF, including the documents incorporated by reference herein, identifies additional factors that could affect the operating results and performance of the Company. Readers are encouraged to carefully consider such factors.

Readers are also cautioned against placing undue reliance on forward-looking statements, which are given as of the date expressed in this AIF, or the MD&A disclosure incorporated by reference herein, and not to use future-oriented information or financial outlooks for anything other than their intended purpose. The forward-looking statements contained herein are expressly qualified in their entirety by this cautionary statement. The Company undertakes no obligation to publicly update or revise any forward-looking statements in this AIF or the MD&A or other disclosure incorporated by reference herein, whether as a result of new information, future events or otherwise, except as required by law.

Non-IFRS Measures

The Company prepares and reports its consolidated financial statements in accordance with IFRS (as defined herein). However, this AIF may make reference to certain non-IFRS measures including key ‎performance indicators used by management. These measures are not recognized measures under IFRS ‎and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable ‎to similar measures presented by other companies. Rather, these measures are provided as additional ‎information to complement those IFRS measures by providing further understanding of the Company’s results of ‎operations from management’s perspective. Accordingly, these measures should not be considered in ‎isolation nor as a substitute for analysis of the Company’s financial information reported under IFRS. The ‎Company uses non-IFRS measures including “gross margins” and “working capital” which may be calculated ‎differently by other companies. These non-IFRS measures and metrics are used to provide investors with ‎supplemental measures of the Company’s operating performance and liquidity and thus highlight trends in the Company’s ‎business that may not otherwise be apparent when relying solely on IFRS measures. The Company also ‎believes that securities analysts, investors and other interested parties frequently use non-IFRS measures ‎in the evaluation of companies in similar industries. Management also uses non-IFRS measures and ‎metrics in order to facilitate operating performance comparisons from period to period, to prepare ‎annual operating budgets and forecasts and to determine components of executive compensation. For ‎definitions and reconciliations of these non-IFRS measures to the relevant reported measures, please ‎‎see ‎the “Non-GAAP Measures and Additional GAAP Measures”‎ section of the MD&A. A copy of the MD&A can be accessed ‎under the Company’s ‎profile on SEDAR at www.sedar.com‎ and on EDGAR at www.sec.gov.

Draganfly Inc. | Annual Information Form          Page 3

Market, Independent Third Party and Industry Data

Unless otherwise indicated, the Company has obtained the market and industry data contained in this AIF from its internal research, management’s estimates and third-party public information and other industry publications. While the Company believes such internal research, management’s estimates and third-party public information is reliable, such internal research and management’s estimates have not been verified by any independent sources and the Company has not verified any third party public information. While the Company is not aware of any misstatements regarding the market and industry data contained in this AIF, such data involves risks and uncertainties and are subject to change based on various factors, including those described under “Cautionary Statement Regarding Forward-Looking Information and Statements” and “Risk Factors”.

Monetary References

Except as otherwise indicated, all dollar amounts in this AIF are expressed in Canadian ‎dollars and references to $ are to Canadian dollars. References to US$ are to United States dollars‎.

GLOSSARY OF TERMS

In this AIF, unless otherwise indicated or the context otherwise requires, the following terms shall have the indicated meanings. Words importing the singular include the plural and vice versa and words importing any gender include all genders. A reference to an agreement means the agreement as it may be amended, supplemented or restated from time to time.

“affiliate” or “associate” when used to indicate a relationship with a person or company, has the meaning set forth in the Securities Act (British Columbia), as amended, including the regulations promulgated thereunder;

“ATM Shares” has the meaning set out under the heading “General Development of the Business of the Company – Three Year History – January 1, 2023 to Effective Date”;‎

“BCBCA” means the Business Corporations Act (British Columbia), as amended, including the regulations promulgated thereunder;

“Board of Directors” or “Board” means the board of directors of the Company, as constituted from time to time, including, where applicable, any committee thereof;

“Canadian Securities Laws” means the securities legislation and regulations, and the instruments, policies, rules, orders, codes, notices and interpretation notes, of the securities regulation authorities of any applicable jurisdiction, or jurisdictions collectively, in Canada, as well as of the applicable stock exchanges (including the CSE);

“CAGR”‎ means compound annual growth rate;

“CARs” has the meaning set out under the heading “The Ongoing Business of the Company – Regulatory Framework”;

“CIPO” means the Canadian Intellectual ‎Property Office;

“Coldchain” means Coldchain Technology Services, LLC;

“Common Shares” means the common shares without par value in the capital of the Company;

Draganfly Inc. | Annual Information Form          Page 4

“Company” or “Draganfly” means Draganfly Inc.;

“Consolidation” has the meaning set out under the heading “General Development of the Business of the Company – Three Year History – Financial year ended December 31, 2021”;‎

“CSE” means the Canadian Securities Exchange;

“DAC” has the meaning set out under the heading “Corporate Structure – Name, Address and Incorporation”;

“DDL” means Digital Dreams Labs, Inc.;

“Draganfly Innovations” means Draganfly Innovations Inc., a wholly-owned subsidiary of the Company;

“Draganfly Innovations USA” means Draganfly Innovations USA Inc., a wholly-owned subsidiary of the Company;

“Dronelogics” means Dronelogics Systems Inc., a wholly-owned subsidiary of the Company;

“EDGAR” means the Electronic Data Gathering, Analysis, and Retrieval system of the SEC;

“Effective Date” means the effective date of this AIF, being March 27, 2023;

“FAA” means Federal Aviation Administration;

“Former Draganfly” has the meaning set out under the heading “Corporate Structure – Name, Address and Incorporation”;

“Former Draganfly Shares” has the meaning set out under the heading “General Development of the Business of the Company – Three Year History – Financial year ended December 31, 2019”;‎

‎”IFRS” ‎means International Financial Reporting Standards as issued by the International Accounting Standards Board, as adopted ‎by the Canadian Accounting Standards Board‎;

“ILS” means Integrated Launcher Solutions, Inc.;

“Global UAV Subsidiaries” has the meaning set out under the heading “General Development of the Business of the Company – Three Year History – Financial year ended December 31, 2021”;‎

“ITAR” means International Traffic in Arms Regulations;

“Nasdaq” means the Nasdaq Capital Market;

“NI 51-102” means National Instrument 51-102 – Continuous Disclosure Obligations of the Canadian Securities Administrators;

“NI 52-110” means National Instrument 52-110 – Audit Committees of the Canadian Securities Administrators;

“NPA” has the meaning set out under the heading “The Ongoing Business of the Company – Regulatory Framework”;

“OTCQB” means the middle tier of the United States Over-the-Counter market;

Draganfly Inc. | Annual Information Form          Page 5

“Preferred Shares” has the meaning set out under the heading “Corporate Structure – Name, Address and Incorporation”;

“Regulation A+ Offering” has the meaning set out under the heading “General Development of the Business of the Company – Three Year History – Financial year ended December 31, 2020”;‎

“RPAS” means remotely piloted aircraft systems;

“SEDAR” means the System for Electronic Document Analysis and Retrieval;

“SFOC” has the meaning set out under the heading “The Ongoing Business of the Company – Regulatory Framework”;

“Small RPAS Advanced” has the meaning set out under the heading “The Ongoing Business of the Company – Regulatory Framework”;

“Small RPAS Basic” has the meaning set out under the heading “The Ongoing Business of the Company – Regulatory Framework”;

“sUAS” means small unmanned aircraft systems;

‎”UAV” means unmanned aerial vehicles;

“US Offering” has the meaning set out under the heading “General Development of the Business of the Company – Three Year History – Financial year ended December 31, 2021”;‎

“U.S. Prospectus Supplement” has the meaning set out under the heading “General Development of the Business of the Company – Three Year History – January 1, 2023 to Effective Date”;‎

“USPTO” means United States Patent and ‎Trademark Office;

“UVS” means unmanned vehicle systems;

“Valqari” means Valgari LLC;

“Vital” means Vital Intelligence Inc; and

“Vital APA” has the meaning set out under the heading “General Development of the Business of the Company – Three Year History – Financial year ended December 31, 2021.

CORPORATE STRUCTURE

Name, Address and Incorporation

‎The Company was incorporated as Drone Acquisition Corp. (“DAC”) under the BCBCA on June 1, 2018 for the purpose of reorganizing and recapitalizing the business of Draganfly Innovations Inc. (“Former Draganfly”)‎. Effective July 17, 2019, the Company amended its articles to ‎remove various classes of authorized but unissued preferred shares and replace them with only one class of preferred ‎shares (the “Preferred Shares”). Effective August 15, 2019, the Company changed its name to “Draganfly Inc.” On August 22, 2019, the Company amended its articles to re-designate its Class A Common Shares as Common ‎Shares‎.

The Company’s head office is located at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7, and the registered office is located at Suite 2800, Park Place, 666 Burrard Street, Vancouver, British Columbia V6C 2Z7.

Draganfly Inc. | Annual Information Form          Page 6

Intercorporate Relationships

The following chart shows the Company’s subsidiaries as at the Effective Date:‎

GENERAL DEVELOPMENT OF THE BUSINESS OF THE COMPANY

Founded in 1998, Former Draganfly is recognized as one of the first commercial multi-rotor manufacturers and has a legacy for its innovation and superior customer service. Zenon Dragan is the founder of Former Draganfly, and is a recognized leading expert on UAV.

Former Draganfly introduced its first systems in 1999 and since evolved and shaped the UAV industry. The company’s aircraft are widely used by public safety agencies worldwide and were one of the first UAV to receive a FAA Certificate of ‎‎Authorization the fall of 2009 with the Mesa County Colorado Sheriff’s Office. In 2012, the Royal Canadian Mounted Police flew one of the company’s drones to locate and save the life of an accident victim. Draganfly aircraft have achieved many industry firsts, including:

● one of the first public safety UAV to shoot aerial photos documenting a manned aircraft accident in an urban area;

● one of the first UAV operated by a public safety organization flown at night to locate and save a life;

● one of the first UAV helicopter to be granted a county wide U.S. FAA Certificate of ‎‎Authorization;

● one of the first to have a drone included in the Smithsonian National Air and Space Museum;

● named as a test platform at one of the U.S. FAA’s certified test sites; and

● four of the first six compliance certifications for its products issued by Transport ‎Canada.

Three Year History

A detailed description on the significant developments of the business of the Company over the last three completed financial years is set out below.

Financial year ended December 31, 2020

On January 9, 2020, the Company completed the listing of its Common Shares for trading ‎on the OTCQB tier of the OTC Markets under the symbol “DFLYF”.

On March 26, 2020, the Company announced that it had been selected as the exclusive global systems integrator for a project with Vital Intelligence Inc., a healthcare data services and deep learning company in conjunction with the University of South Australia, using technology developed with help from the Australian Department of Defence Science and Technology Group.

Draganfly Inc. | Annual Information Form          Page 7

On April 30, 2020, the Company completed the acquisition of all of the shares of Dronelogics Systems Inc. for a purchase price of $2,000,0000 paid by way of a cash payment of $500,000 and 3,225,438 Common Shares at a deemed price of $0.50 per Common Share. In connection with the acquisition, Justin Hannewyk, President of Dronelogics, was appointed to the Board.

‎On June 18, 2020, the Company announced that John M. Mitnick was appointed to the Board.

On July 3, 2020, the Company announced that Scott Larson, a director of the Company, was appointed President of the Company.

On July 6, 2020, Draganfly completed a non-brokered private placement of 961,538 Common Shares at a price of $0.52 per Common Share for gross proceeds of $500,000.

On July 16, 2020, Draganfly completed a shares for debt transaction for payment of a third party strategic vendor’s invoices. Draganfly issued an aggregate of 555,409 Common Shares at a deemed price of $0.55 per Common Share to settle $305,475.03 of outstanding debt.

On November 10, 2020, the Company announced that its wholly-owned subsidiary Dronelogics, entered into lease agreements with the wholly-owned subsidiaries of Global UAV Technologies, Pioneer Arial Surveys Ltd. and High Eye Aerial Imaging Inc. (the “Global UAV Subsidiaries”), pursuant to which Dronelogics will lease all of the assets of the Global UAV Subsidiaries with an exclusive option to purchase the assets at any time during the term of the lease agreements. Pursuant to the lease agreements, Dronelogics paid an initial deposit of $50,000 upon signing and will pay four quarterly lease payments to each of the Global UAV Subsidiaries for an aggregate amount of $31,500 per quarter (for a total amount of $126,000 during the term of the lease agreements). In the event the Company exercises the option, it is required to pay the remainder of the lease payments outstanding as well as $220,000 in Common Shares based on a 30 day volume weighted average price per Common Share following the execution of the lease agreements, for aggregate consideration of $396,000. On ‎January 28‎, 2021, the Company notified the Global UAV Subsidiaries that it would be terminating the lease ‎agreements and no longer pursuing this transaction.‎

On December 2, 2020, the Company announced that it had completed an initial closing of its Regulation A+ offering of units of the Company (the “Regulation A+ Offering”). The Company issued 2,556,496 units at price of US$0.47 per unit for gross proceeds in the amount of US$1,201,553 in the first closing. Each unit is comprised of one Common Share and one Common Share purchase warrant, with each warrant entitling the holder to acquire one Common Share at a price of US$0.71 per Common Share until November 30, 2022. The Common Shares and Warrants issued in connection with the offering are subject to a nine month hold period which will expire on August 30, 2021.

On December 22, 2020, the Company announced that it had been selected by Coldchain Technology Services, LLC (“Coldchain”) to immediately develop and provide flight services of a robust vaccine delivery payload for use in critical regions for drone delivery of the COVID-19 vaccine.

Financial year ended December 31, 2021

On January 6, 2021, the Company announced the awarding of a new patent for a vertical take-off and landing (VTOL) cargo delivery drone with variable center of gravity.

On January 21, 2021, the Company announced that it had been selected to provide engineering and development services for a drone-based air support defense system for Integrated Launcher Solutions Inc. (“ILS”). The Company entered into a memorandum of understanding with ILS with the objective to create the terms and conditions surrounding a project management and development agreement for the production of ILS’s multi-launching air support defence system.

Draganfly Inc. | Annual Information Form          Page 8

On March 2, 2021, the Company announced that it will be the exclusive supplier of drones to Woz ED’s drone program across its ‎national K-12 curriculum with the expected deployment of approximately 3000 drones in ‎‎2021‎. The Company entered into a memorandum of understanding with Woz ED with the objective to create the terms and conditions surrounding a business agreement. The memorandum of understanding automatically terminates after 60 days; however, the Company anticipates entering into a definitive agreement with Woz ED during the third quarter of 2021.

On March 9, 2021, the Company announced that it had completed the final closing of the Regulation A+ Offering. The Company issued 32,443,457 units at price of US$0.47 per unit for gross proceeds in the amount of approximately US$15.3 million in the final closing. Each unit is comprised of one Common Share and one Common Share purchase warrant, with each warrant entitling the holder to acquire one Common Share at a price of US$0.71 per Common Share for a period of two years from the date of issuance. The Common Shares and Warrants issued in connection with the offering are subject to a nine month hold period.

On March 9, 2021, the Company also announced that it has entered into an asset purchase agreement with Vital Intelligence Inc. (“Vital”) to purchase all the assets of Vital in consideration for: (a) a cash payment of $500,000 with $50,000 paid upon execution of the asset purchase agreement, $200,000 to be paid at closing and $250,000 to be paid on the six-month anniversary date of closing; and (b) 1,200,000 units (on a post-Consolidated basis) of the Company with each unit being comprised of one common share of the Company and one common share purchase warrant (the “Vital APA”). Each warrant will entitle the holder to acquire one common share for a period of 24 months following closing at an exercise price of $2.67 per common share and the Company will be able to accelerate the expiry date of the warrants after one year in the event the underlying common shares have a value of at least 30% greater than the exercise price of the warrants. The units will be held in escrow following closing with 300,000 units (on a post-Consolidated basis) being released at closing and the remainder to be released upon the Company reaching certain revenue milestones received from the purchased assets. The Company completed the acquisition on March 25, 2021. As of the Effective Date, the revenue milestone targets attributable to the purchased assets under the Vital APA were not met, and accordingly, the Company will cancel the 900,000 units (calculated on a post-Consolidated basis).

On March 23, 2021, the Company announced that it signed a services deal to deploy EagleEye™ AI flight services with Windfall Geotek Inc. Windfall Geotek Inc. contractually agreed to have Draganfly provide $1,000,000 in flight services over the course of the next year with $500,000 already directly funded and allocated.

On May 13, 2021, the Company announced that it entered into a definitive agreement with Coldchain to develop, deploy and operate solutions for the delivery of medical supplies, medicine, and vaccines. The definitive agreement provides for phase one of a planned five-phase roll-out for the comprehensive development, deployment, and operation of a medical drone delivery service prototype as well as the development of a solution for the timely delivery of medical supplies, medicine, and vaccines. Phase one will also include working with various regulatory bodies, including the FAA, to obtain licenses and approvals for initial non-commercial beta test delivery routes. The Company has agreed Phase one has a value of US$125,000, which will be paid by ColdChain over a maximum of 10 months and the parties have agreed to negotiate an extension to the definitive agreement for phase two prior to the expiry of phase one. Under phase two, Coldchain will commit to purchasing no less than US$625,000 in equipment and services from Draganfly.

On May 19, 2021, the Company announced that it signed a contract with ILS for the development, prototyping, and eventual production of a non-lethal 40 mm ‎multi-‎launching systems that can be mounted and deployed from drones, drone systems, robots, ‎robotic systems, and other stationary platforms or similar systems. As part of the contract, Draganfly has provided ILS with strategic vendor financing of US$150,000 to assist in the development of the project and in consideration ILS has granted Draganfly a worldwide royalty equal to 8% of the gross revenue received from the project for a period of five years from earlier of the repayment date or maturity date of the loan. The loan is secured against the intellectual property related to the project.

On July 22, 2021, the Company announced the expected listing of its Common Shares on the Nasdaq, subject to meeting the final listing requirements of the Nasdaq.

On July 27, 2021, the Company announced that in connection with the proposed listing of the Common Shares on the Nasdaq, the Company will consolidate its Common Shares effective July 29, 2021 (the “Consolidation”) on a basis of one new Common Share for every five then issued and outstanding Common Shares under a new CSE stock symbol “DPRO”.

Draganfly Inc. | Annual Information Form          Page 9

On July 29, 2021, the Company announced that its application to list its Common Shares on the Nasdaq was approved by The Nasdaq Stock Market LLC and the Common Shares began trading on July 30, 2021 under the ticker “DPRO”.

On August 3, 2021, the Company announced that it completed an underwritten public offering in the United States (the “US Offering”) of 5,000,000 post-Consolidation Common Shares at a price of US$4.00 per Common Share, for total gross proceeds of approximately US$20,000,000, before deducting underwriting discounts and expenses of the US Offering. ThinkEquity, a division of Fordham Financial Management, Inc., acted as sole book-running manager for the US Offering.

On August 12, 2021, the Company announced that it launched its new, North American designed and built, Draganflyer Commander2 drone system. The Draganflyer Commander2 is a small Unmanned Aerial System (sUAS) and replaced the Company’s Commander platform launched in 2015.

On September 9, 2021, the Company announced that Julie Myers Wood was appointed to the Board and that Justin Hannewyk resigned from the Board.

On September 15, 2021, the Company announced that the over-allotment option granted to the underwriters in connection with the US Offering was exercised in respect of 95,966 post-Consolidation Common Shares. The exercise of the over-allotment at US$4.00 per Common Share produced additional gross proceeds of US$383,864, bringing the aggregate gross proceeds to Draganfly under the US Offering to US$20,383,864, before deducting underwriting discounts and expenses of the US Offering.

On September 22, 2021, the Company announced that it entered into an exclusive manufacturing agreement with Valqari LLC (“Valqari”) to produce Valqari’s Drone Delivery Stations. As per the manufacturing agreement, Draganfly will be the exclusive manufacturer of Valqari’s Drone Delivery Stations. Valqari will be ordering at least $400,000 of manufacturing services during the initial phase of the agreement. As of the Effective Date, Valqari has not placed any orders under this manufacturing agreement.

On October 12, 2021, the Company announced that it signed a minimum $9 million manufacturing agreement with Digital Dream Labs, Inc. (“DDL”) to design and develop an AI consumer companion robot drone. As per the terms of the agreement, Draganfly will be the exclusive manufacturer and assembler of the drone. DDL will order at least 50,000 units annually with delivery starting in 2022 and it is entitled to royalty equal to eight percent of the aggregate invoiced amounts of products sold, shipped and/or provided to DDL or the Company to customers/retailers in either distribution channel, from time to time, less returns or credits actually taken for granted, customary trade discounts and markdown, and allowances with respect to the products. The drone will be integrated into DDL’s existing product family, including support, sales and distribution channels used for its other consumer robots. Draganfly has also been granted a right of first refusal to become the exclusive manufacturer and assembler of subsequent drone or UAV-based robots to be added to DDL’s product portfolio. The parties have entered into a binding letter agreement reflecting the above terms and will use commercially reasonable efforts to enter into a definitive agreement. The binding letter agreement will govern the relationship between DDL and Draganfly and there can be no assurance that a definitive agreement will be completed or entered into amongst the parties. As of the Effective Date, the Company and DDL have not entered into the definitive agreement and the initial order has not been fulfilled.

Financial year ended December 31, 2022

On March 22, 2022, the Company announced that it had received an order for the Company’s Medical Response and Search and Rescue Drones from Coldchain for immediate deployment with Revived Soldiers Ukraine. Draganfly provided an immediate combined total of 10 North American-made Medical Response and Search and Rescue Drones. In addition, Draganfly donated three drone systems to Revived Soldiers Ukraine. The total initial order size (subject to conditions) is up to 200 units.

On May 9, 2022, the Company announced that John M. Mitnick was appointed as Chairman of the Board, effective April 27, 2022.

Draganfly Inc. | Annual Information Form          Page 10

On May 9, 2022, the Company announced that Cameron Chell, Chief Executive Officer of the Company, was appointed as President of the Company, effective April 27, 2022.

On May 9, 2022, the Company announced that Scott Larson would be stepping down as Interim President and appointed as Lead Director effective April 27, 2022.

On May 9, 2022, the Company announced that Paul Mullen, Vice President of Draganfly’s Vital Intelligence Group, was appointed as Chief Operating Officer of the Company, effective March 1, 2022 .

One June 1, 2022, the Company announced the launch of its new North American-made Heavy Lift and Commander 3 XL Drones. The Heavy Lift is capable of automated missions and manual flight operations with a payload capacity of 67 pounds. The Commander 3 XL is a high-endurance, weather-resistant, multirotor UAV that is designed for easy assemble and rapid deployment.

One June 7, 2022, the Company announced the launch of its new North American-made Long-range Light Detection and Ranging (“LiDAR”) system. The LiDAR system provides accurate distance measurements and improved resolution over conventional photogrammetry methods.

One June 21, 2022, the Company announced that Alabama State University (ASU) was offering the Draganfly Drone Technology Course through ASU’s Division of Continuing Education. The program provides an introduction to unmanned aerial vehicles (UAVs) and explores advanced topics including regulations, airspace operations, and navigation.

On August 1, 2022, the Company announced that Deborah R. Greenberg, was appointed as Chief Legal Officer of the Company, effective July 4, 2022. Her role was subsequently expanded to include the Human Resources and Information Technology functions as the Chief Legal and Corporate Services Officer, effective December 1, 2022.

On November 17, 2022, the Company announced DEF-C, a Ukrainian company involved in the civil and ‎defense sectors, had selected the Company as an exclusive provider of drones and related services.‎

On November 18, 2022, the Company announced the fulfillment of an additional order of 30 reconnaissance drones through its channel partner DEF-C, along with continued support from DroneAid. Draganfly’s drone technology is being deployed to provide valuable intelligence, surveillance, and reconnaissance information.On December 7, 2022, the Company announced the launch of the Draganfly UAS A.I.R. Space flight facility dedicated to the advancement of UAS program Adoption, Innovation & Research. The facility will provide a control site for the design, validation and optimization of standard operating procedures, sensor selection and data collection techniques.

January 1, 2023 to the Effective Date

On January 17, 2023, the Company announced Lufthansa Industry Solutions, an IT service provider and a ‎subsidiary of Lufthansa Group, has entered into a non-binding letter of intent with Draganfly to explore ‎providing its drone solutions and vital intelligence technology for use into its existing infrastructure and ‎customer solutions.‎

On January 31, 2023, the Company announced Remote Sensing Instruments, a longstanding Geospatial Technology company in India working in the field of Remote Sensing and Geographic Information System, has entered into a strategic agreement with the Company for the development of manufacturing, distribution, and sales of Draganfly products in India.

Draganfly Inc. | Annual Information Form          Page 11

On January 31, 2023, the Company entered into an equity distribution agreement with Maxim ‎Group LLC ‎dated January 31, 2023, pursuant to which the Company could, from time ‎to time, distribute in an ‎‎‎”at-the-market offering” of up to US$15 million in common ‎shares of the ‎Company (the ‎‎”ATM Shares”) in the United States only, on the Nasdaq.‎ The Offering is being made pursuant to a prospectus supplement dated January 31, 2023, ‎to the short form base shelf prospectus‎ dated July 14, 2021 ‎qualifying the distribution of the Offered Shares in each of the ‎provinces of ‎British Columbia, ‎Saskatchewan and Ontario, and a prospectus supplement to the ‎registration statement on Form F-10, as amended, that became ‎effective ‎on July 29, 2021 (File No. 3‎333-258074‎) ‎containing the Canadian base shelf prospectus ‎under the Multi-‎jurisdictional Disclosure System, registering the offer and sale of the ATM Shares under the United ‎States Securities Act of ‎‎1933, as amended (the “Securities Act”). To date,‎ the Company has distributed 650,729 ATM Shares under the Offering at an average price of ‎‎$2.62 per share for net proceeds of $1,705,013.‎

Significant Acquisitions During 2022

Draganfly did not complete any significant acquisitions during its most recently completed financial year for which disclosure is required under Part 8 of NI 51-102.

ThE ONGOING BUSINESS OF THE COMPANY

‎General

The Company is an award-winning, industry-leading manufacturer, contract engineering, and product development ‎company within the UAV space, serving the public safety, agriculture, industrial inspections, and mapping and surveying ‎markets. The Company is driven by passion, ingenuity, and the need to provide efficient solutions and first-class ‎services to its customers around the world with the goal of saving time, money, and lives. ‎

The business of the Company is conducted through three wholly-owned subsidiaries: (a) Draganfly Innovations Inc.; (b) ‎Draganfly Innovations USA Inc.; and (c) Dronelogics Systems Inc.

The business of Draganfly Innovations and Draganfly Innovations USA is the provision of engineering services and ‎manufacture of commercial UAV, RPAS, and ‎UVS and software, serving the public safety, agriculture, industrial inspections, and ‎mapping and surveying markets. ‎

‎Dronelogics is a solutions integrator for custom robotics, hardware and software that provides a wide scope of ‎services including sales, training, rentals, maintenance, flying and data processing services. ‎

Drone Industry Overview

Drones or UAV have rapidly evolved from a military origin to commercial and civil government ‎applications from security to farming. The increased automation of drones provides additional value to ‎existing workflows, triggering more widespread adoption. A global shift to sustainable and eco-friendly ‎options has further increased demand for drone usage.

Drone applications are being utilized in multiple industries on a global basis. A portion of manned ‎military aircraft (“MMA”) created the drone industry as a safe, inexpensive option. Defense will remain the ‎largest market over the foreseeable future. However, the mobile phone industry created an affordable ‎technology stack for drones. The ability to carry a camera enabled many people to utilize the platforms ‎for media production and beyond. That demand initiated in the consumer market and has migrated along ‎with technological advancements into the growth of commercial drone industry.‎

The major segments of the drone market are drone hardware, software and services. Drone hardware are ‎the physical goods, including drone platforms, aerial mobility platforms and components and systems. ‎The software segment includes flight planning, navigation and computer vision, unmanned traffic ‎management (“UTM”), fleet operations, ecosystems, networks and software development kits (“SDKs”). Drone ‎services include the provision of flight operations, data analysis and hardware repair and maintenance. Drone service providers ‎‎(“DSPs”) include system integrators, pilot training providers, retailers and marketplaces, coalitions and ‎organizations, drone test sites, insurance providers and university/educational facilities. The commercial drone industry has been growing rapidly in recent years, with drones becoming increasingly popular for a wide range of applications. From capturing aerial footage to conducting inspections of infrastructure, drones offer a cost-effective and efficient solution to a range of tasks. According to Teal Group, the global market for commercial drones is expected to reach $63.9 billion by 2030, with strong demand coming from industries such as agriculture, construction, and logistics.

Draganfly Inc. | Annual Information Form          Page 12

One of the biggest drivers of growth in the commercial drone industry is the availability of advanced technologies such as Artificial Intelligence (“AI”), machine learning, and computer vision. These technologies enable drones to perform a wide range of tasks that were previously difficult or impossible, such as automated inspections and precision agriculture. Additionally, the development of high-quality, lightweight sensors and cameras has made it possible to capture high-resolution images and video footage, in challenging environments.

Drone application methods are being used by a variety of industries today. There are approximately ‎eight methods that are garnering the most attention: mapping, surveying, inspection, ‎filming/photography, dispensing/spraying, warehousing, monitoring/detection, and delivery. These ‎applications are being used today by the civil government, educational facilities, agricultural, ‎construction, health care, real estate, energy, transportation, insurance, security, and scientific industries.

Products and Services

The Company can provide its customers with an entire suite of products and services that include: quadcopters, ‎‎fixed wing ‎aircrafts, ground based robots, handheld controllers, flight training, and software used for tracking, live ‎‎streaming, ‎and data collection. In addition, Draganfly has launched a health/telehealth platform. The initial focus ‎of the platform is a COVID-19 screening set of technologies that remotely detects a number of key COVID-19 ‎respiratory symptoms. The Company is also offering sanitary spraying services to indoor and outdoor public ‎gathering spaces such as sport stadiums and fields to provide additional protection against the spread of contagious ‎viruses such as COVID-19. ‎

Product sales and provision of services accounted for 73% and 27%, respectively, of revenues of Draganfly for the financial year ended December 31, 2022.

Draganfly Products

‎‎Manufactured Solutions

The Company is among the longest-running manufacturer of multirotor drones in the world. Draganfly’s drones include the following:

● Draganfly Commander 3XL - The Commander 3 XL Drone is a modular platform capable of carrying payloads of more than 20 pounds making it the ideal choice for industry leaders across a variety of major markets including public safety and agriculture.The Commander 3 XL Drone’s fuselage consists of a simple rectangular tube. Each component of the drone has been specifically designed to ensure the airframe can pack down into a transportable case.

● Draganfly Heavy Lift Drone - The Draganfly Heavy Lift Drone is a versatile, multi-rotor unmanned aerial vehicle (UAV), designed to enhance deliveries and flight times. Compatible with a variety of interchangeable payloads, this heavy-duty drone can carry more and fly longer. The DHL Drone can be configured to carry up to 67 pounds.

● Draganflyer Commander2 ‎– The Draganflyer Commander2 is a multi-mission, high-endurance, electric sUAS that ‎combines the signature design elements of our past Draganflyer systems with the most advanced features ‎to date. The Commander2 can be used for numerous applications across many industries including ‎agriculture, public safety, and aerial 3D modeling. Paired with powerful MAVLink-based flight planning ‎software, the Draganflyer Commander2 supports both fully- and semi-automated missions, as well as ‎manual flight operations with a pilot in the loop for a high level of system control to handle any ‎operational task‎.

Draganfly Inc. | Annual Information Form          Page 13

● Draganfly Medical Response – The Draganfly Medical Response Drone is an integrated solution that features a Draganfy Drone combined with a cold-chain logistics enclosure. This solution is able to provide first responders with visual oversight of a scene and ensures the timely delivery of temperature-sensitive medical supplies including blood, vaccines and test samples to dangerous or hard-to-reach areas.

● Draganfly Long Range LiDAR - Draganfly’s Long Range LiDAR (DLR- LiDAR) system provides accurate distance measurements and improved resolution over conventional photogrammetry methods. The cutting-edge sensor technology can be mounted on UAV, airplanes, and helicopters for those professionals requiring precision imagery.

● Tango2 – a high endurance, dual battery, sUAS capable of carrying a wide array of payload systems. The aircraft utilizes the Draganfly intelligent power management system to extend flight time while increasing safety. This sUAS is ideal for agricultural monitoring and research, mapping, surveying, environmental monitoring, and search and rescue.

Universal Control System

The Draganfly Universal Control System is a complete, handheld ground control system that is built to ‎integrate ‎with other software and hardware systems. The Draganfly Universal Control System is designed ‎to provide precise ‎control over sUAS helicopters, fixed-wing, and ground-based robots. Draganfly ‎software provides sophisticated ‎flight planning, automated takeoff, grid following, waypoints, landing, ‎data collection, and video downlink.‎

Software

The Draganfly Surveyor drone flight planning software is an intuitive, easy to use, application that ‎enables ‎customers to quickly plan, fly, and process meaningful data. Based on the project, camera type, ‎optics, and ‎altitude, the drone software determines the appropriate camera shutter interval, aircraft ‎speed, and flight plan to ‎capture the optimum required photo overlap to generate 2D and 3D maps and ‎models. The Draganfly Surveyor ‎directly integrates with Pix4Dmapper for survey-grade results and can ‎be used alongside other third-party ‎photogrammetry programs.‎

Vital Intelligence

The Draganfly Vital Intelligence platform is a touchless health ‎assessment system that leverages proprietary machine-vision methods to measure biometrics such as heart rate, oxygen saturation and blood pressure. Vital ‎Intelligence is a data platform that turns an existing camera into a touchless ‎ detection system. Draganfly integrates this technology into a ‎variety of ‎platforms and camera systems – both on the ground and in the air – to support use cases such as visitor intake and other general health and wellness applications.

‎ Draganfly Services

Custom Engineering

Draganfly is a contract engineering partner for government agencies, enterprise organizations, academic ‎institutions, ‎and businesses of all sizes. The Draganfly team’s truest capabilities are actualized during the ‎engineering process as ‎hardware designers, software designers, engineers, project managers, and ‎vertical-specific experts come together to ‎build custom drone solutions for its partners. Draganfly’s end-‎to-end engineering services include‎:

● Hardware design: Component, product, and system design;

Draganfly Inc. | Annual Information Form          Page 14

● Software design: Custom software and interface design;

● Development: Including integration with third party platforms, PixX4D, Pixhawk, Ardupilot, DJI ‎and ‎more‎;

● Modeling: 3D design and modeling of mechanical components;

● ITAR ‎(International Traffic in Arms Regulations) equipment management: Approved handling and integration ‎of ITAR, and Controlled Goods ‎technologies‎; and

● Support: Testing, training, documentation, and repairs.

Training

Draganfly offers custom-designed training packages that are tailored to specific operations and use ‎cases. The ‎Company also offers basic training for new UAV owners, up to advanced classes for users ‎who understand the ‎fundamentals and are looking for new ways to increase flight efficiency or comply ‎with federal regulations‎.

Flight Services

Draganfly has a team of qualified pilots that conduct flights on behalf of its customers. The team ‎specializes in ‎working with emergency services including police, fire, and search and rescue personnel. ‎Draganfly also supports ‎industrial applications, utility and power companies, environmental and ‎agricultural entities and others‎.

Geographic Information Systems (GIS) Data Services

Draganfly has a team of qualified GIS Data Specialists and Surveyors that support the delivery of services to clients in various markets. These services include the creation and maintenance of data sets of spatial analysis.

Spraying Services

Draganfly operates, in partnership with a leader in natural and organic disinfectants, to ‎administer a sanitization ‎spraying service in large public venues by misting a surface spray across the ‎entire venue in four to six hours.‎

Principal Markets

Draganfly has more than 20 years of experience designing and manufacturing professional drones for ‎military, ‎public safety, energy, agriculture, and insurance. Draganfly has sold products and services to a number of countries ‎but predominantly focuses on the North American market given its geographical ‎location.‎

Military and Government

Military and government contractors have partnered with Draganfly to improve personnel and infrastructure ‎‎safety. Draganfly works with partners to design and manufacture custom airframes, design and develop ‎payloads, ‎and manage complex flight operations. Draganfly team members hold advanced pilot ‎certificates and are ‎approved to fly in controlled airspace and at airports. Since the Company’s ‎development team is cleared by ‎Canada’s Controlled Goods Program, the team is permitted to handle ‎ITAR equipment and technologies, and the ‎Company’s facilities are built to protect those technologies ‎and ensure they are only handled by approved ‎personnel.‎

Draganfly Inc. | Annual Information Form          Page 15

Public Safety

In 2013, the Royal Canadian Mounted Police flew one of the Company’s drones to locate and save the life of an ‎accident victim, which we believe was one of the first times a public safety organization used a UAV to save a life. ‎Years later, the Company is still a ‎leader in using drone technology to keep the public safe. Draganfly works with its ‎partners to identify ‎unknowns, such as substances, spills, packages, and chemicals while not putting human lives at ‎risk‎. ‎Draganfly builds aerial and ground systems with custom payloads and sensors to scan scenes, survey ‎public ‎events, locate objects, and clear debris faster and more safely than on-the-ground manpower. The ‎Company also ‎empowers its partners to maximize existing infrastructures via custom API integrations ‎that ensure Draganfly’s ‎technology enhances their safety systems‎

Environmental and Energy

Draganfly offers a suite of commercial UAV solutions for energy companies and those servicing the ‎energy market, ‎like surveyors and consultants. Draganfly equips energy companies with the hardware ‎and software they need to ‎optimize existing operations, improve safety, and respond after a natural ‎disaster. Partners can use Draganfly ‎hardware and 3D modeling software to remotely inspect sites that ‎would put human lives at risk. They also conduct ‎environmental monitoring with Draganfly’s sample ‎collection solutions, assessing water and ground pollution, gas ‎composition, infrastructure, and other ‎environments.‎

Agriculture

Draganfly works with its partners to collect high-quality data, using multi- and hyper-spectral imaging, 3D ‎modeling, ‎and a suite of sophisticated sensor technology that assesses environmental factors. Seed ‎companies use Draganfly ‎technology to optimize growth season, measuring seed trial results throughout ‎the research and development ‎process. Farmers can use Draganfly flight and data collection services to ‎monitor hectares of land year-round, ‎assessing factors like fertilizer efficiency, weed production, and ‎more.

Operations

Canadian Operations

Draganfly Innovation Inc.’s products are manufactured at its machine shop within its leased head office ‎based in ‎Saskatoon, Saskatchewan, Canada. Draganfly Innovations Inc. operates the fully operational ‎facility located at ‎‎2108 St. George Avenue, Saskatoon, SK S7M 0K7. This facility is to be used only for ‎the purposes of Draganfly ‎Innovations Inc. operating its business of design, development, production, ‎distribution, sale and/or licensing of ‎drones or robots, or such other use as permitted by the landlord ‎from time to time. ‎

Dronelogics Systems Inc.’s products and services are provided through its leased space located at Unit 319, 2999 ‎‎Underhill Avenue, ‎Burnaby, British Columbia‎. ‎

‎United States Operations

‎The Company, through its wholly-owned subsidiary, Draganfly Innovations USA Inc., has a leased space in ‎Palm Beach ‎‎Gardens, Florida that currently stores some inventory for operations in the ‎United States. ‎

Draganfly Inc. | Annual Information Form          Page 16

Competitive Conditions

Although Draganfly is acknowledged as a drone industry pioneer that we believe was the first to develop the ‎commercial multi rotor ‎helicopter, there ‎are now many drone hardware companies in the world. As technology ‎has ‎improved ‎and costs for hardware and software have come down, the line between consumer and commercial ‎‎‎drones has blurred, enabling the rise of Prosumer drones. A prosumer drone is a drone is designed to satisfy elements of professional and consumer segments, often featuring integrated sensors designed to deliver a combination of performance and value with little ability to customize the drone for the required use-case Historically, Draganfly has serviced early adopters in the public safety industry. At ‎this stage of ‎‎the commercial drone adoption curve, the average public safety organization (local, ‎regional, and even federal law ‎‎enforcement, for example), has been introduced to drones through the adoption of Consumer and Prosumer platforms. Hence, these ‎organizations tend to use lower cost drones ‎‎that have become quite sophisticated that can accomplish ‎most of their use cases. The dominant companies in the ‎industry area Chinese drone manufacturers that ‎are reputed to own over 70% of the consumer and now commercial ‎drone ‎market. The majority of foreign manufactured ‎drones are geared towards broad applications involving the masses. Draganfly ‎has ‎moved away from ‎competing directly with these companies and in some cases sells these products through its subsidiary, ‎Dronelogics Systems Inc., or ‎has chosen to serve niche markets outside of where the foreign manufactured drones tends to ‎be. ‎There are also ‎some organizations that tend to be US based that either prefer or are mandated to not use ‎foreign ‎drones such as ‎those produced by China. Some of these organizations are sensitive to their work ‎being exposed to that ‎of overseas ‎governments which has at least for the time being, created a niche ‎market for players such as ‎Draganfly. The ‎combined shift away from foreign made drones (national security issues) and regulatory improvements by the FAA ‎in respect of drone usage is driving industry demand. As Draganfly has evolved to move with the industry trends, ‎the ‎Company now uses some third party hardware and software as part ‎of some of its customization and engineering services work. ‎Draganfly ‎has also moved into innovative engineering ‎procurement which is very specialized. As the drone industry matures, ‎this may bring more competitors to this space or ‎the ‎Company’s customers may choose to develop the in-house ‎expertise to do the work that they currently ‎‎outsource to Draganfly. However, it is the Company’s view that there ‎will be a growing customer base ‎that will ‎require specialized drone hardware, software and service solutions outside of the capabilities of the consumer & prosumer drone platforms that only a handful of companies can do.‎

The market remains highly competitive. Private equity continues to significantly capitalize drone start-ups at ‎industry high valuations. The publicly-traded companies in the drone segment trade at different valuations, with a ‎steep discount to private-equity backed ventures. Some of the other publicly traded companies we may compete ‎with include Alpine 4 Tech, Inc., Aerovironment Inc., EHang Holdings Limited, AgEagle, Drone Delivery Canada, ‎Inc., and Red Cat Holdings, Inc.‎

Regulatory Framework

A new regulatory framework relating to the use of drones in Canada was published by Transport ‎Canada ‎in ‎January 2019 and came into effect on June 1, 2019. The changes, published in the ‎Canadian Aviation ‎Regulations ‎‎(“CARs”), Part IX, introduce new rules based on the weight of the RPA and the intended ‎operation. This framework ‎creates three broad ‎categories of RPAS: (i) small RPAS in limited (low risk) ‎operations (“Small RPAS Basic”); (ii) ‎‎small RPAS in advanced (complex) operations (“Small RPAS ‎Advanced”); and (iii) all other RPA ‎operations that ‎fall outside (i) and (ii) above. These regulations focus ‎on foundational issues ‎such as aircraft marking and ‎registration, pilot knowledge and certification, ‎airworthiness of the ‎aircraft, and flight rules.‎

‎ Small RPAS Basic are defined as RPAS weighing between 250 grams and 25 kilograms and operated in ‎rural ‎and ‎unpopulated areas. These RPAS will require identification markings, including name, address ‎‎and contact ‎information of the owner and pilot of the RPA. Pilots must be at least 14 years of ‎age and ‎must hold a valid Basic ‎RPA licence that is specific to small drones. Additional ‎restrictions are imposed ‎that include that the RPA cannot ‎operate: (i) within approximately 30 meters of ‎people or open-air ‎assemblies of people, (ii) above 400 feet, (iii) ‎within approximately 1.85 kilometers of ‎heliports or (iv) ‎within approximately 5.5 kilometers of airports. These ‎regulations require the RPA to ‎always be operated ‎within visual line-of-sight.‎

Draganfly Inc. | Annual Information Form          Page 17

Small RPAS Advanced are defined as RPAS weighing between 250 grams and 25 kilograms and ‎operated in ‎urban ‎and/or populated areas. These RPAS will require identification, marking and ‎registration ‎with Transport Canada as ‎well as meeting specified design standards acceptable to ‎Transport ‎Canada. The RPA will be assigned a unique ‎identification/registration number issued by ‎Transport ‎Canada. Pilots must be at least 16 years of age and must ‎hold a valid Advanced RPAS licence ‎‎that is specific to small drones. Approval for operation must be granted by Air ‎Traffic Control ‎when ‎operating in controlled airspace or near controlled aerodromes. A set of flight rules must be ‎‎followed at ‎all times for these more complex operations. Restrictions, including distances from ‎people, are ‎‎determined based on the safety certification of the RPA being operated. The RPA ‎must always be ‎operated within ‎visual line-of-sight.‎

The current legislation utilizes a similar Special Flight Operations Certificate (“SFOC”) application ‎‎process, as the ‎previous regulations, to approve any operations that do not fit within the ‎regulatory ‎regime set out above, such as ‎operating beyond visual-line-of-sight. For those wishing ‎to operate ‎outside of the regulatory framework set out in ‎CARs, part IX, there will be a variety of ‎SFOC application ‎processes tailored to the nature and use of the RPA. The ‎more complex and ‎riskier the proposed ‎operation, the more thorough and detailed the SFOC application process.‎

‎ Those operators requiring an SFOC must apply to the Transport Canada Civil Aviation Regional ‎Office at ‎least 30 ‎working days prior to the date of the proposed RPAS operation. Transport ‎Canada has wide ‎discretion in reviewing ‎and approving SFOC applications; however, to date the ‎Company has never been ‎refused an SFOC for which it has ‎applied. The purpose of the SFOC ‎application review is to ensure that ‎the proposed operation is safe and associated ‎risks have ‎been adequately mitigated by the Company.‎

‎ ‎In April 2020, Transport Canada published a Notice of Proposed Amendment (defined herein as “NPA”) as the first ‎‎step in ‎the publication of new regulations for beyond visual line-of-sight operations. The NPA ‎provided a ‎synopsis ‎of the high-level policies Transport Canada is proposing to support beyond ‎visual line-of-sight ‎operations in lower ‎risk environments such as remote and isolated areas. ‎These new regulations will also ‎provide clear direction and ‎guidance on the use of heavier aircraft ‎‎(up to 650 kilograms), operations at ‎higher altitudes than currently permitted ‎in CARs, Part IX, and will ‎set the foundation for an operator ‎certification program. Once published, these ‎regulations will ‎permit routine beyond visual-line-of-sight ‎operations without the need for the Company to request ‎‎specific permission for each operation, as is ‎currently required with the current SFOC process. ‎ The first draft of ‎these regulations were expected to be published in Canada Gazette in Spring of 2021; however, as at the date of ‎this AIF, the first draft has not been published.

The Company is currently fully compliant with all current regulatory requirements and has applied ‎for, and ‎received ‎Transport Canada approval for several SFOCs.‎

Components

The Company obtains hardware components, various subsystems and systems, and raw materials from ‎a limited ‎group of suppliers. The Company does not have long-term agreements with any of these ‎suppliers that obligate ‎such suppliers to continue to sell components, subsystems, systems or products ‎to the Company. The Company’s ‎reliance on these suppliers involves significant risks and uncertainties, ‎including whether suppliers will provide an ‎adequate supply of required raw materials, components, ‎subsystems, or systems of sufficient quality, will increase ‎prices for the raw materials, components, ‎subsystems or systems, and will perform their obligations on a timely ‎basis. See “‎Risk Factors”.‎

Intangible Properties

Intangibles such as patents, software, specific technology know-how, and applications expertise all have a significant effect on the Company’s business. At present, drone delivery technology cannot be purchased as an off-the-shelf solution; therefore, the Company has been focused on developing proprietary technology which meets or exceeds anticipated Canadian government requirements. By virtue of being the first commercial ‎UAV company in the industry, the Company’s subsidiary, Draganfly Innovations, holds commercial patents. ‎

Draganfly Inc. | Annual Information Form          Page 18

As at the Effective Date, the Company has the following patents and patents pending in the application stage in its portfolio and intends to continue to expand and grow its intellectual property portfolio:

Title	Country	Application No.	Issue Date	Patent No.	Status
Multi Rotor UAV With Compact Folding Rotor Arms	Canada	2,917,434	4/23/2019	2,917,434	Issued
Vehicle with Aerial and Ground Mobility	Canada	2,787,279	10/22/2013	2,787,279	Issued
Vertical Takeoff and Landing Unmanned Aircraft System	Canada	2,935,793	1/15/2021	2,935,793	Issued
Wheel with Folding Segments	Canada	2,787,075	10/29/2013	2,787,075	Issued
Action Camera System for Unmanned Aerial Vehicle	United States	15/707,752	1/22/2019	10,187,580	Issued
Action Camera System for Unmanned Aerial Vehicle	United States	14/533,995	9/19/2017	9,769,387	Issued
Cascade Recognition for Personal Tracking via Unmanned Aerial Vehicle (UAV)	United States	14/642,370	7/18/2017	9,710,709	Issued
Cascade Recognition for Personal Tracking via Unmanned Aerial Vehicle (UAV)	United States	15/651,672	2/13/2018	9,892,322	Issued
Cascade Recognition for Personal Tracking via Unmanned Aerial Vehicle (UAV)	United States	15/894,292	10/8/2019	10,438,062	Issued
Dual Rotor Helicopter with Tilted Rotational Axes	United States	12/458,608	11/8/2011	8,052,081	Issued
Helicopter with Folding Rotor Arms	United States	13/200,825	10/23/2012	8,292,215	Issued
Multi Rotor UAV With Compact Folding Rotor Arms	United States	14/994,080	7/31/2018	10,035,581	Issued
Pixel Based Image Tracking System For Unmanned Aerial Vehicle (UAV) Action Camera System	United States	15/256,193	10/10/2017	9,785,147	Issued
Pixel Based Image Tracking System for Unmanned Aerial Vehicle (UAV) Action Camera System	United States	14/825,956	9/13/2016	9,442,485	Issued
Real Time Noise Reduction System for Dynamic Motor Frequencies Aboard an Unmanned Aerial Vehicle (UAV)	United States	14/642,496	11/8/2016	9,489,937	Issued
System and Method for Adaptive Y Axis Power Usage and Non Linear Battery Usage for Unmanned Aerial Vehicle Equipped with Action Camera System	United States	14/825,914	12/6/2016	9,511,878	Issued

Draganfly Inc. | Annual Information Form          Page 19

Tandem Wing Aircraft System with Shrouded Propeller	United States	15/584,815	8/13/2019	10,377,488	Issued
Vehicle with Aerial and Ground Mobility	United States	14/641,468	3/21/2017	9,598,171	Issued
Vehicle with Aerial and Ground Mobility	United States	13/846,074	3/31/2015	8,991,740	Issued
Vertical Take Off And Landing (VTOL) Aircraft Having Variable Center Of Gravity	United States	15/706,158	10/20/2020	10,807,707	Issued
Vertical Takeoff and Landing Unmanned Aircraft System	United States	15/164,718	8/28/2018	10,059,442	Issued
Visually Intelligent Camera Device with Peripheral Control Outputs	United States	14/939,369	8/6/2019	10,375,359	Issued
Wheel with Folding Segments	United States	13/739,419	6/17/2014	8,753,155	Issued

As at the Effective Date, the Company also has the following registered trademarks and pending applications‎:

Description	Name/Title	Official No.	Governmental Entity
Trademark Application (Status: Filed)	DRAGANFLY	1,972,336	CIPO
Registered Trademark	DRAGANFLYER EXPLORE	TMA1,025,742	CIPO
Registered Trademark	DRAGANFLYER APEX	TMA1,025,624	CIPO
Registered Trademark	DRAGANFLYER COMMANDER	TMA1,008,809	CIPO
Registered Trademark	DRAGANFUEL	TMA997,118	CIPO
Registered Trademark	DRAGANFLY INNOVATIONS	TMA908,564	CIPO
Registered Trademark	DRAGANFLYER	TMA906,939	CIPO
Registered Trademark	DRAGANFLY & DESIGN	TMA905,935	CIPO
Registered Trademark	DRAGANFLY	TMA1,071,582	CIPO
Registered Trademark	DRAGANFLY	TMA1,069,670	CIPO
Registered Trademark	DRAGANFLYER GUARDIAN	TMA904,883	CIPO
Registered Trademark	DRAGANVIEW	TMA886,217	CIPO
Registered Trademark	DRAGANFLYER APEX	6248237	USPTO
Registered Trademark	DRAGANFLY	6373176	USPTO
Registered Trademark	DRAGANFLYER COMMANDER	5760146	USPTO
Registered Trademark	DRAGANFUEL	5563360	USPTO
Registered Trademark	DRAGANFLY INNOVATIONS	5130969	USPTO
Registered Trademark	DRAGANFLYER	4920316	USPTO
Registered Trademark	DRAGANFLY & Design	5130970	USPTO
Registered Trademark	DRAGANFLYER GUARDIAN	4995725	USPTO
Registered Trademark	DRAGANVIEW	4920317	USPTO
Trademark Application2	DRAGANFLY	88488410	USPTO

Draganfly Inc. | Annual Information Form          Page 20

Specialized Skill and Knowledge

There is a specialized skill required for the development, operations, maintenance, sales and marketing ‎of the ‎Company’s technology. The Company’s current staff possesses the necessary skills and ‎knowledge required for the ‎Company’s business; however, additional employees may be added to staff ‎as needed. All operational staff hold ‎the appropriate licenses and certificate as mandated by Transport ‎Canada.‎

‎‎Changes to Contracts

No aspect of Draganfly’s business is anticipated to ‎be affected in the current financial year by renegotiation or ‎termination of any contract. ‎

Employees/Consultants

As at December 31, 2022 and as of the Effective Date, the Company had 55 employees (49 employees located in Canada and 6 employees located in the U.S.) and 5 full-time and part-time consultants whose services were, and continue to be, used on a regular basis for day-to-day operations.

Reorganizations

There have been no material reorganizations of the Company or any of its subsidiaries within the three most recently completed financial years or completed during or proposed for the current financial year.

RISK FACTORS

An investment in the Company’s common shares, without par value, (the “Common Shares”) is highly speculative and involves significant risks. In addition to the other ‎information contained in this AIF and the documents incorporated by ‎reference herein and therein, you should review and carefully consider the risks described herein. The risks described herein are not the only risk factors facing us and should not be ‎considered exhaustive. Additional risks and uncertainties not currently known to us, or that we currently ‎consider immaterial, may also materially and adversely affect our business, operations and condition, financial ‎or otherwise.‎

Risks Related to the Company, its Business and Industry

The Company has a history of losses.

The Company has incurred net losses since its inception. The Company cannot assure that it can become profitable or avoid net losses in the future or that there will be any earnings or revenues in any future quarterly or other periods. The Company expects that its operating expenses will increase as it grows its business, including expending substantial resources for research, development and marketing. As a result, any decrease or delay in generating revenues could result in material operating losses.

A shareholder’s holding in the Company may be diluted if the Company issues additional Common ‎Shares or other securities in the future.‎

‎The Company may issue additional Common Shares or other securities in the future, which may dilute a ‎shareholder’s holding in the Company. ‎The Company’s articles permit the issuance of an unlimited ‎number of Common Shares, and shareholders have no pre-emptive rights in connection with further ‎issuances of any securities. The directors of the Company have the discretion to ‎determine if an ‎issuance of Common Shares or other securities is warranted, the price at which any such securities are ‎issued and the other ‎terms of issue of Common Shares or securities. In addition, the Company may ‎issue additional Common Shares upon the exercise of incentive stock options to ‎acquire Common ‎Shares under its share compensation plan or upon the exercise or conversion of other outstanding convertible securities of the Company, which will result in further dilution to shareholders. In addition, ‎the issuance of Common Shares or other securities in any potential ‎future acquisitions, if any, may also ‎result in further dilution to shareholder interests.‎

Draganfly Inc. | Annual Information Form          Page 21

The Company expects to incur substantial research and development costs and devote significant resources to ‎identifying and commercializing new products and services, which could significantly reduce its profitability and ‎may never result in revenue to the Company.‎

‎The Company’s future growth depends on penetrating new markets, adapting existing products to new applications, ‎and introducing new products and services that achieve market acceptance. The Company plans to incur ‎substantial research and development costs as part of its efforts to design, develop and commercialize new ‎products and services and enhance its existing products. The Company believes that there are significant opportunities in a number of business areas. Because the Company accounts for research and development costs as ‎operating expenses, these expenditures will adversely affect its earnings in the future. Further, the Company’s ‎research and development programs may not produce successful results, and its new products and services may not ‎achieve market acceptance, create any additional revenue or become profitable, which could materially harm the ‎Company’s business, prospects, financial results and liquidity.‎

The Company’s adoption of new business models could fail to produce any financial returns.‎

‎Forecasting the Company’s revenues and profitability for new business models is inherently uncertain and ‎volatile. The Company’s actual revenues and profits for its business models may be significantly less ‎than the Company’s forecasts. Additionally, the new business models could fail for one or more of the ‎Company’s products and/or services, resulting in the loss of Company’s investment in the development and ‎infrastructure needed to support the new business models, and the opportunity cost of diverting management and ‎financial resources away from more successful businesses.‎

The Company will be affected by operational risks and may not be adequately insured for certain risks.‎

‎The Company will be affected by a number of operational risks and the Company may not be adequately insured ‎for certain risks, including: labour disputes; catastrophic accidents; fires; blockades or other acts of social activism; ‎changes in the regulatory environment; impact of non-compliance with laws and regulations; natural phenomena, ‎such as inclement weather conditions, floods, earthquakes and ground movements. There is no assurance that the ‎foregoing risks and hazards will not result in damage to, or destruction of, the Company’s technologies, personal ‎injury or death, environmental damage, adverse impacts on the Company’s operation, costs, monetary losses, ‎potential legal liability and adverse governmental action, any of which could have an adverse impact on the ‎Company’s future cash flows, earnings and financial condition. Also, the Company may be subject to or affected ‎by liability or sustain loss for certain risks and hazards against which the Company cannot insure or which the ‎Company may elect not to insure because of the cost. This lack of insurance coverage could have an adverse ‎impact on the Company’s future cash flows, earnings, results of operations and financial condition.‎

The Company operates in evolving markets, which makes it difficult to evaluate the Company’s business and ‎future prospects.‎

‎The Company’s unmanned aerial vehicles (“UAVs”) are sold in rapidly evolving markets. The commercial UAV market is in early stages of ‎customer adoption. Accordingly, the Company’s business and future prospects may be difficult to evaluate. The ‎Company cannot accurately predict the extent to which demand for its products and services will increase, if at all. ‎The challenges, risks and uncertainties frequently encountered by companies in rapidly evolving markets could ‎impact the Company’s ability to do the following:‎

● generate sufficient revenue to reach and maintain profitability;‎

● acquire and maintain market share;‎

Draganfly Inc. | Annual Information Form          Page 22

● achieve or manage growth in operations;‎

● develop and renew contracts;‎

● attract and retain additional engineers and other highly-qualified personnel;‎

● successfully develop and commercially market new products;‎

● adapt to new or changing policies and spending priorities of governments and government agencies; and

● access additional capital when required and on reasonable terms.‎

If the Company fails to address these and other challenges, risks and uncertainties successfully, its business, results ‎of operations and financial condition would be materially harmed.‎

The Company operates in a competitive market.

The Company faces competition and new competitors will continue to emerge throughout the world. Services offered by the Company’s competitors may take a larger share of consumer spending than anticipated, which could cause revenue generated from the Company’s products and services to fall below expectations. It is expected that competition in these markets will intensify. Some of the other publicly traded companies we may compete with include Alpine 4 Tech, Inc., Aerovironment Inc., EHang Holdings Limited, AgEagle, Drone Delivery Canada, Inc., and Red Cat Holdings, Inc.

If competitors of the Company develop and market more successful products or services, offer competitive products or services at lower price points, or if the Company does not produce consistently high-quality and well-received products and services, revenues, margins, and profitability of the Company will decline.

The Company’s ability to compete effectively will depend on, among other things, the Company’s pricing of services and equipment, quality of customer service, development of new and enhanced products and services in response to customer demands and changing technology, reach and quality of sales and distribution channels and capital resources. Competition could lead to a reduction in the rate at which the Company adds new customers, a decrease in the size of the Company’s market share and a decline in its customers. Examples include but are not limited to competition from other companies in the UAV industry.

In addition, the Company could face increased competition should there be an award of additional licenses in jurisdictions in which the Company operates in.

The markets in which the Company competes are characterized by rapid technological change, which requires ‎the Company to develop new products and product enhancements and could render the Company’s existing ‎products obsolete. ‎

‎Continuing technological changes in the market for the Company’s products could make its products less ‎competitive or obsolete, either generally or for particular applications. The Company’s future success will depend ‎upon its ability to develop and introduce a variety of new capabilities and enhancements to its existing product and ‎service offerings, as well as introduce a variety of new product offerings, to address the changing needs of the ‎markets in which it offers products. Delays in introducing new products and enhancements, the failure to choose ‎correctly among technical alternatives or the failure to offer innovative products or enhancements at competitive ‎prices may cause existing and potential customers to purchase the Company’s competitors’ products.‎

If the Company is unable to devote adequate resources to develop new products or cannot otherwise successfully ‎develop new products or enhancements that meet customer requirements on a timely basis, its products could lose ‎market share, its revenue and profits could decline, and the Company could experience operating losses.‎

Draganfly Inc. | Annual Information Form          Page 23

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental agencies, or ‎limitations put on the use of small UAV in response to public privacy concerns, may prevent the Company from ‎expanding sales of its small UAV to non-military customers in Canada.‎

‎Transport Canada is responsible for establishing, managing, and developing safety and security ‎standards and regulations for civil aviation in Canada, and includes unmanned civil aviation ‎‎(drones). Civil operations include law enforcement, scientific research, or use by private sector ‎companies for commercial purposes. The CARs govern civil ‎aviation safety and security in Canada, and by extension govern operation of drones in Canada ‎to an acceptable level of safety.‎

While Transport Canada has been a leader in the development of regulations for the commercial ‎use of RPAS and continues to move forward rapidly with its regulatory development, it has ‎acknowledged the challenge of regulations keeping pace with the rapid development in ‎technology and the growing demand for commercial RPAS use, particularly in the beyond visual ‎line-of-sight environment. In 2012, the Canadian Aviation Regulation Advisory Council UAS ‎working group released its Phase 2 report which outlined a proposed set of revision to the CARs ‎to permit beyond visual line of sight operations. This report was the basis for the recently released NPA by Transport Canada on lower ‎risk beyond visual line-of-sight.‎

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental ‎agencies, including the granting of certain SFOCs, or limitations put on the use of RPAS in ‎response to public safety concerns, may prevent the Company from testing or operating its ‎aircraft and/or expanding its sales which could have an adverse impact on the Company’s ‎business, prospects, results of operations and financial condition.‎

There are risks associated with the regulatory regime and permitting requirements of the Company’s business.‎

‎A significant portion of the Company’s business is based on the operation of RPAS. The operation of ‎RPAS poses a risk or hazard to airspace users as well as personnel on the ground. As ‎the RPAS ‎industry is rapidly developing, the regulatory environment for RPAS is constantly evolving to keep pace. ‎‎As such, whenever a policy change with respect to operating regulations occurs, there is a risk that the ‎Company ‎could find itself to be in non-compliance with these new regulations. While the Company ‎endeavours to take all ‎necessary action to reduce the risks associated with the operations of RPAS and ‎to remain well-informed and up-‎to-date on any addendums and changes to the applicable regulations, ‎there is no assurance that an incident ‎involving an RPAS or the Company’s non-compliance would not ‎create a significant current or future liability for ‎the company.‎

The regulation of RPAS operations within the Canadian Domestic Airspace is still evolving and is expected ‎to continue to change ‎with the proliferation of RPAS, advancements in technology, and standardization within the ‎industry. ‎Changes to the regulatory regime may be disruptive and result in the Company needing to adopt ‎‎significant changes in its operations and policies, which may be costly and time-consuming, and may ‎materially ‎adversely affect the Company’s ability to manufacture and make delivery of its products and ‎services in a timely ‎fashion.‎

The Company’s business and research and development activities are subject to oversight by Transport ‎Canada, the federal ‎institution responsible for transportation policies and programs, including the rules in ‎the CARs. Currently, Transport Canada requires that any non-recreational operators of RPAS have a ‎‎SFOC. The Company’s ability to develop, test, demonstrate, and sell products and ‎services depends on ‎its ability to acquire and maintain a valid SFOC.‎

‎In addition, there exists public concern regarding the privacy implications of Canadian commercial and ‎law ‎enforcement use of small UAV. This concern has included calls to develop explicit written policies ‎and procedures ‎establishing UAV usage limitations. There is no assurance that the response from ‎regulatory agencies, customers and ‎privacy advocates to these concerns will not delay or restrict the ‎adoption of small UAV by prospective non-military customers‎.‎

Draganfly Inc. | Annual Information Form          Page 24

The Company may be subject to the risks associated with future acquisitions.

As part of the Company’s overall business strategy, the Company may pursue select strategic acquisitions that would provide additional product or service offerings, additional industry expertise, and a stronger industry presence in both existing and new jurisdictions. Any such future acquisitions, if completed, may expose the Company to additional potential risks, including risks associated with: (a) the integration of new operations, services and personnel; (b) unforeseen or hidden liabilities; (c) the diversion of resources from the Company’s existing business and technology; (d) potential inability to generate sufficient revenue to offset new costs; (e) the expenses of acquisitions; or (f) the potential loss of or harm to relationships with both employees and existing users resulting from its integration of new businesses. In addition, any proposed acquisitions may be subject to regulatory approval.

‎The Company’s inability to retain management and key employees could impair the future success of the Company.

The Company’s future success depends substantially on the continued services of its executive officers and its key development personnel. If one or more of its executive officers or key development personnel were unable or unwilling to continue in their present positions, the Company might not be able to replace them easily or at all. In addition, if any of its executive officers or key employees joins a competitor or forms a competing company, the Company may lose experience, know-how, key professionals and staff members as well as business partners. These executive officers and key employees could develop drone technologies that could compete with and take customers and market share away from the Company.

A significant growth in the number of personnel would place a strain upon the Company’s management and resources.

The Company may experience a period of significant growth in the number of personnel that could place a strain upon its management systems and resources. The Company’s future will depend in part on the ability of its officers and other key employees to implement and improve financial and management controls, reporting systems and procedures on a timely basis and to expand, train, motivate and manage its workforce. The Company’s current and planned personnel, systems, procedures and controls may be inadequate to support its future operations.

The Company faces uncertainty and adverse changes in the economy.‎

‎

Adverse changes in the economy could negatively impact the Company’s business. Future economic distress may ‎result in a decrease in demand for the Company’s products, which could have a material adverse impact on the ‎Company’s operating results and financial condition. Uncertainty and adverse changes in the economy could also ‎increase costs associated with developing and publishing products, increase the cost and decrease the availability of ‎sources of financing, and increase the Company’s exposure to material losses from bad debts, any of which could ‎have a material adverse impact on the financial condition and operating results of the Company.

The Company is subject to certain market-based financial risks associated with its operations.

The Company could be subject to interest rate risks, which is the risk that the value of a financial instrument might be adversely affected by a change in the interest rates. In seeking to minimize the risks from interest rate fluctuations, the Company manages exposure through its normal operating and financing activities, however market fluctuations could increase the costs at which the Company can access capital and its ability to obtain financing and the Company’s cash balances carry a floating rate of interest. In addition, the Company engages in transactions in currencies other than its functional currency. Depending on the timing of these transactions and the applicable currency exchange rates, conversions to the Company’s functional currency may positively or negatively impact the Company.

Draganfly Inc. | Annual Information Form          Page 25

The COVID-19‎ pandemic could negatively affect our business, operations and future financial performance.

In March 2020 the World Health Organization designated the outbreak of a novel strain of coronavirus, specifically identified ‎as COVID-19, as a global pandemic. This resulted in governments, companies, and individuals worldwide enacting emergency measures to combat the spread of ‎the virus, including the implementation of travel bans, mandated and self-imposed quarantine ‎periods and physical distancing, that have caused a material disruption to businesses globally. Throughout the course of the pandemic, the impact of COVID-19 has varied significantly due to both global and localized infection rates, notwithstanding widespread vaccine availability within Canada and the United States beginning in spring 2020.

As a result of the pandemic, global equity markets have experienced significant volatility and weakness. ‎Governments and central banks have reacted with significant monetary and fiscal interventions designed ‎to stabilize economic conditions. Such volatility has let to significant challenges to the global supply chain, disrupted labor markets and has recently contributed to rising levels of inflation. The Company has experienced material pandemic related impacts, including the loss of its primary customer engineering customer in 2020 due to mandated stay-at-home orders. The duration and impact of the COVID-19 outbreak is unknown at this ‎time, as is the efficacy of the government and central bank interventions. ‎ As such, the Company cannot predict with any certainty what the future impacts the pandemic may have on its business.

Management of the Company has and continues to closely monitor the impact of the COVID-19 global pandemic, with a focus on the health and safety of the Company’s employees, customers, and business continuity. Since the outbreak of the pandemic, the Company has taken various ‎steps to mitigate the impact of COVID-19, including following government or health authority guidelines and restrictions at its facilities to ‎ensure the safety of its staff and product consumers. The Company will continue to follow government or health authority guidelines and restrictions and has experienced minimal disruption to its operations and supply chain. However, there is no guarantee that the company’s mitigation efforts will prove successful in combating the spread of the virus or that supply chain disruptions will not occur in the future. As the ‎Company reintegrates its personnel to its workplace, it may incur additional costs to adapt the workplace to ‎meet applicable health and safety requirements. The occurrence of additional waves of the virus or its variants, or insufficient vaccination levels may require the Company to revise or delay such plans. ‎To the extent that it is unable to effectively protect its workforce against the transmission of the virus, the ‎Company may be forced to slow or reverse its reintegration efforts and could face allegations of liability.‎

Given the uncertainties associated with the ongoing COVID-19 pandemic, including ‎the uncertainty surrounding the remaining duration and outcome, COVID-19 variants and vaccine efficacy, the Company is unable to estimate the full impact of the COVID-19 pandemic on its business, financial condition, results of operations, and/or cash flows; however, the impact could be material. The Company cannot accurately predict ‎the future impact COVID-19 may have on, among others, the: (i) demand for drone ‎delivery services, (ii) severity and the length of potential measures taken by governments to manage the ‎spread of the virus and their effect on labour availability and supply lines, (iii) availability of essential ‎supplies, (iv) purchasing power of the Canadian dollar, or (v) ability of the Company to obtain necessary ‎financing. Despite global vaccination efforts, it is not possible to reliably estimate the length and ‎severity of these developments and the impact on the financial results and condition of the Company in ‎the future.‎

The conflict between Russia and Ukraine could destabilize global markets and threatens global peace.

On February 24, 2022, Russian military forces launched a full-scale military invasion of Ukraine. In response, Ukrainian military personal and civilians are actively resisting the invasion. Many countries throughout the world have provided aid to the Ukraine in the form of financial aid and in some cases military equipment and weapons to assist in their resistance to the Russian invasion. The North Atlantic Treaty Organization (“NATO”) has also mobilized forces to NATO member countries that are close to the conflict as deterrence to further Russian aggression in the region. The outcome of the conflict is uncertain and is likely to have wide ranging consequences on the peace and stability of the region and the world economy. Certain countries including Canada and the United States, have imposed strict financial and trade sanctions against Russia and such sanctions may have far reaching effects on the global economy. The long-term impacts of the conflict and the sanctions imposed on Russia remain uncertain.

Draganfly Inc. | Annual Information Form          Page 26

Negative macroeconomic and geopolitical trends could affect the Company’s ability to access sources of ‎capital.‎

The COVID-19 pandemic and the Russian invasion of Ukraine could negatively impact the Company’s ability to obtain financing and access sources of capital. Both events have led to significant market volatility as governments undertake measures to prevent the spread of COVID-19 and discourage political conflict. These events have contributed to significant uncertainty in global markets, increased inflationary pressures, and could lead to a tightening of credit markets and a decline in economic activity. These impacts could have a material adverse effect on the Company’s ‎liquidity and ability to obtain financing in the future.‎ As the Company has a history of losses and present revenues do not allow it to sustain its operations, an inability to access credit or capital markets could undermine the Company’s ability to continue as a going concern.

‎‎The Company may be subject to the risks associated with foreign operations in other countries.

The Company’s primary revenues are expected to be achieved in Canada and the US. However, the Company may expand to markets outside of North America and become subject to risks normally associated with conducting business in other countries. As a result of such expansion, the Company may be subject to the legal, political, social and regulatory requirements and economic conditions of foreign jurisdictions. The Company cannot predict government positions on such matters as foreign investment, intellectual property rights or taxation. A change in government positions on these issues could adversely affect the Company’s business.

If the Company expands its business to foreign markets, it will need to respond to rapid changes in market conditions, including differing legal, regulatory, economic, social and political conditions in these countries. If the Company is not able to develop and implement policies and strategies that are effective in each location in which it does business, then the Company’s business, prospects, results of operations and financial condition could be materially and adversely affected.

There are tax risks the Company may be subject to in carrying on business in Canada.

The Company is a resident of Canada for purposes of the Income ‎Tax Act (Canada). Since the ‎Company is operating in a new and developing industry there is a risk that ‎foreign governments may look to ‎increase their tax revenues or levy additional taxes to level the playing ‎field for perceived disadvantages to ‎traditional brick and mortar businesses. There is no guarantee that ‎governments will not impose such additional ‎adverse taxes in the future‎.‎

If critical components or raw materials used to manufacture the Company’s products become scarce or ‎unavailable, then the Company may incur delays in manufacturing and delivery of its products, which could ‎damage its business.‎

‎The Company obtains hardware components, various subsystems and systems from a limited group of suppliers. ‎The Company does not have long-term agreements with any of these suppliers that obligate it to continue to sell ‎components, subsystems, systems or products to the Company. The Company’s reliance on these suppliers ‎involves significant risks and uncertainties, including whether its suppliers will provide an adequate supply of ‎required components, subsystems, or systems of sufficient quality, will increase prices for the components, ‎subsystems or systems and will perform their obligations on a timely basis.‎

‎

Draganfly Inc. | Annual Information Form          Page 27

Recently, the global supply chain has experienced significant disruptions caused by the COVID-19 pandemic and by geopolitical conflict, including the war in Ukraine. These disruptions have impacted a variety of products and goods and have had various downstream effects, making it more difficult to reliably and timely source and supply goods and has also resulted in shortages of labor and equipment. The macroeconomic impacts of the COVID-19 pandemic and global conflicts have contributed to inflationary pressure and increased market volatility, adding additional pricing uncertainty. These conditions, if not mitigated or remedied in a timely manner, could delay or preclude delivery of raw materials needed to manufacture our products or delivery of the Company’s products to customers, particularly in international markets. If the ‎Company is unable to obtain components from third-party suppliers in the quantities and of the quality that it ‎requires, on a timely basis and at acceptable prices, then it may not be able to deliver its products on a timely or ‎cost-effective basis to its customers, or at all, which could cause customers to terminate their contracts with the Company, ‎increase the Company’s costs and seriously harm its business, results of operations and financial condition. ‎Moreover, if any of the Company’s suppliers become financially unstable, then it may have to find new suppliers. ‎It may take several months to locate alternative suppliers, if required, or to redesign the Company’s products to ‎accommodate components from different suppliers. The Company may experience significant delays in ‎manufacturing and shipping its products to customers and incur additional development, manufacturing and other ‎costs to establish alternative sources of supply if the Company loses any of these sources or is required to redesign ‎its products. The Company cannot predict if it will be able to obtain replacement components within the time ‎frames that it requires at an affordable cost, if at all.‎

Natural outdoor elements such as wind and precipitation may have a material adverse effect on the ‎use and effectiveness of the Company’s products.

The Company’s business will involve the operation and flying of UAVs, a technology-based product ‎used outside. As such, the business is subject to various risks inherent in a technology-based ‎businesses operated in outdoor conditions, including faulty parts, breakdowns and crashes. Although ‎the Company anticipates the use of its UAVs in good climactic conditions and that adequate flying ‎conditions will be monitored by trained personnel, there can be no assurance that unpredictable natural ‎outdoor elements will not have a material adverse effect on the use and effectiveness of its products.‎

The Company’s products may be subject to the recall or return.

Manufacturers and distributors of products are sometimes subject to the recall or return of their products ‎‎for a variety of reasons, including product defects, safety concerns, packaging issues and inadequate ‎or inaccurate ‎labeling disclosure. If any of the Company’s equipment were to be recalled due to an ‎alleged product ‎defect, safety concern or for any other reason, the Company could be required to incur ‎unexpected expenses of the recall ‎and any legal proceedings that might arise in connection with the ‎recall. The Company may lose a significant ‎amount of sales and may not be able to replace those sales ‎at an acceptable margin or at all. In ‎addition, a product recall may require significant management time ‎and attention. Additionally, product recalls may lead to ‎increased scrutiny of the Company’s operations ‎by Transport Canada or other regulatory agencies, requiring ‎further management time and attention and ‎potential legal fees, costs and other expenses.‎‎

‎‎If the Company releases defective products or services, its operating results could suffer.‎

‎Products and services designed and released by the Company involve extremely complex software ‎programs and ‎are difficult to develop and distribute. While the Company has quality controls in place to ‎detect and prevent defects in its ‎products and services before they are released, these quality controls ‎are subject to human error, ‎overriding, and reasonable resource constraints. Therefore, these quality ‎controls and preventative measures may ‎not be effective in detecting and preventing defects in the ‎Company’s products and services before they have been released into ‎the marketplace. In such an ‎event, the Company could be required, or decide voluntarily, to suspend the availability of the product or ‎services, which could significantly harm its business and operating results‎.‎

Draganfly Inc. | Annual Information Form          Page 28

The Company’s products and services are complex and could have unknown defects or errors, which may give ‎rise to legal claims against the Company, diminish its brand or divert its resources from other purposes.‎

The Company’s UAVs rely on complex avionics, sensors, user-friendly interfaces and tightly integrated, ‎electromechanical designs to accomplish their missions. Despite testing, the Company’s products have contained ‎defects and errors and may in the future contain defects, errors or performance problems when first introduced, ‎when new versions or enhancements are released, or even after these products have been used by the Company’s ‎customers for a period of time. These problems could result in expensive and time-consuming design modifications ‎or warranty charges, delays in the introduction of new products or enhancements, significant increases in the ‎Company’s service and maintenance costs, exposure to liability for damages, damaged customer relationships and ‎harm to the Company’s reputation, any of which could materially harm the Company’s results of operations and ‎ability to achieve market acceptance. In addition, increased development and warranty costs could be substantial ‎and could significantly reduce the Company’s operating margins.‎

‎The existence of any defects, errors, or failures in the Company’s products or the misuse of the Company’s ‎products could also lead to product liability claims or lawsuits against it. A defect, error or failure in one of the ‎Company’s UAV could result in injury, death or property damage and significantly damage the Company’s ‎reputation and support for its UAV in general. The Company anticipates this risk will grow as its UAV begins to be ‎used in Canadian domestic airspace and urban areas. The Company’s UAV test systems also have the potential to ‎cause injury, death or property damage in the event that they are misused, malfunction or fail to operate properly ‎due to unknown defects or errors.‎ Although the Company maintains insurance policies, it cannot provide any assurance that this insurance will be ‎adequate to protect the Company from all material judgments and expenses related to potential future claims or ‎that these levels of insurance will be available in the future at economical prices or at all. A successful product ‎liability claim could result in substantial cost to us. Even if the Company is fully insured as it relates to a particular claim, the ‎claim could nevertheless diminish the Company’s brand and divert management’s attention and resources, which ‎could have a negative impact on the Company’s business, financial condition and results of operations.‎

Shortfalls in available external research and development funding could adversely affect the Company.‎

‎The Company depends on its research and development activities to develop the core technologies used in its UAV ‎products and for the development of the Company’s future products. A portion of the Company’s research and ‎development activities can depend on funding by commercial companies and the Canadian government. Canadian ‎government and commercial spending levels can be impacted by a number of variables, including general ‎economic conditions, specific companies’ financial performance and competition for Canadian government ‎funding with other Canadian government-sponsored programs in the budget formulation and appropriation ‎processes. Moreover, the Canadian, federal and provincial governments provide energy rebates and incentives to ‎commercial companies, which directly impact the amount of research and development that companies ‎appropriate for energy systems. To the extent that these energy rebates and incentives are reduced or eliminated, ‎company funding for research and development could be reduced. Any reductions in available research and ‎development funding could harm the Company’s business, financial condition and operating results.‎

The Company could be prohibited from shipping its products to certain countries if it is unable to obtain ‎Canadian government authorization regarding the export of its products, or if current or future export laws limit ‎or otherwise restrict the Company’s business.‎

The Company must comply with Canadian federal and provincial laws regulating the export of its products. In ‎some cases, explicit authorization from the Canadian government is needed to export its products. The export ‎regulations and the governing policies applicable to the Company’s business are subject to change. The Company ‎cannot provide assurance that such export authorizations will be available for its products in the future. ‎Compliance with these laws has not significantly limited the Company’s operations or sales in the recent past, but ‎could significantly limit them in the future. Non-compliance with applicable export regulations could potentially ‎expose the Company to fines, penalties and sanctions. If the Company cannot obtain required government ‎approvals under applicable regulations, the Company may not be able to sell its products in certain international ‎jurisdictions, which could adversely affect the Company’s financial condition and results of operations.‎

Draganfly Inc. | Annual Information Form         29

Negative consumer perception regarding the Company’s products‎ could have a material adverse effect on the demand for the Company’s ‎products and the business, results of operations, financial condition and cash flows of the Company.

The Company believes the UAV industry is highly dependent upon consumer perception regarding the ‎safety, efficacy, and quality of the UAV used. Consumer perception of these products can be ‎significantly influenced by scientific research or findings, regulatory investigations, litigation, media attention, ‎and other publicity regarding the use of UAV. There can be no assurance that future scientific research, ‎findings, regulatory proceedings, litigation, media attention, or other research findings or publicity will be ‎favourable to the UAV market. Future research reports, findings, regulatory proceedings, litigation, media ‎attention or other publicity that are perceived as less favourable than, or that question, earlier research ‎reports, findings or publicity could have a material adverse effect on the demand for the Company’s ‎products and the business, results of operations, financial condition and cash flows of the Company. The ‎dependence upon consumer perceptions means that adverse scientific research reports, findings, ‎regulatory proceedings, litigation, media attention or other publicity, whether or not accurate or with merit, ‎could have a material adverse effect on the Company, the demand for the Company’s products, and the ‎business, results of operations, financial condition and cash flows of the Company. Further, adverse ‎publicity reports or other media attention regarding the safety, the efficacy, and quality of UAV based surveys in general, or the Company’s products specifically, ‎could have a material adverse effect.‎

If the Company fails ‎‎to successfully promote its product brand, this could have a material adverse ‎effect on the Company’s business, prospects, ‎‎financial condition and results of operations‎.

The Company believes that brand recognition is an important factor to its success. If the Company fails ‎‎to promote its brands successfully, or if the expenses of doing so are disproportionate to any increased ‎‎net sales it achieves, it would have a material adverse effect on the Company’s business, prospects, ‎‎financial condition and results of operations. This will depend largely on the Company’s ability to ‎‎maintain trust, be a technology leader, and continue to provide high-quality and secure technologies, ‎‎products and services. Any negative publicity about the Company or its industry, the quality and reliability of the Company’s technologies, products and services, the Company’s risk management ‎‎processes, changes to the Company’s technologies, products and services, its ability to effectively ‎‎manage and resolve customer complaints, its privacy and security practices, litigation, regulatory activity, and the experience of sellers and buyers with the Company’s products or services, could adversely affect the Company’s reputation and the confidence in and use of the ‎‎Company’s technologies, products and services. Harm to the Company’s brand can arise from ‎‎many sources, including; failure by the Company or its partners to satisfy expectations of service and quality; inadequate protection of sensitive information; compliance failures and claims; litigation and ‎‎other claims; employee misconduct; and misconduct by the Company’s partners, service ‎‎providers, or other counterparties. If the Company does not successfully maintain a strong and trusted brand, its business could be materially and adversely affected.‎ ‎

The Company may be subject to electronic communication security risks.

A significant potential vulnerability of electronic communications is the security of transmission of confidential information over public networks. Cyberattacks could result in unauthorized access to the Company’s computer systems or its third-party IT service provider’s systems and, if successful, misappropriate personal or confidential information. Anyone who is able to circumvent the Company’s security measures could misappropriate proprietary information or cause interruptions in its operations. The Company may be required to expend capital and other resources to protect against such security breaches or to alleviate problems caused by such breaches.

Since the outset of the COVID-19 pandemic, there has been an increase in the volume and sophistication of targeted cyber-attacks. Pandemic-adjusted operations, such as work ‎from home arrangements and remote access to the Company’s systems, may pose heightened risk of ‎cyber security and privacy breaches and may put additional stress on the Company’s IT infrastructure. A failure of such infrastructure could severely limit the Company’s ability ‎to conduct ordinary operations or expose the Company to liability. To date, the Company’s systems have functioned capably, and it has not experienced a material impact to its ‎operations as a result of an IT infrastructure issue.‎ In addition, the outbreak of hostilities between Russia and Ukraine and the response of the global community to such aggression is widely seen as increasing the risk of state-sponsored cyberattacks.

Draganfly Inc. | Annual Information Form         30

Even the most well-protected IT networks, systems and facilities remain potentially vulnerable because the techniques used in attempted security breaches are continually evolving and generally are not recognized until launched against a target or, in some cases, are designed not to be detected and, in fact, may not be detected. Any such compromise of the Company’s or its third party’s IT service providers’ data security and access, public disclosure, or loss of personal or confidential business information, could result in legal claims and proceedings, liability under laws to protect privacy of personal information, and regulatory penalties, and could disrupt our operations, require significant management attention and resources to remedy any damages that result, and damage our reputation and customers willingness to transact business with us, any of which could adversely affect our business.

The Company’s business could be adversely affected if its consumer protection and data privacy practices are not ‎perceived as adequate or there are breaches of its security measures or unintended disclosures of its consumer data.‎

‎The rate of privacy law-making is accelerating globally and interpretation and application of consumer protection ‎and data privacy laws in Canada, the United States, Europe and elsewhere are often uncertain, contradictory and in ‎flux. As business practices are being challenged by regulators, private litigants, and consumer protection agencies ‎around the world, it is possible that these laws may be interpreted and applied in a manner that is inconsistent with ‎the Company’s data and/or consumer protection practices. If so, this could result in increased litigation government ‎or court-imposed fines, judgments or orders requiring that the Company change its practices, which could have an ‎adverse effect on its business and reputation. Complying with these various laws could cause the Company to incur ‎substantial costs or require it to change its business practices in a manner adverse to its business.‎

‎The Company relies on its business partners, and they may be given access to sensitive and proprietary ‎information in order to provide services and support to the Company’s teams.‎

‎The Company relies on various business partners, including third-party service providers, vendors, licensing partners, ‎development partners, and licensees, among others, in some areas of the Company’s business. In some cases, these ‎third parties are given access to sensitive and proprietary information in order to provide services and support to the ‎Company’s teams. These third parties may misappropriate the Company’s information and engage in ‎unauthorized use of it. The failure of these third parties to provide adequate services and technologies, or the failure ‎of the third parties to adequately maintain or update their services and technologies, could result in a disruption to ‎the Company’s business operations. Further, disruptions in the financial markets and economic downturns may ‎adversely affect the Company’s business partners and they may not be able to continue honoring their obligations ‎to the Company. Alternative arrangements and services may not be available to the Company on commercially ‎reasonable terms or the Company may experience business interruptions upon a transition to an alternative partner ‎or vendor. If the Company loses one or more significant business partners, the Company’s business could be ‎harmed.‎

Draganfly Inc. | Annual Information Form         31

If the Company fails to protect, or incurs significant costs in defending, its intellectual property and other ‎proprietary rights, the Company’s business, financial condition, and results of operations could be materially ‎harmed.‎

‎The Company’s success depends, in large part, on its ability to protect its intellectual property and other proprietary ‎rights. The Company relies primarily on patents, trademarks, copyrights, trade secrets and unfair competition laws, ‎as well as license agreements and other contractual provisions, to protect the Company’s intellectual property and ‎other proprietary rights. However, a portion of the Company’s technology is not patented, and the Company may ‎be unable or may not seek to obtain patent protection for this technology. Moreover, existing Canadian legal ‎standards relating to the validity, enforceability and scope of protection of intellectual property rights offer only ‎limited protection, may not provide the Company with any competitive advantages, and may be challenged by ‎third parties. The laws of countries other than Canada may be even less protective of intellectual property rights. ‎Accordingly, despite its efforts, the Company may be unable to prevent third parties from infringing upon or ‎misappropriating its intellectual property or otherwise gaining access to the Company’s technology. Unauthorized ‎third parties may try to copy or reverse engineer the Company’s products or portions of its products or otherwise ‎obtain and use the Company’s intellectual property. Moreover, many of the Company’s employees have access to ‎the Company’s trade secrets and other intellectual property. If one or more of these employees leave to work for ‎one of the Company’s competitors, then they may disseminate this proprietary information, which may as a result ‎damage the Company’s competitive position. If the Company fails to protect its intellectual property and other ‎proprietary rights, then the Company’s business, results of operations or financial condition could be materially ‎harmed. From time to time, the Company may have to initiate lawsuits to protect its intellectual property and other ‎proprietary rights. Pursuing these claims is time consuming and expensive and could adversely impact the ‎Company’s results of operations.‎

‎In addition, affirmatively defending the Company’s intellectual property rights and investigating whether the ‎Company is pursuing a product or service development that may violate the rights of others may entail significant ‎expense. Any of the Company’s intellectual property rights may be challenged by others or invalidated through ‎administrative processes or litigation. If the Company resorts to legal proceedings to enforce its intellectual property ‎rights or to determine the validity and scope of the intellectual property or other proprietary rights of others, then the ‎proceedings could result in significant expense to the Company and divert the attention and efforts of the ‎Company’s management and technical employees, even if the Company prevails.‎

Obtaining and maintaining the Company’s patent protection depends on compliance with various procedural, document ‎submission, fee payment, and other requirements imposed by governmental patent agencies, and its patent ‎protection could be reduced or eliminated for non-compliance with these requirements.‎

‎The CIPO, the USPTO and various foreign national or international patent agencies ‎require compliance with a number of procedural, documentary, fee payment, and other similar provisions during ‎the patent application process. Periodic maintenance fees on any issued patent are due to be paid to the CIPO, the USPTO and ‎various foreign national or international patent agencies in several stages over the lifetime of the patent. While an ‎inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the ‎applicable rules, there are situations in which non-compliance can result in abandonment or lapse of the patent or ‎patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance ‎events that could result in abandonment or lapse of patent rights include, but are not limited to, failure to timely file ‎national and regional stage patent applications based on the Company’s international patent application, failure to respond to ‎official actions within prescribed time limits, non-payment of fees, and failure to properly legalize and submit ‎formal documents. If the Company fails to maintain the patents and patent applications covering its product candidates, its ‎competitors might be able to enter the market, which would have a material adverse effect on the Company’s business. ‎

While a patent may be granted by a national patent office, there is no guarantee that the granted patent is valid. ‎Options exist to challenge the validity of a patent which, depending upon the jurisdiction, may include re-‎examination, opposition proceedings before the patent office, and/or invalidation proceedings before the relevant ‎court. Patent validity may also be the subject of a counterclaim to an allegation of patent infringement.‎

Pending patent applications may be challenged by third parties in protest or similar proceedings. Third parties can ‎typically submit prior art material to patentability for review by the patent examiner. Regarding Patent Cooperation ‎Treaty applications, a positive opinion regarding patentability issued by the International Searching Authority does ‎not guarantee allowance of a national application derived from the Patent Cooperation Treaty application. The ‎coverage claimed in a patent application can be significantly reduced before the patent is issued, and the patent’s ‎scope can be modified after issuance. It is also possible that the scope of claims granted may vary from jurisdiction ‎to jurisdiction.‎

Draganfly Inc. | Annual Information Form         32

The grant of a patent does not have any bearing on whether the invention described in the patent application would ‎infringe the rights of earlier filed patents. It is possible to both obtain patent protection for an invention and yet still ‎infringe the rights of an earlier granted patent.‎

The Company may be sued by third parties for alleged infringement of their proprietary rights, which could be ‎costly, time-consuming and limit the Company’s ability to use certain technologies in the future.‎

‎The Company may become subject to claims that its technologies infringe upon the intellectual property or other ‎proprietary rights of third parties. Any claims, with or without merit, could be time-consuming and expensive, and ‎could divert the Company’s management’s attention away from the execution of its business plan. Moreover, any ‎settlement or adverse judgment resulting from these claims could require the Company to pay substantial amounts ‎or obtain a license to continue to use the disputed technology, or otherwise restrict or prohibit the Company’s use of ‎the technology. The Company cannot assure that it would be able to obtain a license from the third party asserting ‎the claim on commercially reasonable terms, if at all, that the Company would be able to develop alternative ‎technology on a timely basis, if at all, or that the Company would be able to obtain a license to use a suitable ‎alternative technology to permit the Company to continue offering, and the Company’s customers to continue ‎using, the Company’s affected product. An adverse determination also could prevent the Company from offering ‎its products to others. Infringement claims asserted against the Company may have a material adverse effect on its ‎business, results of operations or financial condition.‎

‎The Company may not be able to protect its intellectual property rights throughout the world.‎

‎Filing, prosecuting, and defending patents on all of the Company’s product candidates throughout the world would be ‎prohibitively expensive. Therefore, the Company has filed applications and/or obtained patents only in key markets ‎including the United States and Canada. Competitors may use the Company’s technologies in jurisdictions where it has not ‎obtained patent protection to develop their own products and their products may compete with products of the Company.‎‎

‎Failure to adhere to the Company’s financial reporting obligations and other public company requirements could adversely ‎affect the market price of the Common Shares.‎

‎The Company ‎is subject to ‎reporting and other obligations under applicable securities laws in Canada and the United States, and the rules ‎of the CSE and the Nasdaq. These reporting and other obligations ‎place significant demands on the Company’s management, administrative, operational and ‎accounting resources. If the Company is unable to meet such ‎demands in a timely and effective manner, ‎its ability to comply with its financial reporting obligations ‎and other rules applicable to reporting issuers ‎could be impaired. Moreover, any failure to maintain effective ‎internal controls could cause the Company ‎to fail to satisfy its reporting obligations or result in material misstatements in its ‎financial statements. If ‎the Company cannot provide reliable financial reports or prevent fraud, its reputation and operating ‎‎results could be materially adversely affected which could also cause investors to lose confidence in its ‎reported ‎financial information, which could result in a reduction in the trading price of the Common ‎Shares.‎

In addition, the Company does not expect that its disclosure controls and procedures and internal ‎controls over financial reporting will ‎prevent all errors or fraud. A control system, no matter how well ‎designed and implemented, can provide only ‎reasonable, not absolute, assurance that the control ‎system’s objectives will be met. Further, the design of a control ‎system must reflect the fact that there ‎are resource constraints, and the benefits of controls must be considered ‎relative to their costs. Due to ‎the inherent limitations in all control systems, no evaluation of controls can provide ‎absolute assurance ‎that all control issues within an organization are detected. The inherent limitations include the ‎realities that ‎judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors ‎or ‎mistakes. Controls can also be circumvented by individual acts of certain persons, by collusion of two ‎or more ‎people or by management override of the controls. Due to the inherent limitations in a control ‎system, ‎misstatements due to errors or fraud may occur and may not be detected in a timely manner or ‎at all‎.‎

Draganfly Inc. | Annual Information Form         33

We have limited operating experience as a publicly traded company in the United States

We have limited operating experience as a publicly traded company in the United States. Although our management team have experience managing a publicly-traded company, there is no assurance that the past experience of our management team will be sufficient to operate the Company as a publicly traded company in the United States, including timely compliance with the disclosure requirements of the SEC. We are required to develop and implement internal control systems and procedures in order to satisfy the periodic and current reporting requirements under applicable SEC regulations and comply with the listing standards of the Nasdaq. These requirements place significant strain on our management team, infrastructure and other resources. In addition, our management team may not be able to successfully or efficiently manage the Company as a U.S. public reporting company that is subject to significant regulatory oversight and reporting obligations.

‎If the Company is required to write down goodwill and other intangible assets, the Company’s financial ‎condition and results could be negatively affected. ‎

‎Goodwill impairment arises when there is deterioration in the capabilities of acquired assets to generate cash flows, ‎and the fair value of the goodwill dips below its book value. The Company is required to review its goodwill for ‎impairment at least annually. Events that may trigger goodwill impairment include deterioration in economic ‎conditions, increased competition, loss of key personnel, and regulatory action. Should any of these occur, an impairment of ‎goodwill relating to the acquisition of Dronelogics Systems Inc. could have a negative effect on the assets of the ‎Company.‎

From time to time, the Company may become involved in legal proceedings, which could adversely affect the ‎Company.‎

‎The Company may, from time to time in the future, become subject to legal proceedings, claims, litigation and ‎government investigations or inquiries, which could be expensive, lengthy, and disruptive to normal business ‎operations. In addition, the outcome of any legal proceedings, claims, litigation, investigations or inquiries may be ‎difficult to predict and could have a material adverse effect on the Company’s business, operating results, or ‎financial condition.‎

The Company’s directors and officers may have conflicts of interest in conducting their duties.

Because directors and officers of the Company are or may become directors or officers of other ‎reporting companies or have significant shareholdings in other technology companies, the directors and ‎officers of the Company may have conflicts of interest in conducting their duties. The Company and its ‎directors and officers will attempt to minimize such conflicts. In the event that such a conflict of interest ‎arises at a meeting of the directors of the Company, a director who has such a conflict will abstain from ‎voting for or against a particular matter in which the director has the conflict. In appropriate cases, the ‎Company will establish a special committee of independent directors to review a particular matter in ‎which several directors, or officers, may have a conflict. In determining whether or not the Company will ‎participate in a particular program and the interest therein to be acquired by it, the directors will primarily ‎consider the potential benefits to the Company, the degree of risk to which the Company may be ‎exposed and its financial position at that time. Other than as indicated, the Company has no other ‎procedures or mechanisms to deal with conflicts of interest.‎

Our Articles ‎provide that the Company must indemnify a director or former director against all judgments, penalties ‎or fines to which such person is or may be liable by reason of such person being or having been a director of the ‎Company and the executive officers and directors may also have rights to indemnification from the Company, ‎including ‎pursuant to directors’ and officers’ liability insurance policies, that will survive termination of their ‎‎agreements‎.‎

Draganfly Inc. | Annual Information Form         34

Changes in accounting standards and subjective assumptions, estimates and judgments by management ‎related to ‎complex accounting matters could significantly affect the Company’s reported financial results ‎or financial condition.‎

‎Generally accepted accounting principles and related accounting pronouncements, implementation ‎guidelines and ‎interpretations with regard to a wide range of matters that are relevant to the Company’s ‎business, including but not limited to ‎revenue recognition, impairment of goodwill and intangible assets, ‎inventory, income taxes and litigation, are highly ‎complex and involve many subjective assumptions, ‎estimates and judgments. Changes in these rules or their ‎interpretation or changes in underlying ‎assumptions, estimates or judgments could significantly change the Company’s reported ‎financial ‎performance or financial condition in accordance with generally accepted accounting principles.‎

Risks Related to Our Common Shares

The market price of the Common Shares may be highly volatile.‎

The market price of the Common Shares may be highly volatile and could be subject to wide fluctuations ‎in response to a number of factors that are beyond our control, including but not limited ‎to‎

● revenue or results of operations in any quarter failing to meet the expectations, published or otherwise, of ‎the investment community;‎

● actual or anticipated changes or fluctuations in our results of operations;‎

● announcements by us or our competitors of new products or new or terminated significant contracts, ‎commercial relationships or capital commitments;‎

● rumors and market speculation involving us or other companies in our industry;‎

● changes in our executive management team or the composition of the board of directors of the Company (the “Board”);‎

● fluctuations in the share prices of other companies in the technology and emerging growth sectors;‎

● general market conditions and macroeconomic trends driven by factors outside our control, such as the COVID-19 pandemic and/or geopolitical conflicts, including supply chain disruptions, market volatility, inflation, and labor challenges, among other factors;

● actual or anticipated developments in our business or our competitors’ businesses or the competitive ‎landscape generally;‎

● litigation involving us, our industry or both, or investigations by regulators into our operations or those of ‎competitors;‎

● announced or completed acquisitions of businesses or technologies by us or our competitors;‎

● new laws or regulations or new interpretations of existing laws or regulations applicable to our ‎business;‎

● shareholder activism and related publicity;‎

● foreign exchange rates; and

● other risk factors as set out in this AIF and in the documents incorporated by ‎reference into this AIF.‎

If the market price of our Common Shares drops significantly, shareholders could institute securities class action ‎lawsuits against us, regardless of the merits of such claims. Such a lawsuit could cause us to incur substantial ‎costs and could divert the time and attention of our management and other resources from our business. This ‎could harm our business, results of operations and financial condition.‎

There is no guarantee that an active trading market for our Common Shares will be maintained on ‎the CSE and/or the Nasdaq. Investors may not be able to sell their Common Shares quickly or at the ‎latest market price if the trading in our Common Shares is not active.‎

Our Common Shares are currently listed on the CSE, Nasdaq, and the Frankfurt Stock Exchange, however, our shareholders may be unable to sell significant quantities of Common Shares into the public ‎trading markets without a significant reduction in the price of their Common Shares, or at all and there can be no guarantee that an active trading market for the Common Shares ‎may be maintained. There can be no assurance that ‎there will be sufficient liquidity of our Common Shares on the trading market, and that we will continue to meet ‎the listing requirements of the CSE, the Nasdaq or any other public listing exchange.

Draganfly Inc. | Annual Information Form         35

Future issuances of equity securities by us or sales by our existing shareholders may cause the price ‎of our Common Shares to fall.‎

The market price of our Common Shares could decline as a result of issuances of securities or sales by our ‎existing shareholders in the market, including by our directors, executive officers and significant shareholders, or ‎the perception that these sales could occur. Sales of our Common Shares by shareholders might also make it ‎more difficult for us to sell Common Shares at a time and price that we deem appropriate. We also expect to ‎issue Common Shares in the future. Future issuances of Common Shares, or the perception that such issuances ‎are likely to occur, could affect the prevailing trading prices of the Common Shares.‎

We may never pay dividends over the foreseeable future.‎

Investors should not rely on an investment in our Common Shares to provide dividend ‎income. The Company does not anticipate that it will pay any cash dividends to holders of its Common ‎Shares in the foreseeable future. Instead, the Company plans to retain any earnings to maintain and expand ‎its operations. In addition, any future debt financing arrangement may contain terms prohibiting or limiting ‎the amount of dividends that may be declared or paid on its Common Shares. Accordingly, investors must ‎rely on sales of their Common Shares after price appreciation, which may never occur, as the only way to ‎realize any return on their investment. As a result, investors seeking cash dividends should not purchase the ‎Company’s Common Shares.‎

United States investors may not be able to obtain enforcement of civil liabilities against us.

‎

The Company is incorporated under the laws of British Columbia, Canada, and its principal executive offices are located in Canada. Most of the Company’s directors and officers and most of the experts named in this AIF reside outside of the United States and all or a substantial portion of the Company’s assets and the assets of these persons are located outside the United States. Consequently, it may not be possible for an investor to effect service of process within the United States on the Company or those persons. Furthermore, it may not be possible for an investor to enforce judgments obtained in United States courts based upon the civil liability provisions of United States federal securities laws or other laws of the United States against those persons or the Company. There is doubt as to the enforceability, in original actions in Canadian courts, of liabilities based upon United States federal securities laws and as to the enforceability in Canadian courts of judgments of United States courts obtained in actions based upon the civil liability provisions of the United States federal securities laws. Therefore, it may not be possible to enforce those actions against the Company, certain of the Company’s directors and officers or the experts named in this AIF.

We are an emerging growth company and take advantage of reduced disclosure requirements ‎applicable to emerging growth companies, which could make our Common Shares less attractive to ‎investors.‎

We are an “emerging growth company” as defined in the JOBS Act. We will remain an emerging growth ‎company until the earliest to occur of (i) the last day of the fiscal year in which we have total annual gross ‎revenue of $1.235 billion or more; (ii) December 31, 2026 (the last day of the fiscal year ending after the fifth ‎anniversary of the date of the completion of the first sales of its common equity pursuant to an effective ‎registration statement under the Securities Act); (iii) ‎the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-‎year period; or (iv) the date we qualify as a “large accelerated filer” under the rules of the SEC, which means the ‎market value of our Common Shares held by non-affiliates exceeds $700 million as of the last business day of ‎its most recently completed second fiscal quarter after we have been a reporting company in the United States ‎for at least 12 months. For so long as we remain an emerging growth company, we are permitted to and intend to ‎rely upon exemptions from certain disclosure requirements that are applicable to other public companies that ‎are not emerging growth companies. These exemptions include not being required to comply with the auditor ‎attestation requirements of Section 404 (“Section 404”) of the Sarbanes-Oxley Act (2002), as amended (the “Sarbanes-Oxley Act”).‎

Draganfly Inc. | Annual Information Form         36

We may take advantage of some, but not all, of the available exemptions available to emerging growth ‎companies. We cannot predict whether investors will find our Common Shares less attractive if we rely on these ‎exemptions. If some investors find our Common Shares less attractive as a result, there may be a less active ‎trading market for our Common Shares and the price of our Common Shares may be more volatile.

We incur increased costs as a result of operating as a public company in the United States ‎and our management is required to devote substantial time to compliance requirements.‎

As a U.S. public company, particularly if or when we are no longer an “emerging growth company” as defined ‎under the JOBS Act, we incur significant legal, accounting and other expenses, in addition to those we ‎incur as a Canadian public company, that we did not incur prior to being listed on Nasdaq. In ‎addition, the Sarbanes-Oxley Act, and rules implemented by the SEC and Nasdaq impose various other ‎requirements on public companies, and we spend time and resources to ensure compliance with our ‎reporting obligations in both Canada and the United States.‎

For example, pursuant to Section 404, we are required to furnish a report by our management on our internal ‎control over financial reporting (“ICFR”), which, if or when we are no longer an emerging growth company, must ‎be accompanied by an attestation report on ICFR issued by our independent registered public accounting firm. ‎To achieve compliance with Section 404, we must document and evaluate our ICFR, ‎which is both costly and challenging. In this regard, we must dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the ‎adequacy of our ICFR, continue steps to improve control processes as appropriate, validate through testing that ‎controls are functioning as documented and implement a continuous reporting and improvement process for ‎ICFR. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will ‎be able to conclude that our ICFR is effective as required by Section 404. This ‎could result in a determination that there are one or more material weaknesses in our ICFR, which could cause an ‎adverse reaction in the financial markets due to a loss of confidence in the reliability of our consolidated ‎financial statements.‎

In addition, becoming a public company in the United States has increased legal and financial compliance as well ‎as regulatory costs, such as additional Nasdaq fees, and has made some of our public company obligations ‎more time consuming. We invest resources to comply with evolving laws, regulations and standards in ‎both Canada and the United States, and this investment results in increased general and administrative ‎expenses and increased diversion of management’s time and attention from revenue-generating activities to ‎compliance activities. If our efforts to comply with public company laws, regulations and standards in the ‎United States are insufficient, regulatory authorities may initiate legal proceedings against us and our business ‎may be harmed.‎

Being a public company in the United States and complying with applicable rules and ‎regulations also makes it more expensive for us to obtain sufficient levels of director and officer liability insurance ‎coverage. This factor may also make it more difficult for us to attract and retain qualified executive officers and ‎members of our Board of Directors.‎

Draganfly Inc. | Annual Information Form         37

As a foreign private issuer, we are subject to different U.S. securities laws and rules than a domestic U.S. ‎issuer, which may limit the information publicly available compared to U.S. domestic issuers.‎

We are currently a “foreign private issuer” under applicable U.S. federal securities laws and, therefore, are ‎not required to comply with all of the periodic disclosure and current reporting requirements of the United States Securities Exchange Act of 1934, as amended (the “Exchange Act”), and related rules and regulations. As a result, we do ‎not file the same reports that a U.S. domestic issuer would file with the SEC, although we are required to file ‎with or furnish to the SEC the continuous disclosure documents that we are required to file in Canada under ‎Canadian securities laws. In addition, our officers, directors and principal shareholders are exempt from the ‎reporting and “short swing” profit recovery provisions of Section 16 of the Exchange Act. Therefore, our ‎shareholders may not know on as timely a basis when our officers, directors and principal shareholders purchase ‎or sell our securities as the reporting periods under the corresponding Canadian insider reporting requirements are ‎longer. In addition, as a foreign private issuer, we are exempt from the proxy rules under the Exchange Act. We ‎are also exempt from Regulation FD, which prohibits issuers from making selective disclosures of material non-‎public information. While we expect to comply with the corresponding requirements relating to proxy statements ‎and disclosure of material non-public information under Canadian securities laws, these requirements differ from ‎those under the Exchange Act and Regulation FD and shareholders should not expect to receive in every case the ‎same information at the same time as such information is provided by U.S. domestic issuers.‎

In addition, as a foreign private issuer, we have the option to follow certain Canadian corporate governance ‎practices, except to the extent that such laws would be contrary to U.S. federal securities laws and Nasdaq ‎listing rules and provided that we disclose the requirements we are not following and describe the Canadian ‎practices we follow instead. We rely on this exemption in part. As a result, our shareholders may not have ‎the same protections afforded to shareholders of U.S. domestic issuers that are subject to all U.S. corporate ‎governance requirements.‎

At some point in the future, we may cease to be a foreign private issuer. If we cease to ‎qualify, we will be subject to the same reporting requirements and corporate governance requirements as a U.S. ‎domestic issuer, which may increase our costs of being a public company in the ‎United States.‎

DESCRIPTION OF CAPITAL STRUCTURE

Common Shares

The Company’s authorized share structure consists of: (i) an unlimited number of Common Shares; and (ii) an unlimited ‎number of Preferred Shares, issuable in series.‎

As of the date hereof, 34,984,965 Common Shares are issued and outstanding (34,270,579 as at December 31, 2022). Each Common Share entitles the holder ‎to receive notice of and attend all meetings of the shareholders. Each Common Share carries the right to one vote. The ‎holders of Common Shares are entitled to receive any dividends declared by the Company in respect of the Common ‎Shares at such time and in such amount as may be determined by the Board, in its discretion. In the event of the ‎liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary, holders of Common Shares ‎are also entitled to participate, rateably, in the distribution of the assets of the Company, subject to the rights of the ‎holders of any other class of shares ranking in priority to the Common Shares. ‎

As of the date hereof, nil Preferred Shares are issued and outstanding (nil as at December 31, 2022). The Preferred Shares may be issuable in series ‎and the directors may, from time to time before the issue of any Preferred Shares of any particular series, define and ‎attach special rights, privileges, restrictions, and conditions to the Preferred Shares of any series, including voting rights, ‎entitlement to dividends, and redemption, conversion, and exchange rights. In the event of the liquidation, dissolution, or ‎winding up of the Company, whether voluntary or involuntary, holders of Preferred Shares will rank on a parity with ‎holders of the Preferred Shares of every other series and be entitled to preference over the Common Shares and over ‎any other shares of the Company ranking junior to the Preferred Shares.‎

Draganfly Inc. | Annual Information Form         38

Market for Securities

Trading Price and Volume of Common Shares

The Common Shares are listed and posted for trading on the CSE under the symbol “DPRO” and on the Nasdaq under the symbol “DPRO”.‎

The following table sets forth the price range (high and low prices) in Canadian dollars of the Common Shares and volume traded on the CSE, for the periods indicated below.

2022	High (C$)	Low (C$)	Total Volume
January	‎2.22‎	‎1.34‎	‎556,191‎
February	‎1.75‎	‎1.35‎	‎184,388‎
March	‎4.80‎	‎1.50‎	‎2,242,098‎
April	‎3.18‎	‎1.60‎	‎532,294‎
May	‎1.80‎	‎1.10‎	‎545,077‎
June	‎1.40‎	‎1.07‎	‎218,936‎
July	‎1.28‎	‎1.05‎	‎202,991‎
August	‎1.42‎	‎1.10‎	‎172,346‎
September	‎1.50‎	‎0.90‎	‎455,428‎
October	‎1.05‎	‎0.75‎	‎153,156‎
November	‎1.61‎	‎0.65‎	‎1,541,206‎
December	‎1.49‎	‎0.98‎	‎527,001‎

2023	High (C$)	Low (C$)	Total Volume
January	3.00	1.00	1,970,927
February	3.25	2.13	1,830,083
March 1 - 24	3.30	2.24	1,086,704

On March 24, 2023, the last trading day of the Common Shares on the CSE before the date of this ‎AIF, the closing ‎price of the Common Shares was C$2.23.

The following table provides the price ranges and trading volume of the Common Shares on Nasdaq for ‎the periods indicated below:‎

2022	High (US$)	Low (US$)	Total Volume
January	‎1.75‎	‎1.05‎	‎3,471,937‎
February	‎1.37‎	‎1.03‎	‎2,241,423‎
March	‎3.84‎	‎1.15‎	‎205,933,220‎
April	‎2.53‎	‎1.22‎	‎7,473,351‎
May	‎1.39‎	‎0.90‎	‎3,753,768‎
June	‎1.13‎	‎0.81‎	‎3,794,745‎
July	‎0.98‎	‎0.80‎	‎2,255,558‎
August	‎1.10‎	‎0.83‎	‎2,922,827‎
September	‎1.15‎	‎0.65‎	‎4,120,534‎
October	‎0.76‎	‎0.59‎	‎1,916,755‎
November	‎1.22‎	‎0.50‎	‎17,995,175‎
December	‎1.10‎	‎0.72‎	‎3,747,548‎

2023	High (US$)	Low (US$)	Total Volume
January	2.28	0.73	13,712,600
February	2.46	1.56	14,657,500
March 1 - 24	2.45	1.61	7,354,800

On March 24, 2023, the last trading day of the Common Shares on the Nasdaq before the date of this ‎AIF, the closing ‎price of the Common Shares was US$1.65.

Draganfly Inc. | Annual Information Form         39

Prior Sales

Common Shares

The following table summarizes the issuances of common shares for the year ended December 31, 2022:

Date of Issuance	Number of Common ‎Shares Issued	Issuance Price
January 4, 2022	941(1)	C$3.55
January 4, 2022	1,600(1)	C$3.55
January 4, 2022	13,997(1)	C$3.55
March 23, 2022	12,500(2)	C$2.15
May 2, 2022	11,666(3)	C$1.60
September 7, 2022	271,500(3)	Average price of C$1.3508
September 7, 2022	224,997(3)	C$1.25
September 9, 2022	8,608(3)	C$1.21
September 29, 2022	86,776(3)	US$0.66
October 13, 2022	240,044(3)	C$1.04
November 10, 2022	147,943(3)	US$0.5908
November 23, 2022	81,061(3)	C$0.8615

Notes:

(1)	Issued pursuant to the exercise of warrants of the Company‎.
(2)	Issued pursuant to the exercise of stock options of the Company‎.
(3)	Issued pursuant to the settlement of RSUs of the Company‎.

Stock Options

During the year ended December 31, 2022, the Company did not grant any stock options pursuant to its share compensation plan.

Restricted Share Units

During the year ended December 31, 2022, the Company granted restricted share units (“RSUs”) pursuant to its share compensation plan exercisable for an aggregate of 1,820,972 Common Shares. The particulars of such grants are set forth in the following table:

Date of Grant	Number of RSUs Granted	Grant Date Fair Value
June 30, 2022	1,630,000	C$1.26
July 26, 2022	190,972	C$1.08

ESCROWED SECURITIES

As of the Effective Date, there are no securities that are currently held in escrow or that are subject to contractual restriction on transfer.

Draganfly Inc. | Annual Information Form         40

DIVIDENDS

The Company has not declared or paid a dividend. Other than the requirements of the BCBCA, there are ‎no restrictions on the Company that would prevent it from paying a dividend. However, as of the Effective Date, the Board of Directors intends to retain any future earnings (when available) for reinvestment in ‎the Company’s business, and therefore, it has no current intention to declare or pay dividends on the ‎Common Shares in the foreseeable future. Any future determination to pay dividends on the Common ‎Shares will be at the sole discretion of the Board of Directors after considering a variety of factors and ‎conditions existing from time to time including its earnings, financial condition and other relevant factors‎.

DIRECTORS AND OFFICERS

As at the date hereof, the Board is comprised of seven individuals. The following table sets forth the names and municipalities of residence of the current directors and executive officers of the Company, their respective positions and offices with the Company and the date first appointed or elected as a director and/or officer and their principal occupation(s) within the past five years.

Name, Occupation and Security Holding

Name and Municipality of Residence	Position Held and Date Appointed	Principal Occupation within the past five years‎
Cameron Chell Bowen Island, British Columbia, Canada	President(since April 27, 2022) and Chief Executive Officer, and a Director (August 14, 2019)	Chairman and Chief Executive Officer of the ‎Company from ‎August ‎‎2019 to May 9, 2022; President and CEO of the Company since April 27, 2022; President, Chairman ‎and co-founder of ‎CurrencyWorks Inc. from ‎‎November 2017 to present; Chief ‎Executive Officer ‎and co-founder of ‎Business Instincts Group ‎Inc‎., a ‎Calgary-based Venture Creation Firm, ‎from 2009 to ‎‎‎2021; co-founder of BitRail, LLC from May 2019 to ‎May ‎‎‎2020; co-creator and Chairman of KODAKOne ‎from May ‎‎2017 to May ‎‎2020; director of Health ‎Outcomes Worldwide ‎from June 2017 to ‎February ‎‎2021; and Chairman of TruTrace ‎Technologies Inc. ‎from April ‎‎2017 to September 2020‎
Scott Larson(3)(4) Vancouver, British Columbia, Canada	President and Director(July 3, 2020 to April 27, 2022) and Lead Director since April 27, 2022	Interim President from July 2020 to May 2022. Current CEO of SpaceAlpha Insights, an Earth Observation company building out space-based dual-purpose Synthetic Aperture Radar technology; former ‎‎Chief Executive Officer of ‎Helios Wire, ‎a satellite company ‎building out a ‎space-enabled ‎IoT/M2M network‎, from 2016 to ‎‎2019; and former ‎Chief ‎Executive Officer and founder of ‎UrtheCast ‎‎Corp. from 2010 to 2015‎.‎
Olen Aasen(1)(2)(3)(4) Vancouver, British Columbia, Canada	Director (August 14, 2019)	Practicing lawyer since 2007.‎
Andrew Hill Card Jr.(2) Jaffrey, New Hampshire, United States	Director (November 7, 2019)	Chairman of the National Endowment for ‎Democracy (NED), ‎a non-‎profit organization ‎‎dedicated to the growth and ‎strengthening of ‎‎democratic institutions around the world, ‎from ‎January 2018 to January ‎‎2021; Interim Chief ‎Executive ‎Officer of the George & Barbara Bush ‎‎Foundation from June ‎‎2020 to December 2020; and ‎President of ‎Franklin Pierce ‎University in New ‎Hampshire from January 2015 to ‎August ‎‎2016‎; Chief of Staff to President George W. Bush from January 2001 to April 2006; as well as 11th Secretary of Transportation.

Draganfly Inc. | Annual Information Form         41

Name and Municipality of Residence	Position Held and Date Appointed	Principal Occupation within the past five years‎
John M. Mitnick(1)(2) McLean, Virginia, United States	Director (June 18, 2020) and Chairman (April 27, 2022)	Executive Vice President, General Counsel, and Secretary of Valaurum, Inc., since August 2022; Member of Board of Directors of Valaurum, Inc., ‎March 2016 ‎to February ‎‎2018 and October ‎‎2019 to present; Advisor to Carbon ‎Neutral Royalty Ltd. ‎from ‎February 2022 to present; General ‎Counsel of the U.S. ‎Department ‎of Homeland Security from ‎February ‎‎2018 to September 2019; and ‎Senior Vice President, ‎‎General Counsel, and Secretary of The Heritage ‎‎Foundation ‎from March 2014 to February 2018‎.‎
Denis Silva(3) Vancouver, British Columbia, Canada	Director (August 14, 2019)	Corporate and securities partner with the law ‎firm DLA Piper (Canada) ‎LLP ‎since July 2020; ‎and ‎partner at the law firm Gowling WLG ‎‎(Canada) LLP ‎from 2015 to 2020‎.
Julie Myers Wood(1)(4) Mclean, Virginia, United States	Director (September 9, 2021)	Chief Executive Officer of Guidepost Solutions LLC ‎since ‎May 2014. ‎
Paul Sun Oakville, Ontario, Canada	Chief Financial Officer (August 14, 2019)	Chief Financial Officer of the Company since August 2019; Chief Financial Officer of Former ‎Draganfly since July 2015; and Managing Director, ‎Institutional Equity Sales at Beacon Securities Limited‎ from January 2013 to December 2014.
Deborah R. Greenberg Montreal, Quebec, Canada	Chief Legal and Corporate Services Officer and Corporate Secretary (July 4, 2022)	Chief Legal Officer of the Company since July 4, 2022; Chief Legal and Corporate Services Officer of the Company since December 1, 2022; Chief Legal Officer (2017-2019) and Chief Information Officer (2019-2021) at Canada Mortgage and Housing Corporation; Various roles including General Counsel at Aimia from 2007-2017.
Paul Mullen Burnaby, BC, Canada	Chief Operating Officer (March 1, 2022)	Chief Operating Officer of the company since March 1, 2022; Vice President since April 13, 2021. Vice President (2019-2021) Monark Ventures. Various Roles including Manager Sales, Technical Service Delivery & Operations at Shaw Cablesystems G.P. from 2001-2018.

Notes:

(1)	Member of the Audit Committee.
(2)	Member of the Nominating and Corporate Governance Committee.
(3)	Member of the Compensation Committee
(4)	Member of the ATM Committee

As at the Effective Date, the directors and senior officers of Draganfly, as a group, beneficially own or control, directly or indirectly, 708,902 Common Shares or 2.0% of the issued and outstanding Common Shares.

The directors listed above will hold office until the next annual meeting of the Company or until their successors are elected or appointed.

Draganfly Inc. | Annual Information Form         42

Corporate Cease Trade Orders, Bankruptcies, Penalties or Sanctions

To the knowledge of management, no director or executive officer as at the date hereof, is or was within 10 years before the date hereof, a director, chief executive officer or chief financial officer of any company (including Draganfly), that (a) was subject to an order that was issued while the director or executive officer was acting in the capacity as director, chief executive officer or chief financial officer, or (b) was subject to an order that was issued after the director or executive officer ceased to be a director, chief executive officer or chief financial officer and which resulted from an event that occurred while that person was acting in the capacity as director, chief executive officer or chief financial officer. For the purposes hereof, “order” means (a) a cease trade order, (b) an order similar to a cease trade order, or (c) an order that denied the relevant company access to any exemption under securities legislation, that was in effect for a period of more than 30 consecutive days.

To the knowledge of management, other than as disclosed herein, no director or executive officer of Draganfly, or a shareholder holding a sufficient number of securities of Draganfly to affect materially the control of the company (a) is, as at the date hereof, or has been within the 10 years before the date hereof, a director or executive officer of any company (including Draganfly) that, while that person was acting in that capacity, or within a year of that person ceasing to act in that capacity, became bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency or was subject to or instituted any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or trustee appointed to hold its assets, or (b) has, within the 10 years before the date hereof, become bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or become subject to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver, receiver manager or trustee appointed to hold the assets of the director, executive officer or shareholder.

By Order of the Supreme Court of Newfoundland and Labrador dated June 17, 2020, Deloitte Restructuring Inc. ‎was appointed as the receiver and manager of all current and future assets, undertakings, and properties of the ‎Kami Mine Limited Partnership, Kami General Partner Limited, and Alderon Iron Ore Corp. The receivership was ‎initiated by a secured creditor of the Kami Mine Limited Partnership after its failure to refinance the secured debt ‎due to the COVID-19 pandemic. Mr. Aasen was Corporate Secretary of Alderon Iron Ore Corp. and Secretary and ‎Director of Kami General Partner Limited until April 28, 2020.‎

Penalties or Sanctions

To the knowledge of management ‎, no director, executive officer or shareholder holding a sufficient number of securities of Draganfly to materially affect the control of the Company has been subject to: (i) any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory authority or has entered into a settlement agreement with a securities regulatory authority; or (ii) any other penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable investor in making an investment decision.

Conflicts of Interest

There are potential conflicts of interest to which the directors and officers of Draganfly will be subject to in connection with the operations of Draganfly. In particular, certain of the directors and officers of Draganfly are involved in managerial or director positions with other companies whose operations may, from time to time, be in direct competition with those of Draganfly or with entities which may, from time to time, provide financing to, or make equity investments in, competitors of Draganfly.

In accordance with the applicable corporate and securities legislation, directors who have a material interest or any person who is a party to a material contract or a proposed material contract with Draganfly are required, subject to certain exceptions, to disclose that interest and generally abstain from voting on any resolution to approve the contract. In addition, the directors are required to act honestly and in good faith with a view to the best interests of Draganfly. Certain of the directors and each of the executive officers of Draganfly have either other employment or other business or time restrictions placed on them and accordingly, these directors of Draganfly will only be able to devote part of their time to the affairs of Draganfly. To the extent that conflicts of interest arise, such conflicts will be resolved in accordance with the provisions of the applicable corporate law.

Draganfly Inc. | Annual Information Form         43

AUDIT COMMITTEE

Audit Committee Charter

The full text of the Company’s Audit Committee Charter is included as Schedule A to the AIF.

Audit Committee Composition

The following are the members of the Audit Committee as at the date hereof:

Olen Aasen (Chair)	Independent(1)	Financially Literate(1)
Julie Myers Wood	Independent(1)	Financially Literate(1)
John M. Mitnick	Independent(1)	Financially Literate(1)

Note:

(1) As defined by NI 52-110.

Relevant Education and Experience

Olen Aasen

Mr. Aasen is a corporate and securities lawyer with more than 15 years of experience in corporate, securities ‎and regulatory matters. He has been the Corporate Secretary, General Counsel or Vice President, Legal at ‎various Canadian and U.S. listed companies. Mr. Aasen obtained a J.D. from the University of British ‎Columbia in 2006 and was called to the British Columbia Bar in 2007. Mr. Aasen was also appointed to the ‎‎2016 Legal 500 GC Powerlist for Canada‎.

Julie Myers Wood

Chief Executive Officer of Guidepost Solutions LLC ‎since ‎May 2014; ‎Chief Executive Officer of ICS ‎Consulting LLC; ‎and has held several ‎highlevel ‎positions within the U.S. ‎government including at the ‎‎Departments of Justice, Homeland ‎Security, Treasury, ‎and Commerce, ‎as well as at the White ‎House‎

John M. Mitnick

Executive Vice President, General Counsel, and Secretary of Valaurum, Inc., since August 2022; Member of Board of Directors of Valaurum, Inc., ‎March 2016 ‎to February ‎‎2018 and October ‎‎2019 to present; Advisor to Carbon ‎Neutral Royalty Ltd. ‎from ‎February 2022 to present; General ‎Counsel of the U.S. ‎Department ‎of Homeland Security from ‎February ‎‎2018 to September 2019; and ‎Senior Vice President, ‎‎General Counsel, and Secretary of The Heritage ‎‎Foundation ‎from March 2014 to February 2018‎.

‎

Each member of the Audit Committee has:

● an understanding of the accounting principles used by the Company to prepare its financial statements, and the ability to assess the general application of those principles in connection with estimates, accruals and reserves;

● experience with analyzing or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by the Company’s financial statements, or experience actively supervising individuals engaged in such activities; and

● an understanding of internal controls and procedures for financial reporting.

Draganfly Inc. | Annual Information Form         44

Audit Committee Oversight

At no time since the commencement of the Company’s financial year ended December 31, 2022, was a recommendation of the Committee to nominate or compensate an external auditor not adopted by the Board of Directors.

Reliance on Certain Exemptions

At no time since the commencement of the Company’s financial year ended December 31, 2022, has the Company relied on any exemption from NI 52-110, including Section 2.4 of NI 52-110 (De Minimis Non-Audit Services), or an exemption granted under Part 8 of NI 52-110.

The Company has relied upon the exemption provided by section 6.1 of NI 52-110 which exempts venture issuers from the requirement to comply with the restrictions on the composition of its audit committee.

Pre-Approval Policies and Procedures

The Audit Committee is authorized by the Board to review the performance of the Company’s external auditors and approve in advance provision of services other than auditing and to consider the independence of the external auditors, including reviewing the range of services provided in the context of all consulting services bought by the Company. The Audit Committee is authorized to approve any non-audit services or additional work which the Chairman of the Audit Committee deems as necessary who will notify the other members of the Audit Committee of such non-audit or additional work.

External Auditor Service Fees

The aggregate fees billed by the Company’s external auditors in each of the last two fiscal years for audit fees are as follows:

Financial Year Ending	Audit Fees(1) ($)	Audit Related Fees(2) ($)	Tax Fees(3) ($)	All Other Fees(4) ($)
2022	250,000	63,900	11,000	-
2021	227,500	24,000	11,000	-

Notes:

(1)	“Audit Fees” include fees necessary to perform the annual audit and quarterly reviews of our financial statements. Audit Fees include fees for review of tax provisions and for accounting consultations on matters reflected in the financial statements. Audit Fees also include audit or other attest services required by legislation or regulation, such as comfort letters, consents, reviews of securities filings and statutory audits.
(2)	“Audit-Related Fees” for assurance and related services that are reasonably related to the performance of the audit or review of the Company’s financial statements and are not reported as audit fees. The services provided in this category include due diligence assistance, accounting consultations on proposed transactions, and consultation on International Financial Reporting Standards conversion.
(3)	“Tax Fees” include fees for all tax services other than those included in “Audit Fees” and “Audit-Related Fees”. This category includes fees for tax compliance, tax planning and tax advice.
(4)	“All Other Fees” includes all fees other than those reported as Audit Fees, Audit-Related Fees or Tax Fees.

Legal Proceedings AND Regulatory actions

Draganfly is not, and has not been at any time within the most recently completed financial year, a party to any legal proceedings, nor is or was Draganfly’s property the subject of any legal proceedings, known or contemplated, that involves a claim for damages exclusive of interest and costs that met or exceeded 10% of the Company’s current assets.

Draganfly Inc. | Annual Information Form         45

Further, there have not been any (a) penalties or sanctions imposed against the Company by a court relating to securities legislation or by a securities regulatory authority during the year ended December 31, 2022, (b) any other penalties or sanctions imposed by a court or regulatory body against the Company that would likely be considered important to a reasonable investor in making an investment decision, or (c) settlement agreements entered into by the Company before a court relating to securities legislation or with a securities regulatory authority during the year ended December 31, 2022.

INTERESTS OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS

Other than as set forth herein, or as previously disclosed, the Company is not aware of any material interests, ‎direct or indirect, by way of beneficial ownership of securities or otherwise, of any director or executive officer ‎or any shareholder holding more than 10% of the Common Shares or any associate or affiliate of any of the ‎foregoing in any transaction within the three most recently completed financial years or during the current ‎financial year or any proposed or ongoing transaction of the Company which has or will materially affect the ‎Company‎.

AUDITOR, TRANSFER AGENT AND REGISTRAR

The auditors of the Company are Dale Matheson Carr-Hilton Labonte LLP, Chartered Professional Accountants, 1500-1700, 1140 W Pender Street, Vancouver, BC V6E 4G1.

Endeavor Trust Corporation is the transfer agent and registrar for the Common Shares at its principal office in Vancouver, British Columbia.

MATERIAL CONTRACTS

There are no material contracts entered into by Draganfly within the most recently completed financial year, or ‎before the most recently completed financial year but which are still in effect, other than contracts entered into ‎in the ordinary course of business‎.

INTERESTS OF EXPERTS

There is no person or company whose profession or business gives authority to a statement made by such person or company and who is named as having prepared or certified a statement, report or valuation described or included in a filing, or referred to in a filing, made under NI 51-102 by the Company during, or related to, the Company’s most recently completed financial year other than Dale Matheson Carr-Hilton Labonte LLP, the Company’s auditors.

Dale Matheson Carr-Hilton Labonte LLP are the auditors of the Company and have confirmed that they are independent with respect to the Company within the meaning of the relevant rules and related interpretations prescribed by the relevant bodies in Canada and any applicable legislation or regulations.

Denis Silva, a director of the Company, is a lawyer at DLA Piper (Canada) LLP, which is a law firm that provides legal services to the Company. As of the date hereof, the associates and partners of DLA Piper (Canada) LLP, as a group, beneficially own, directly or indirectly, less than 1% of the outstanding Common Shares.

ADDITIONAL INFORMATION

Additional information relating to the Company may be found on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.‎

Additional information, including directors’ and officers’ remuneration and indebtedness, principal holders of ‎Draganfly’s securities and securities authorized for issuance under equity compensation plans, where applicable, ‎will be contained in ‎Draganfly’s information circular for the next annual meeting of shareholders that involves the ‎election of directors and additional information as provided in ‎Draganfly’s comparative financial statements for its ‎most recently completed financial year. Draganfly will provide this information to any person, upon request made ‎to the Chief Financial Officer of ‎Draganfly at 2108 St. George Avenue Saskatoon, Saskatchewan S7M 0K7. The ‎documents will also be located on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.‎

Additional financial information is provided in the Company’s comparative financial statements and ‎management’s discussion and analysis for the period ended December 31, 2022, which are also available on ‎SEDAR and EDGAR.

Draganfly Inc. | Annual Information Form         46

 ‎
SCHEDULE A

DRAGANFLY INC.

AUDIT COMMITTEE CHARTER

PURPOSE

Senior management of Draganfly Inc. (the “Company”), as overseen by its Board of Directors (the “Board”), has primary responsibility for the Company’s financial reporting, accounting systems and internal controls. The Audit Committee (the “Committee”) is a standing committee of the Board established for the purposes of overseeing:

(a)	the quality and integrity of the Company’s financial and accounting reporting processes, audits of the financial statements of the Company, and internal accounting and financial control systems of the Company;
(b)	the external auditor’s qualifications and independence;
(c)	management’s responsibility for assessing the effectiveness of internal controls; and
(d)	the Company’s compliance with legal and regulatory requirements in connection with financial and accounting matters.

COMPOSITION AND OPERATION

1. The Committee shall be composed of at least three members, each of whom:

(a) must be an “Independent Director” (as defined in the Definitions section of this Charter), taking into account the rules and regulations of any securities regulatory authorities and/or stock exchanges that may be applicable to the Company;

(b) must not accept any consulting, advisory, or other compensatory fee from the Company (or any subsidiary) other than for board or committee service;

(c) must not be an “Affiliated Person” (as defined in the Definitions section of this Charter) of the Company or any of its subsidiaries;

(d) must not have participated in the preparation of the financial statements of the Company or any current subsidiary of the Company at any time during the past three years; and

(e) must be Financially Literate.

In addition, at least one member will be a “Committee Financial Expert” (as defined in the Definitions section of this Charter).

The foregoing requirements are subject to any exemptions, exceptions, cure periods or phase-in accommodations that may be available to the Company under applicable securities laws and stock exchange rules.

2. The members of the Committee shall be appointed by the Board to serve one-year terms and are permitted to serve an unlimited number of consecutive terms.

3. The Committee shall appoint a chair (the “Chair”) from among its members who shall be an independent director. If the Chair is not present at any meeting of the Committee, one of the other Committee members present at the meeting shall be chosen to preside at the meeting.

4. The Committee will make every effort to meet at least four times per year and each member is entitled to request that an additional meeting be called, which will be held within two weeks of the request for such meeting. A quorum at meetings of the Committee shall be two members present in person or by telephone. The Committee may also act by unanimous written consent of its members as described under the heading “Authority” in this Charter.

5. The external auditor may request the Chair to call a meeting of the Committee to consider any matter that the auditor believes should be brought to the attention of the directors or the shareholders of the Company. In addition to the external auditor, each committee chair, members of board, as well as the Chief Executive Officer (“CEO”) and the Chief Financial Officer (“CFO”) shall be entitled to request the Chair to call a meeting, which meeting shall be held within two weeks of the request.

6. Notice of the time and place of every meeting shall be given in writing or by email communication to each member of the Committee at least 24 hours prior to the time fixed for such meeting.

7. The Committee shall fix its own procedure at meetings, keep records of its proceedings and provide a verbal report to the Board routinely at the next regularly scheduled Board meeting and shall provide copies of finalized minutes of meetings to the Corporate Secretary to be kept with the official minute books of the Company.

8. The Committee will review and approve its minutes of meetings and copies will be made available to the external auditor or its members as requested.

9. In camera sessions will be scheduled for each regularly scheduled quarterly Committee meeting, and as needed from time to time.

10. On an ad-hoc basis, the Committee may also meet separately with the Chief Executive Officer and the Chief Financial Officer and such other members of management as they may deem necessary.

RESPONSIBILITIES AND DUTIES

Overall Committee:

To fulfill its responsibilities and duties the Committee will:

(a)	review this Charter periodically, but at least once per annum, and recommend to the Board any necessary amendments;
(b)	review and, where necessary, recommend revisions to the Company’s disclosure in the Company’s public disclosures and securities filings (including its Management Information Circular) regarding Committee’s composition and responsibilities and how they are discharged;
(c)	assist the Board in the discharge of its responsibilities relating to the quality, acceptability and integrity of the Company’s accounting policies and principles, reporting practices and internal controls;
(d)	review and recommend approval by the Board of all significant and material financial disclosure documents to be released by the Company, including but not limited to, quarterly and annual financial statements and management discussion and analysis, annual reports, Form 40-F, annual information forms, and prospectuses containing material information of a financial nature; and
(e)	oversee the relationship and maintain a direct line of communication with the Company’s internal and external auditors and assess their respective performance.

- 2 -

Public Filings, Policies and Procedures:

The Committee is responsible for:

(a)	ensuring adequate procedures are in place for the review of the Company’s disclosure of financial information extracted or derived from the Company’s financial statements and periodically assess the Company’s disclosure controls and procedures, and management’s evaluation thereof, to ensure that financial information is recorded, processed, summarized and reported within the time periods required by law;
(b)	reviewing disclosures made to the Committee by the CEO and the CFO during their certification process for any significant deficiencies in the design or operation of internal controls or material weakness therein and any fraud involving management or other employees who have a significant role in internal controls; and
(c)	reviewing with management and the external auditor any correspondence with securities regulators or other regulatory or government agencies which raise material issues regarding the Company’s financial reporting or accounting policies.

External Auditors

The responsibilities and duties of the Committee as they relate to the external auditor are to:

(a)	consider and make recommendations to the Board with respect to the appointment, compensation, and retention of the external auditor to be nominated for appointment by shareholders at each annual general meeting of the Company;
(b)	review the performance of the external auditor and, where appropriate, recommend to the Board the removal of the external auditor;
(c)	confirm the independence and effectiveness of the external auditor, which will require receipt from the external auditor of a formal written statement delineating all relationships between the auditor and the Company and any other factors that might affect the independence of the auditor;
(d)	oversee the work of the external auditor generally, and review and report to the Board on the planning and results of external audit work, including:

(i)	the external auditor’s engagement letter or other reports of the auditor;
(ii)	the reasonableness of the estimated fees and other compensation to be paid to the external auditor;
(iii)	the form and content of the quarterly and annual audit report, which should include, inter alia:

(A)	a summary of the Company’s internal controls and procedures;
(B)	any material issues raised in the most recent meeting of the Committee; and
(C)	any other related audit, review or attestation services performed for the Company by the external auditors.

- 3 -

(e)	actively engage in dialogue with the external auditor with respect to any disclosed relationships or services that may affect the independence and objectivity of the external auditor and take, or recommend the Board take, appropriate actions to oversee the independence of the external auditor;
(f)	monitor the relationship between management and the external auditor and resolve any disagreements between them regarding financial reporting; and
(g)	engage the external auditor in discussions regarding any amendments to critical accounting policies and practices; alternative treatments of financial information within generally accepted accounting principles related to material items that have been discussed with management, including any potential ramifications and the preferred treatment by the independent auditor; and lastly, written communication between management and the independent auditor, including but not limited to, the management letter and schedule of adjusted differences.

Internal Controls and Financial Reporting

The Committee will:

(a)	obtain reasonable assurance from discussions with (and/or reports from) management, and reports from the external auditors that the Company’s financial and accounting systems are reliable and that the prescribed internal controls are operating effectively;
(b)	in consultation with the external auditor, the CEO, the CFO, and where necessary, other members of management, review the integrity of the Company’s financial reporting process and the internal control structure;
(c)	review the acceptability of the Company’s accounting principles and direct the auditors’ examinations to particular areas of question or concern, as required;
(d)	request the auditors to undertake special examinations (e.g., review compliance with conflict of interest policies) when it deems necessary;
(e)	together with management, review control weaknesses identified by the external and internal auditors;
(f)	review the appointments of the CFO and other key financial executives; and
(g)	during the annual audit process, consider if any significant matters regarding the Company’s internal controls and procedures over financial reporting, including any significant deficiencies or material weaknesses in their design or operation, need to be discussed with the external auditor, and review whether internal control recommendations made by the auditor have been implemented by management.

Ethical and Legal Compliance

The responsibilities and duties of the Committee as they relate to compliance and risk management are to:

(a)	obtain reasonable assurances as to the integrity of the CEO and other senior management and that the CEO and other senior management strive to create a culture of integrity throughout the Company;
(b)	review the adequacy, appropriateness and effectiveness of the Company’s policies and business practices which impact on the integrity, financial and otherwise, of the Company, including those relating to hedging, insurance, accounting, information services and systems and financial controls, and management reporting;

- 4 -

(c)	receive a report from management on tax issues and planning, including compliance with the Company’s source deduction obligations and other remittances under applicable tax or other legislation;
(d)	review annually the adequacy and quality of the Company’s financial and accounting staffing, including the need for and scope of internal audit reviews (if any);
(e)	establish procedures for a) the receipt, retention and treatment of complaints received by the Company regarding accounting, internal controls, or auditing matters; and b) the confidential, anonymous submission by employees of the Company of concerns regarding questionable accounting or auditing matters.
(f)	review any complaints and concerns received regarding accounting, internal controls, or auditing matters or with respect to the Company’s Code of Ethical Conduct, and the investigation and resolution thereof, and provide all relevant information relating to such complaints and concerns to the Nominating and Governance Committee;
(g)	review and monitor the Company’s compliance with applicable legal and regulatory requirements related to financial reporting and disclosure;
(h)	review all “related party transactions” (as such term is defined under applicable securities laws and stock exchange rules) for any potential conflicts of interest; and
(i)	carry the responsibility for reviewing reports from management, external auditors with respect to the Company’s compliance with the laws and regulations having a material impact on financial reporting and disclosure, including: tax and financial reporting laws and regulations; legal withholding requirements; environmental; and any other laws and regulations which expose directors to liability.

AUTHORITY

1. The Committee shall have the authority to:

(a)	engage independent counsel and other advisors as it determines necessary to carry out its duties;
(b)	set and pay the compensation for the external auditor engaged for the purpose of preparing or issuing an audit report or performing other audit, review or attest services for the Company;
(c)	set and pay the compensation for any independent counsel and other advisors employed by the Committee;
(d)	incur ordinary administrative expenses that are necessary or appropriate in carrying out its duties; and
(e)	communicate directly with the external auditors.

2.	The Committee shall have the power, authority and discretion delegated to it by the Board which shall not include the power to change the membership of or fill vacancies in the Committee.
3.	A resolution approved in writing by the members of the Committee shall be valid and effective as if it had been passed at a duly called meeting. Such resolution shall be filed with the minutes of the proceedings of the Committee and shall be effective on the date stated thereon or on the latest date stated in any counterpart.

- 5 -

4.	The Board shall have the power at any time to revoke or override the authority given to or acts done by the Committee except as to acts done before such revocation or act of overriding and to terminate the appointment or change the membership of the Committee or fill vacancies in it as it shall see fit.
5.	The Committee shall have unrestricted and unfettered access to all Company personnel and documents and shall be provided with the resources necessary to carry out its responsibilities.
6.	At the invitation of the Chair, one or more officers or employees of the Company may, and if required by the Committee, shall attend a meeting of the Committee.
7.	The Committee shall have the authority to obtain advice and assistance from outside legal, accounting or financials advisors in its sole discretion.

DEFINITIONS

Capitalized terms used in this Charter and not otherwise defined have the meaning attributed to them below:

“Affiliated Person” means an “affiliate” of, or a person “affiliated” with, a specified person, which is a person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the person specified.

“Committee Financial Expert” means a person who has the following attributes:

(a)	past employment experience in finance or accounting;
(b)	requisite professional certification in accounting; or
(c)	or any other comparable experience or background which results in the individual’s financial sophistication, including being or having been a chief executive officer, chief financial officer or other senior officer with financial oversight responsibilities.

“Executive Officer” means the Company’s president, principal financial officer, principal accounting officer (or, if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division or function (such as sales, administration or finance), any other officer who performs a policy-making function, or any other person who performs similar policy-making functions for the Company.

“Family Member” means a person’s spouse, parents, children, siblings, mothers and fathers-in-law, sons and daughters-in-law, brothers and sisters-in-law, and anyone (other than domestic employees) who shares such person’s home.

“Financially Literate” means the ability to read and understand a set of fundamental financial statements, including the Company’s balance sheet, income statement, and cash flow statement, that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised in the Company’s financial statements.

“Independent Director” means a director that is “independent” as the term is defined in both National Instrument 52-110 - Audit Committees (“NI 52-110”) and Nasdaq Rule 5605(a)(2), as each may be amended from time to time, and being a person other than an Executive Officer or employee of the Company or any other individual having a relationship which, in the opinion of the Company’s board of directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. The following persons shall not be considered independent:

(a) a director who is, or at any time during the past three years was, employed by the Company;

- 6 -

(b) a director who accepted or who has a Family Member who accepted any compensation from the Company in excess of $120,000 during any period of twelve consecutive months within the three years preceding the determination of independence, other than the following:

(i)	compensation for board or board committee service;
(ii)	compensation paid to a Family Member who is an employee (other than an Executive Officer) of the Company; or
(iii)	benefits under a tax-qualified retirement plan, or non-discretionary compensation.

Provided, however, that in addition to the requirements contained in this paragraph (B), audit committee members are also subject to additional, more stringent requirements under Rule 5605(c)(2).

(c)

a director who is a Family Member of an individual who is, or at any time during the past three years was, employed by the Company as an Executive Officer;

(d)

a director who is, or has a Family Member who is, a partner in, or a controlling Shareholder or an Executive Officer of, any organization to which the Company made, or from which the Company received, payments for property or services in the current or any of the past three fiscal years that exceed 5% of the recipient’s consolidated gross revenues for that year, or $200,000, whichever is more, other than the following:

(i)	payments arising solely from investments in the Company’s securities; or
(ii)	payments under non-discretionary charitable contribution matching programs.

(e)	a director of the Company who is, or has a Family Member who is, employed as an Executive Officer of another entity where at any time during the past three years any of the Executive Officers of the Company serve on the compensation committee of such other entity; or
(f)	a director who is, or has a Family Member who is, a current partner of the Company’s outside auditor, or was a partner or employee of the Company’s outside auditor who worked on the Company’s audit at any time during any of the past three years.

Adopted by the Board on August 19, 2019, and amended Updated and Approved, 2021.

- 7 -

EX-99.2

Exhibit 99.2

Draganfly Inc.

Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

(Expressed in Canadian Dollars)

 

Report of Independent Registered Public Accounting Firm

To the shareholders and the board of directors of Draganfly Inc.

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated statements of financial position of Draganfly Inc. (the “Company”) as of December 31, 2022 and 2021, the related consolidated statements of comprehensive loss, changes in shareholders’ equity and cash flows, for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and its financial performance and its cash flows for the years then ended, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.

Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has incurred losses in developing its business, and further losses are anticipated. The Company requires additional funds to meet its obligations and the costs of its operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in this regard are described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting in accordance with the standards of the PCAOB. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion in accordance with the standards of the PCAOB.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ DMCL

DALE MATHESON CARR-HILTON LABONTE LLP

CHARTERED PROFESSIONAL ACCOUNTANTS

We have served as the Company’s auditor since 2018

Vancouver, Canada

March 27, 2023

F-1

Draganfly Inc.

Consolidated Statements of Financial Position

Expressed in Canadian Dollars

		December 31,			December 31,
As at	Notes	2022			2021
ASSETS
Current Assets
Cash and cash equivalents	4	$	7,894,781		$	23,075,713
Receivables	5		2,088,965			1,407,127
Inventory	6		1,055,942			3,390,822
Notes receivable	7		169,300			190,170
Prepaids	8		2,307,724			5,494,877
Total current assets			13,516,712			33,558,709
Non-current Assets
Goodwill	11		-			5,940,409
Equipment	10		404,691			297,043
Intangible assets	11		179,801			593,901
Investments	9		192,583			291,066
Notes receivable	7		-			964,006
Right of use assets	12		344,746			468,106
TOTAL ASSETS		$	14,638,533		$	42,113,240
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Trade payables and accrued liabilities	14	$	2,816,676		$	799,139
Customer deposits			194,758			172,134
Deferred income	15		63,690			73,286
Loans payable	16		81,512			6,745
Derivative liability	17		57,314			5,560,002
Lease liabilities	13		133,962			110,481
Total current liabilities			3,347,912			6,721,787
Non-current Liabilities
Loans payable	16		5,059			86,572
Lease liabilities	13		244,681			378,642
TOTAL LIABILITIES			3,597,652			7,187,001
SHAREHOLDERS’ EQUITY
Share capital	17		83,600,089			81,038,365
Reserves – share-based payments	17		7,264,340			6,406,117
Accumulated deficit			(79,976,546	)		(52,322,182	)
Accumulated other comprehensive income (loss)			152,998			(196,061	)
TOTAL SHAREHOLDERS’ EQUITY			11,040,881			34,926,239
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY		$	14,638,533		$	42,113,240

Nature and Continuance of Operations (Note 1)

Subsequent Events (Note 7, 17, 24)

Approved and authorized for issuance by the Board of Directors on March 27, 2023.

/s/ Scott Larson	/s/ Cameron Chell
Director	Director

The accompanying notes are an integral part of these consolidated financial statements.

F-2

Draganfly Inc.

Consolidated Statements of Comprehensive Loss

Expressed in Canadian Dollars

		For the years ended December 31,
	Note	2022			2021
REVENUE
Sales of goods	18	$	5,550,432		$	5,103,399
Provision of services	18		2,054,627			1,950,466
TOTAL REVENUE			7,605,059			7,053,865
COST OF SALES	6		(6,814,384	)		(4,410,777	)
GROSS PROFIT			790,675			2,643,088
OPERATING EXPENSES
Amortization	11		179,482			135,966
Depreciation	10,12		593,277			175,098
Director fees	20		522,349			370,094
Insurance			3,722,237			2,962,767
Office and miscellaneous	19		5,397,961			6,455,998
Professional fees	20		6,821,583			4,445,949
Research and development			651,302			510,895
Share-based payments	17		3,311,024			3,952,595
Travel			396,388			143,904
Wages and salaries	20		6,105,020			2,768,010
			(27,700,623	)		(21,921,276	)
OTHER INCOME (EXPENSE)
Change in fair value of derivative liability	3,17		5,502,688			8,149,812
Finance and other costs			44,345			5,074
Foreign exchange gain (loss)			745,102			362,448
Loss on disposal of assets	10		(10,755	)		-
Loss on write-off of notes receivable	7		(309,385	)		(891,471	)
Government income			2,446			24,148
Write down of deposit	8		(228,572	)		-
Loss on impairment of goodwill and intangibles	11		(6,454,914	)		(4,579,763	)
Other income (expense)			(35,371	)		4,968
NET LOSS			(27,654,364	)		(16,202,972	)
OTHER COMPREHENSIVE INCOME (LOSS)
Items that may be reclassified to profit or loss
Foreign exchange translation			447,542			136,475
Items that will not be reclassified to profit or loss
Change in fair value of equity investments at FVOCI	9		(98,483	)		(332,640	)
COMPREHENSIVE LOSS		$	(27,305,305	)	$	(16,399,137	)
Net loss per share
Basic & diluted		$	(0.82	)	$	(0.59	)
Weighted average number of common shares outstanding - basic & diluted			33,556,969			27,787,348

The accompanying notes are an integral part of these consolidated financial statements.

F-3

Draganfly Inc.

Consolidated Statements of Changes in Shareholders’ Equity

Expressed in Canadian Dollars

												Accumulated Other Comprehensive Income (Loss)
	Number of Shares		Share Capital			Reserves – Share-Based Payments			Accumulated Deficit			Change in Fair Value of Investments at FVTOCI			Exchange Differences on Translation of Foreign Operations		Total Shareholders’ Equity
Balance at December 31, 2020		17,218,695	$	36,943,304		$	3,024,007		$	(36,119,210	)	$	-		$	104	$	3,848,205
Shares issued for acquisition of Vital		1,200,000		2,303,999			1,241,250			-			-			-		3,545,249
Shares issued for financing		11,584,657		36,092,187			-			-			-			-		36,092,187
Share issue costs		-		(4,678,821	)		864,060			-			-			-		(3,814,761	)
Shares issued for exercise of RSUs		448,660		1,752,052			(1,752,052	)		-			-			-		-
Shares issued for exercise of warrants		1,939,534		4,929,790			-			-			-			-		4,929,790
Shares issued for exercise of stock options		405,499		1,937,866			(923,743	)		-			-			-		1,014,123
Shares issued in lieu of cash		371,901		1,757,988			-			-			-			-		1,757,988
Share-based payments		-		-			3,952,595			-			-			-		3,952,595
Net loss		-		-			-			(16,202,972	)		-			-		(16,202,972	)
Change in fair value of equity investments at FVOCI		-		-			-			-			(332,640	)		-		(332,640	)
Translation of foreign operations		-		-			-			-			-			136,475		136,475
Balance at December 31, 2021		33,168,946	$	81,038,365		$	6,406,117		$	(52,322,182	)	$	(332,640	)	$	136,579	$	34,926,239
Shares issued for exercise of stock options		12,500		51,875			(25,000	)		-			-			-		26,875
Shares issued for exercise of warrants		16,538		87,170			-			-			-			-		87,170
Shares issued for the exercise of RSUs		1,072,595		2,427,801			(2,427,801	)		-			-			-		-
Share issue costs		-		(5,122	)		-			-			-			-		(5,122	)
Share-based payments		-		-			3,311,024			-			-			-		3,311,024
Net loss		-		-			-			(27,654,364	)		-			-		(27,654,364	)
Change in fair value of equity investments at FVOCI		-		-			-			-			(98,483	)		-		(98,483	)
Translation of foreign operations		-		-			-			-			-			447,542		447,542
Balance at December 31, 2022		34,270,579	$	83,600,089		$	7,264,340		$	(79,976,546	)	$	(431,123	)	$	584,121	$	11,040,881

The accompanying notes are an integral part of these consolidated financial statements.

F-4

Draganfly Inc.

Consolidated Statements of Cash Flows

Expressed in Canadian Dollars

	For the year ended December 31,
	2022			2021
OPERATING ACTIVITIES
Net loss	$	(27,654,364	)	$	(16,202,972	)
Adjustments for:
Amortization		179,482			135,966
Depreciation		593,277			175,098
Change in fair value of derivative liability		(5,502,688	)		(8,149,812	)
Write down of inventory		1,976,514			-
Impairment of notes receivable		309,385			891,471
Impairment of goodwill and intangibles		6,454,914			4,579,763
Write down of deposit		228,572			-
Finance and other costs		(34,427	)		(926	)
Income from government assistance		-			(24,148	)
Share-based payments		3,311,024			3,952,595
		(20,138,311	)		(14,642,965	)
Net changes in non-cash working capital items:
Receivables		(681,838	)		(596,336	)
Inventory		(150,241	)		(2,157,203	)
Prepaids		2,958,581			(3,401,868	)
Trade payables and accrued liabilities		1,661,697			(1,044,133	)
Customer deposits		22,624			(213,315	)
Deferred income		(21,543	)		51,186
Cash used in operating activities		(16,349,031	)		(22,004,634	)
INVESTING ACTIVITIES
Cash paid for acquisition, net of cash received		-			(466,643	)
Purchase of equipment		(79,713	)		(212,579	)
Disposal of equipment		10,755			-
Purchase of intangible assets		(4,684	)		-
Purchase of investments		-			(623,706	)
Repayment (Issuance) of notes receivable		842,297			(2,002,678	)
Cash provided by (used in) investing activities		768,655			(3,305,606	)
FINANCING ACTIVITIES
Proceeds from issuance of common shares for financing		-			44,255,651
Share issue costs		(5,122	)		(3,814,762	)
Proceeds from issuance of common shares for warrants exercised		87,170			4,929,790
Proceeds from issuance of common shares for stock options exercised		26,875			1,014,123
Proceeds from issuance of loans		-			60,000
Repayment of loans		(6,746	)		(48,747	)
Repayment of lease liabilities		(150,275	)		(128,996	)
Cash provided by (used in) financing activities		(48,098	)		46,267,059
Effects of exchange rate changes on cash		447,542			136,478
Change in cash		(15,628,474	)		20,956,819
Cash and cash equivalents, beginning of year		23,075,713			1,982,416
Cash and cash equivalents, end of year	$	7,894,781		$	23,075,713
Cash and cash equivalents consist of the following:
Cash held in banks	$	7,500,607		$	22,729,212
Guaranteed investment certificate		394,174			346,501
	$	7,894,781		$	23,075,713

The accompanying notes are an integral part of these consolidated financial statements.

F-5

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

1. NATURE AND CONTINUANCE OF OPERATIONS

Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company’s shares trade on the Canadian Securities Exchange (the “CSE”), on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8”. The Company’s head office is located at 2108 St. George Avenue, Saskatoon, SK, S7M 0K7 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.

Share consolidation

During the year ended December 31, 2021 in conjunction with its Regulation A financing, the Company underwent a share consolidation at a 5-1 ratio. All reference to share, per share amounts, warrants, RSU’s and stock options in these financial statements have been retroactively restated to reflect the consolidation.

These consolidated financial statements have been prepared on the assumption that the Company will continue as a going concern, meaning it will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations. To date, the Company has not been profitable and has an accumulated deficit of $79,976,546. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing and or achieve profitable operations in the future . These factors indicate the existence of a material uncertainty that may cast significant doubt on the Company’s ability to continue as a going concern. These financial statements do not reflect adjustments that would be necessary if the going concern assumption were not appropriate. These adjustments could be material.

2. BASIS OF PREPARATION

Statement of Compliance

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations issued by the International Reporting Interpretation Committee (“IFRIC”). The principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all years presented, unless otherwise stated.

These consolidated financial statements were authorized for issue by the Board of Directors on March 27, 2023.

Basis of consolidation

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases.

The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

Name of Subsidiary	Place of Incorporation	Ownership Interest
Draganfly Innovations Inc.	Canada	100%
Draganfly Innovations USA, Inc.	US	100%
Dronelogics Systems Inc.	Canada	100%

All intercompany balances and transactions were eliminated on consolidation.

Significant estimates and assumptions

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make estimates and assumptions about reported amounts at the date of the consolidated financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.

F-6

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Impairment of Non-financial assets

The CGU’s recoverable amount is evaluated using the higher of the value in use and fair value less costs to sell. In determining the recoverable amount, the Company utilizes discounted cash flow techniques. Management calculates the discounted cash flows based upon its best estimate of a number of economic, operating, engineering, environmental, political and social assumptions. Any changes in the assumptions due to changing circumstances may affect the recoverable amount estimate.

Share-based payments

The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield of the stock option.

Income taxes

Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the company is likely to recognize their recovery from the generation of taxable income.

Inventory

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price less costs to sell. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market- driven changes that may reduce future selling prices.

Contingencies

The assessment of contingencies involves the exercise of significant judgment and estimates of the outcome of future events. In assessing loss contingencies related to legal proceedings that are pending against the Company and that may result in regulatory or government actions that may negatively impact the Company’s business or operations, the Company and its legal counsel evaluate the perceived merits of the legal proceeding or unasserted claim or action as well as the perceived merits of the nature and amount of relief sought or expected to be sought, when determining the amount, if any, to recognize as a contingent liability or when assessing the impact on the carrying value of the Company’s assets. Contingent assets are not recognized in the consolidated financial statements.

Investments in Private companies

Where the fair value of investments in private companies recorded on the statement of financial position cannot be derived from active markets, they are determined using a variety of valuation techniques. The inputs to these models are derived from observable market data where possible, but where observable market data is not available, judgment is required to establish fair value and this value may not be indicative of recoverable value.

F-7

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Expected credit losses on trade receivables and notes receivable

When determining expected credit losses (“ECLs”), the Company considers the historic credit losses observed by the Company, customer-specific payment history and economic conditions. When determining whether the credit risk of a financial asset has increased significantly since initial recognition and when estimating ECL’s, the Company considers reasonable and supportable information that is relevant and available without undue cost or effort. This includes both quantitative and qualitative information and analysis, based on the Company’s historical experience, informed credit assessment ad forward-looking information

Useful lives of equipment and intangible assets

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

Significant judgments

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments in applying the Company’s consolidated financial statements include:

Business combinations

The definition of whether a set of assets acquired and liabilities assumed constitute a business may require the Company to make certain judgements taking into account all facts and circumstances. A business is presumed to be an integrated set of activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs, or economic benefits.

Business combination versus asset acquisition

The Company considered the applicability of IFRS 3 – Business Combinations (“IFRS 3”) with respect to acquisitions (Note 3). IFRS 3 defines a business as having a system where inputs enter a process to produce outputs. The Company has determined that the acquisition of Dronelogics Systems Inc. and certain assets of Vital Intelligence Inc. are business combinations and, accordingly, have accounted for as such.

Other significant judgments

−	The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;
−	the classification of financial instruments;
−	the assessment of revenue recognition using the five-step approach under IFRS 15; and
−	the determination of the functional currency of the company.

Foreign currency translation

Transactions in foreign currencies are translated into the functional currency at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Gains and losses resulting from foreign exchange adjustments are included in profit or loss.

F-8

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

The functional currencies of the parent company and each subsidiary are as follows:

Draganfly Inc.	Canadian Dollar
Draganfly Innovations Inc.	Canadian Dollar
Draganfly Innovations USA, Inc.	US Dollar
Dronelogics Systems Inc.	Canadian Dollar

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all revenue and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translation of foreign operations in other comprehensive loss.

Share-based payments

The Company operates a stock option plan. Share-based payments to employees are measured at the grant date fair value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of the goods or services received or the fair value of the equity instruments issued, if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The corresponding amount is recorded to the share-based payment reserve. The fair value of options is determined using a Black–Scholes Option Pricing Model. The number of options expected to vest is reviewed and adjusted at the end of each reporting period such that the amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments that eventually vest. Amounts recorded for forfeited or expired unexercised options are transferred to deficit in the year of forfeiture or expiry. Amounts recorded for forfeited unvested options are reversed in the period the forfeiture occurs.

Restricted Share Units

The restricted share units (“RSUs”) entitle employees, directors, or officers to either the issuance of common shares or cash payments payable upon vesting based on vesting terms determined by the Company’s Board of Directors at the time of the grant. On the grant date of RSUs, the Company determines whether it has a present obligation to settle in cash. If the Company has a present obligation to settle in cash, the RSUs are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and at the date of settlement, with any changes in fair value recognized in profit or loss for the period. RSUs settled in common share are measured at the fair value of awards on the grant date using the prior days closing price. Amounts recorded for forfeited unvested RSUs are reversed in the period the forfeiture occurs. The expense is recognized on a graded vesting basis over the vesting period, with a corresponding charge to profit or loss.

Loss per share

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. For all periods presented, the loss attributable to common shareholders equals the reported loss attributable to owners of the Company. Diluted income per share is calculated by the treasury stock method. Under the treasury stock method, the weighted average number of common shares outstanding for the calculation of diluted loss per share assumes that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at the average market price during the period. For the periods presented, the Company incurred a loss and therefore basic loss per share equals diluted loss per share.

F-9

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Financial Instruments

Financial instruments are accounted for in accordance with IFRS 9 Financial Instruments: Classification and Measurement. A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

Financial assets/liabilities	Classification
Cash	Amortized cost
Accounts receivable	Amortized cost
Notes receivable	Amortized cost
Investments	Fair value through other comprehensive income
Accounts payable	Amortized cost
Customer deposits	Amortized cost
Loans payable	Amortized cost
Derivative liability	Fair value through profit or loss

a) Financial assets

Classification and measurement

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the cash flows are not solely principal and interest, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.

Financial assets at FVTPL

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are recorded to profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of financial assets held at FVTPL are included in the profit or loss in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

Financial assets at FVTOCI

Financial assets carried at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income. There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

F-10

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Financial assets at amortized cost

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

Impairment of financial assets at amortized cost

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

Derecognition of financial assets

Financial assets are derecognized when the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recorded to profit or loss. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive loss.

b) Financial liabilities

The Company classifies its financial liabilities into one of two categories as follows:

FVTPL - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans are included in this category.

Derecognition of financial liabilities

Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are recognized in profit or loss.

Impairment of non-financial assets

The carrying amounts of the non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:

● an intangible asset with an indefinite useful life;

● an intangible asset not yet available for use; and

● goodwill recognized in a business combination.

The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest identifiable group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets.

F-11

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.

An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the units, and then to reduce the carrying amounts of the other assets in the unit (group of units) on a pro rata basis.

In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

Income taxes

Current income tax:

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

Current income taxes relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

Deferred income tax:

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

Inventory

Inventory consists of raw materials and finished goods for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Cost is determined using the weighted average cost basis. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

F-12

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Revenue recognition

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

Sales of goods

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred, being when the products are delivered to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. Delivery occurs when the products have been shipped to the specific location or picked up by the customer.

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

Some contracts include multiple performance obligations, such as the manufacturing of hardware and support. Support is performed by another party and does not include an integration service. It is therefore accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on stand-alone selling price. Where is the stand-alone selling price is not directly observable, the price is estimated based on expect cost plus margin.

Services

The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized over time as the services are rendered.

Rental equipment

The Company provides rental of equipment which is measured based on rates through contracts or other written agreements with customers. Revenue is recognized in the period when services are performed and only when there is reasonable assurance that the revenue will be collected.

Deferred Revenue

A payment received is included as deferred revenue when products has yet be shipped to customers as of the period end. The amount to be recognized within twelve months following the year-end date is classified as current

Cost of Goods Sold

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, or lower of cost and net realizable value adjustments as required.

Intangible Assets and Goodwill

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications, brands and software.

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

F-13

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Intangible assets with finite useful lives are amortized on a straight line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.

Class of intangible asset	Useful live
Customer relationship	5 years
Brand	5 years
Software	5 years

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.

Equipment

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statement of comprehensive loss during the financial period in which they are incurred.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the statement of comprehensive loss.

Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

Class of equipment	Depreciation rate
Computer equipment	30%
Furniture and equipment	20%
Leasehold improvements	Expected lease term
Vehicles	30%

Research and development expenditures

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following:

(i)	the technical feasibility of completing the intangible asset so that it will be available for use or sale;
(ii)	its intention to complete the intangible asset and use or sell it;
(iii)	its ability to use or sell the intangible asset;
(iv)	how the intangible asset will generate probable future economic benefits. The Company can also demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset;
(v)	the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
(vi)	its ability to measure reliably the expenditure attributable to the intangible asset during its development.

F-14

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Government Assistance

Government grants are recognized when there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

SR&ED Investment tax credits

The Company claims federal investment tax credits as a result of incurring scientific research and experimental development (“SR&ED”) expenditures. Federal investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Federal investment tax credits are accounted for as a reduction of research and development expense for items of a period expense nature or as a reduction of property and equipment for items of a capital nature. Management has made a number of estimates and assumptions in determining the expenditures eligible for the federal investment tax credit claim. It is possible that the allowed amount of the federal investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency.

The Company claims provincial investment tax credits as a result of incurring SR&ED expenditures. Provincial investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Management has made a number of estimates and assumptions in determining the expenditures eligible for the provincial investment tax credit claim. The provincial investment tax credits are refundable and have been recorded as a SR&ED tax credit receivable, and as a reduction in research and development expenses on the statement of comprehensive loss. It is possible that the allowed amount of the provincial investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency and the Alberta Tax and Revenue Administration.

Leases

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset is recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

The lease term is the non-cancellable period of a lease plus periods covered by an optional lease extension option if it is reasonably certain that the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

A lease modification is accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

New accounting standards issued not yet effective

Accounting standards or amendments to existing accounting standards that have been issued but have future effective dates are either not applicable or are not expected to have a significant impact on the Company’s consolidated financial statements.

F-15

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

3. VITAL INTELLIGENCE ACQUISITION

On March 25, 2021, the Company acquired the assets of Vital Intelligence Inc. (“Vital”), a company that had developed a health/telehealth platform that could detect a number of key underlying respiratory symptoms. The Company acquired it for consideration of: (a) a cash payment of $500,000 and (b) ‎1,200,000 units of the Company with each unit being comprised of one common share and one warrant (the “Acquisition”). Each warrant will entitle the holder to acquire one common share for a period of 24 months following closing for $13.35 and the Company will be able to accelerate the expiry date of the warrants after one year in the event the underlying common shares have a value of at least 30% greater than the exercise price of the warrants. The units will be held in escrow with 300,000 units being released at closing with a value of the of $3,545,249 and the remainder to be released upon the Company reaching certain revenue milestones received from the purchased assets. The units were issued on March 22, 2021. On August 19, 2021 the parties agreed to reduce the final payment from $250,000 to $227,984 due to certain assets listed in the purchase agreement had not been delivered by Vital.

The units of the Company are to be releasable from escrow in accordance with the terms and conditions of the agreement, as follows:

a)	300,000 units shall be released on the closing date;
b)	300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $2,000,000;
c)	300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $4,000,000; and
d)	300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $6,000,000.

Upon acquisition, the 900,000 shares held in escrow were classified as a derivative liability and were valued based upon:

● A weighted average probability of achieving the milestones necessary to release the shares held in escrow, and

● Discounted due to the lack of liquidity.

On acquisition, the fair value of the derivative liability (note 17) was $4,797,717. At December 31, 2022, the liability was revalued based upon new weighted average probabilities of achieving the revenue milestones. As a result, the fair value was adjusted to $57,314 (2021 – $694,230), with the difference flowing through profit or loss.

F-16

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

3. VITAL INTELLIGENCE ACQUISITION (CONT’D)

Contingent consideration
Fair value of contingent consideration	$	4,797,717
Change in fair value of contingent consideration		(4,103,487	)
Contingent consideration at December 31, 2021		694,230
Change in fair value of contingent consideration		(636,916	)
Contingent consideration at December 31, 2022 (note 17)	$	57,314

The PPA is as follows:

Number of units of Draganfly Inc.		578,248
Fair value of units	$	14.43
Fair value of units of Draganfly Inc.	$	8,342,966
Cash portion of purchase price		466,643
Total	$	8,809,609

Identifiable intangible assets
Brand	$	23,000
Software		433,000
		456,000
Goodwill		8,353,609
Total consideration	$	8,809,609

Significant estimates were as follows:

● Number of units issued based upon a weighted average calculation for the Company achieving the revenue targets.

● Brand fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 0.25% and discount rate of 14.4% per annum.

● Software fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 5.0% and discount rate of 14.4% per annum.

Furthermore, the excess of the consideration paid over the fair value of the identifiable assets (liabilities) acquired was recognized as goodwill, which primarily consisted of continued development of the technology platform integrating the latest technological developments.

4. CASH AND CASH EQUIVALENTS

	December 31, 2022		December 31, 2021
Cash held in banks	$	7,500,607	$	22,729,212
Guaranteed investment certificates		394,174		346,501
	$	7,894,781	$	23,075,713

F-17

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

4. CASH AND CASH EQUIVALENTS (CONT’D)

On March 27, 2020, the Company purchased a $142,000 guaranteed investment certificate (“GIC”) to secure its credit cards for 1 year at a rate of 0.50% per annum. On March 27, 2021 the Company renewed the GIC for $142,710 for 1 year at a rate of 0.10% per annum. On March 27, 2022 the Company renewed the GIC for $142,852 for 1 year at a rate of 1.00% per annum. On August 23, 2022 the Company redeemed the renewed GIC for $143,436 and purchased a new GIC for $143,436 for 1 year at a rate of 4.5% per annum.

On May 28, 2021, the Company purchased an additional $140,000 GIC to further secure its credit cards. The terms of the GIC are for 1 year at a rate of 0.35% per annum. On May 30, 2022 the Company renewed the GIC for $140,493 for 1 year at a rate of 0.75% per annum. On August 23, 2022 the Company redeemed the renewed GIC for $140,738 and purchased a new GIC for $140,738 for 1 year at a rate of 4.5% per annum.

On December 21, 2021, the Company purchased an additional $50,000 USD GIC to further secure its credit cards. The terms of the GIC are for 1 year at 0.05% per annum. The $50,000 GIC was renewed for $50,018 USD on October 22^nd, 2022 for five months at 0.05% per annum.

All GIC’s must be maintained and renewed upon maturity until such time as the associated credit cards are cancelled. At any time, the Company can redeem the GIC’s and correspondingly cancel the credit cards at its discretion.

5. RECEIVABLES

	December 31, 2022		December 31, 2021
Trade accounts receivable	$	1,343,795	$	951,314
Corporate taxes receivable		-		182,820
Taxes receivable		745,170		272,993
	$	2,088,965	$	1,407,127

6. INVENTORY

	December 31, 2022		December 31, 2021
Finished goods	$	542,934	$	3,017,363
Parts		513,008		373,459
	$	1,055,942	$	3,390,822

During the year ended December 31, 2022, $6,048,348 (2021 - $3,420,713) of inventory was recognized in cost of sales including an allowance to value its inventory for obsolete and slow-moving inventory of $1,976,514 (2021 - $nil).

Cost of sales consist of the following:

	December 31, 2022		December 31, 2021
Inventory	$	6,048,348	$	3,420,713
Consulting and services		730,170		679,345
Other		35,866		310,719
	$	6,814,384	$	4,410,777

F-18

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

7. NOTES RECEIVABLE

	Maturity Date	Rate			Principal		Interest		Accretion		(Impairment)/ Recovery			Repayments			Balance December 31, 2022
Note 1(1)	2023-03-31		0	%	$	190,396	$	-	$	12,764	$	-		$	(33,860	)	$	169,300
Note 2(1)	2024-09-22		5	%		1,003,682		48,992		27,971		(1,080,645	)		-			-
Note 3	2022-04-26		8	%		-		37,177		-		771,260			(808,437	)		-
Total					$	1,194,078	$	86,169	$	40,735	$	(309,385	)	$	(842,297	)	$	169,300

	Maturity Date	Rate			Principal		Interest		Accretion		(Impairment)/ Recovery			Repayments		Balance December 31, 2021
Note 1(1)	2022-10-21		0	%	$	180,597	$	-		9,573		-			-		190,170
Note 2(1)	2024-09-22		5	%		943,385		13,156		7,465		-			-		964,006
Note 3	2022-04-26		8	%		750,000		21,260		-		(771,260	)		-		-
Note 4(1)	2023-06-01		8	%		114,833		5,378		-		(120,211	)		-		-
Total					$	1,988,815	$	39,794	$	17,038	$	(891,471	)	$	-	$	1,154,176

(1) These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.

Note 1 was issued on April 4, 2021, is non-interest bearing and is secured by intellectual property. This note is measured at fair value through profit or loss. The parties agreed on an amended maturity date, whereby $34,860 ($25,000 USD) was paid on October 21, 2022, the original maturity date, and the remaining balance will be paid January 21, 2023. Subsequent to the year ended December 31, 2022, the parties mutually agreed to extend the maturity date to March 31, 2023, with a partial repayment of $33,369 ($25,000 USD) due January 30, 2023.

Note 2 was issued on September 9, 2021, bears interest at 5%, is unsecured, and contains a conversion feature upon sale of the recipient. This note is measured at fair value through profit or loss. Management has determined that it is unlikely that the loan will be repaid or the Company will receive some other type of return. Therefore, the loan has been written down to $Nil.

Note 3 was issued on November 17, 2021 pursuant to letter of intent on an acquisition that the Company is no longer pursuing. The loan is interest bearing at 8% and was due April 26, 2022. At December 31, 2021, management determined that it was unlikely that either the loan would be repaid or the Company would receive some other type of return, therefore, the loan was written down to $nil. During the year ended December 31, 2022, the parties agreed on a repayment plan, with $550,000 paid upon execution of the agreement, and $258,437 the remaining balance including interest paid on November 22, 2022.

Note 4 bears interest at 8% and is secured by a general security agreement. At December 31, 2021, management determined that it is unlikely that either the loan will be repaid or the Company will receive some other type of return. Therefore, the loan was written down to $Nil.

8. PREPAIDS

	December 31, 2022		December 31, 2021
Insurance	$	1,148,455	$	2,938,246
Prepaid director fees		-		107,763
Prepaid interest		1,889		6,969
Prepaid marketing services		733,417		1,638,179
Prepaid rent		12,485		-
Prepaid subscriptions		29,194		35,687
Deposits(1)		382,284		768,033
	$	2,307,724	$	5,494,877

(1) A deposit in the amount of $228,572 related to the purchase of Vital inventory was written off as there was uncertainty related to whether the Company would recover the value.

F-19

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

9. INVESTMENTS

Balance at December 30, 2020	-
Acquisitions		623,706
Change in fair value		(332,640	)
Balance at December 31, 2021		291,066
Change in fair value		(98,483	)
Balance at December 31, 2022	$	192,583

Fair value of investments is comprised of:

Public company shares	$	57,143
Private company shares		135,440
Balance at December 31, 2022	$	192,583

Public company shares	$	142,857
Public company warrants		21,429
Private company shares		126,780
Balance at December 31, 2021	$	291,066

On March 10, 2021, the Company purchased 1,428,571 units of a publicly listed company for $500,000. Each unit is comprised of one common share and one warrant. The warrants have an exercise price of $0.50 each and convert to one common share, and expire on March 17, 2023. The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following assumptions:

	December 31, 2022			December 31, 2021			March 10, 2020
Risk free interest rate		4.07	%		0.91	%		0.28	%
Expected volatility		116.00	%		124.09	%		150.88	%
Expected life		0.21 years			2 years			2 years
Expected dividend yield		0	%		0	%		0	%

On October 27, 2021, the Company purchased 50,000 common shares of a private company for USD$100,000. The Company considers if observable market data exists on a quarterly basis to value the investment. Since inception, the Company has not had any adjustments to the fair value of the investment based on observable market data.

F-20

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

10. EQUIPMENT

	Computer Equipment			Furniture and Equipment			Leasehold Improvements			Software			Vehicles			Total
Cost
Balance at December 31, 2020	$	24,397		$	171,606		$	4,352		$	29,967		$	27,652		$	257,974
Additions		29,713			170,866			-			-			12,000			212,579
Revaluation		-			-			-			-			(3,619	)		(3,619	)
Balance at December 31, 2021	$	54,110		$	342,472		$	4,352		$	29,967		$	36,033		$	466,934
Additions		60,240			528,080			-			-			-			588,320
Disposals		(18,688	)		(36,099	)		(4,352	)		(29,967	)		-			(89,106	)
Balance at December 31, 2022	$	95,662		$	834,453		$	-		$	-		$	36,033		$	966,148
Accumulated depreciation
Balance at December 31, 2020	$	12,392		$	59,963		$	3,220		$	22,496		$	6,033		$	104,104
Charge for the year		12,899			42,314			1,132			2,241			7,201			65,787
Balance at December 31, 2021	$	25,291		$	102,277		$	4,352		$	24,737		$	13,234		$	169,891
Charge for the year		32,627			433,855			-			-			3,435			469,917
Disposals		(15,920	)		(33,342	)		(4,352	)		(24,737	)		-			(78,351	)
Balance at December 31, 2022	$	41,998		$	502,790		$	-		$	-		$	16,669		$	561,457
Net book value:
December 31, 2021	$	28,819		$	240,195		$	-		$	5,230		$	22,799		$	297,043
December 31, 2022	$	53,664		$	331,663		$	-		$	-		$	19,364		$	404,691

11. INTANGIBLE ASSETS AND GOODWILL

	Patents		Customer Relationships		Brand			Software (1)			Goodwill			Total
Cost
Balance at December 31, 2020	$	41,931	$	197,000	$	-		$	119,000		$	2,166,563		$	2,524,494
Additions		-		-		23,000			433,000			8,353,609			8,809,609
Impairment		-		-		-			-			(4,579,763	)		(4,579,763	)
Balance at December 31, 2021	$	41,931	$	197,000	$	23,000		$	552,000		$	5,940,409		$	6,754,340
Additions		-		-		-			4,684			-			4,684
Foreign exchange translation		-		-		1,571			29,576			257,782			288,929
Impairment		-		-		(24,571	)		(462,577	)		(6,198,191	)		(6,685,339	)
Balance at December 31, 2022	$	41,931	$	197,000	$	-		$	123,683		$	-		$	362,614
Accumulated amortization
Balance at December 31, 2020	$	41,931	$	26,267	$	-		$	15,866		$	-		$	84,064
Charge for the year		-		34,147		3,450			98,369			-			135,966
Balance at December 31, 2021		41,931		60,414		3,450			114,235			-			220,030
Charge for the year		-		27,317		4,719			147,446			-			179,482
Foreign exchange translation		-		-		431			13,295			-			13,726
Impairment		-		-		(8,600	)		(221,825	)		-			(230,425	)
Balance at December 31, 2022	$	41,931	$	87,731	$	-		$	53,151		$	-		$	182,813
Net book value:
December 31, 2021	$	-	$	136,586	$	19,550		$	437,765		$	5,940,409		$	6,534,310
December 31, 2022	$	-	$	109,269	$	-		$	70,532		$	-		$	179,801

(1) Software acquired via acquisition of Vital and Dronelogics.

Brand

On March 25, 2021, the Company acquired the assets of Vital (note 3) and assigned $23,000 to the fair value of the brand.

Software

On March 25, 2021, the Company acquired the assets of Vital and assigned $433,000 to the fair value of the software.

Goodwill

On April 30, 2020, the Company acquired a 100% interest in Dronelogics, which included goodwill with a value of $2,166,563.

On March 25, 2021, the Company acquired the assets of Vital, which included goodwill. Goodwill was valued at $8,353,609.

F-21

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

11. INTANGIBLE ASSETS AND GOODWILL (CONT’D)

On December 31, 2022 the Company performed its annual goodwill impairment test on Vital and Dronelogics. The Company determined the recoverable amount based on a value in use calculation using the following key assumptions:

● 5 year post tax cash flow projections expected to be generated based on a financial forecast with a terminal growth rate of 2% (2021 – 2%).

● Budgeted cash flows calculated using a weighted average revenue EBITDA margin of 6.5% (2021 – 14%) for Dronelogics and 0% (2021 – 42%) for Vital respectively were estimated by management based on the past performance and future growth prospects as well as observed trends among comparable companies.

● Cash flows were discounted at the weighted average cost of capital of 19% (2021 – 17%) for Dronelogics and 29% (2021 – 24%) for Vital based on peer group averages and adjusted for the Company’s risk factors.

Based on the annual goodwill impairment test, the Company determined that the goodwill for Dronelogics and Vital required impairment, as such the Company recorded an impairment charge of $2,166,563 (2021 – nil) for Dronelogics and $4,031,628 (2021 - $4,579,763) for Vital. In addition to the goodwill, the Company deemed that the brand and software for Vital required impairment, as such the Company recorded an impairment charge of $15,971 and $240,752 respectively.

The most sensitive inputs to the value in use model are the growth and discount rates. All else being equal:

● A 10% reduction in the Value in use for the discounted cash flow model would result in a reduction of $104,248 for Dronelogics (2021 – $597,100) and $Nil for Vital (2021 - $570,133).

Changing the above assumption would have no impact on the carrying amount for Dronelogics and Vital.

12. RIGHT OF USE ASSETS

	Total
Cost
Balance at December 31, 2020	$	242,967
Additions		447,242
Lease adjustment		(7,092	)
Balance at December 31, 2021 and 2022	$	683,117
Accumulated depreciation
Balance at December 31, 2020	$	98,548
Charge for the year		109,311
Historical correction		7,152
Balance at December 31, 2021	$	215,011
Charge for the year		123,360
Balance at December 31, 2022	$	338,371
Net book value:
December 31, 2021	$	468,106
December 31, 2022	$	344,746

F-22

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

13. LEASE LIABILITES

The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 7.5% to 10.5%

	Total
Balance at December 31, 2020	$	158,124
Additions		440,675
Interest expense		26,964
Lease payments		(128,995	)
Lease removal		(7,645	)
Balance at December 31, 2021	$	489,123
Interest expense		39,795
Lease payments		(150,275	)
Balance at December 31, 2022	$	378,643

Which consists of:
	December 31, 2022		December 31, 2021
Current lease liability	$	133,962	$	110,481
Non-current lease liability		244,681		378,642
Ending balance	$	378,643	$	489,123

Maturity analysis	Total
Less than one year	$	147,340
One to three years		209,078
Four to five years		83,850
Total undiscounted lease liabilities		440,268
Amount representing interest		(61,625	)
	$	378,643

14. TRADE PAYABLES AND ACCRUED LIABILITIES

	December 31, 2022		December 31, 2021
Trade accounts payable	$	751,422	$	362,890
Accrued liabilities		2,031,545		402,540
Government grant payable		33,709		33,709
	$	2,816,676	$	799,139

15. DEFERRED INCOME

At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.

	December 31, 2022		December 31, 2021
Deferred income from customers	$	58,457	$	68,053
Deferred income from government		5,233		5,233
	$	63,690	$	73,286

F-23

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

16. LOANS PAYABLE

	December 31, 2022			December 31, 2021
Opening balance	$	93,317		$	97,916
Issuance of loans payable		-			60,000
Fair value adjustment		(4,891	)		(24,576	)
Repayment of loans payable		(6,746	)		(44,428	)
Accretion expense		4,891			4,405
Ending balance	$	86,571		$	93,317

	Start Date	Maturity Date	Rate			Carrying Value December 31, 2022		Carrying Value December 31, 2021
CEBA	2020-05-19	2023-12-31		0	%	$	37,383	$	37,384
CEBA	2021-04-23	2023-12-31		0	%		37,383		37,383
Vehicle loan	2019-08-30	2024-09-11		6.99	%		11,805		18,550
Total						$	86,571	$	93,317

On May 19, 2020, Dronelogics received a $40,000 CEBA loan. This loan is currently interest-free and 25% of the loan, up to $10,000, is forgivable if the loan is repaid on or before December 31, 2023. If the loan is not repaid by that date, the loan can be converted to a three-year term loan at an interest rate of 5%. On December 4, 2020, the Government of Canada allowed for an expansion of the CEBA loan by $20,000, of which, an additional $10,000 is forgivable if the entire loan is repaid on or before December 31, 2023.

On April 23, 2021, Draganfly Innovations Inc. received a $60,000 CEBA loan. This loan is currently interest free and up to $20,000 is forgivable if the loan is repaid on or before December 31, 2023. If the loan is not repaid by that date, the loan can be converted to a three-year term loan at an interest rate of 5%.

The CEBA loans are unsecured, and the vehicle loan is secured by the vehicle.

F-24

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

17. SHARE CAPITAL

Authorized share capital

Unlimited number of common shares without par value.

Issued share capital

During the year ended December 31, 2022,

● The Company issued 16,538 common shares for the exercise of warrants for $87,170.

● The Company issued 12,500 common shares for the exercise of stock options for $26,875.

● The Company issued 1,072,595 common shares for the vesting of restricted share units.

During the year ended December 31, 2021,

● The Company issued 1,939,534 common shares for the exercise of warrants for $4,929,790.

● The Company issued 448,660 common shares for the vesting of Restricted Share Units.

● The Company issued 405,499 common shares for the exercise of stock options for $1,014,123.

● The Company issued 371,901 common shares in lieu of cash for services rendered.

● The Company issued 6,488,669 units for the Regulation A+ financing in the United States for proceeds of $18,815,485. Each unit is comprised of one common share and one share purchase warrant. These warrants had a fair value of $0.57 USD allocated to them, have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years. The fair value of $8,261,511 was allocated to warrant derivative liability.

● The Company issued 1,200,000 units for the acquisition of Vital Intelligence. Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.

● The Company issued 5,095,966 common shares in a private placement for $25,538,213.

F-25

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

17. SHARE CAPITAL (CONT’D)

Stock Options

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.

As at December 31, 2022, the Company had the following options outstanding and exercisable:

Grant Date	Expiry Date	Exercise Price		Remaining Contractual Life (years)		Number of Options Outstanding		Number of Options Exercisable
October 30, 2019	October 30, 2029	$	2.50		6.84		286,665		286,665
November 19, 2019	November 19, 2029	$	2.50		6.89		50,000		50,000
April 30, 2020	April 30, 2030	$	2.50		7.33		85,000		85,000
April 30, 2020	April 30, 2030	$	3.85		7.33		110,000		110,000
July 3, 2020	July 3, 2025	$	3.20		2.51		100,000		100,000
November 24, 2020	November 24, 2030	$	2.50		7.90		32,000		32,000
February 2, 2021	February 2, 2031	$	13.20		8.10		30,000		20,000
March 8, 2021	March 8, 2026	$	13.90		3.19		10,000		10,000
April 27, 2021	April 27, 2031	$	10.15		8.33		147,666		50,326
September 9, 2021	September 9, 2026	$	4.84		3.69		25,826		8,608
							877,157		752,599

	Number of Options			Weighted Average Exercise Price
Outstanding, December 31, 2020		1,193,659		$	2.75
Exercised		(405,494	)		2.50
Granted		247,826			10.12
Outstanding, December 31, 2021		1,035,991		$	4.60
Exercised		(12,500	)		2.15
Forfeited		(146,334	)		4.77
Outstanding, December 31, 2022		877,157		$	4.60

No options were granted by the Company for the year ended December 31, 2022

During the year ended December 31, 2021,

● The Company granted 30,000 options to an employee. Each option is exercisable at $13.20 per share for 10 years.

● The Company granted 10,000 options to a consultant. Each option is exercisable at $13.90 per share for 5 years.

● The Company granted 182,000 options to employees and a consultant. Each option is exercisable at $10.15 per share for 10 years.

● The Company granted 25,826 options to an employee. Each option is exercisable at $4.84 per share for 5 years.

During the year ended December 31, 2022, the Company recorded $502,837 (2021- $1,660,894) in stock-based compensation in relation to the vesting of stock options. The fair values of stock options granted were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

F-26

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

17. SHARE CAPITAL (CONT’D)

Year ended December 31,	2022		2021
Risk free interest rate		-		0.69%-1.40	%
Expected volatility		-		111.87%-113.16	%
Expected life		-		5 years
Expected dividend yield		-		0	%
Exercise price	$	-	$	13.20-13.90

Volatility is calculated using the historical volatility method based on a comparative company’s stock price.

Restricted Share Units

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time.

The aggregate sales price (meaning the sum of all cash, property, notes, cancellation of debt, or other consideration received or to be received by the Company for the sale of the securities) or amount of common shares issued during any consecutive 12-month period will not exceed the greatest of the following: (i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date. At the election of the Board of Directors, upon each vesting date, participants receive (a) the issuance of common shares from treasury equal to the number of RSUs vesting, or (b) a cash payment equal to the number of vested RSUs multiplied by the fair market value of a common share, calculated as the closing price of the common shares on the CSE for the trading day immediately preceding such payment date; or (c) a combination of (a) and (b).

On the grant date of RSUs, the Company determines whether it has a present obligation to settle in cash. If the Company has a present obligation to settle in cash, the RSUs are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and at the date of settlement, with any changes in fair value recognized in profit or loss for the period. The Company has a present obligation to settle in cash if the choice of settlement in shares has no commercial substance, or the Company has a past practice or a stated policy of setting in cash, or generally settles in cash whenever the counterparty asks for cash settlement. If no such obligation exists, RSUs are accounted for as equity settled share-based payments and are valued using the share price on grant date. Upon settlement:

a) If the Company elects to settle in cash, the cash payment is accounted for as the repurchase of an equity interest (i.e. as a deduction from equity), except as noted in (c) below.

b) If the Company elects to settle by issuing shares, the value of RSUs initially recognized in reserves is reclassified to share capital, except as noted in (c) below.

c) If the Company elects the settlement alternative with the higher fair value, as at the date of settlement, the Company recognizes an additional expense for the excess value given (i.e. the difference between the cash paid and the fair value of shares that would otherwise have been issued, or the difference between the fair value of the shares and the amount of cash that would otherwise have been paid, whichever is applicable).

As at December 31, 2022, the Company had the following RSUs outstanding:

	Number of RSUs
Outstanding, December 31, 2020		614,666
Vested		(448,660	)
Issued		348,826
Outstanding, December 31, 2021		514,832
Vested		(1,072,595	)
Issued		1,820,972
Forfeited		(64,334	)
Outstanding, December 31, 2022		1,198,875

During the year ended December 31, 2022, 1,072,595 RSU’s fully vested according to the terms and the Company granted 1,820,972 RSUs to employees and consultants of the Company with each RSU exercisable into one common share of the Company upon the vesting conditions being met for a period of eighteen months from the grant date. In addition, 64,334 RSU’s were forfeited by employees who have left the Company.

During the year ended December 31, 2021, 323,661 RSUs fully vested according to the terms and the Company accelerated the vesting of 124,999 RSUs. The Company issued 348,826 RSUs to employees of the Company with each RSU exercisable into one common share of the Company or the cash equivalent thereof upon the vesting conditions being met for a period of three years from the grant date.

During the year ended December 31, 2022, the Company recorded share-based payment expense of $2,808,187 (2021: $2,291,701) for RSUs, based on the fair values of RSUs granted which were calculated using the closing price of the Company’s stock on the day prior to grant.

Warrants

During the years ended December 31, 2021 and 2020, the Company issued warrants (“USD Warrants”) with a USD exercise price. Being in a foreign currency that is not the Company’s functional currency and these warrants were not issued in exchange for services, these USD Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, these USD Warrants are revalued on a quarterly basis to fair market value with the change in fair value being recorded profit or loss. The initial fair value of these USD Warrants was parsed out from equity and recorded as a financial liability.

F-27

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

17. SHARE CAPITAL (CONT’D)

To reach a fair value of the USD Warrants, a Black Scholes calculation is used, calculated in USD as the Company also trades on the Nasdaq. The Black Scholes value per USD Warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period from the Bank of Canada.

Warrant Derivative Liability

Balance at December 31, 2020	$	748,634
Warrant issuance		8,261,511
Exercised		(98,048	)
Change in fair value of warrants outstanding		(4,046,325	)
Balance at December 31, 2021	$	4,865,772
Change in fair value of warrants outstanding		(4,865,772	)
Balance at December 31, 2022	$	-

Derivative liability balance at	December 31, 2022		December 31, 2021
Warrants	$	-	$	4,865,772
Contingent consideration (note 3)		57,314		694,230
Ending balance	$	57,314	$	5,560,002

Details of these warrants and their fair values are as follows:

Issue Date	Exercise Price	Number of Warrants Outstanding at December 31, 2022		Fair Value at December 31, 2022		Number of Warrants Outstanding at December 31, 2021		Fair Value at December 31, 2021
November 30, 2020	US$ 3.55		-	$	-		482,425	$	182,262
February 5, 2021(1)	US$ 3.55		1,319,675		-		1,323,275		951,226
March 5, 2021(2)	US$ 3.55		5,142,324		-		5,154,321		3,732,284
July 29, 2021 (3)	US$5.00		250,000		-		250,000		-
September 14, 2021 (4)	US$5.00		4,798		-		4,798		-
			6,716,797	$	-		7,214,819	$	4,865,772

1)	Subsequent to December 31, 2022, the warrants expired on February 5, 2023.
2)	Subsequent to December 31, 2022, the warrants expired on March 5, 2023.
3)	The warrants expire July 29, 2024.
4)	The warrants expire September 14, 2024.

The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

	December 31, 2022			December 31, 2021
Risk free interest rate		4.07	%		0.23%-0.95	%
Expected volatility		91.66%-93.48	%		70.95%-144.59	%
Expected life		0.10-0.18 years			2-3 years
Expected dividend yield		0	%		0	%

Volatility is calculated using the historical volatility method.

F-28

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

17. SHARE CAPITAL (CONT’D)

	Number of Warrants			Weighted Average Exercise Price
Outstanding, December 31, 2020		2,416,864		$	2.95
Exercised		(1,939,534	)		2.54
Forfeited		(6,000	)		2.50
Issued		7,943,489			5.10
Outstanding, December 31, 2021		8,414,819		$	4.99
Exercised		(16,538	)		4.51
Expired		(481,484	)		4.61
Outstanding December 31, 2022		7,916,797		$	5.08

As at December 31, 2022, the Company had the following warrants outstanding:

Date issued	Expiry date	Exercise price	Number of warrants outstanding
February 5, 2021	February 5, 2023	US$ 3.55		1,319,675
March 5, 2021	March 5, 2023	US$ 3.55		5,142,324
March 22, 2021	March 22, 2023	CDN$ 13.35		1,200,000
July 29, 2021	July 29, 2024	US$ 5.00		250,000
September 14, 2021	September 14, 2024	US$ 5.00		4,798
				7,916,797

The weighted average remaining contractual life of warrants outstanding as of December 31, 2022, was 0.47 years (December 31, 2021 – 1.20 years).

The 1,200,000 warrants issued on March 22, 2021 to acquire Vital, 900,000 of the warrants are currently held in escrow, to be released upon completion of the milestones (note 3).

18. SEGMENTED INFORMATION

The Company organizes its three segments based on product lines as well as a Corporate segment. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. The Company aggregates the information for the segments by analyzing the revenue steam and allocating direct costs to that respective segment. The Corporate segment is aggregated by relying on the entity that includes corporate costs (Draganfly Inc.)

December 31, 2022	Drones			Vital		Corporate			Total
Sales of goods		5,388,262			162,170		-			5,550,432
Provision of services		2,054,627			-		-			2,054,627
Total revenue	$	7,442,889		$	162,170	$	-		$	7,605,059
Segment loss	$	9,929,789		$	602,580	$	12,926,884		$	23,459,253
Finance and other costs		(3,529	)		-		(40,816	)		(44,345	)
Depreciation		586,185			-		7,092			593,277
Amortization		179,482			-		-			179,482
Impairment of goodwill and intangibles		2,166,563			4,288,351		-			6,454,914
Change in fair value of derivative liability		-			-		(5,502,688	)		(5,502,688	)
Loss (recovery) on write-off of notes receivable		1,080,645			-		(771,260	)		309,385
Loss on write down of inventory		251,754			1,724,760		-			1,976,514
Write down of deposit		-			228,572		-			228,572
Net loss for the year	$	14,190,889		$	6,844,263	$	6,619,212		$	27,654,364

December 31, 2021	Drones		Vital		Corporate			Total
Sales of goods		4,957,134		146,265		-			5,103,399
Provision of services		1,950,466		-		-			1,950,466
Total revenue	$	6,907,600	$	146,265	$	-		$	7,053,865
Segment loss	$	7,819,739	$	257,656	$	10,498,164		$	18,575,560
Finance and other costs		16,272		-		(21,346	)		(5,074	)
Depreciation		175,098		-		-			175,098
Amortization		135,966		-		-			135,966
Impairment of goodwill and intangibles		-		4,579,763		-			4,579,763
Change in fair value of derivative liability		-		-		(8,149,812	)		(8,149,812	)
Loss on write-off of notes receivable		-		-		891,471			891,471
Net loss for the year	$	8,147,075	$	4,837,419	$	3,218,477		$	16,202,972

Geographic revenue segmentation  is as follows:	For the years ended December 31,
	2022		2021
Canada	$	6,919,038	$	4,982,373
United States		686,021		2,071,492
	$	7,605,059	$	7,053,865

Geographic revenue is measured by aggregating sales based on the country and the entity where the sale was made.

F-29

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

19. OFFICE AND MISCELLANEOUS

	For the years ended December 31,
	2022		2021
Advertising, Marketing, and Investor Relations	$	4,431,818	$	5,165,791
Compliance fees		152,826		432,874
Contract Work		441,798		300,975
Other		371,519		556,358
	$	5,397,961	$	6,455,998

20. RELATED PARTY TRANSACTIONS

On August 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management. The services are provided by a team of consultants and the costs of all charges are based on the fees set in the Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2022, the company incurred fees of $442,485 (December 31, 2021 - $315,643). As at December 31, 2022, the Company was indebted to this company in the amount of $30,804 (December 31, 2021 - $nil).

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the Consultant Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2022, the Company incurred fees of $566,487 (December 31, 2021 - $290,225). As at December 31, 2022, the Company was indebted to this company in the amount of $nil (December 31, 2021 - $nil).

On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. The costs of all charges are based on the fees set in the Executive Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. On May 9, 2022, Scott Larson ceased to be President of the Company and entered into an agreement to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the consulting agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2022, the Company incurred fees of $383,288 (December 31, 2021 - $205,191). As at December 31, 2022, the Company was indebted to this company in the amount of $20,745 (December 31, 2021 - $nil).

F-30

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

20. RELATED PARTY TRANSACTIONS (CONT’D)

Trade receivables/payables and accrued receivables/payables:

As at December 31, 2022, the Company had $nil (December 31, 2021 - $155,108) receivable from related parties outstanding that were included in accounts receivable and $51,549 (December 31, 2021 - $nil) payable from related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

Key management compensation

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the year ended December 31, 2022 and 2021 included:

For the years ended December 31,		2022		2021
Director fees	$	522,349	$	370,094
Salaries		843,917		722,068
Share-based payments		2,106,906		2,475,949
	$	3,473,172	$	3,568,111

Other related party transactions

For the years ended December 31,	2022		2021
Management fees paid to a company controlled by CEO and director		566,487		290,225
Management fees paid to a company that the CEO holds an economic interest in		442,485		315,643
Management fees paid to a company controlled by the former President and director		383,288		205,691
	$	1,392,260	$	811,559

21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

Credit risk

Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. The Company’s primary exposure to credit risk is on its cash held in bank accounts and trade receivables. Trade receivables include balances of $920,062 that are past due with no corresponding allowance recorded. The majority of cash is deposited in bank accounts held with major bank in Canada and the United States. As most of the Company’s cash is held by one bank there is a concentration of credit risk. This risk is managed by using major banks that are high credit quality financial institutions as determined by rating agencies. The Company does have past due outstanding receivables however the expected loss rate for undue balance is estimated to be nominal.

F-31

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company’s normal operating requirements on an ongoing basis. The Company ensures that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations and its holdings of cash and cash equivalents. Historically, the Company’s sole source of funding has been the issuance of equity securities for cash, primarily through private placements. The Company’s access to financing is always uncertain. There can be no assurance of continued access to significant equity funding.

The following is an analysis of the contractual maturities of the Company’s financial liabilities at December 31, 2022:

	1 year		1 – 5 years		More than 5 years
Trade payables and accrued liabilities	$	2,816,676	$	-	$	-
Customer deposits		194,758		-		-
Deferred income		63,690		-		-
Loans payable		81,512		5,059		-
Derivative liability		57,314		-		-
Lease liability		133,962		244,681		-
	$	3,347,912	$	249,740	$	-

Foreign exchange risk

Foreign currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company does not hedge its exposure to fluctuations in foreign exchange rates.

The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net loss upon consolidation as follows:

	December 31, 2022		December 31, 2021
Foreign exchange rate	$	969,977	$	150,715

Interest rate risk

Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its cash equivalents as these instruments have original maturities of three months or less and are therefore exposed to interest rate fluctuations on renewal.

Fair value

A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

F-32

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

Equity securities in investee companies and warrants are measured at fair value. The financial assets and liabilities measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the statements of financial position. These financial assets are measured at fair value through profit and loss.

December 31, 2022	Level 1		Level 2		Level 3		Total
Equity securities in investee companies	$	57,143	$	135,440	$	-	$	192,583
Notes receivable		-		-		169,300		169,300
Derivative liability		-		-		57,314		57,314
Total	$	57,143	$	135,440	$	226,614	$	419,197

December 31, 2021	Level 1		Level 2		Level 3		Total
Equity securities in investee companies	$	164,286	$	126,780	$	-	$	291,066
Notes receivable		-		1,154,176		-		1,154,176
Derivative liability		-		-		5,560,002		5,560,002
Total	$	164,286	$	1,280,956	$	5,560,002	$	7,005,244

Capital Management

The Company manages its capital to maintain its ability to continue as a going concern and to provide returns to shareholders and benefits to other stakeholders. The capital structure of the Company consists of shareholders’ equity

The Company manages its capital structure and makes adjustments to it in light of economic conditions. The Company, upon approval from its board of directors, will balance its overall capital structure through new equity issuances or by undertaking other activities as deemed appropriate under the specific circumstances. The Company is not subject to externally imposed capital requirements and the Company’s overall strategy with respect to capital risk management remains unchanged from the year ended December 31, 2021.

F-33

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

22. INCOME TAXES

The following table reconciles the expected income taxes at the Canadian statutory income tax rates to the amounts recognized in the statements of comprehensive loss for the years ended December 31, 2022, 2021:

	December 31, 2022			December 31, 2021
Loss before income taxes	$	27,654,364		$	16,202,972
Canadian statutory rates		27%			27%
Expected income tax recovery		7,338,900			4,196,600
Impact of different foreign statutory tax rates		-			34,900
Non-deductible items		(1,214,400	)		116,400
Share issue costs		1,400			887,600
Adjustments to prior years provision versus statutory tax returns		(742,400	)		376,500
Differences between prior year provision and final tax return		867,500			(206,000	)
Change in deferred tax asset not recognized		(6,251,000	)		(5,406,000	)
Income tax	$	-		$	-

The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:

	December 31, 2022			December 31, 2021
Deferred income tax assets (liabilities):
Share issuance costs	$	568,000		$	728,000
Non-capital losses		14,602,000			7,043,000
Property and equipment		953,000			449,000
Capital gain reserve		-			74,000
Scientific Research and Experimental Development		367,000			291,000
Total deferred income tax assets	$	16,490,000		$	8,585,000
Deferred income tax not recognized		(16,490,000	)		(8,585,000	)
Net deferred tax assets	$	-		$	-

The Company has non-capital loss carry forward of approximately $48,808,245 which may be carried forward to apply against future year income tax for Canadian income tax purposes, subject to the final determination by taxation authorities, expiring in the years 2036 to 2041.

F-34

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

23. SUPPLEMENTAL CASH FLOW DISCLOSURES

During the year ended December 31, 2022:

- During the year ended December 31, 2022, $508,607 of inventory that was used for rental services was transferred to equipment.

During the year ended December 31, 2021:

- The Company issued 371,901 common shares in lieu of cash for services rendered.

- The Company issued 1,200,000 units for the acquisition of Vital Intelligence. Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.

24. SUBSEQUENT EVENTS

Subsequent to December 31, 2022, the Company entered into an equity distribution agreement. The agreement will allow the Company from time to time, to distribute in an at-the-market offering (“ATM”) up to $15,000,000 (USD) in common shares. Draganfly intends to use the net proceeds from the ATM for general corporate ‎purposes, including to fund ongoing operations, growth initiatives and/or ‎for working capital requirements ‎including the continuing development and marketing of the Company’s ‎core products, potential acquisitions and ‎research and development‎.

From February 1, 2023 to February 17, 2023, the Company distributed 650,729 ATM shares under the ATM offering at an average price of 2.62 per share for net proceeds of $1,705,013.

F-35

EX-99.3

Exhibit 99.3

Management Discussion and Analysis

For the year ended December 31, 2022

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

This Management’s Discussion and Analysis (“MD&A”) is presented and dated as of March 27, 2023, and should be read in conjunction the annual consolidated financial statements and related notes for the year ended December 31, 2022. The Company’s audited consolidated financial statements have been prepared on a “going concern” basis, which presumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.

The operations of the Company have been primarily funded through its Regulation A+ Offering of units, its Nasdaq prospectus financing, internally generated cashflow and private placements of equity and convertible debentures. The continued operations of the Company are dependent on the Company’s ability to generate profitable operations in the future, develop and execute a sufficient financing plan for future operations and receive continued financial support from shareholders and other providers of finance.

The consolidated financial statements do not reflect the adjustments, if any, or changes in presentation that may be necessary should the Company not be able to continue on a going concern basis.

All currency amounts in the accompanying financial statements and this management discussion and analysis are in Canadian dollars unless otherwise noted.

‎

Special Note Regarding Forward Looking Information

This Management Discussion & Analysis (“MD&A”) is intended to provide readers with the information that management believes is required to gain an understanding of the current results of Draganfly Inc. (the “Company” or “Draganfly”) and to assess the Company’s future prospects. Accordingly, certain sections of this report, other than statements of historical fact, may contain forward-looking statements that are based on current plans and expectations and are subject to certain risks and uncertainties. These forward-looking statements include information about possible or assumed future results of our business, financial condition, results of operations, liquidity, plans and objectives. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions.

The statements we make regarding the following matters are forward-looking by their nature and are based on certain of the assumptions noted below:

● the intentions, plans and future actions of the Company;

● statements relating to the business and future activities of the ‎Company;

● anticipated developments in operations of the Company;

● market position, ability to compete and future ‎financial or operating performance of the Company;

● the timing and amount of funding required to execute the ‎Company’s business plans;

● capital expenditures;

● the effect on the Company of any changes to existing or new ‎legislation or policy or government regulation;

● ‎the availability of labor;

● requirements for additional capital;

● goals, strategies and future ‎growth;

● the adequacy of financial resources;

● expectations regarding revenues, ‎expenses and anticipated cash needs‎;

● general market conditions and macroeconomic trends driven by geopolitical conflicts, including supply chain disruptions, market volatility, inflation, and labor challenges, among other factors.

The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. The forward-looking statements are based on our beliefs, assumptions, and expectations of future performance, taking into account the information currently available to us. Furthermore, unless otherwise stated, the forward-looking statements contained in this Annual Report are made as of the date hereof, and we have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, changes or otherwise, except as required by law.

2

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

These statements are only predictions based upon our current expectations and projections about future events. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements. These include, without limitation, the Company’s current and planned operations and the expected results of new operations and new clients. These risks and uncertainties include, but are not restricted to:

● The Company’s history of losses;

● The dilution of holdings in the Company’s securities;

● Research and development costs;

● The failure of new business models to produce financial returns;

● Operational risks for which the Company may not be adequately insured;

● The Company operates in an evolving market that makes it difficult to evaluate business and future prospects;

● Competitive market conditions and challenges from competitors;

● The pace of technological change and the Company’s ability to stay on top of market and technology changes;

● The failure to obtain necessary regulatory approvals and permits or limitations placed on the development, operation, and sale of unmanned aerial vehicles (“UAVs”) by governments;

● Risks associated with any particular future acquisitions that would allow the company to provide additional product or service offerings;

● The Company’s ability to retain key employees and personnel and the Company’s ability to manage growth;

● Adverse economic changes;

● Negative macroeconomic and geopolitical trends that could restrict the Company’s ability to access capital;

● Uncertainties associated with operations in foreign countries;

● Adverse tax policies;

● An inability to access critical components or raw materials used to manufacture the Company’s products and supply chain disruptions;

● Weather and other natural outdoor conditions that can imperil the use of UAVs;

● The Company’s products may be subject to recalls or returns or defective products or services that could negatively affect the Company’s operating results;

● An inability to secure adequate funding for research and development;

● Export controls or restrictions on the Company’s ability to deliver its product outside of Canada;

● Consumer perception regarding the use and safety of UAVs;

● A failure to successfully market the Company’s products;

● Security risks associated with electronic communications and IT infrastructure;

● Inadequate consumer protection and data privacy practices;

● An inability of our business partners to fulfill their obligations to us or to secure company information;

● A failure to protect the Company’s intellectual property, proprietary rights, and trade secrets, including through a failure to adequately apply for or seek such protections;

● Failure to adhere to financial reporting obligations and mandates associated with being a public company;

● The Company’s limited experience operating as publicly traded corporation;

● Changes in accounting standards and subjective assumptions, estimates and judgments by management related to ‎complex accounting matters;

● Write-downs of goodwill or other intangible assets;

● Legal proceedings in which the Company may become involved;

● Conflicts of interests among our directors and officers;

● Volatility related to our share price;

● A failure to maintain an active trading market for our common shares;

● The Company may never pay dividends, and a return on an investment in the Company will depend upon an appreciation in the price of our shares after purchase;

● The Company may be classified as a “passive foreign investment company” for U.S. federal income tax purposes;

● United States investors may not be able to obtain an enforcement of civil liabilities against the Company

● The Company’s status as an “emerging growth company”;

● Increased costs and compliance matters related to our status as a public company in the United States; and

● The Company’s status as a “foreign private issuer.”

Readers are cautioned to read more about the potential risks the Company faces under the heading “Business Risks” at the end of this MD&A.

3

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Non-GAAP Measures and Additional GAAP Measures

In this MD&A we describe certain income and expense items that are unusual or non-recurring. There are terms not defined by International Financial Reporting Standards (IFRS). Our usage of these terms may vary from the usage adopted by other companies. Specifically, Gross profit, Gross margin and Cash flow from operations are undefined terms by IFRS that may be referenced herein. We provide this detail so that readers have a better understanding of the significant events and transactions that have had an impact on our results.

Throughout this document, reference is made to “gross profit,” “gross margin,” and “working capital”, which are non-IFRS measures. Management believes that gross profit, defined as revenue less operating expenses, is a useful supplemental measure of operations. Gross profit helps provide an understanding on the level of costs needed to create revenue. Gross margin illustrates the gross profit as a percentage of revenue. Management believes that working capital, defined as current assets less current liabilities, is an indicator of the Corporation’s liquidity and its ability to meet its current obligations. Readers are cautioned that these non-IFRS measures may not be comparable to similar measures used by other companies. Readers are also cautioned not to view these non-IFRS financial measures as an alternative to financial measures calculated in accordance with International Financial Reporting Standards (“IFRS”).

Core Business and Strategy

Draganfly creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company is incorporated under the British Columbia Business Corporations Act and has its registered office located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z75 with a head office at 2108 St. George Avenue, Saskatoon, SK, S7M 0K7.

Recognized as being at the forefront of UAV (unmanned aerial vehicles) technology for two decades, Draganfly is an award-winning, industry-leading manufacturer, contract engineering, and product development company within the commercial UAV space serving the public safety, agriculture, industrial inspections, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.

Founded in 1998, Draganfly is recognized as one of the first commercial multi-rotor manufacturers and has a legacy for its innovation and superior customer service. The company has sold products and services to over 50 countries.

Draganfly can provide its customers with an entire suite of products and services that include quad-copters, fixed-wing aircrafts, ground based robots, handheld controllers, flight training, and software used for tracking, live streaming, data collection, and health monitoring. The integrated UAV system is equipped for automated take-offs and landings with altitude and return to home functions as well as in-house created survey software. Draganfly’s standard features combined with custom fit camera payloads ranging from multi-spectral, hyper-spectral, LIDAR, thermal, and infrared allows Draganfly to offer a truly unique solution to clients.

With 23 issued and one pending fundamental UAV patents in the portfolio, Draganfly will continue to expand and grow its intellectual property portfolio.

4

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Historically, the main business of the Company was as a manufacturing company offering commercial UAVs directly to its customer base across various industry verticals. The Company has evolved to offer engineering procurement for certain customers in a vertical that it did not previously serve, such as military applications. The rationale is three-fold: engage in long term contracts that tend to be recurring in nature, gain exposure to an industry that the Company otherwise did not have access to, and leverage our innovation learnings into other products that can be sold in other industries.

Draganfly works with its customers to customize a product or platform from idea to research and development (R&D) to completion and testing. A work plan is created with timelines and budgets which includes materials, travel, testing, and engineering time. The work plan is approved by the customer before work begins. To date, the majority of this work is considered proprietary in nature and is protected by trade secrets and other intellectual property protections.

With its acquisition of Dronelogics in April 2020, the Company has further broadened its scope to provide custom built parts, accessories, drone services, and the ability to sell third-party manufactured UAVs along with support services that it did not typically offer before.

On March 9, 2021, the Company announced that it completed the final closing of its Regulation A+ Offering of units sold pursuant to the Company’s Regulation A+ offering circular (the “Offering Document”) filed with the U.S. Securities and Exchange Commission. The Company issued 5,154,293 units for gross proceeds in the ‎amount of $15,504,135 (US$12,112,606) in the final closing. Each unit is comprised of one common share of the Company ‎‎and one common share purchase warrant, with each warrant entitling the ‎holder to acquire one common share at a price of US$3.55 per common share for period of two years from the date of issuance. ‎The common shares and warrants issued in connection with the offering are subject to a nine month ‎hold period.‎ In total, the Company issued 7,000,000 units under its Offering Document for aggregate gross proceeds of US$16,450,000.

On July 30, 2021, the Company’s shares began trading on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO”. The Company’s shares continue to trade on the Canadian Stock Exchange (the “CSE”), however, as of July 30, 2021 they now trade under the symbol “DPRO” on that exchange as well. The Company’s shares also trade on the Frankfurt Stock Exchange under the Symbol “3UB”.

In order to become compliant with Nasdaq regulations, the company also underwent a stock consolidation. Effective July 29, 2021, the Company consolidated its issued and outstanding common shares on a 5 to 1 basis, which resulted in 27,045,909 common shares outstanding post-consolidation.

Subsequent to December 31, 2022, the Company entered into an equity distribution agreement. The agreement will allow the Company from time to time, to distribute in an at-the-market offering (“ATM”) up to $15,000,000 (USD) in common shares. Draganfly intends to use the net proceeds from the ATM for general corporate ‎purposes, including to fund ongoing operations, growth initiatives and/or ‎for working capital requirements ‎including the continuing development and marketing of the Company’s ‎core products, potential acquisitions and ‎research and development‎.

Additional information relating to the Company may be found at the Company’s website, www.draganfly.com.

2022 Highlights

● 2022 Total Revenues of $7,605,059 with Product Sales of $5,550,432

Although, the Company’s products are still well regarded in the industry, the commercial UAV space as a whole has been impacted by lower priced consumer drones that can now offer similar functionality. The Company recognized an opportunity to address this market by acquiring Dronelogics, a company that among other things, resells lower priced, third party drones as well as other third party products. 2022 revenues increased by $551,194 from $7,053,865 in 2021 to $7,605,059 with the bulk of this revenue coming from product sales. Service revenue increased by $104,161 from $1,950,466 in 2021 to $2,054,627 in 2022.

● Gross Profit was $790,675 with a Gross Margin decrease of 27.1% in 2022 compared to 2021. Gross profit not including a one-time non-cash write down of inventory of $1,976,514 would have been $2,767,189 with a decrease of 1.1%.

In 2022, the Company’s total gross margin was 10.4% compared to 37.5% in 2021. Gross margin excluding the one-time non-cash write down of inventory of $1,976,514 would have been 36.4% compared to 37.5% in 2021.

5

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

● Continued Diversification of its Product and Services Offering

Given the Company’s deep engineering talent, the Company continues to expand its product and services available to its customers. Doing this leverages the Company’s core skill set of innovation that tends to lead to future projects, bringing in more consistent revenue. With its acquisition of Dronelogics, the Company has increased its scope of products and services to include the sale of third-party manufactured UAVs and drone-as-a-service type work. This has proved beneficial during the current pandemic as not all services are impacted the same way so having a larger breadth of products and services, in part mitigates some risk for the Company.

● Functional Reorganization

The Company has undertaken an effort to reorganize its functions into departments such as Finance, Sales and Marketing, Operations, Human Resources, etc. with the key goal of obtaining efficiencies by streamlining processes and procedures at a corporate shared service level as opposed to segmenting departments at the subsidiary level. As part of the ongoing reorganization, Justin Hannewyk and Rich Cochrane, the President and Vice President of Dronelogics, respectively, are no longer with the Company.

● Risks Related to Operations

The Company’s UAVs are sold in rapidly evolving markets. The commercial UAV market is in early stages of customer adoption. Accordingly, the Company’s business and future prospects may be difficult to evaluate. The Company cannot accurately predict the extent to which demand for its products and services will increase, if at all. The challenges, risks and uncertainties frequently encountered by companies in rapidly evolving markets could impact the Company’s ability to do the following:

● generate sufficient revenue to maintain profitability;

● acquire and maintain market share;

● achieve or manage growth in operations;

● develop and renew contracts;

● attract and retain additional engineers and other highly qualified personnel;

● successfully develop and commercially market new products;

● adapt to new or changing policies and spending priorities of governments and government agencies; and

● access additional capital when required and on reasonable terms.

For further and more detailed risk disclosure, please reference “Business Risks” at the end of this MD&A.

6

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Outlook and Guidance

General

The Company believes that drone regulations are gradually evolving in favor of additional use cases, which could lead to more revenue opportunities from a greater pool of customers. With the Company capitalized and having easier access to funds in the public markets on both sides of the border, the Company will increasingly focus on some of its growth initiatives in the United States, Canada, and abroad. Operationally, having more capital will help the Company expand and diversify its engineering, drone, and health services businesses. This will require more human resources from an oversight, sales, and engineering perspective and the Company anticipates adding additional staff to accommodate these plans. Further, the Company will continue to focus on innovation, product development, and expanding its hardware offerings opportunistically into niche segments of the UAV and related sectors. Finally, the Company has considered providing various other non-engineering services and it may make more sense to buy an existing industry player than to build out this offering. With the Company listed on the Nasdaq, it will open up further opportunities to use its Common Shares as a currency for potential acquisitions. The Company expects to be active in this regard reviewing partnerships, investments, and acquisitions in the current fiscal year and the near future.

Selected Financial Information

The following selected financial data has been extracted from the unaudited condensed consolidated interim financial statements, prepared in accordance with International Financial Reporting Standards, for the fiscal years indicated and should be read in conjunction with the unaudited condensed consolidated interim financial statements. All earnings per share calculations are shown post-consolidation.

For the year ended December 31,	2022			2021
Total revenues	$	7,605,059		$	7,053,865
Gross Profit (as a % of revenues)(1)		10.4%			37.5%
Net loss		(27,654,364	)		(16,202,972	)
Net loss per share ($)
-Basic		(0.82	)		(0.58	)
-Diluted		(0.82	)		(0.58	)
Comprehensive loss		(27,305,305	)		(16,399,137	)
Comprehensive loss per share ($)
-Basic (post-consolidation)		(0.81	)		(0.59	)
-Diluted (post-consolidation)		(0.81	)		(0.59	)
Change in cash and cash equivalents	$	(15,180,932	)	$	21,093,297

(1) Gross Profit (as a % of revenues) would have been 36.4% not including a one-time non-cash write down of inventory for $1,976,514.

The net loss and comprehensive loss for the year ended December 31, 2022, includes non-cash changes comprised of a change in fair value of derivative liability of $5,502,688 ($8,149,812 – 2021), an expense for impairment of notes receivable of $309,385 ($891,471 – 2021), a write down of inventory of $1,976,514 ($nil – 2021), and an expense for goodwill and intangibles impairment of $6,454,914 ($4,579,763 – 2021) and would otherwise have been a loss of $24,416,239 ($18,881,550 – 2021) for the net loss, and $24,067,180 ($19,077,715 – 2021) for the comprehensive loss, respectively.

As at	December 31, 2022		December 31, 2021
Total assets	$	14,638,533	$	42,113,240
Working capital		10,168,800		26,836,922
Total non-current liabilities		249,740		465,214
Shareholders’ equity	$	11,040,881	$	34,926,239
Number of shares outstanding		34,270,579		33,168,946

Shareholders’ equity and working capital as at December 31, 2022, includes a fair value of derivative liability of $57,314 ($5,560,002 – 2021) and would otherwise be $11,098,195 ($40,486,241 – 2021) and $10,226,114 ($32,396,924 - 2021) respectively.

7

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Results of Operations

Revenue

For the year ended December 31,	2022		2021
Product sales	$	5,550,432	$	5,103,399
Custom engineering services		2,054,627		1,950,466
Total revenue	$	7,605,059	$	7,053,865

Total revenue for the year ended December 31, 2022, increased by $551,194 or 7.8% as compared to 2021. The increase in revenue is largely due to increased sales from Dronelogics.

Product sales increased $447,033 or 8.8% in 2022 as compared to 2021. The increase in revenue is largely due to increased sales from Dronelogics.

Services revenue increased by $104,161 or 5.3% in 2022 as compared to 2021. The increase was due primarily to increased efforts to increase revenue from services.

Cost of Goods Sold / Gross Margin

For the year ended December 31,	2022			2021
Cost of goods sold(1)	$	(6,814,384	)	$	(4,410,777	)
Gross profit	$	790,675		$	2,643,088
Gross margin (%)		10.4%			37.5%

(1) Cost of goods sold would have been $4,837,870 not including a one-time non-cash write down of inventory for $1,976,514.

Gross profit is the difference between the revenue received and the direct cost of that revenue. Gross margin is gross profit divided by revenue and is often presented as a percent.

For the year ended December 31, 2022, the Company’s Gross Profit decreased by $1,852,413 or 70.1% compared to 2021. As a percentage of sales, gross margin decreased from 37.5% in 2021 to 10.4% in 2022.

For the year ended December 31, 2022, not including the one-time non-cash write down of inventory of $1,976,514 the Company’s Gross Profit increased by $124,101 or 4.7% compared to 2021. As a percentage of sales, gross margin decreased from 37.5% in 2021 to 36.4% in 2022.

Selling, General, and Administrative (SG&A)

For the year ended December 31,	2022		2021
Insurance	$	3,722,237	$	2,962,767
Office and Miscellaneous		5,397,961		6,455,998
Professional Fees		6,821,583		4,445,949
Research and development		651,302		510,895
Share-based payments		3,311,024		3,952,595
Travel		396,388		143,904
Wages and salaries		6,105,020		2,768,010
Total	$	26,405,515	$	21,240,118

8

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

For the year ended December 31, 2022, SG&A expenses increased by 24.3%, from $21,240,118 in 2021 to $26,405,515 in 2022. The largest contributors to the increase are insurance cost, professional fees expense, advertising, marketing and investor relations expenses, and wages.

Net and Comprehensive Income (Loss)

For the year ended December 31,	2022			2021
Loss from operations	$	(26,909,948	)	$	(19,278,188	)
Change in fair value of derivative liability		5,502,688			8,149,812
Finance and other costs		44,345			5,074
Foreign exchange gain (loss)		745,102			362,448
Loss on disposal of assets		(10,755	)		-
Impairment of notes receivable		(309,385	)		(891,471	)
Impairment of goodwill		(6,454,914	)		(4,579,763	)
Income from government assistance		2,446			24,148
Write down of deposit		(228,572	)		-
Other income (loss)		(35,371	)		4,968
Net loss		(27,654,364	)		(16,202,972	)
Cumulative translation differences		447,542			136,475
Unrealized gain on investments available for sale		(98,483	)		(332,640	)
Comprehensive loss	$	(27,305,305	)	$	(16,399,137	)

For the year ended December 31, 2022, the Company recorded a comprehensive loss of $27,305,305 compared to $16,399,137 in 2021.

The net and comprehensive loss for the year ended December 31, 2022, includes non-cash changes comprised of a gain in fair value of derivative liability of $5,502,688, an expense on impairment for notes receivable of $309,385, a write down of inventory of $1,976,514, and an expense for goodwill and intangibles impairment of $6,454,914 and would otherwise be losses of $24,416,239 and $24,067,180 respectively. The net and comprehensive loss the for the same period last year, includes non-cash changes comprised of a gain in fair value of derivative liability of $8,149,812, a note receivable impairment of $891,471, and an expense for goodwill impairment of $4,579,763 and would otherwise be losses of $18,881,550 and $19,077,715 respectively. The other largest contributors to the year over year increase are insurance cost, professional fees expense, advertising, marketing and investor relations expenses, and wages.

9

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Authorized share capital

Unlimited number of common shares without par value.

Issued share capital

During the year ended December 31, 2022:

● The Company issued 16,538 common shares for the exercise of warrants for $87,170.

● The Company issued 12,500 common shares for the exercise of stock options for $26,875.

● The Company issued 1,072,595 common shares for the vesting of Restricted Share Units.

During the year ended December 31, 2021:

● The Company issued 1,939,534 common shares for the exercise of warrants for $4,929,790.

● The Company issued 448,660 common shares for the vesting of Restricted Share Units.

● The Company issued 405,499 common shares for the exercise of stock options for $1,014,123.

● The Company issued 371,901 common shares in lieu of cash for services rendered.

● The Company issued 6,488,669 units for the Regulation A+ financing in the United States for proceeds of $18,815,485. Each unit is comprised of one common share and one share purchase warrant. These warrants had a fair value of $0.57 USD allocated to them, have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years. The fair value of $8,261,511 was allocated to warrant derivative liability.

● The Company issued 1,200,000 units for the acquisition of Vital Intelligence. Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.

● The Company issued 5,095,966 common shares in a private placement for $25,538,213.

10

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Vital Intelligence Acquisition

On March 25, 2021, the Company acquired the assets of Vital Intelligence Inc. (“Vital”) for consideration of: (a) a cash payment of $500,000 with ‎‎$50,000 paid upon execution of the asset purchase agreement, $200,000 to be paid at closing and ‎‎$250,000 to be paid on the six-month anniversary date of ‎closing; and (b) ‎1,200,000 units of the ‎Company with each unit being comprised of one common share of the Company and one common share ‎purchase warrant (the “Acquisition”). Each warrant will entitle the holder to acquire one common share for a period of 24 ‎months following closing at an exercise price of $13.35 per common share and the Company will be able ‎to accelerate the expiry date of the warrants after one year in the event the underlying common shares ‎have a value of at least 30% greater than the exercise price of the warrants. The units will be held in ‎escrow following closing with 300,000 units being released at closing with a value of $3,545,249 and the remainder to be released ‎upon the Company reaching certain revenue milestones received from the purchased assets. On August 19, 2021, the parties agreed to reduce the final payment from $250,000 to $227,984 as certain assets listed in the purchase agreement had not been delivered by Vital.

The units of the Company are to be released from escrow in accordance with the terms and conditions of the Escrow Agreement, as follows:

a)	300,000 units shall be released on the closing date;
b)	300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $2,000,000;
c)	300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $4,000,000; and
d)	300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $6,000,000.

The 900,000 shares held in escrow are classified as a derivative liability and are valued based upon the weighted average probability of achieving the milestones necessary to release the shares held in escrow, discounted for liquidity. The 900,000 units will be forfeited and cancelled within two years of the closing if the Company does not meet the revenue milestones.

On acquisition, the fair value of the derivative liability was $4,797,717. At December 31, 2022, the liability was revalued based upon new weighted average probabilities of achieving the revenue milestones. As a result, the fair value was adjusted to $57,314 (2021 - $694,230), with the difference flowing through profit or loss.

Contingent consideration
Fair value of contingent consideration	$	4,797,717
Change in fair value of contingent consideration		(4,103,487	)
Contingent consideration at December 31, 2021		694,230
Change in fair value of contingent consideration		(636,916	)
Contingent consideration at December 31, 2022	$	57,314

The Vital Intelligence product platform is a combination of proprietary Intellectual Property along with external technology. The base technology is computer vision signal processing that incorporates learning algorithms that can detect heart rate, breathing/respiratory rate, coughs, mask usage, social distancing, temperature, oxygen saturation of blood, and blood pressure. Combined, all these data points provide and deliver an analysis of health and better accuracy in determining infection with various respiratory related issues.

Vital Intelligence has developed a suite of products designed to maximize the use of its technology by serving a variety of different market segments and sectors:

● Drone Vital Sign Detection: Video from a drone is analyzed and can provide an individuals’ heart rate, respiratory rate, and also detect coughing. The data is processed via either a local or cloud storage service in near-real time.

● Drone Social Distancing Detection: Video cameras attached to drones collect data which is then used to determine social distancing. The data is processed via either a local or cloud storage service in real or near-real time.

11

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

● Thermography Kiosk: This product, also branded as Safe Set Solution, is a moveable kiosk (consisting of a thermal detection camera, laptop and stand) to provide thermal detection and reporting systems. The Kiosk is able to be placed in entryways or throughways to capture temperature readouts of passers-by.

● Thermography Detection Camera System: This group of products is a stationary camera system, or systems of networked cameras aimed at critical entryways or locations designed to capture core-body temperature of individuals entering a space. Algorithms read video feeds and allow for facility use decisions to be made. An example would be capturing temperature readouts from individuals and then integrating that data into a company’s employee badge systems for compliance and monitoring as well as door locking systems to grant access to a space.

● Social Distancing Camera System: This product is a stationary camera system, or system of networked cameras aimed at high traffic areas in order to capture data on social distancing. Information is provided via overlay on capture footage. The technology can be used on archived or real-time video footage to assist community health workers in predicting outbreaks of infections.

The purchase price allocation (“PPA”) is as follows:

Number of units of Draganfly Inc.		578,248
Fair value of units	$	14.43
Fair value of units of Draganfly Inc.	$	8,342,966
Cash portion of purchase price		466,643
Total	$	8,809,609

Identifiable intangible assets
Brand	$	23,000
Software		433,000
		456,000
Goodwill		8,375,625
Goodwill adjustment for inventory not received		(22,016	)
Total consideration	$	8,809,609

Significant estimates are as follows:

● Number of units issued based upon a weighted average calculation for the Company achieving revenue targets.

● Brand based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 0.25% and discount rate of 14.4% per annum.

● Software based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 5.0% and discount rate of 14.4% per annum.

Summary of Quarterly Results

The following selected quarterly financial data has been extracted from the financial statements, prepared in accordance with International Financial Reporting Standards.

Total revenue for the three months ended December 31, 2022, decreased by $321,103 or 19.6% as compared to the same period in 2021. The decrease was due to lower sales from services.

SG&A expenses increased 17.2% compared to the same period in 2021 due to higher professional fees, wage costs, partially offset by lower insurance costs. The other income (expense) and comprehensive loss for the fourth quarter of 2022 includes non-cash changes comprised of a fair value derivative liability expense recovery of $334,016, write down of inventory of $1,976,514, an expense on impairment for notes receivable of $1,080,645, and an expense for goodwill and intangibles impairment of $6,454,914 and would otherwise be an other expense of $374,346 and comprehensive loss of $7,482,545, respectively.

Total revenue for the three months ended December 31, 2022, decreased by $562,058 or 30.0% as compared to the three months ended September 30, 2022. The primary decrease in revenue is due to the decrease in service revenue as well as product sales. Product sales decreased by $340,240 or 25% in the fourth quarter of 2022 as compared to the third quarter of 2022 primarily due to delayed timing of certain product orders as well as increased competition.

12

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

SG&A expenses decreased by $74,554 or 1.1% compared to the third quarter of 2022 due to decreased office and miscellaneous costs and share-based payments, partially offset by an increase in professional fees.

The table below summarizes the quarterly results over the past eight fiscal quarters. All earnings per share calculations are shown post-consolidation.

	2022 Q4			2022 Q3			2022 Q2			2022 Q1
Revenue	$	1,314,162		$	1,876,221		$	2,370,115		$	2,044,562
Cost of goods sold(2)	$	(2,980,133	)	$	(1,249,313	)	$	(1,356,526	)	$	(1,228,412	)
Gross profit(3)	$	(1,665,971	)	$	626,908		$	1,013,589		$	816,150
Gross margin – percentage		-126.8%			33.4%			42.8%			39.9%
Operating expenses	$	(7,342,669	)	$	(7,007,691	)	$	(7,176,445	)	$	(6,173,819	)
Operating income (loss)	$	(9,008,640	)	$	(6,380,783	)	$	(6,162,856	)	$	(5,357,669	)
Operating loss per share - basic	$	(0.26	)	$	(0.19	)	$	(0.19	)	$	(0.16	)
Operating loss per share - diluted	$	(0.26	)	$	(0.19	)	$	(0.19	)	$	(0.16	)
Other income (expense)	$	(7,575,889	)	$	1,039,968		$	6,638,171		$	(846,666	)
Change in fair value of derivative liability (1)	$	334,016		$	305,094		$	6,094,438		$	(1,230,860	)
Other comprehensive income (loss)	$	(76,073	)	$	348,282		$	165,009		$	(88,159	)
Comprehensive income (loss)	$	(16,660,602	)	$	(4,992,533	)	$	640,324		$	(6,292,494	)
Comprehensive income (loss) per share - basic	$	(0.49	)	$	(0.15	)	$	0.02		$	(0.19	)
Comprehensive income (loss) per share - diluted	$	(0.49	)	$	(0.15	)	$	0.02		$	(0.19	)

	2021 Q4			2021 Q3			2021 Q2			2021 Q1
Revenue	$	1,635,265		$	1,896,992		$	1,981,872		$	1,539,736
Cost of goods sold	$	(1,008,827	)	$	(1,123,942	)	$	(1,253,279	)	$	(1,024,729	)
Gross profit	$	626,438		$	773,050		$	728,593		$	515,007
Gross margin – percentage		38.3%			40.8%			36.8%			33.4%
Operating expenses	$	(5,733,767	)	$	(8,006,957	)	$	(3,340,952	)	$	(4,839,600	)
Operating loss	$	(5,107,329	)	$	(7,233,907	)	$	(2,612,359	)	$	(4,324,593	)
Operating loss per share - basic	$	(0.16	)	$	(0.25	)	$	(0.10	)	$	(0.21	)
Operating loss per share - diluted	$	(0.15	)	$	(0.23	)	$	(0.10	)	$	(0.21	)
Other income (expense)	$	17,811,440		$	31,135,835		$	(4,955,575	)	$	(40,876,484	)
Change in fair value of derivative liability (1)	$	23,428,117		$	30,562,044		$	4,821,177	)	$	(41,019,172	)
Other comprehensive income (loss)	$	(151,465	)	$	73,472		$	(404,602	)	$	286,430
Comprehensive income (loss)	$	12,635,466		$	23,975,400		$	8,095,356		$	(44,914,647	)
Comprehensive income (loss) per share - basic	$	0.39		$	0.82		$	(0.31	)	$	(2.14	)
Comprehensive income (loss) per share - diluted	$	0.38		$	0.77		$	(0.31	)	$	(2.14	)

(1)	Included in other income (expense).
(2)	Cost of goods sold would have been $1,003,619 not including a one-time non-cash write down of inventory for $1,976,514.
(3)	Gross profit would have been $310,543 not including a one-time non-cash write down of inventory for $1,976,514.

13

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Liquidity and Capital Resources

The Company’s liquidity risk is derived from its loans, accounts payable, and accrued liabilities, as it may encounter difficulty discharging those obligations, but the Company endeavors to mitigate that risk through the careful management of its debt holders and the assertive pursuit of capital inflow for its operations. The Company’s working capital of $10,168,800 as at December 31, 2022, would be increased to $10,226,114, if the non-cash derivative liability was excluded. The Company’s working capital as at December 31, 2021 was $26,836,922.

The Company considers the items included in capital to include shareholders’ equity. The Company manages its capital structure and makes adjustments to it in light of changes in economic and business conditions, financing environment, and the risk characteristics of the underlying assets. The Company does not have any contracted or committed capital expenditures as of the date of this MD&A. The Company utilizes its credit card facilities from time to time to make various purchases for their operations. Based on the Company’s existing operations, the Company will need to raise additional capital during the next twelve months and beyond to support its business plan.

Subsequent to December 31, 2022, the Company entered into an equity distribution agreement. The agreement will allow the Company from time to time, to distribute in an at-the-market offering (ATM”) up to $15,000,000 (USD) in common shares. Draganfly intends to use the net proceeds from the ATM for general corporate ‎purposes, including to fund ongoing operations, growth initiatives and/or ‎for working capital requirements ‎including the continuing development and marketing of the Company’s ‎core products, potential acquisitions and ‎research and development‎.

From February 1, 2023 to February 17, 2023, the Company distributed 650,729 ATM shares under the ATM offering at an average price of 2.62 per share for net proceeds of $1,705,013.

Further, in order to maintain or adjust its capital structure, the Company may issue new shares, new debt, or scale back the size and nature of its operations. The Company is not subject to externally imposed capital requirements. As at December 31, 2022, shareholders’ equity was $11,040,881 and at December 31, 2021, shareholder’s equity was $34,926,239. The Company’s shareholder’s equity at December 31, 2022 would be $11,098,195 ($40,486,241 – 2021) if the non-cash derivative liability was excluded.

On February 5, 2021, the Company closed a second tranche of its Regulation A+ Offering for gross proceeds in the amount of $4,003,195 (US$3,135,838). On March 9, 2021, the Company announced that it completed the final closing of its Regulation A+ offering of units sold pursuant to the Company’s Regulation A+ offering circular (the “Offering Document”) filed with the U.S. Securities and Exchange Commission. The Company issued 5,154,293 units at the offering price set out in the Offering Document for gross proceeds in the ‎amount of $15,504,135 (US$12,112,606) in the final closing. Each unit is comprised of one common share of the Company ‎‎and one common share purchase warrant, with each warrant entitling the ‎holder to acquire one common share at a price of US$3.55 per common share for period of two years from the date of issuance. ‎The common shares and warrants issued in connection with the offering are subject to a nine month ‎hold period.‎ In total, the Company issued 7,000,000 units under its Offering Document for aggregate gross proceeds of US$16,450,000.

On August 3, 2021, the Company announced that it closed on gross proceeds of a US$20,000,000 share offering that was filed with the U.S. Securities and Exchange Commission as part of its successful Nasdaq listing. The Company issued 5,000,000 shares at US$4.00.

We expect, from time to time, to evaluate the acquisition of businesses, intellectual property, products and technologies for which a portion of the net proceeds may be used. There is always the potential that any acquisition or investment in a company or product has a negative impact on future cash flows of the Company.

Our plan of operations for the next year includes the following: (i) hiring engineers to perform more engineering service work, to complete contracts on a timelier basis, and to perform R&D for the Company’s next generation of products; (ii) hiring sales/marketing employees for our product lines and engineering services work; (iii) hiring sales/marketing employees for further expansion into services (e.g. drone as a service); (iv) diversifying and expanding business lines organically and by potential acquisitions; (v) updating machinery used for manufacturing and production; (vi) continuing to patent innovative ideas for new products; and (vii) developing and increasing current product offering to various niche industries that are not currently being served.

14

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

This expected use of the net proceeds from the Regulation A+ Offering and Nasdaq financing represents our intentions based upon our current financial condition, results of operations, and conditions. As of the date of this MD&A, we cannot predict with certainty all of the particular uses for the net proceeds received from the closing of the Regulation A+ Offering and Nasdaq financing. The amounts and timing of our actual expenditures may vary significantly depending on numerous factors.

Off-Balance Sheet Arrangements

The Company has no material undisclosed off-balance sheet arrangements that have or are reasonably likely to have, a current or future effect on our results of operations, financial condition, revenues or expenses, liquidity, capital expenditures or capital resources.

Contractual Obligations

As of December 31, 2022, and as of the date of this MD&A, and in the normal course of business, the following is a summary of the Company’s material obligations to make future payments, representing contracts, and other commitments that are known and committed.

On December 1, 2020, and October 6, 2021, the Company entered into 2 separate amendments for the lease agreements, where the leases were amended with a change in annual payments. As a result of IFRS 16, the right of use asset and lease liability were setup and recorded. The total right of use assets and lease liabilities for the Company are as follows:

Right of Use Asset

	Total
Cost
Balance at December 31, 2020	$	242,967
Additions		447,242
Lease removal		(7,092	)
Balance at December 31, 2021 and 2022	$	683,117
Accumulated depreciation
Balance at December 31, 2020	$	98,548
Charge for the year		109,311
Historical correction		7,152
Balance at December 31, 2021	$	215,011
Charge for the period		123,360
Balance at December 31, 2022	$	338,371
Net book value:
December 31, 2021	$	468,106
December 31, 2022	$	344,746

Lease Liability

	Total
Balance at December 31, 2020	$	158,124
Additions		440,675
Interest expense		26,964
Lease payments		(128,995	)
Lease removal		(7,645	)
Balance at December 31, 2021	$	489,123
Interest expense		39,795
Lease payments		(150,275	)
Balance at December 31, 2022		378,643
Which consists of:
Current lease liability	$	133,962
Non-current lease liability		244,681
Balance at December 31, 2022	$	378,643

15

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Related Party Transactions

On August 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management. The services are provided by a team of up to six consultants and the costs of all charges are based on the fees set in the Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2022, the company incurred fees of $442,485 compared to $315,643 in 2021. As at December 31, 2022, the Company was indebted to this company in the amount of $30,804 (December 31, 2021 - $nil).

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the Consultant Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2022, the Company incurred fees of $566,487 compared to $290,225 in 2021. As at December 31, 2022, the Company was indebted to this company in the amount of $nil (December 31, 2021 - $nil).

On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. The costs of all charges are based on the fees set in the Executive Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. On May 9, 2022, Scott Larson ceased to be President of the Company and entered into an agreement to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the consulting agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2022, the Company incurred fees of $383,288 (December 31, 2021 - $205,191). As at December 31, 2022, the Company was indebted to this company in the amount of $20,745 (December 31, 2021 - $nil).

Trade receivables/payables and accrued receivables/payables:

As at December 31, 2022, the Company had $nil (December 31, 2021 - $155,108) receivable from related parties outstanding that were included in accounts receivable and $51,549 (December 31, 2021 - $nil) payable from related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

16

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Key management compensation

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the year ended December 31, 2022, 2021 included:

For the years ended December 31,	2022		2021
Director fees	$	522,349	$	370,094
Salaries		843,917		722,068
Share-based payments		2,106,906		2,475,949
	$	3,473,172	$	3,568,111

Other related parties

For the years ended December 31,		2022		2021
Management fees paid to a company controlled by CEO and director		566,487		290,225
Management fees paid to a company that the CEO holds an economic interest in		442,485		315,643
Management fees paid to a company controlled by the former President and director		383,288		205,691
	$	1,392,260	$	811,559

Share Capital

Common shares issued

	Number of Common Shares		Share Capital
Balance, December 31, 2020		17,218,695	$	36,943,304
Shares issued for exercise of warrants		1,939,534		4,929,790
Shares issued for acquisition		1,200,000		2,303,999
Shares issued for exercise of RSUs		448,660		1,752,052
Shares issued for exercise of stock options		405,499		1,937,866
Shares issued for financing		6,488,691		18,717,438
Share issue costs		-		(273,169	)
Shares issued in lieu of cash for services rendered		371,901		1,757,988
Shares issued for financing		5,095,966		17,374,749
Share issue costs		-		(4,393,420	)
Share issue costs		-		(12,232	)
Balance, December 31, 2021		33,168,946	$	81,038,365
Shares issued for exercise of warrants		16,538		87,170
Share issue costs		-		(5,122	)
Shares issued for exercise of stock options		12,500		51,875
Shares issued for the exercise of RSU’s		1,072,595		2,427,801
Balance, December 31, 2022		34,270,579	$	83,600,089

Stock options

The following is the summary of the Company’s stock option activity. Number of options and weighted average exercise prices in the table below are shown as they were outstanding, forfeited, granted, and exercised:

	Number of Options			Weighted Average Exercise Price
Outstanding, December 31, 2020		1,193,659		$	2.75
Exercised		(405,494	)		2.50
Granted		247,826			10.12
Outstanding, December 31, 2021		1,035,991		$	4.60
Exercised		(12,500	)		2.15
Forfeited		(146,334	)		4.77
Outstanding, December 31, 2022		877,157		$	4.60

17

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Restricted Share Units (RSUs)

The following is the summary of the Company’s RSU activity. Number of RSUs in the table below are shown as they were outstanding, exercised, forfeited, and granted:

	Number of RSUs
Outstanding, December 31, 2020		614,666
Exercised		(448,660	)
Granted		348,826
Outstanding, December 31, 2021		514,832
Exercised		(1,072,595	)
Issued		1,820,972
Forfeited		(64,334	)
Outstanding, December 31, 2022		1,198,875

Warrants

During the years ended December 31, 2021 and 2020, the Company issued warrants (“USD Warrants”) with a USD exercise price. Being in a foreign currency that is not the Company’s functional currency and these warrants were not issued in exchange for services, these USD Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, these USD Warrants are revalued on a quarterly basis to fair market value with the change in fair value being recorded profit or loss. The initial fair value of these USD Warrants was parsed out from equity and recorded as a financial liability.

To reach a fair value of the USD Warrants, a Black Scholes calculation is used, calculated in USD as the Company also trades on the OTCQB. The Black Scholes value per USD Warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period from the Bank of Canada.

Warrant Derivative Liability

Balance at January 1, 2021	$	748,634
Warrant issuance		8,261,511
Exercised		(98,048	)
Change in fair value of warrants outstanding		(4,046,325	)
Balance at December 31, 2021	$	4,865,772
Change in fair value of warrants outstanding		(4,865,772	)
Balance at December 31, 2022	$	-

Derivative liability
Warrants	$	-
Contingent consideration		57,314
Derivative liability at December 31, 2022	$	57,314

18

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

The derivative financial liability consists of the fair value of the non-compensatory share purchase warrants that have exercise prices that differ from the functional currency of the Company and are within the scope of IAS 32 “Financial Instruments: Presentation”. Details of these warrants and their fair values are as follows:

Issue Date	Exercise Price	Number of Warrants Outstanding at December 31, 2022		Fair Value at December 31, 2022		Number of Warrants Outstanding at December 31, 2021		Fair Value at December 31, 2021
November 30, 2020	US$3.55		-	$	-		482,425	$	182,262
February 5, 2021(1)	US$3.55		1,319,675		-		1,323,275		951,226
March 5, 2021(2)	US$3.55		5,142,324		-		5,154,321		3,732,284
July 29, 2021 (3)	US$5.00		250,000		-		250,000		-
September 14, 2021 (4)	US$5.00		4,798		-		4,798		-
			6,716,797	$	-		7,214,819	$	4,865,772

1) Subsequent to December 31, 2022, the warrants expired on February 5, 2023.

2) Subsequent to December 31, 2022, the warrants expired on March 5, 2023.

3) The warrants expire July 29, 2024.

4) The warrants expire September 14, 2024.

The following is the summary of the Company’s warrant activity. Number of warrants and weighted average exercise prices in the table below are shown as they were outstanding, exercised, forfeited, and granted:

	Number of Warrants			Weighted Average Exercise Price
Outstanding, December 31, 2020		2,416,864		$	2.95
Exercised		(1,939,534	)		2.54
Issued		7,943,489			5.10
Forfeited		(6,000	)		2.50
Outstanding, December 31, 2021		8,414,819		$	4.99
Exercised		(16,538	)		4.51
Expired		(481,484	)		4.61
Outstanding, December 31, 2022		7,916,797			5.08

As at December 31, 2022, the Company had the following warrants outstanding:

Date issued	Expiry date	Exercise price	Number of warrants outstanding
February 5, 2021	February 5, 2023	US$3.55		1,319,675
March 5, 2021	March 5, 2023	US$3.55		5,142,324
March 22, 2021	March 22, 2023	CDN$13.35		1,200,000
July 29, 2021	July 29, 2024	US$5.00		250,000
September 14, 2021	September 14, 2024	US$5.00		4,798
				7,916,797

The weighted average remaining contractual life of warrants outstanding as of December 31, 2022, was 0.47 years (December 31, 2021 – 1.20 years).

Of the 1,200,000 warrants issued on March 22, 2021, with regards to the Vital Intelligence Acquisition, 900,000 of the warrants are currently held in escrow, to be released only upon completion of the milestones.

19

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Critical Accounting Policies and Estimates

Measurement Uncertainty (Use of Estimates)

The preparation of the consolidated financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and contingent liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Estimates and judgments are continuously evaluated and are based on management’s experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. However, actual outcomes can differ from these estimates.

The key sources of estimation uncertainty that have a significant risk of causing material adjustment to the amounts recognized in the consolidated financial statements are:

SR&ED tax credits

The determination of the amount of the Saskatchewan Scientific Research & Experimental Development (“SR&ED”) tax credit receivable requires management to make calculations based on its interpretation of eligible expenditures in accordance with the terms of the programs. The reimbursement claims submitted by the Company are subject to review by the relevant government agencies. Although the Company has used its best judgment and understanding of the related program agreements in determining the receivable amount, it is possible that the amounts could increase or decrease by a material amount in the near-term dependent on the review and audit by the government agency.

Allowance for uncollectible trade and other receivables

The Company makes use of estimates when making allowances for uncollectible trade and other receivables. The Company evaluates each receivable at year end using factors such as age of receivable, payment history, and credit risk to estimate when determining if an allowance is required, and the amount of the allowance.

Share-based payment transactions

The Company measures the cost of share-based payment transactions with employees by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected lives and forfeiture rates of the share options and volatility of the market value of the underlying shares.

Significant estimates and assumptions

The preparation of financial statements in accordance with IFRS requires the Company to use judgment in applying its accounting policies and make estimates and assumptions about reported amounts at the date of the financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.

Share-based payments

The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield of the stock option.

20

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Income taxes

Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the company is likely to recognize their recovery from the generation of taxable income.

Inventories

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions.

Contingencies

The assessment of contingencies involves the exercise of significant judgment and estimates of the outcome of future events. In assessing loss contingencies related to legal proceedings that are pending against the Company and that may result in regulatory or government actions that may negatively impact the Company’s business or operations, the Company and its legal counsel evaluate the perceived merits of the legal proceeding or unasserted claim or action as well as the perceived merits of the nature and amount of relief sought or expected to be sought, when determining the amount, if any, to recognize as a contingent liability or when assessing the impact on the carrying value of the Company’s assets. Contingent assets are not recognized in the annual financial statements.

Useful lives of equipment and intangible assets

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

Other Significant judgments

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments in applying the Company’s consolidated financial statements include:

● The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;

● the classification of financial instruments;

● the assessment of revenue recognition using the five-step approach under IFRS 15 and the collectability of amounts receivable;

● the determination of whether a set of assets acquired and liabilities assumed constitute a business; and

● the determination of the functional currency of the company.

21

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Foreign currency translation

The Company’s functional currency is the Canadian dollar, and transactions in foreign currencies are translated into Canadian dollars at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Revenue and expenses denominated in a foreign currency are translated at the monthly average exchange rate. Gains and losses resulting from the translation adjustments are included in income.

The functional currencies for the parent company and each subsidiary are as follows:

Draganfly Inc.	Canadian Dollar
Draganfly Innovations Inc.	Canadian Dollar
Draganfly Innovations USA, Inc.	U.S. Dollar
Dronelogics Systems Inc.	Canadian Dollar

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all earnings and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translating foreign operations in accumulated other comprehensive income (“AOCI”).

Transactions and balances:

Foreign currency transactions are translated into functional currency using the exchange rates prevailing at the date of the transaction. Foreign currency monetary items are translated at the period-end exchange rate. Non-monetary items measured at historical cost continue to be carried at the exchange rate at the date of the transaction. Non-monetary items measured at fair value are reported at the exchange rate at the date when fair values were determined.

Exchange differences arising on the translation of monetary items or on settlement of monetary items are recognized in the statement of comprehensive loss in the period in which they arise, except where deferred in equity as a qualifying cash flow or net investment hedge.

Exchange differences arising on the translation of non-monetary items are recognized in other comprehensive income to the extent that gains and losses arising on those non-monetary items are also recognized in other comprehensive income. Where the non-monetary gain or loss is recognized in profit or loss, the exchange component is also recognized in profit or loss.

Share-based payments

The Company operates a stock option plan. Share-based payments to employees are measured at the fair value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of goods or services received or the fair value of the equity instruments issued, if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The corresponding amount is recorded to the option reserve. The fair value of options is determined using a Black–Scholes Option Pricing Model. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments that eventually vest. Amounts recorded for forfeited or expired unexercised options are transferred to deficit in the year of forfeiture or expiry. Amounts recorded for forfeited unvested options are reversed in the period the forfeiture occurs.

Share-based payment expense relating to cash-settled awards, including restricted share units is accrued over the vesting period of the units based on the quoted market value of Company’s common shares. As these awards will be settled in cash, the expense and liability are adjusted each reporting period for changes in the underlying share price.

22

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Restricted Share Units

The restricted share units (“RSUs”) entitle employees, directors, or officers to cash payments payable upon vesting based on vesting terms determined by the Company’s Board of Directors at the time of the grant. A liability for outstanding RSUs is measured at fair value on the grant date and is subsequently adjusted for changes in fair value at each reporting date until settlement. The liability is recognized on a graded vesting basis over the vesting period, with a corresponding charge to profit or loss.

Loss per share

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. For all periods presented, the loss attributable to common shareholders equals the reported loss attributable to owners of the Company. Diluted loss per share is calculated by the treasury stock method. Under the treasury stock method, the weighted average number of common shares outstanding for the calculation of diluted loss per share assumes that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at the average market price during the period.

Financial instruments

All financial assets are initially recorded at fair value and classified into one of four categories: fair value through profit or loss (“FVTPL”), fair value through other comprehensive income (“FVTOCI”) and at amortized costs. All financial liabilities are initially recorded at fair value and classified as either FVTPL or other financial liabilities. Financial instruments comprise cash and accounts payable and accrued liabilities.

Financial assets

Classification and measurement

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the business model is not to hold the debt instrument, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument

basis) to designate them as at FVTOCI.

Financial assets at FVTPL

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are recorded to profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of financial assets held at FVTPL are included in the income statement in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

23

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Financial assets at FVTOCI

Financial assets carried at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive loss.

Financial assets at amortized cost

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

Impairment of financial assets at amortized cost

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

Derecognition of financial assets

Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are generally recognized in profit or loss.

Financial liabilities

The Company classifies its financial liabilities into one of two categories as follows:

FVTPL - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans are included in this category. The Company derecognizes a financial liability when its contractual obligations are discharged, cancelled or expire.

Derecognition of financial liabilities

Financial liabilities are derecognized when its contractual obligations are discharged or cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are generally recognized in profit or loss.

24

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Impairment of assets

The carrying amount of the Company’s non-financial assets (which include equipment and intangible assets) is reviewed at each reporting date to determine whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss. An impairment loss is recognized whenever the carrying amount of an asset or its cash generating unit exceeds its recoverable amount. Impairment losses are recognized in the statement of comprehensive loss.

The recoverable amount of assets is the greater of an asset’s fair value less cost to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects the current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate cash inflows largely independent of those from other assets, the recoverable amount is determined for the cash-generating unit to which the asset belongs.

An impairment loss is only reversed if there is an indication that the impairment loss may no longer exist and there has been a change in the estimates used to determine the recoverable amount. Any reversal of impairment cannot increase the carrying value of the asset to an amount higher than the carrying amount that would have been determined had no impairment loss been recognized in previous years. Assets that have an indefinite useful life are not subject to amortization and are tested annually for impairment.

INCOME TAXES

Current Income tax

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

Current income tax relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

Deferred Income Tax

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and li abilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

Inventory

Inventory consists of raw materials for manufacturing of multi-rotor helicopters, industrial aerial video systems, civilian small unmanned aerial systems or vehicles, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Cost is determined using the weighted average cost basis. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

25

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Revenue recognition

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

Sales of goods

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized when control of the products has transferred, being when the products are delivered to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. Delivery occurs when the products have been shipped to the specific location or picked up by the customer, the risks of obsolescence and loss have been transferred to the customer.

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

Some contracts include multiple deliverables, such as the manufacturing of hardware and support. Support is performed by another party and does not include an integration service. It is therefore accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on the stand-alone selling prices. Where these are not directly observable, they are estimated based on expect cost plus margin.

A receivable is recognized when the goods are delivered as this is the point in time that the consideration is unconditional because only the passage of time is required before the payment is due.

Consulting services

The Company provides consulting, custom engineering, investigation, and solution services on a project by project basis under fixed-price and variable price contracts. Revenue from services provided is recognized in the accounting period in which the services are rendered. For fixed-price contracts, revenue is recognized based on the actual service provided to the end of the reporting period as a proportion of the total services to be provided. This is determined based on the actual labour hours spent relative to the total expected labour hours. If contracts include the manufacturing of hardware, revenue for the hardware is recognized when the hardware is delivered, the legal title has passed and the customer has accepted the hardware.

Estimates of revenues, costs or extent of progress toward completion are revised if circumstances change. Any resulting increases or decreases in estimated revenues or costs are reflected in profit or loss in the period in which the circumstances that give rise to the revision become known by management.

In case of fixed-price contracts, the customer pays the fixed amount based on a payment schedule. If the services rendered by the Company exceed the payment, a contract asset is recognized. If the payments exceed the services rendered, a contract liability is recognized. If the contract includes an hourly fee, revenue is recognized in the amount to which the Company has a right to invoice. Customers are invoiced on a monthly basis and consideration is payable when invoiced.

Cost of Goods Sold

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, excess or obsolete inventory, or lower of cost and net realizable value adjustments as required.

26

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Intangible Assets

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets includes intellectual property, which consists of patent and trademark applications.

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

Intangible assets with finite useful lives are amortized by a declining balance at a 20% rate over their estimated useful lives from the date they are available for use. The amortization period of the Company’s intellectual property is 5 years.

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired. Goodwill is allocated to the cash generating unit to which it relates.

Equipment

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statement of comprehensive loss during the financial period in which they are incurred.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the statement of comprehensive loss.

Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

Class of equipment	Depreciation rate
Computer equipment		30	%
Furniture and equipment		20	%
Leasehold improvements		Over expected life of lease
Vehicles		30	%

Research and development expenditures

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following: (i) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (ii) its intention to complete the intangible asset and use or sell it; (iii) its ability to use or sell the intangible asset; (iv) how the intangible asset will generate probable future economic benefits. Among other things, the Company can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset; (v) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (vi) its ability to measure reliably the expenditure attributable to the intangible asset during its development.

27

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Government Assistance

Government grants are recognized when there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

SR&ED Investment tax credits

The Company claims federal investment tax credits as a result of incurring SR&ED expenditures. Federal investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Federal investment tax credits are accounted for as a reduction of research and development expense for items of a period expense nature or as a reduction of property and equipment for items of a capital nature. Management has made a number of estimates and assumptions in determining the expenditures eligible for the federal investment tax credit claim. It is possible that the allowed amount of the federal investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency.

The Company claims provincial investment tax credits as a result of incurring SR&ED expenditures. Provincial investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Management has made a number of estimates and assumptions in determining the expenditures eligible for the provincial investment tax credit claim. The provincial investment tax credits are refundable and have been recorded as SR&ED tax credit receivable, and as a reduction in research and development expenses on the statement of comprehensive loss. It is possible that the allowed amount of the provincial investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency and the Tax and Revenue Administration.

Leases

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset will be recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

The lease term is the non-cancellable period of a lease and includes periods covered by an optional lease extension option if reasonably certain the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

A lease modification will be accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

Business Risks

The Company does engage in significant transactions and activities in currencies other than its functional currency. Depending on the timing of the transactions and the applicable currency exchange rates such conversions may positively or negatively impact the Company.

28

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

An investment in the Company’s Common Shares is highly speculative and involves significant risks. In addition to the other ‎information contained in this MD&A and the documents incorporated by ‎reference herein and therein, you should review and carefully consider the risks described herein. The risks described herein are not the only risk factors facing us and should not be ‎considered exhaustive. Additional risks and uncertainties not currently known to us, or that we currently ‎consider immaterial, may also materially and adversely affect our business, operations and condition, financial ‎or otherwise.‎

Risks Related to the Company, its Business and Industry

The Company has a history of losses.

The Company has incurred net losses since its inception. The Company cannot assure that it can become profitable or avoid net losses in the future or that there will be any earnings or revenues in any future quarterly or other periods. The Company expects that its operating expenses will increase as it grows its business, including expending substantial resources for research, development and marketing. As a result, any decrease or delay in generating revenues could result in material operating losses.

A shareholder’s holding in the Company may be diluted if the Company issues additional Common ‎Shares or other securities in the future.‎

‎The Company may issue additional Common Shares or other securities in the future, which may dilute a ‎shareholder’s holding in the Company. ‎The Company’s articles permit the issuance of an unlimited ‎number of Common Shares, and shareholders have no pre-emptive rights in connection with further ‎issuances of any securities. The directors of the Company have the discretion to ‎determine if an ‎issuance of Common Shares or other securities is warranted, the price at which any such securities are ‎issued and the other ‎terms of issue of Common Shares or securities. In addition, the Company may ‎issue additional Common Shares upon the exercise of incentive stock options to ‎acquire Common ‎Shares under its share compensation plan or upon the exercise or conversion of other outstanding convertible securities of the Company, which will result in further dilution to shareholders. In addition, ‎the issuance of Common Shares or other securities in any potential ‎future acquisitions, if any, may also ‎result in further dilution to shareholder interests.‎

The Company expects to incur substantial research and development costs and devote significant resources to ‎identifying and commercializing new products and services, which could significantly reduce its profitability and ‎may never result in revenue to the Company.‎

‎The Company’s future growth depends on penetrating new markets, adapting existing products to new applications, ‎and introducing new products and services that achieve market acceptance. The Company plans to incur ‎substantial research and development costs as part of its efforts to design, develop and commercialize new ‎products and services and enhance its existing products. The Company believes that there are significant opportunities in a number of business areas. Because the Company accounts for research and development costs as ‎operating expenses, these expenditures will adversely affect its earnings in the future. Further, the Company’s ‎research and development programs may not produce successful results, and its new products and services may not ‎achieve market acceptance, create any additional revenue or become profitable, which could materially harm the ‎Company’s business, prospects, financial results and liquidity.‎

The Company’s adoption of new business models could fail to produce any financial returns.‎

‎Forecasting the Company’s revenues and profitability for new business models is inherently uncertain and ‎volatile. The Company’s actual revenues and profits for its business models may be significantly less ‎than the Company’s forecasts. Additionally, the new business models could fail for one or more of the ‎Company’s products and/or services, resulting in the loss of Company’s investment in the development and ‎infrastructure needed to support the new business models, and the opportunity cost of diverting management and ‎financial resources away from more successful businesses.‎

29

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

The Company will be affected by operational risks and may not be adequately insured for certain risks.‎

‎The Company will be affected by a number of operational risks and the Company may not be adequately insured ‎for certain risks, including: labour disputes; catastrophic accidents; fires; blockades or other acts of social activism; ‎changes in the regulatory environment; impact of non-compliance with laws and regulations; natural phenomena, ‎such as inclement weather conditions, floods, earthquakes and ground movements. There is no assurance that the ‎foregoing risks and hazards will not result in damage to, or destruction of, the Company’s technologies, personal ‎injury or death, environmental damage, adverse impacts on the Company’s operation, costs, monetary losses, ‎potential legal liability and adverse governmental action, any of which could have an adverse impact on the ‎Company’s future cash flows, earnings and financial condition. Also, the Company may be subject to or affected ‎by liability or sustain loss for certain risks and hazards against which the Company cannot insure or which the ‎Company may elect not to insure because of the cost. This lack of insurance coverage could have an adverse ‎impact on the Company’s future cash flows, earnings, results of operations and financial condition.‎

The Company operates in evolving markets, which makes it difficult to evaluate the Company’s business and ‎future prospects.‎

‎The Company’s unmanned aerial vehicles (“UAVs”) are sold in rapidly evolving markets. The commercial UAV market is in early stages of ‎customer adoption. Accordingly, the Company’s business and future prospects may be difficult to evaluate. The ‎Company cannot accurately predict the extent to which demand for its products and services will increase, if at all. ‎The challenges, risks and uncertainties frequently encountered by companies in rapidly evolving markets could ‎impact the Company’s ability to do the following:‎

● generate sufficient revenue to reach and maintain profitability;‎

● acquire and maintain market share;‎

● achieve or manage growth in operations;‎

● develop and renew contracts;‎

● attract and retain additional engineers and other highly qualified personnel;‎

● successfully develop and commercially market new products;‎

● adapt to new or changing policies and spending priorities of governments and government agencies; and

● access additional capital when required and on reasonable terms.‎

If the Company fails to address these and other challenges, risks and uncertainties successfully, its business, results ‎of operations and financial condition would be materially harmed.‎

The Company operates in a competitive market.

The Company faces competition and new competitors will continue to emerge throughout the world. Services offered by the Company’s competitors may take a larger share of consumer spending than anticipated, which could cause revenue generated from the Company’s products and services to fall below expectations. It is expected that competition in these markets will intensify. Some of the other publicly traded companies we may compete with include Alpine 4 Tech, Inc., Aerovironment Inc., EHang Holdings Limited, AgEagle, Drone Delivery Canada, Inc., and Red Cat Holdings, Inc.

If competitors of the Company develop and market more successful products or services, offer competitive products or services at lower price points, or if the Company does not produce consistently high-quality and well-received products and services, revenues, margins, and profitability of the Company will decline.

The Company’s ability to compete effectively will depend on, among other things, the Company’s pricing of services and equipment, quality of customer service, development of new and enhanced products and services in response to customer demands and changing technology, reach and quality of sales and distribution channels and capital resources. Competition could lead to a reduction in the rate at which the Company adds new customers, a decrease in the size of the Company’s market share and a decline in its customers. Examples include but are not limited to competition from other companies in the UAV industry.

30

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

In addition, the Company could face increased competition should there be an award of additional licenses in jurisdictions in which the Company operates in.

The markets in which the Company competes are characterized by rapid technological change that could render the Company’s existing ‎products obsolete, which requires ‎the Company to continually develop new products and product enhancements.

‎Continuing technological changes in the market for the Company’s products could make its products less ‎competitive or obsolete, either generally or for particular applications. The Company’s future success will depend ‎upon its ability to develop and introduce a variety of new capabilities and enhancements to its existing product and ‎service offerings, as well as introduce a variety of new product offerings, to address the changing needs of the ‎markets in which it offers products. Delays in introducing new products and enhancements, the failure to choose ‎correctly among technical alternatives or the failure to offer innovative products or enhancements at competitive ‎prices may cause existing and potential customers to purchase the Company’s competitors’ products.‎

If the Company is unable to devote adequate resources to develop new products or cannot otherwise successfully ‎develop new products or enhancements that meet customer requirements on a timely basis, its products could lose ‎market share, its revenue and profits could decline, and the Company could experience operating losses.‎

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental agencies, or ‎limitations put on the use of small UAV in response to public privacy concerns, may prevent the Company from ‎expanding sales of its small UAV to non-military customers in Canada or elsewhere.‎

‎Transport Canada is responsible for establishing, managing, and developing safety and security ‎standards and regulations for civil aviation in Canada, and includes unmanned civil aviation ‎‎(drones). Civil operations include law enforcement, scientific research, or use by private sector ‎companies for commercial purposes. The Canadian Aviation Regulations (“CARs”) govern civil ‎aviation safety and security in Canada, and by extension govern operation of drones in Canada ‎to an acceptable level of safety.‎

While Transport Canada has been a leader in the development of regulations for the commercial ‎use of remotely piloted aircraft systems (“RPAS”), and continues to move forward rapidly with its regulatory development, it has ‎acknowledged the challenge of regulations keeping pace with the rapid development in ‎technology and the growing demand for commercial RPAS use, particularly in the beyond visual ‎line-of-sight environment. In 2012, the Canadian Aviation Regulation Advisory Council UAS ‎working group released its Phase 2 report which outlined a proposed set of revision to the CARs ‎to permit Beyond Visual Line of Sight (“BVLOS”) operations. This report was the basis for the recently released Notice of Proposed Amendment (“NPA”) by Transport Canada on lower ‎risk beyond visual line-of-sight.‎

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental ‎agencies in Canada, the United States, or other jurisdictions, including the granting of certain Special Flight Operations Certificates (“SFOCs”) or the like, or limitations put on the use of RPAS in ‎response to public safety concerns, may prevent the Company from testing or operating its ‎aircraft and/or expanding its sales which could have an adverse impact on the Company’s ‎business, prospects, results of operations and financial condition.‎

There are risks associated with the regulatory regime and permitting requirements of the Company’s business.‎

‎A significant portion of the Company’s business is based on the operation of RPAS. The operation of ‎RPAS poses a risk or hazard to airspace users as well as personnel on the ground. As ‎the RPAS ‎industry is rapidly developing, the regulatory environment for RPAS is constantly evolving to keep pace. ‎‎As such, whenever a policy change with respect to operating regulations occurs, there is a risk that the ‎Company ‎could find itself to be in non-compliance with these new regulations. While the Company ‎endeavours to take all ‎necessary action to reduce the risks associated with the operations of RPAS and ‎to remain well-informed and up-‎to-date on any addendums and changes to the applicable regulations, ‎there is no assurance that an incident ‎involving an RPAS or the Company’s non-compliance would not ‎create a significant current or future liability for ‎the company.‎

31

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

The regulation of RPAS operations within the Canadian Domestic Airspace (“CDA”) is still evolving and is expected ‎to continue to change ‎with the proliferation of RPAS, advancements in technology, and standardization within the ‎industry. ‎Changes to the regulatory regime may be disruptive and result in the Company needing to adopt ‎‎significant changes in its operations and policies, which may be costly and time-consuming, and may ‎materially ‎adversely affect the Company’s ability to manufacture and make delivery of its products and ‎services in a timely ‎fashion.‎

The Company’s business and research and development activities are subject to oversight by Transport ‎Canada, the federal ‎institution responsible for transportation policies and programs, including the rules in ‎the CARs. Currently, Transport Canada requires that any non-recreational operators of RPAS have a ‎‎SFOC. The Company’s ability to develop, test, demonstrate, and sell products and ‎services depends on ‎its ability to acquire and maintain a valid SFOC.‎

‎In addition, there exists public concern regarding the privacy implications of Canadian commercial and ‎law ‎enforcement use of small UAV. This concern has included calls to develop explicit written policies ‎and procedures ‎establishing UAV usage limitations. There is no assurance that the response from ‎regulatory agencies, customers and ‎privacy advocates to these concerns will not delay or restrict the ‎adoption of small UAV by prospective non-military customers‎.‎

The Company may be subject to the risks associated with future acquisitions.

As part of the Company’s overall business strategy, the Company may pursue select strategic acquisitions that would provide additional product or service offerings, additional industry expertise, and a stronger industry presence in both existing and new jurisdictions. Any such future acquisitions, if completed, may expose the Company to additional potential risks, including risks associated with: (a) the integration of new operations, services and personnel; (b) unforeseen or hidden liabilities; (c) the diversion of resources from the Company’s existing business and technology; (d) potential inability to generate sufficient revenue to offset new costs; (e) the expenses of acquisitions; or (f) the potential loss of or harm to relationships with both employees and existing users resulting from its integration of new businesses. In addition, any proposed acquisitions may be subject to regulatory approval.

‎The Company’s inability to retain management and key employees could impair the future success of the Company.

The Company’s future success depends substantially on the continued services of its executive officers and its key development personnel. If one or more of its executive officers or key development personnel were unable or unwilling to continue in their present positions, the Company might not be able to replace them easily or at all. In addition, if any of its executive officers or key employees joins a competitor or forms a competing company, the Company may lose experience, know-how, key professionals and staff members as well as business partners. These executive officers and key employees could develop drone technologies that could compete with and take customers and market share away from the Company.

A significant growth in the number of personnel would place a strain upon the Company’s management and resources.

The Company may experience a period of significant growth in the number of personnel that could place a strain upon its management systems and resources. The Company’s future will depend in part on the ability of its officers and other key employees to implement and improve financial and management controls, reporting systems and procedures on a timely basis and to expand, train, motivate and manage its workforce. The Company’s current and planned personnel, systems, procedures and controls may be inadequate to support its future operations.

The Company faces uncertainty and adverse changes in the economy.‎

‎

Adverse changes in the economy could negatively impact the Company’s business. Future economic distress may ‎result in a decrease in demand for the Company’s products, which could have a material adverse impact on the ‎Company’s operating results and financial condition. Uncertainty and adverse changes in the economy could also ‎increase costs associated with developing and publishing products, increase the cost and decrease the availability of ‎sources of financing, and increase the Company’s exposure to material losses from bad debts, any of which could ‎have a material adverse impact on the financial condition and operating results of the Company.‎

32

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

The Company is subject to certain market-based financial risks associated with its operations.

The Company could be subject to interest rate risks, which is the risk that the value of a financial instrument might be adversely affected by a change in the interest rates. In seeking to minimize the risks from interest rate fluctuations, the Company manages exposure through its normal operating and financing activities, however market fluctuations could increase the costs at which the Company can access capital and its ability to obtain financing and the Company’s cash balances carry a floating rate of interest. In addition, the Company engages in transactions in currencies other than its functional currency. Depending on the timing of these transactions and the applicable currency exchange rates, conversions to the Company’s functional currency may positively or negatively impact the Company.

The COVID-19‎ pandemic could negatively affect our business, operations and future financial performance.

In March 2020, the World Health Organization designated the outbreak of a novel strain of coronavirus, specifically identified ‎as COVID-19, as a global pandemic. This resulted in governments, companies, and individuals worldwide enacting emergency measures to combat the spread of ‎the virus, including the implementation of travel bans, mandated and self-imposed quarantine ‎periods and physical distancing, that have caused a material disruption to businesses globally. Throughout the course of the pandemic, the impact of COVID-19 has varied significantly due to both global and localized infection rates, notwithstanding widespread vaccine availability within Canada and the United States beginning in spring 2020.

As a result of the pandemic, global equity markets have experienced significant volatility and weakness. ‎Governments and central banks have reacted with significant monetary and fiscal interventions designed ‎to stabilize economic conditions. Such volatility has let to significant challenges to the global supply chain, disrupted labor markets and has recently contributed to rising levels of inflation. The Company has experienced material pandemic related impacts, including the loss of its primary customer engineering customer in 2020 due to mandated stay-at-home orders. The duration and impact of the COVID-19 outbreak is unknown at this ‎time, as is the efficacy of the government and central bank interventions. ‎ As such, the Company cannot predict with any certainty what the future impacts the pandemic may have on its business.

Company management has and continues to closely monitor the impact of the COVID-19 global pandemic, with a focus on the health and safety of the Company’s employees, customers, and business continuity. Since the outbreak of the pandemic, the Company has taken various ‎steps to mitigate the impact of COVID-19, ‎including following government or health authority guidelines and restrictions at its facilities to ‎ensure the safety of ‎its staff and product consumers. The Company will continue to follow government or health authority guidelines ‎and restrictions and has experienced minimal disruption to its operations and supply chain‎. However, there is no guarantee that the company’s mitigation efforts will prove successful in combating the spread of the virus or that supply chain disruptions will not occur in the future. As the ‎Company reintegrates its personnel to its workplace, it may incur additional costs to adapt the workplace to ‎meet applicable health and safety requirements. The occurrence of additional waves of the virus or its variants, or insufficient vaccination levels may require the Company to revise or delay such plans. ‎To the extent that it is unable to effectively protect its workforce against the transmission of the virus, the ‎Company may be forced to slow or reverse its reintegration efforts and could face allegations of liability.‎

Given the uncertainties associated with the ongoing COVID-19 pandemic, including ‎the uncertainty surrounding the remaining duration and outcome, COVID-19 variants and vaccine efficacy, the Company is unable to estimate the full impact of the COVID-19 pandemic on its business, financial condition, results of operations, and/or cash flows; however, the impact could be material. The Company cannot accurately predict ‎the future impact COVID-19 may have on, among others, the: (i) demand for drone ‎delivery services, (ii) severity and the length of potential measures taken by governments to manage the ‎spread of the virus and their effect on labour availability and supply lines, (iii) availability of essential ‎supplies, (iv) purchasing power of the Canadian dollar, or (v) ability of the Company to obtain necessary ‎financing. Despite global vaccination efforts, it is not possible to reliably estimate the length and ‎severity of these developments and the impact on the financial results and condition of the Company in ‎the future.‎

33

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

The conflict between Russia and Ukraine could destabilize global markets and threatens global peace.

On February 24, 2022, Russian military forces launched a full-scale military invasion of Ukraine. In response, Ukrainian military personal and civilians are actively resisting the invasion. Many countries throughout the world have provided aid to the Ukraine in the form of financial aid and in some cases military equipment and weapons to assist in their resistance to the Russian invasion. The North Atlantic Treaty Organization (“NATO”) has also mobilized forces to NATO member countries that are close to the conflict as deterrence to further Russian aggression in the region. The outcome of the conflict is uncertain and is likely to have wide ranging consequences on the peace and stability of the region and the world economy. Certain countries including Canada and the United States, have imposed strict financial and trade sanctions against Russia and such sanctions may have far reaching effects on the global economy. The long-term impacts of the conflict and the sanctions imposed on Russia remain uncertain.

Negative macroeconomic and geopolitical trends could affect the Company’s ability to access sources of ‎capital.‎

The COVID-19 pandemic and the Russian invasion of Ukraine could negatively impact the Company’s ability to obtain financing and access sources of capital. Both events have led to significant market volatility as governments undertake measures to prevent the spread of COVID-19 and discourage political conflict. These events have contributed to significant uncertainty in global markets, increased inflationary pressures, and could lead to a tightening of credit markets and a decline in economic activity. These impacts could have a material adverse effect on the Company’s ‎liquidity and ability to obtain financing in the future.‎ As the Company’s history of losses and present revenues do not allow it to sustain its operations, an inability to access credit or capital markets could undermine the Company’s ability to continue as a going concern.

‎‎The Company may be subject to the risks associated with foreign operations in other countries.

The Company’s primary revenues are expected to be achieved in Canada and the US. However, the Company may expand to markets outside of North America and become subject to risks normally associated with conducting business in other countries. As a result of such expansion, the Company may be subject to the legal, political, social and regulatory requirements and economic conditions of foreign jurisdictions. The Company cannot predict government positions on such matters as foreign investment, intellectual property rights or taxation. A change in government positions on these issues could adversely affect the Company’s business.

If the Company expands its business to foreign markets, it will need to respond to rapid changes in market conditions, including differing legal, regulatory, economic, social and political conditions in these countries. If the Company is not able to develop and implement policies and strategies that are effective in each location in which it does business, then the Company’s business, prospects, results of operations and financial condition could be materially and adversely affected.

There are tax risks the Company may be subject to in carrying on business in Canada.

The Company is a resident of Canada for purposes of the Income ‎Tax Act (Canada) (the “Tax Act”). Since the ‎Company is operating in a new and developing industry there is a risk that ‎foreign governments may look to ‎increase their tax revenues or levy additional taxes to level the playing ‎field for perceived disadvantages to ‎traditional brick and mortar businesses. There is no guarantee that ‎governments will not impose such additional ‎adverse taxes in the future‎.‎

If critical components or raw materials used to manufacture the Company’s products become scarce or ‎unavailable, then the Company may incur delays in manufacturing and delivery of its products, which could ‎damage its business.‎

‎The Company obtains hardware components, various subsystems and systems from a limited group of suppliers. ‎The Company does not have long-term agreements with any of these suppliers that obligate it to continue to sell ‎components, subsystems, systems or products to the Company. The Company’s reliance on these suppliers ‎involves significant risks and uncertainties, including whether its suppliers will provide an adequate supply of ‎required components, subsystems, or systems of sufficient quality, will increase prices for the components, ‎subsystems or systems and will perform their obligations on a timely basis.‎

34

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Recently, the global supply chain has experienced significant disruptions caused by the COVID-19 pandemic and by geopolitical conflict, including the war in Ukraine. These disruptions have impacted a variety of products and goods and have had various downstream effects, making it more difficult to reliably and timely source and supply goods and has also resulted in shortages of labor and equipment. The macroeconomic impacts of the COVID-19 pandemic and global conflicts have contributed to inflationary pressure and increased market volatility, adding additional pricing uncertainty. These conditions, if not mitigated or remedied in a timely manner, could delay or preclude delivery of raw materials needed to manufacture our products or delivery of the Company’s products to customers, particularly in international markets. If the ‎Company is unable to obtain components from third-party suppliers in the quantities and of the quality that it ‎requires, on a timely basis and at acceptable prices, then it may not be able to deliver its products on a timely or ‎cost-effective basis to its customers, or at all, which could cause customers to terminate their contracts with the Company, ‎increase the Company’s costs and seriously harm its business, results of operations and financial condition. ‎Moreover, if any of the Company’s suppliers become financially unstable, then it may have to find new suppliers. ‎It may take several months to locate alternative suppliers, if required, or to redesign the Company’s products to ‎accommodate components from different suppliers. The Company may experience significant delays in ‎manufacturing and shipping its products to customers and incur additional development, manufacturing, and other ‎costs to establish alternative sources of supply if the Company loses any of these sources or is required to redesign ‎its products. The Company cannot predict if it will be able to obtain replacement components within the time ‎frames that it requires at an affordable cost, if at all.‎

Natural outdoor elements such as wind and precipitation may have a material adverse effect on the ‎use and effectiveness of the Company’s products.

The Company’s business will involve the operation and flying of UAVs, a technology-based product ‎used outside. As such, the business is subject to various risks inherent in a technology-based ‎businesses operated in outdoor conditions, including faulty parts, breakdowns, and crashes. Although ‎the Company anticipates the use of its UAVs in good climactic conditions and that adequate flying ‎conditions will be monitored by trained personnel, there can be no assurance that unpredictable natural ‎outdoor elements will not have a material adverse effect on the use and effectiveness of its products.‎

The Company’s products may be subject to the recall or return.

Manufacturers and distributors of products are sometimes subject to the recall or return of their products ‎‎for a variety of reasons, including product defects, safety concerns, packaging issues and inadequate ‎or inaccurate ‎labeling disclosure. If any of the Company’s equipment were to be recalled due to an ‎alleged product ‎defect, safety concern or for any other reason, the Company could be required to incur ‎unexpected expenses of the recall ‎and any legal proceedings that might arise in connection with the ‎recall. The Company may lose a significant ‎amount of sales and may not be able to replace those sales ‎at an acceptable margin or at all. In ‎addition, a product recall may require significant management time ‎and attention. Additionally, product recalls may lead to ‎increased scrutiny of the Company’s operations ‎by Transport Canada or other regulatory agencies, requiring ‎further management time and attention and ‎potential legal fees, costs and other expenses.‎‎

‎‎If the Company releases defective products or services, its operating results could suffer.‎

‎Products and services designed and released by the Company involve extremely complex software ‎programs, and ‎are difficult to develop and distribute. While the Company has quality controls in place to ‎detect and prevent defects in its ‎products and services before they are released, these quality controls ‎are subject to human error, ‎overriding, and reasonable resource constraints. Therefore, these quality ‎controls and preventative measures may ‎not be effective in detecting and preventing defects in the ‎Company’s products and services before they have been released into ‎the marketplace. In such an ‎event, the Company could be required, or decide voluntarily, to suspend the availability of the product or ‎services, which could significantly harm its business and operating results‎.‎

35

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

The Company’s products and services are complex and could have unknown defects or errors, which may give ‎rise to legal claims against the Company, diminish its brand or divert its resources from other purposes.‎

The Company’s UAVs rely on complex avionics, sensors, user-friendly interfaces and tightly integrated, ‎electromechanical designs to accomplish their missions. Despite testing, the Company’s products have contained ‎defects and errors and may in the future contain defects, errors or performance problems when first introduced, ‎when new versions or enhancements are released, or even after these products have been used by the Company’s ‎customers for a period of time. These problems could result in expensive and time-consuming design modifications ‎or warranty charges, delays in the introduction of new products or enhancements, significant increases in the ‎Company’s service and maintenance costs, exposure to liability for damages, damaged customer relationships and ‎harm to the Company’s reputation, any of which could materially harm the Company’s results of operations and ‎ability to achieve market acceptance. In addition, increased development and warranty costs could be substantial ‎and could significantly reduce the Company’s operating margins.‎

‎The existence of any defects, errors, or failures in the Company’s products or the misuse of the Company’s ‎products could also lead to product liability claims or lawsuits against it. A defect, error or failure in one of the ‎Company’s UAV could result in injury, death or property damage and significantly damage the Company’s ‎reputation and support for its UAV in general. The Company anticipates this risk will grow as its UAV begins to be ‎used in Canadian domestic airspace and urban areas. The Company’s UAV test systems also have the potential to ‎cause injury, death or property damage in the event that they are misused, malfunction or fail to operate properly ‎due to unknown defects or errors.‎

‎Although the Company maintains insurance policies, it cannot provide any assurance that this insurance will be ‎adequate to protect the Company from all material judgments and expenses related to potential future claims or ‎that these levels of insurance will be available in the future at economical prices or at all. A successful product ‎liability claim could result in substantial cost to us. Even if the Company is fully insured as it relates to a particular claim, the ‎claim could nevertheless diminish the Company’s brand and divert management’s attention and resources, which ‎could have a negative impact on the Company’s business, financial condition and results of operations.‎

Shortfalls in available external research and development funding could adversely affect the Company.‎

‎The Company depends on its research and development activities to develop the core technologies used in its UAV ‎products and for the development of the Company’s future products. A portion of the Company’s research and ‎development activities can depend on funding by commercial companies and the Canadian government. Canadian ‎government and commercial spending levels can be impacted by a number of variables, including general ‎economic conditions, specific companies’ financial performance and competition for Canadian government ‎funding with other Canadian government-sponsored programs in the budget formulation and appropriation ‎processes. Moreover, the Canadian, federal and provincial governments provide energy rebates and incentives to ‎commercial companies, which directly impact the amount of research and development that companies ‎appropriate for energy systems. To the extent that these energy rebates and incentives are reduced or eliminated, ‎company funding for research and development could be reduced. Any reductions in available research and ‎development funding could harm the Company’s business, financial condition and operating results.‎

The Company could be prohibited from shipping its products to certain countries if it is unable to obtain ‎Canadian government authorization regarding the export of its products, or if current or future export laws limit ‎or otherwise restrict the Company’s business.‎

The Company must comply with Canadian federal and provincial laws regulating the export of its products. In ‎some cases, explicit authorization from the Canadian government is needed to export its products. The export ‎regulations and the governing policies applicable to the Company’s business are subject to change. The Company ‎cannot provide assurance that such export authorizations will be available for its products in the future. ‎Compliance with these laws has not significantly limited the Company’s operations or sales in the recent past, but ‎could significantly limit them in the future. Non-compliance with applicable export regulations could potentially ‎expose the Company to fines, penalties and sanctions. If the Company cannot obtain required government ‎approvals under applicable regulations, the Company may not be able to sell its products in certain international ‎jurisdictions, which could adversely affect the Company’s financial condition and results of operations.‎

36

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

Negative consumer perception regarding the Company’s products‎ could have a material adverse effect on the demand for the Company’s ‎products and the business, results of operations, financial condition and cash flows of the Company.

The Company believes the UAV industry is highly dependent upon consumer perception regarding the ‎safety, efficacy, and quality of the UAV used. Consumer perception of these products can be ‎significantly influenced by scientific research or findings, regulatory investigations, litigation, media attention, ‎and other publicity regarding the use of UAV. There can be no assurance that future scientific research, ‎findings, regulatory proceedings, litigation, media attention, or other research findings or publicity will be ‎favourable to the UAV market. Future research reports, findings, regulatory proceedings, litigation, media ‎attention or other publicity that are perceived as less favourable than, or that question, earlier research ‎reports, findings or publicity could have a material adverse effect on the demand for the Company’s ‎products and the business, results of operations, financial condition and cash flows of the Company. The ‎dependence upon consumer perceptions means that adverse scientific research reports, findings, ‎regulatory proceedings, litigation, media attention or other publicity, whether or not accurate or with merit, ‎could have a material adverse effect on the Company, the demand for the Company’s products, and the ‎business, results of operations, financial condition and cash flows of the Company. Further, adverse ‎publicity reports or other media attention regarding the safety, the efficacy, and quality of UAV based surveys in general, or the Company’s products specifically, ‎could have a material adverse effect.‎

If the Company fails ‎‎to successfully promote its product brand, this could have a material adverse ‎effect on the Company’s business, prospects, ‎‎financial condition and results of operations‎.

The Company believes that brand recognition is an important factor to its success. If the Company fails ‎‎to promote its brands successfully, or if the expenses of doing so are disproportionate to any increased ‎‎net sales it achieves, it would have a material adverse effect on the Company’s business, prospects, ‎‎financial condition and results of operations. This will depend largely on the Company’s ability to ‎‎maintain trust, be a technology leader, and continue to provide high-quality and secure technologies, ‎‎products and services. Any negative publicity about the Company or its industry, the quality and reliability of the Company’s technologies, products and services, the Company’s risk management ‎‎processes, changes to the Company’s technologies, products and services, its ability to effectively ‎‎manage and resolve customer complaints, its privacy and security practices, litigation, regulatory activity, and the experience of sellers and buyers with the Company’s products or services, could adversely affect the Company’s reputation and the confidence in and use of the ‎‎Company’s technologies, products and services. Harm to the Company’s brand can arise from ‎‎many sources, including; failure by the Company or its partners to satisfy expectations of service and quality; inadequate protection of sensitive information; compliance failures and claims; litigation and ‎‎other claims; employee misconduct; and misconduct by the Company’s partners, service ‎‎providers, or other counterparties. If the Company does not successfully maintain a strong and trusted brand, its business could be materially and adversely affected.‎ ‎

The Company may be subject to electronic communication security risks.

A significant potential vulnerability of electronic communications is the security of transmission of confidential information over public networks. Cyberattacks could result in unauthorized access to the Company’s computer systems or its third-party IT service provider’s systems and, if successful, misappropriate personal or confidential information. Anyone who is able to circumvent the Company’s security measures could misappropriate proprietary information or cause interruptions in its operations. The Company may be required to expend capital and other resources to protect against such security breaches or to alleviate problems caused by such breaches.

Since the outset of the COVID-19 pandemic, there has been an increase in the volume and sophistication of targeted cyber-attacks. Pandemic-adjusted operations, such as work ‎from home arrangements and remote access to the Company’s systems, may pose heightened risk of ‎cyber security and privacy breaches and may put additional stress on the Company’s IT infrastructure. A failure of such infrastructure could severely limit the Company’s ability ‎to conduct ordinary operations or expose the Company to liability. To date, the Company’s systems have functioned capably, and it has not experienced a material impact to its ‎operations as a result of an IT infrastructure issue.‎ In addition, the outbreak of hostilities between Russia and Ukraine and the response of the global community to such aggression is widely seen as increasing the risk of state-sponsored cyberattacks.

Even the most well-protected IT networks, systems and facilities remain potentially vulnerable because the techniques used in attempted security breaches are continually evolving and generally are not recognized until launched against a target or, in some cases, are designed not to be detected and, in fact, may not be detected. Any such compromise of the Company’s or its third party’s IT service providers’ data security and access, public disclosure, or loss of personal or confidential business information, could result in legal claims and proceedings, liability under laws to protect privacy of personal information, and regulatory penalties, and could disrupt our operations, require significant management attention and resources to remedy any damages that result, and damage our reputation and customers willingness to transact business with us, any of which could adversely affect our business.

37

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

The Company’s business could be adversely affected if its consumer protection and data privacy practices are not ‎perceived as adequate or there are breaches of its security measures or unintended disclosures of its consumer data.‎

‎The rate of privacy law-making is accelerating globally and interpretation and application of consumer protection ‎and data privacy laws in Canada, the United States, Europe and elsewhere are often uncertain, contradictory and in ‎flux. As business practices are being challenged by regulators, private litigants, and consumer protection agencies ‎around the world, it is possible that these laws may be interpreted and applied in a manner that is inconsistent with ‎the Company’s data and/or consumer protection practices. If so, this could result in increased litigation government ‎or court-imposed fines, judgments or orders requiring that the Company change its practices, which could have an ‎adverse effect on its business and reputation. Complying with these various laws could cause the Company to incur ‎substantial costs or require it to change its business practices in a manner adverse to its business.‎

‎The Company relies on its business partners, and they may be given access to sensitive and proprietary ‎information in order to provide services and support to the Company’s teams.‎

‎The Company relies on various business partners, including third-party service providers, vendors, licensing partners, ‎development partners, and licensees, among others, in some areas of the Company’s business. In some cases, these ‎third parties are given access to sensitive and proprietary information in order to provide services and support to the ‎Company’s teams. These third parties may misappropriate the Company’s information and engage in ‎unauthorized use of it. The failure of these third parties to provide adequate services and technologies, or the failure ‎of the third parties to adequately maintain or update their services and technologies, could result in a disruption to ‎the Company’s business operations. Further, disruptions in the financial markets and economic downturns may ‎adversely affect the Company’s business partners and they may not be able to continue honoring their obligations ‎to the Company. Alternative arrangements and services may not be available to the Company on commercially ‎reasonable terms or the Company may experience business interruptions upon a transition to an alternative partner ‎or vendor. If the Company loses one or more significant business partners, the Company’s business could be ‎harmed.‎

If the Company fails to protect, or incurs significant costs in defending, its intellectual property and other ‎proprietary rights, the Company’s business, financial condition, and results of operations could be materially ‎harmed.‎

‎The Company’s success depends, in large part, on its ability to protect its intellectual property and other proprietary ‎rights. The Company relies primarily on patents, trademarks, copyrights, trade secrets and unfair competition laws, ‎as well as license agreements and other contractual provisions, to protect the Company’s intellectual property and ‎other proprietary rights. However, a portion of the Company’s technology is not patented, and the Company may ‎be unable or may not seek to obtain patent protection for this technology. Moreover, existing Canadian legal ‎standards relating to the validity, enforceability and scope of protection of intellectual property rights offer only ‎limited protection, may not provide the Company with any competitive advantages, and may be challenged by ‎third parties. The laws of countries other than Canada may be even less protective of intellectual property rights. ‎Accordingly, despite its efforts, the Company may be unable to prevent third parties from infringing upon or ‎misappropriating its intellectual property or otherwise gaining access to the Company’s technology. Unauthorized ‎third parties may try to copy or reverse engineer the Company’s products or portions of its products or otherwise ‎obtain and use the Company’s intellectual property. Moreover, many of the Company’s employees have access to ‎the Company’s trade secrets and other intellectual property. If one or more of these employees leave to work for ‎one of the Company’s competitors, then they may disseminate this proprietary information, which may as a result ‎damage the Company’s competitive position. If the Company fails to protect its intellectual property and other ‎proprietary rights, then the Company’s business, results of operations or financial condition could be materially ‎harmed. From time to time, the Company may have to initiate lawsuits to protect its intellectual property and other ‎proprietary rights. Pursuing these claims is time consuming and expensive and could adversely impact the ‎Company’s results of operations.‎

38

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

In addition, affirmatively defending the Company’s intellectual property rights and investigating whether the ‎Company is pursuing a product or service development that may violate the rights of others may entail significant ‎expense. Any of the Company’s intellectual property rights may be challenged by others or invalidated through ‎administrative processes or litigation. If the Company resorts to legal proceedings to enforce its intellectual property ‎rights or to determine the validity and scope of the intellectual property or other proprietary rights of others, then the ‎proceedings could result in significant expense to the Company and divert the attention and efforts of the ‎Company’s management and technical employees, even if the Company prevails.‎

Obtaining and maintaining the Company’s patent protection depends on compliance with various procedural, document ‎submission, fee payment, and other requirements imposed by governmental patent agencies, and its patent ‎protection could be reduced or eliminated for non-compliance with these requirements.‎

‎The Canadian Intellectual ‎Property Office (“CIPO”), the United States Patent and ‎Trademark Office (“USPTO”) and various foreign national or international patent agencies ‎require compliance with a number of procedural, documentary, fee payment, and other similar provisions during ‎the patent application process. Periodic maintenance fees on any issued patent are due to be paid to the CIPO, the USPTO and ‎various foreign national or international patent agencies in several stages over the lifetime of the patent. While an ‎inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the ‎applicable rules, there are situations in which non-compliance can result in abandonment or lapse of the patent or ‎patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance ‎events that could result in abandonment or lapse of patent rights include, but are not limited to, failure to timely file ‎national and regional stage patent applications based on the Company’s international patent application, failure to respond to ‎official actions within prescribed time limits, non-payment of fees, and failure to properly legalize and submit ‎formal documents. If the Company fails to maintain the patents and patent applications covering its product candidates, its ‎competitors might be able to enter the market, which would have a material adverse effect on the Company’s business. ‎

While a patent may be granted by a national patent office, there is no guarantee that the granted patent is valid. ‎Options exist to challenge the validity of a patent which, depending upon the jurisdiction, may include re-‎examination, opposition proceedings before the patent office, and/or invalidation proceedings before the relevant ‎court. Patent validity may also be the subject of a counterclaim to an allegation of patent infringement.‎

Pending patent applications may be challenged by third parties in protest or similar proceedings. Third parties can ‎typically submit prior art material to patentability for review by the patent examiner. Regarding Patent Cooperation ‎Treaty applications, a positive opinion regarding patentability issued by the International Searching Authority does ‎not guarantee allowance of a national application derived from the Patent Cooperation Treaty application. The ‎coverage claimed in a patent application can be significantly reduced before the patent is issued, and the patent’s ‎scope can be modified after issuance. It is also possible that the scope of claims granted may vary from jurisdiction ‎to jurisdiction.‎

The grant of a patent does not have any bearing on whether the invention described in the patent application would ‎infringe the rights of earlier filed patents. It is possible to both obtain patent protection for an invention and yet still ‎infringe the rights of an earlier granted patent.‎

The Company may be sued by third parties for alleged infringement of their proprietary rights, which could be ‎costly, time-consuming and limit the Company’s ability to use certain technologies in the future.‎

‎The Company may become subject to claims that its technologies infringe upon the intellectual property or other ‎proprietary rights of third parties. Any claims, with or without merit, could be time-consuming and expensive, and ‎could divert the Company’s management’s attention away from the execution of its business plan. Moreover, any ‎settlement or adverse judgment resulting from these claims could require the Company to pay substantial amounts ‎or obtain a license to continue to use the disputed technology, or otherwise restrict or prohibit the Company’s use of ‎the technology. The Company cannot assure that it would be able to obtain a license from the third party asserting ‎the claim on commercially reasonable terms, if at all, that the Company would be able to develop alternative ‎technology on a timely basis, if at all, or that the Company would be able to obtain a license to use a suitable ‎alternative technology to permit the Company to continue offering, and the Company’s customers to continue ‎using, the Company’s affected product. An adverse determination also could prevent the Company from offering ‎its products to others. Infringement claims asserted against the Company may have a material adverse effect on its ‎business, results of operations or financial condition.‎

39

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

The Company may not be able to protect its intellectual property rights throughout the world.‎

‎Filing, prosecuting, and defending patents on all the Company’s product candidates throughout the world would be ‎prohibitively expensive. Therefore, the Company has filed applications and/or obtained patents only in key markets ‎including the United States and Canada. Competitors may use the Company’s technologies in jurisdictions where it has not ‎obtained patent protection to develop their own products and their products may compete with products of the Company.‎‎

‎Failure to adhere to the Company’s financial reporting obligations and other public company requirements could adversely ‎affect the market price of the Common Shares.‎

‎The Company ‎is subject to ‎reporting and other obligations under applicable securities laws in Canada and the United States, and the rules ‎of the CSE, Nasdaq and the Frankfurt Stock Exchange. These reporting and other obligations ‎place significant demands on the Company’s management, administrative, operational and ‎accounting resources. If the Company is unable to meet such ‎demands in a timely and effective manner, ‎its ability to comply with its financial reporting obligations ‎and other rules applicable to reporting issuers ‎could be impaired. Moreover, any failure to maintain effective ‎internal controls could cause the Company ‎to fail to satisfy its reporting obligations or result in material misstatements in its ‎financial statements. If ‎the Company cannot provide reliable financial reports or prevent fraud, its reputation and operating ‎‎results could be materially adversely affected which could also cause investors to lose confidence in its ‎reported ‎financial information, which could result in a reduction in the trading price of the Common ‎Shares.‎

In addition, the Company does not expect that its disclosure controls and procedures and internal ‎controls over financial reporting will ‎prevent all errors or fraud. A control system, no matter how well ‎designed and implemented, can provide only ‎reasonable, not absolute, assurance that the control ‎system’s objectives will be met. Further, the design of a control ‎system must reflect the fact that there ‎are resource constraints, and the benefits of controls must be considered ‎relative to their costs. Due to ‎the inherent limitations in all control systems, no evaluation of controls can provide ‎absolute assurance ‎that all control issues within an organization are detected. The inherent limitations include the ‎realities that ‎judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors ‎or ‎mistakes. Controls can also be circumvented by individual acts of certain persons, by collusion of two ‎or more ‎people or by management override of the controls. Due to the inherent limitations in a control ‎system, ‎misstatements due to errors or fraud may occur and may not be detected in a timely manner or ‎at all‎.‎

We have limited operating experience as a publicly traded company in the U.S.

We have limited operating experience as a publicly traded company in the U.S. Although our management team have experience managing a publicly-traded company, there is no assurance that the past experience of our management team will be sufficient to operate the Company as a publicly traded company in the United States, including timely compliance with the disclosure requirements of the U.S. Securities and Exchange Commission (the “SEC”). We are required to develop and implement internal control systems and procedures in order to satisfy the periodic and current reporting requirements under applicable SEC regulations and comply with the listing standards of the Nasdaq. These requirements place significant strain on our management team, infrastructure and other resources. In addition, our management team may not be able to successfully or efficiently manage the Company as a U.S. public reporting company that is subject to significant regulatory oversight and reporting obligations.

If the Company is required to write down goodwill and other intangible assets, the Company’s financial ‎condition and results could be negatively affected. ‎

‎Goodwill impairment arises when there is deterioration in the capabilities of acquired assets to generate cash flows, ‎and the fair value of the goodwill dips below its book value. The Company is required to review its goodwill for ‎impairment at least annually. Events that may trigger goodwill impairment include deterioration in economic ‎conditions, increased competition, loss of key personnel, and regulatory action. Should any of these occur, an impairment of ‎goodwill relating to the acquisition of Dronelogics Systems Inc. could have a negative effect on the assets of the ‎Company.‎

40

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

From time to time, the Company may become involved in legal proceedings, which could adversely affect the ‎Company.‎

‎The Company may, from time to time in the future, become subject to legal proceedings, claims, litigation and ‎government investigations or inquiries, which could be expensive, lengthy, and disruptive to normal business ‎operations. In addition, the outcome of any legal proceedings, claims, litigation, investigations or inquiries may be ‎difficult to predict and could have a material adverse effect on the Company’s business, operating results, or ‎financial condition.‎

The Company’s directors and officers may have conflicts of interest in conducting their duties.

Because directors and officers of the Company are or may become directors or officers of other ‎reporting companies or have significant shareholdings in other technology companies, the directors and ‎officers of the Company may have conflicts of interest in conducting their duties. The Company and its ‎directors and officers will attempt to minimize such conflicts. In the event that such a conflict of interest ‎arises at a meeting of the directors of the Company, a director who has such a conflict will abstain from ‎voting for or against a particular matter in which the director has the conflict. In appropriate cases, the ‎Company will establish a special committee of independent directors to review a particular matter in ‎which several directors, or officers, may have a conflict. In determining whether the Company will ‎participate in a particular program and the interest therein to be acquired by it, the directors will primarily ‎consider the potential benefits to the Company, the degree of risk to which the Company may be ‎exposed and its financial position at that time. Other than as indicated, the Company has no other ‎procedures or mechanisms to deal with conflicts of interest.‎

Our Articles ‎provide that the Company must indemnify a director or former director against all judgments, penalties ‎‎or fines to which such person is or may be liable by reason of such person being or having been a director of the ‎‎Company and the executive officers and directors may also have rights to indemnification from the Company, ‎‎including ‎pursuant to directors’ and officers’ liability insurance policies, that will survive termination of their ‎‎‎agreements‎.

Risks Related to Our Common Shares

The market price of the Common Shares may be highly volatile.‎

The market price of the Common Shares may be highly volatile and could be subject to wide fluctuations ‎in response to a number of factors that are beyond our control, including but not limited ‎to‎

● revenue or results of operations in any quarter failing to meet the expectations, published or otherwise, of ‎the investment community;‎

● actual or anticipated changes or fluctuations in our results of operations;‎

● announcements by us or our competitors of new products or new or terminated significant contracts, ‎commercial relationships or capital commitments;‎

● rumors and market speculation involving us or other companies in our industry;‎

● changes in our executive management team or the composition of the board of directors of the Company (the “Board”);‎

● fluctuations in the share prices of other companies in the technology and emerging growth sectors;‎

● general market conditions and macroeconomic trends driven by factors outside our control, such as the COVID-19 pandemic and/or geopolitical conflicts, including supply chain disruptions, market volatility, inflation, and labor challenges, among other factors;

● actual or anticipated developments in our business or our competitors’ businesses or the competitive ‎landscape generally;‎

● litigation involving us, our industry or both, or investigations by regulators into our operations or those of ‎competitors;‎

● announced or completed acquisitions of businesses or technologies by us or our competitors;‎

● new laws or regulations or new interpretations of existing laws or regulations applicable to our ‎business;‎

● shareholder activism and related publicity;‎

● foreign exchange rates; and

● other risk factors as set out in this Annual Report and in the documents incorporated by ‎reference into this Annual Report.‎

41

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

If the market price of our Common Shares drops significantly, shareholders could institute securities class action ‎lawsuits against us, regardless of the merits of such claims. Such a lawsuit could cause us to incur substantial ‎costs and could divert the time and attention of our management and other resources from our business. This ‎could harm our business, results of operations and financial condition.‎

There is no guarantee that an active trading market for our Common Shares will be maintained on ‎the CSE and/or the Nasdaq. Investors may not be able to sell their Common Shares quickly or at the ‎latest market price if the trading in our Common Shares is not active.‎

Our Common Shares are currently listed on the CSE, Nasdaq, and the Frankfurt Stock Exchange, however, our shareholders may be unable to sell significant quantities of Common Shares into the public ‎trading markets without a significant reduction in the price of their Common Shares, or at all and there can be no guarantee that an active trading market for the Common Shares ‎may be maintained. There can be no assurance that ‎there will be sufficient liquidity of our Common Shares on the trading market, and that we will continue to meet ‎the listing requirements of the CSE, the Nasdaq or any other public listing exchange.

Future issuances of equity securities by us or sales by our existing shareholders may cause the price ‎of our Common Shares to fall.‎

The market price of our Common Shares could decline as a result of issuances of securities or sales by our ‎existing shareholders in the market, including by our directors, executive officers and significant shareholders, or ‎the perception that these sales could occur. Sales of our Common Shares by shareholders might also make it ‎more difficult for us to sell Common Shares at a time and price that we deem appropriate. We also expect to ‎issue Common Shares in the future. Future issuances of Common Shares, or the perception that such issuances ‎are likely to occur, could affect the prevailing trading prices of the Common Shares.‎

We may never pay dividends over the foreseeable future.‎

Investors should not rely on an investment in our Common Shares to provide dividend ‎income. The Company does not anticipate that it will pay any cash dividends to holders of its Common ‎Shares in the foreseeable future. Instead, the Company plans to retain any earnings to maintain and expand ‎its operations. In addition, any future debt financing arrangement may contain terms prohibiting or limiting ‎the amount of dividends that may be declared or paid on its Common Shares. Accordingly, investors must ‎rely on sales of their Common Shares after price appreciation, which may never occur, as the only way to ‎realize any return on their investment. As a result, investors seeking cash dividends should not purchase the ‎Company’s Common Shares.‎

The Company may be classified as a “passive foreign investment company” for U.S. federal income tax purposes, which would subject U.S. investors that hold the Company’s Common Shares to potentially significant adverse U.S. federal income tax consequences.

If the Company is classified as a passive foreign investment company (“PFIC”) for U.S. federal income tax purposes in any taxable year, U.S. investors holding Common Shares generally will be subject, in that taxable year and all subsequent taxable years (whether or not the Company continued to be a PFIC), to certain adverse US federal income tax consequences. The Company will be classified as a PFIC in respect of any taxable year in which, after taking into account its income and gross assets (including the income and assets of 25% or more owned subsidiaries), either (i) 75% or more of its gross income consists of certain types of  “passive income” or (ii) 50% or more of the average quarterly value of its assets is attributable to “passive assets” (assets that produce or are held for the production of passive income). Based upon the current and expected composition of the Company’s income and assets, the Company believes that it was not a PFIC for the taxable year ended December 31, 2022 and expects that it will not be a PFIC for the current taxable year. Nevertheless, because the Company’s PFIC status must be determined annually with respect to each taxable year and will depend on the composition and character of the Company’s assets and income, and the value of the Company’s assets (which may be determined, in part, by reference to the market value of Common Shares, which may be volatile) over the course of such taxable year, the Company may be a PFIC in any taxable year. The determination of whether the Company will be or become a PFIC may also depend, in part, on how, and how quickly, the Company uses its liquid assets and the cash raised in an offering. If the Company determines not to deploy significant amounts of cash for active purposes, the Company’s risk of being a PFIC may substantially increase. Because there are uncertainties in the application of the relevant rules and PFIC status is a factual determination made annually after the close of each taxable year, there can be no assurance that the Company will not be a PFIC for any future taxable year. In addition, it is possible that the U.S. Internal Revenue Service may challenge the Company’s classification of certain income and assets as non-passive, which may result in the Company being or becoming a PFIC in the current or subsequent years.

42

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

If the Company is a PFIC for any year during a U.S. holder’s holding period, then such U.S. holder generally will be required to treat any gain realized upon a disposition of Common Shares, or any “excess distribution” received on its Common Shares, as ordinary income, and to pay an interest charge on a portion of such gain or distribution, unless the U.S. holder makes a timely and effective “qualified electing fund” election (“QEF Election”) or a “mark-to-market” election with respect to its Common Shares. A U.S. holder who makes a QEF Election generally must report on a current basis its share of the Company’s net capital gain and ordinary earnings for any year in which the Company is a PFIC, whether or not the Company distributes any amounts to its shareholders. However, U.S. holders should be aware that there can be no assurance that the Company will satisfy the record keeping requirements that apply to a QEF, or that the Company will supply U.S. holders with information that such U.S. holders require to report under the QEF Election rules, in the event that the Company is a PFIC and a U.S. holder wishes to make a QEF Election. Thus, U.S. holders may not be able to make a QEF Election with respect to their Common Shares. A U.S. holder who makes a mark-to-market election generally must include as ordinary income each year the excess of the fair market value of the Common Shares over the taxpayer’s basis therein. Each U.S. holder should consult its own tax advisors regarding the PFIC rules and the U.S. federal income tax consequences of the acquisition, ownership, and disposition of Common Shares.‎

United States investors may not be able to obtain enforcement of civil liabilities against us.

‎

The Company is incorporated under the laws of British Columbia, Canada, and its principal executive offices are located in Canada. Most of the Company’s directors and officers and most of the experts named in this Annual Report reside outside of the United States and all or a substantial portion of the Company’s assets and the assets of these persons are located outside the United States. Consequently, it may not be possible for an investor to effect service of process within the United States on the Company or those persons. Furthermore, it may not be possible for an investor to enforce judgments obtained in United States courts based upon the civil liability provisions of United States federal securities laws or other laws of the United States against those persons or the Company. There is doubt as to the enforceability, in original actions in Canadian courts, of liabilities based upon United States federal securities laws and as to the enforceability in Canadian courts of judgments of United States courts obtained in actions based upon the civil liability provisions of the United States federal securities laws. Therefore, it may not be possible to enforce those actions against the Company, certain of the Company’s directors and officers or the experts named in this Annual Report.

We are an emerging growth company and intend to take advantage of reduced disclosure requirements ‎applicable to emerging growth companies, which could make our Common Shares less attractive to ‎investors.‎

We are an “emerging growth company” as defined in the JOBS Act. We will remain an emerging growth ‎company until the earliest to occur of (i) the last day of the fiscal year in which we have total annual gross ‎revenue of $1.235 billion or more; (ii) December 31, 2026 (the last day of the fiscal year ending after the fifth ‎anniversary of the date of the completion of the first sales of its common equity pursuant to an effective ‎registration statement under the United States Securities Act of 1933, as amended (the “Securities Act”)); (iii) ‎the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-‎year period; or (iv) the date we qualify as a “large accelerated filer” under the rules of the SEC, which means the ‎market value of our Common Shares held by non-affiliates exceeds $700 million as of the last business day of ‎its most recently completed second fiscal quarter after we have been a reporting company in the United States ‎for at least 12 months. For so long as we remain an emerging growth company, we are permitted to and intend to ‎rely upon exemptions from certain disclosure requirements that are applicable to other public companies that ‎are not emerging growth companies. These exemptions include not being required to comply with the auditor ‎attestation requirements of Section 404 (“Section 404”) of the Sarbanes-Oxley Act (2002), as amended (the “Sarbanes-Oxley Act”).‎

43

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

We may take advantage of some, but not all, of the available exemptions available to emerging growth ‎companies. We cannot predict whether investors will find our Common Shares less attractive if we rely on these ‎exemptions. If some investors find our Common Shares less attractive as a result, there may be a less active ‎trading market for our Common Shares and the price of our Common Shares may be more volatile.

We will incur increased costs as a result of operating as a public company in the United States ‎and our management will be required to devote substantial time to new compliance initiatives.‎

As a U.S. public company, particularly if or when we are no longer an “emerging growth company” as defined ‎under the JOBS Act, we will incur significant legal, accounting and other expenses, in addition to those we ‎currently incur as a Canadian public company, that we did not incur prior to being listed in the United States. In ‎addition, the Sarbanes-Oxley Act, and rules implemented by the SEC and Nasdaq impose various other ‎requirements on public companies, and we will need to spend time and resources to ensure compliance with our ‎reporting obligations in both Canada and the United States.‎

For example, pursuant to Section 404, we will be required to furnish a report by our management on our internal ‎control over financial reporting (“ICFR”), which, if or when we are no longer an emerging growth company, must ‎be accompanied by an attestation report on ICFR issued by our independent registered public accounting firm. ‎To achieve compliance with Section 404 within the prescribed period, we will document and evaluate our ICFR, ‎which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the ‎adequacy of our ICFR, continue steps to improve control processes as appropriate, validate through testing that ‎controls are functioning as documented and implement a continuous reporting and improvement process for ‎ICFR. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will ‎be able to conclude within the prescribed timeframe that our ICFR is effective as required by Section 404. This ‎could result in a determination that there are one or more material weaknesses in our ICFR, which could cause an ‎adverse reaction in the financial markets due to a loss of confidence in the reliability of our consolidated ‎financial statements.‎

In addition, becoming a public company in the United States will increase legal and financial compliance as well ‎as regulatory costs, such as additional Nasdaq fees, and will make some of our public company obligations ‎more time consuming. We intend to invest resources to comply with evolving laws, regulations and standards in ‎both Canada and the United States, and this investment may result in increased general and administrative ‎expenses and increased diversion of management’s time and attention from revenue-generating activities to ‎compliance activities. If our efforts to comply with public company laws, regulations and standards in the ‎United States are insufficient, regulatory authorities may initiate legal proceedings against us and our business ‎may be harmed.‎

We also expect that being a public company in the United States and complying with applicable rules and ‎regulations will make it more expensive for us to obtain sufficient levels of director and officer liability insurance ‎coverage. This factor could also make it more difficult for us to attract and retain qualified executive officers and ‎members of our Board of Directors.‎

As a foreign private issuer, we are subject to different U.S. securities laws and rules than a domestic U.S. ‎issuer, which may limit the information publicly available to our U.S. shareholders.‎

We currently qualify as a “foreign private issuer” under applicable U.S. federal securities laws and, therefore, are ‎not required to comply with all the periodic disclosure and current reporting requirements of the Exchange Act and related rules and regulations. As a result, we do ‎not file the same reports that a U.S. domestic issuer would file with the SEC, although we will be required to file ‎with or furnish to the SEC the continuous disclosure documents that we are required to file in Canada under ‎Canadian securities laws. In addition, our officers, directors and principal shareholders are exempt from the ‎reporting and “short swing” profit recovery provisions of Section 16 of the Exchange Act. Therefore, our ‎shareholders may not know on as timely a basis when our officers, directors and principal shareholders purchase ‎or sell our securities as the reporting periods under the corresponding Canadian insider reporting requirements are ‎longer. In addition, as a foreign private issuer, we are exempt from the proxy rules under the Exchange Act. We ‎are also exempt from Regulation FD, which prohibits issuers from making selective disclosures of material non-‎public information. While we expect to comply with the corresponding requirements relating to proxy statements ‎and disclosure of material non-public information under Canadian securities laws, these requirements differ from ‎those under the Exchange Act and Regulation FD and shareholders should not expect to receive in every case the ‎same information at the same time as such information is provided by U.S. domestic issuers.‎

In addition, as a foreign private issuer, we have the option to follow certain Canadian corporate governance ‎practices, except to the extent that such laws would be contrary to U.S. federal securities laws and Nasdaq ‎listing rules and provided that we disclose the requirements we are not following and describe the Canadian ‎practices we follow instead. We plan to rely on this exemption in part. As a result, our shareholders may not have ‎the same protections afforded to shareholders of U.S. domestic issuers that are subject to all U.S. corporate ‎governance requirements.‎

At some point in the future, we may cease to qualify as a foreign private issuer. If we cease to ‎qualify, we will be subject to the same reporting requirements and corporate governance requirements as a U.S. ‎domestic issuer, which may increase our costs of being a public company in the ‎United States.‎

44

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2022

REGULATORY POLICIES

Disclosure Controls and Procedures

Disclosure Controls and Procedures (“DC&P”) are designed to provide reasonable assurance that all material information is gathered and reported on a timely basis to senior management so that appropriate decisions can be made regarding public disclosure and that information required to be disclosed by the issuer under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation. The Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), along with other members of management, have designed, or caused to be designed under the CEO and CFO’s supervision, DC&P and established processes to ensure that they are provided with sufficient knowledge to support the representations made in the interim certificates required to be filed under National Instrument 52-109.

Internal Controls over Financial Reporting

The CEO and CFO, along with participation from other members of management, are responsible for establishing and maintaining adequate Internal Control over Financial Reporting (“ICFR”) to provide reasonable assurance regarding the reliability of financial statements prepared in accordance with IFRS. During the year ended December 31, 2022, there has been no change in the Company’s ICFR that has materially affected, or is reasonably likely to materially affect, the Company’s ICFR.

Limitations of Controls and Procedures

The Company’s management, including its CEO and CFO, believe that any DC&P or ICFR, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, they cannot provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been prevented or detected. These inherent limitations include the realities that judgements in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Accordingly, because of the inherent limitations in a cost effective control system, misstatements due to error or fraud may occur and not be detected. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Other Information

Additional information about the Company is available at www.draganfly.com

Approval

This MD&A is authorized for issue by the Board on March 27, 2023

45

EX-99.4

Exhibit 99.4

CERTIFICATION

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Cameron Chell, certify that:

1. I have reviewed this annual report on Form 40-F of Draganfly Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the issuer as of, and for, the periods presented in this report;

4. The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the issuer and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer’s internal control over financial reporting; and

5. The issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer’s auditors and the audit committee of the issuer’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that are reasonably likely to adversely affect the issuer’s ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.

Date: March 27, 2023
/s/ Cameron Chell
Name:	Cameron Chell
Title:	Chief Executive Officer
(principal executive officer)

EX-99.5

Exhibit 99.5

CERTIFICATION

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Paul Sun, certify that:

1. I have reviewed this annual report on Form 40-F of Draganfly Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the issuer as of, and for, the periods presented in this report;

4. The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the issuer and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer’s internal control over financial reporting; and

5. The issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer’s auditors and the audit committee of the issuer’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that are reasonably likely to adversely affect the issuer’s ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.

Date: March 27, 2023
/s/ Paul Sun
Name:	Paul Sun
Chief	Financial Officer
(principal financial officer)

EX-99.6

Exhibit 99.6

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, as the Chief Executive Officer of Draganfly Inc. certifies that, to the best of his knowledge and belief, the annual report on Form 40-F for the fiscal year ended December 31, 2022, which accompanies this certification, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and the information contained in the annual report on Form 40-F for the fiscal year ended December 31, 2022 fairly presents, in all material respects, the financial condition and results of operations of Draganfly Inc. at the dates and for the periods indicated. The foregoing certification is made pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350) and shall not be relied upon for any other purpose. The undersigned expressly disclaims any obligation to update the foregoing certification except as required by law.

Date: March 27, 2023

/s/ Cameron Chell

Cameron Chell

Chief Executive Officer

(principal executive officer)

EX-99.7

Exhibit 99.7

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, as the Chief Financial Officer of Draganfly Inc. certifies that, to the best of his knowledge and belief, the annual report on Form 40-F for the fiscal year ended December 31, 2022, which accompanies this certification, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and the information contained in the annual report on Form 40-F for the fiscal year ended December 31, 2022 fairly presents, in all material respects, the financial condition and results of operations of Draganfly Inc. at the dates and for the periods indicated. The foregoing certification is made pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350) and shall not be relied upon for any other purpose. The undersigned expressly disclaims any obligation to update the foregoing certification except as required by law.

Date: March 27, 2023

/s/ Paul Sun

Paul Sun

Chief Financial Officer

(principal financial officer)

EX-99.8

Exhibit 99.8

CONSENT OF REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in this Annual Report on Form 40-F of our report dated March 27, 2023, with respect to the consolidated financial statements of Draganfly Inc. as at and for the years ended December 31, 2022 and 2021, which appears in Exhibit 99.2 to this Annual Report on Form 40-F of Draganfly Inc.

We also consent to the incorporation by reference in the Registration Statements on Form F-10 (No. 333-258074), as amended, and Form S-8 (No. 333-259459) of our report dated March 27, 2023 referred to above.

/s/ Dale Matheson Carr-Hilton Labonte LLP

Chartered Professional Accountants

Vancouver, Canada

March 27, 2023

XML

Cover	12 Months Ended
	Dec. 31, 2022 shares
Entity Addresses [Line Items]
Document Type	40-F
Amendment Flag	false
Document Registration Statement	false
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	001-40688
Entity Registrant Name	Draganfly Inc.
Entity Central Index Key	0001786286
Entity Incorporation, State or Country Code	A1
Entity Address, Address Line One	2108 St. George Avenue
Entity Address, City or Town	Saskatoon
Entity Address, State or Province	SK
Entity Address, Country	CA
Entity Address, Postal Zip Code	S7M 0K7
City Area Code	800
Local Phone Number	979-9794
Title of 12(b) Security	Common Shares
Trading Symbol	DRPO
Security Exchange Name	NASDAQ
Annual Information Form	true
Audited Annual Financial Statements	true
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Common Stock, Shares Outstanding	34,270,579
Auditor Name	Dale Matheson Carr-Hilton Labonte LLP
Auditor Firm ID	1173
Auditor Location	Vancouver, Canada
Business Contact [Member]
Entity Addresses [Line Items]
Entity Address, Address Line One	1015 15th Street
Entity Address, Address Line Two	N.W.,Suite 1000
Entity Address, City or Town	Washington
Entity Address, State or Province	DC
Entity Address, Postal Zip Code	20005
City Area Code	202
Local Phone Number	572-3111
Contact Personnel Name	C T Corporation System

XML

Consolidated Statements of Financial Position - CAD ($)	Dec. 31, 2022	Dec. 31, 2021
Current Assets
Cash and cash equivalents	$ 7,894,781	$ 23,075,713
Receivables	2,088,965	1,407,127
Inventory	1,055,942	3,390,822
Notes receivable	169,300	190,170
Prepaids	2,307,724	5,494,877
Total current assets	13,516,712	33,558,709
Non-current Assets
Goodwill		5,940,409
Equipment	404,691	297,043
Intangible assets	179,801	593,901
Investments	192,583	291,066
Notes receivable		964,006
Right of use assets	344,746	468,106
TOTAL ASSETS	14,638,533	42,113,240
Current Liabilities
Trade payables and accrued liabilities	2,816,676	799,139
Customer deposits	194,758	172,134
Deferred income	63,690	73,286
Loans payable	81,512	6,745
Derivative liability	57,314	5,560,002
Lease liabilities	133,962	110,481
Total current liabilities	3,347,912	6,721,787
Non-current Liabilities
Loans payable	5,059	86,572
Lease liabilities	244,681	378,642
TOTAL LIABILITIES	3,597,652	7,187,001
SHAREHOLDERS’ EQUITY
Share capital	83,600,089	81,038,365
Reserves – share-based payments	7,264,340	6,406,117
Accumulated deficit	(79,976,546)	(52,322,182)
Accumulated other comprehensive income (loss)	152,998	(196,061)
TOTAL SHAREHOLDERS’ EQUITY	11,040,881	34,926,239
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 14,638,533	$ 42,113,240

XML

Consolidated Statements of Comprehensive Loss - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
REVENUE
Sales of goods	$ 5,550,432	$ 5,103,399
Provision of services	2,054,627	1,950,466
TOTAL REVENUE	7,605,059	7,053,865
COST OF SALES	(6,814,384)	(4,410,777)
GROSS PROFIT	790,675	2,643,088
OPERATING EXPENSES
Amortization	179,482	135,966
Depreciation	593,277	175,098
Director fees	522,349	370,094
Insurance	3,722,237	2,962,767
Office and miscellaneous	5,397,961	6,455,998
Professional fees	6,821,583	4,445,949
Research and development	651,302	510,895
Share-based payments	3,311,024	3,952,595
Travel	396,388	143,904
Wages and salaries	6,105,020	2,768,010
Total operating expenses	(27,700,623)	(21,921,276)
OTHER INCOME (EXPENSE)
Change in fair value of derivative liability	5,502,688	8,149,812
Finance and other costs	44,345	5,074
Foreign exchange gain (loss)	745,102	362,448
Loss on disposal of assets	(10,755)
Loss on write-off of notes receivable	(309,385)	(891,471)
Government income	2,446	24,148
Write down of deposit	(228,572)
Loss on impairment of goodwill and intangibles	(6,454,914)	(4,579,763)
Other income (expense)	(35,371)	4,968
NET LOSS	(27,654,364)	(16,202,972)
Items that may be reclassified to profit or loss
Foreign exchange translation	447,542	136,475
Items that will not be reclassified to profit or loss
Change in fair value of equity investments at FVOCI	(98,483)	(332,640)
COMPREHENSIVE LOSS	$ (27,305,305)	$ (16,399,137)
Net loss per share
Basic & diluted	$ (0.82)	$ (0.59)
Weighted average number of common shares outstanding - basic & diluted	33,556,969	27,787,348

XML

Consolidated Statements of Changes in Shareholders' Equity - CAD ($)	Issued capital [member]	Reserve of share-based payments [member]	Retained earnings [member]	Reserve of gains and losses from investments in equity instruments [member]	Reserve of exchange differences on translation [member]	Total
Balance at Dec. 31, 2020	$ 36,943,304	$ 3,024,007	$ (36,119,210)		$ 104	$ 3,848,205
Balance, shares at Dec. 31, 2020	17,218,695
IfrsStatementLineItems [Line Items]
Shares issued for acquisition of Vital	$ 2,303,999	1,241,250				3,545,249
Balance, shares	1,200,000
Shares issued for financing	$ 36,092,187					36,092,187
Balance, shares	11,584,657
Share issue costs	$ (4,678,821)	864,060				(3,814,761)
Shares issued for the exercise of RSUs	$ 1,752,052	(1,752,052)
Shares issued for the exercise of RSUs, shares	448,660
Shares issued for exercise of warrants	$ 4,929,790					4,929,790
Shares isued for exercise of warrants, shares	1,939,534
Shares issued for exercise of stock options	$ 1,937,866	(923,743)				1,014,123
Shares issued for exercise of stock options, shares	405,499
Shares issued in lieu of cash	$ 1,757,988					1,757,988
Balance, shares	371,901
Share-based payments		3,952,595				3,952,595
Net loss			(16,202,972)			(16,202,972)
Change in fair value of equity investments at FVOCI				(332,640)		(332,640)
Translation of foreign operations					136,475	136,475
Balance at Dec. 31, 2021	$ 81,038,365	6,406,117	(52,322,182)	(332,640)	136,579	34,926,239
Balance, shares at Dec. 31, 2021	33,168,946
IfrsStatementLineItems [Line Items]
Share issue costs	$ (5,122)					(5,122)
Shares issued for the exercise of RSUs	$ 2,427,801	(2,427,801)
Shares issued for the exercise of RSUs, shares	1,072,595
Shares issued for exercise of warrants	$ 87,170					87,170
Shares isued for exercise of warrants, shares	16,538
Shares issued for exercise of stock options	$ 51,875	(25,000)				26,875
Shares issued for exercise of stock options, shares	12,500
Share-based payments		3,311,024				3,311,024
Net loss			(27,654,364)			(27,654,364)
Change in fair value of equity investments at FVOCI				(98,483)		(98,483)
Translation of foreign operations					447,542	447,542
Balance at Dec. 31, 2022	$ 83,600,089	$ 7,264,340	$ (79,976,546)	$ (431,123)	$ 584,121	$ 11,040,881
Balance, shares at Dec. 31, 2022	34,270,579

XML

Consolidated Statements of Cash Flows - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
OPERATING ACTIVITIES
Net loss	$ (27,654,364)	$ (16,202,972)
Adjustments for:
Amortization	179,482	135,966
Depreciation	593,277	175,098
Change in fair value of derivative liability	(5,502,688)	(8,149,812)
Write down of inventory	1,976,514
Impairment of notes receivable	309,385	891,471
Impairment of goodwill and intangibles	6,454,914	4,579,763
Write down of deposit	228,572
Finance and other costs	(34,427)	(926)
Income from government assistance		(24,148)
Share-based payments	3,311,024	3,952,595
Adjustment for profit loss	(20,138,311)	(14,642,965)
Net changes in non-cash working capital items:
Receivables	(681,838)	(596,336)
Inventory	(150,241)	(2,157,203)
Prepaids	2,958,581	(3,401,868)
Trade payables and accrued liabilities	1,661,697	(1,044,133)
Customer deposits	22,624	(213,315)
Deferred income	(21,543)	51,186
Cash used in operating activities	(16,349,031)	(22,004,634)
INVESTING ACTIVITIES
Cash paid for acquisition, net of cash received		(466,643)
Purchase of equipment	(79,713)	(212,579)
Disposal of equipment	10,755
Purchase of intangible assets	(4,684)
Purchase of investments		(623,706)
Repayment (Issuance) of notes receivable	842,297	(2,002,678)
Cash provided by (used in) investing activities	768,655	(3,305,606)
FINANCING ACTIVITIES
Proceeds from issuance of common shares for financing		44,255,651
Share issue costs	(5,122)	(3,814,762)
Proceeds from issuance of common shares for warrants exercised	87,170	4,929,790
Proceeds from issuance of common shares for stock options exercised	26,875	1,014,123
Proceeds from issuance of loans		60,000
Repayment of loans	(6,746)	(48,747)
Repayment of lease liabilities	(150,275)	(128,996)
Cash provided by (used in) financing activities	(48,098)	46,267,059
Effects of exchange rate changes on cash	447,542	136,478
Change in cash	(15,628,474)	20,956,819
Cash and cash equivalents, beginning of year	23,075,713	1,982,416
Cash and cash equivalents, end of year	7,894,781	23,075,713
Cash and cash equivalents consist of the following:
Cash held in banks	7,500,607	22,729,212
Guaranteed investment certificate	394,174	346,501
Cash and cash equivalents	$ 7,894,781	$ 23,075,713

XML

NATURE AND CONTINUANCE OF OPERATIONS

12 Months Ended

Dec. 31, 2022

Nature And Continuance Of Operations

NATURE AND CONTINUANCE OF OPERATIONS

1. NATURE AND CONTINUANCE OF OPERATIONS

Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company’s shares trade on the Canadian Securities Exchange (the “CSE”), on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8”. The Company’s head office is located at 2108 St. George Avenue, Saskatoon, SK, S7M 0K7 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.

Share consolidation

During the year ended December 31, 2021 in conjunction with its Regulation A financing, the Company underwent a share consolidation at a 5-1 ratio. All reference to share, per share amounts, warrants, RSU’s and stock options in these financial statements have been retroactively restated to reflect the consolidation.

These consolidated financial statements have been prepared on the assumption that the Company will continue as a going concern, meaning it will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations. To date, the Company has not been profitable and has an accumulated deficit of $79,976,546. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing and or achieve profitable operations in the future . These factors indicate the existence of a material uncertainty that may cast significant doubt on the Company’s ability to continue as a going concern. These financial statements do not reflect adjustments that would be necessary if the going concern assumption were not appropriate. These adjustments could be material.

XML

BASIS OF PREPARATION

12 Months Ended

Dec. 31, 2022

BASIS OF PREPARATION

2. BASIS OF PREPARATION

Statement of Compliance

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations issued by the International Reporting Interpretation Committee (“IFRIC”). The principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all years presented, unless otherwise stated.

These consolidated financial statements were authorized for issue by the Board of Directors on March 27, 2023.

Basis of consolidation

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases.

The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

Name of Subsidiary	Place of Incorporation	Ownership Interest
Draganfly Innovations Inc.	Canada	100%
Draganfly Innovations USA, Inc.	US	100%
Dronelogics Systems Inc.	Canada	100%

All intercompany balances and transactions were eliminated on consolidation.

Significant estimates and assumptions

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make estimates and assumptions about reported amounts at the date of the consolidated financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Impairment of Non-financial assets

The CGU’s recoverable amount is evaluated using the higher of the value in use and fair value less costs to sell. In determining the recoverable amount, the Company utilizes discounted cash flow techniques. Management calculates the discounted cash flows based upon its best estimate of a number of economic, operating, engineering, environmental, political and social assumptions. Any changes in the assumptions due to changing circumstances may affect the recoverable amount estimate.

Share-based payments

The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield of the stock option.

Income taxes

Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the company is likely to recognize their recovery from the generation of taxable income.

Inventory

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price less costs to sell. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market- driven changes that may reduce future selling prices.

Contingencies

The assessment of contingencies involves the exercise of significant judgment and estimates of the outcome of future events. In assessing loss contingencies related to legal proceedings that are pending against the Company and that may result in regulatory or government actions that may negatively impact the Company’s business or operations, the Company and its legal counsel evaluate the perceived merits of the legal proceeding or unasserted claim or action as well as the perceived merits of the nature and amount of relief sought or expected to be sought, when determining the amount, if any, to recognize as a contingent liability or when assessing the impact on the carrying value of the Company’s assets. Contingent assets are not recognized in the consolidated financial statements.

Investments in Private companies

Where the fair value of investments in private companies recorded on the statement of financial position cannot be derived from active markets, they are determined using a variety of valuation techniques. The inputs to these models are derived from observable market data where possible, but where observable market data is not available, judgment is required to establish fair value and this value may not be indicative of recoverable value.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Expected credit losses on trade receivables and notes receivable

When determining expected credit losses (“ECLs”), the Company considers the historic credit losses observed by the Company, customer-specific payment history and economic conditions. When determining whether the credit risk of a financial asset has increased significantly since initial recognition and when estimating ECL’s, the Company considers reasonable and supportable information that is relevant and available without undue cost or effort. This includes both quantitative and qualitative information and analysis, based on the Company’s historical experience, informed credit assessment ad forward-looking information

Useful lives of equipment and intangible assets

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

Significant judgments

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments in applying the Company’s consolidated financial statements include:

Business combinations

The definition of whether a set of assets acquired and liabilities assumed constitute a business may require the Company to make certain judgements taking into account all facts and circumstances. A business is presumed to be an integrated set of activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs, or economic benefits.

Business combination versus asset acquisition

The Company considered the applicability of IFRS 3 – Business Combinations (“IFRS 3”) with respect to acquisitions (Note 3). IFRS 3 defines a business as having a system where inputs enter a process to produce outputs. The Company has determined that the acquisition of Dronelogics Systems Inc. and certain assets of Vital Intelligence Inc. are business combinations and, accordingly, have accounted for as such.

Other significant judgments

−	The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;
−	the classification of financial instruments;
−	the assessment of revenue recognition using the five-step approach under IFRS 15; and
−	the determination of the functional currency of the company.

Foreign currency translation

Transactions in foreign currencies are translated into the functional currency at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Gains and losses resulting from foreign exchange adjustments are included in profit or loss.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

The functional currencies of the parent company and each subsidiary are as follows:

Draganfly Inc.	Canadian Dollar
Draganfly Innovations Inc.	Canadian Dollar
Draganfly Innovations USA, Inc.	US Dollar
Dronelogics Systems Inc.	Canadian Dollar

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all revenue and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translation of foreign operations in other comprehensive loss.

Share-based payments

The Company operates a stock option plan. Share-based payments to employees are measured at the grant date fair value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of the goods or services received or the fair value of the equity instruments issued, if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The corresponding amount is recorded to the share-based payment reserve. The fair value of options is determined using a Black–Scholes Option Pricing Model. The number of options expected to vest is reviewed and adjusted at the end of each reporting period such that the amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments that eventually vest. Amounts recorded for forfeited or expired unexercised options are transferred to deficit in the year of forfeiture or expiry. Amounts recorded for forfeited unvested options are reversed in the period the forfeiture occurs.

Restricted Share Units

The restricted share units (“RSUs”) entitle employees, directors, or officers to either the issuance of common shares or cash payments payable upon vesting based on vesting terms determined by the Company’s Board of Directors at the time of the grant. On the grant date of RSUs, the Company determines whether it has a present obligation to settle in cash. If the Company has a present obligation to settle in cash, the RSUs are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and at the date of settlement, with any changes in fair value recognized in profit or loss for the period. RSUs settled in common share are measured at the fair value of awards on the grant date using the prior days closing price. Amounts recorded for forfeited unvested RSUs are reversed in the period the forfeiture occurs. The expense is recognized on a graded vesting basis over the vesting period, with a corresponding charge to profit or loss.

Loss per share

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. For all periods presented, the loss attributable to common shareholders equals the reported loss attributable to owners of the Company. Diluted income per share is calculated by the treasury stock method. Under the treasury stock method, the weighted average number of common shares outstanding for the calculation of diluted loss per share assumes that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at the average market price during the period. For the periods presented, the Company incurred a loss and therefore basic loss per share equals diluted loss per share.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Financial Instruments

Financial instruments are accounted for in accordance with IFRS 9 Financial Instruments: Classification and Measurement. A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

Financial assets/liabilities	Classification
Cash	Amortized cost
Accounts receivable	Amortized cost
Notes receivable	Amortized cost
Investments	Fair value through other comprehensive income
Accounts payable	Amortized cost
Customer deposits	Amortized cost
Loans payable	Amortized cost
Derivative liability	Fair value through profit or loss

a) Financial assets

Classification and measurement

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the cash flows are not solely principal and interest, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.

Financial assets at FVTPL

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are recorded to profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of financial assets held at FVTPL are included in the profit or loss in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

Financial assets at FVTOCI

Financial assets carried at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income. There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Financial assets at amortized cost

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

Impairment of financial assets at amortized cost

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

Derecognition of financial assets

Financial assets are derecognized when the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recorded to profit or loss. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive loss.

b) Financial liabilities

The Company classifies its financial liabilities into one of two categories as follows:

FVTPL - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans are included in this category.

Derecognition of financial liabilities

Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are recognized in profit or loss.

Impairment of non-financial assets

The carrying amounts of the non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:

● an intangible asset with an indefinite useful life;

● an intangible asset not yet available for use; and

● goodwill recognized in a business combination.

The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest identifiable group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.

An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the units, and then to reduce the carrying amounts of the other assets in the unit (group of units) on a pro rata basis.

In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

Income taxes

Current income tax:

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

Current income taxes relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

Deferred income tax:

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

Inventory

Inventory consists of raw materials and finished goods for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Cost is determined using the weighted average cost basis. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Revenue recognition

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

Sales of goods

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred, being when the products are delivered to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. Delivery occurs when the products have been shipped to the specific location or picked up by the customer.

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

Some contracts include multiple performance obligations, such as the manufacturing of hardware and support. Support is performed by another party and does not include an integration service. It is therefore accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on stand-alone selling price. Where is the stand-alone selling price is not directly observable, the price is estimated based on expect cost plus margin.

Services

The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized over time as the services are rendered.

Rental equipment

The Company provides rental of equipment which is measured based on rates through contracts or other written agreements with customers. Revenue is recognized in the period when services are performed and only when there is reasonable assurance that the revenue will be collected.

Deferred Revenue

A payment received is included as deferred revenue when products has yet be shipped to customers as of the period end. The amount to be recognized within twelve months following the year-end date is classified as current

Cost of Goods Sold

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, or lower of cost and net realizable value adjustments as required.

Intangible Assets and Goodwill

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications, brands and software.

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Intangible assets with finite useful lives are amortized on a straight line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.

Class of intangible asset	Useful live
Customer relationship	5 years
Brand	5 years
Software	5 years

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.

Equipment

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statement of comprehensive loss during the financial period in which they are incurred.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the statement of comprehensive loss.

Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

Class of equipment	Depreciation rate
Computer equipment	30%
Furniture and equipment	20%
Leasehold improvements	Expected lease term
Vehicles	30%

Research and development expenditures

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following:

(i)	the technical feasibility of completing the intangible asset so that it will be available for use or sale;
(ii)	its intention to complete the intangible asset and use or sell it;
(iii)	its ability to use or sell the intangible asset;
(iv)	how the intangible asset will generate probable future economic benefits. The Company can also demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset;
(v)	the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
(vi)	its ability to measure reliably the expenditure attributable to the intangible asset during its development.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Government Assistance

Government grants are recognized when there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

SR&ED Investment tax credits

The Company claims federal investment tax credits as a result of incurring scientific research and experimental development (“SR&ED”) expenditures. Federal investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Federal investment tax credits are accounted for as a reduction of research and development expense for items of a period expense nature or as a reduction of property and equipment for items of a capital nature. Management has made a number of estimates and assumptions in determining the expenditures eligible for the federal investment tax credit claim. It is possible that the allowed amount of the federal investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency.

The Company claims provincial investment tax credits as a result of incurring SR&ED expenditures. Provincial investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Management has made a number of estimates and assumptions in determining the expenditures eligible for the provincial investment tax credit claim. The provincial investment tax credits are refundable and have been recorded as a SR&ED tax credit receivable, and as a reduction in research and development expenses on the statement of comprehensive loss. It is possible that the allowed amount of the provincial investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency and the Alberta Tax and Revenue Administration.

Leases

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset is recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

The lease term is the non-cancellable period of a lease plus periods covered by an optional lease extension option if it is reasonably certain that the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

A lease modification is accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

New accounting standards issued not yet effective

Accounting standards or amendments to existing accounting standards that have been issued but have future effective dates are either not applicable or are not expected to have a significant impact on the Company’s consolidated financial statements.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

XML

VITAL INTELLIGENCE ACQUISITION

12 Months Ended

Dec. 31, 2022

Vital Intelligence Acquisition

VITAL INTELLIGENCE ACQUISITION

3. VITAL INTELLIGENCE ACQUISITION

On March 25, 2021, the Company acquired the assets of Vital Intelligence Inc. (“Vital”), a company that had developed a health/telehealth platform that could detect a number of key underlying respiratory symptoms. The Company acquired it for consideration of: (a) a cash payment of $500,000 and (b) ‎1,200,000 units of the Company with each unit being comprised of one common share and one warrant (the “Acquisition”). Each warrant will entitle the holder to acquire one common share for a period of 24 months following closing for $13.35 and the Company will be able to accelerate the expiry date of the warrants after one year in the event the underlying common shares have a value of at least 30% greater than the exercise price of the warrants. The units will be held in escrow with 300,000 units being released at closing with a value of the of $3,545,249 and the remainder to be released upon the Company reaching certain revenue milestones received from the purchased assets. The units were issued on March 22, 2021. On August 19, 2021 the parties agreed to reduce the final payment from $250,000 to $227,984 due to certain assets listed in the purchase agreement had not been delivered by Vital.

The units of the Company are to be releasable from escrow in accordance with the terms and conditions of the agreement, as follows:

a)	300,000 units shall be released on the closing date;
b)	300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $2,000,000;
c)	300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $4,000,000; and
d)	300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $6,000,000.

Upon acquisition, the 900,000 shares held in escrow were classified as a derivative liability and were valued based upon:

● A weighted average probability of achieving the milestones necessary to release the shares held in escrow, and

● Discounted due to the lack of liquidity.

On acquisition, the fair value of the derivative liability (note 17) was $4,797,717. At December 31, 2022, the liability was revalued based upon new weighted average probabilities of achieving the revenue milestones. As a result, the fair value was adjusted to $57,314 (2021 – $694,230), with the difference flowing through profit or loss.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

3. VITAL INTELLIGENCE ACQUISITION (CONT’D)

Contingent consideration
Fair value of contingent consideration	$	4,797,717
Change in fair value of contingent consideration		(4,103,487	)
Contingent consideration at December 31, 2021		694,230
Change in fair value of contingent consideration		(636,916	)
Contingent consideration at December 31, 2022 (note 17)	$	57,314

The PPA is as follows:

Number of units of Draganfly Inc.		578,248
Fair value of units	$	14.43
Fair value of units of Draganfly Inc.	$	8,342,966
Cash portion of purchase price		466,643
Total	$	8,809,609

Identifiable intangible assets
Brand	$	23,000
Software		433,000
		456,000
Goodwill		8,353,609
Total consideration	$	8,809,609

Significant estimates were as follows:

● Number of units issued based upon a weighted average calculation for the Company achieving the revenue targets.

● Brand fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 0.25% and discount rate of 14.4% per annum.

● Software fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 5.0% and discount rate of 14.4% per annum.

Furthermore, the excess of the consideration paid over the fair value of the identifiable assets (liabilities) acquired was recognized as goodwill, which primarily consisted of continued development of the technology platform integrating the latest technological developments.

XML

CASH AND CASH EQUIVALENTS

12 Months Ended

Dec. 31, 2022

Cash and cash equivalents [abstract]

CASH AND CASH EQUIVALENTS

4. CASH AND CASH EQUIVALENTS

	December 31, 2022		December 31, 2021
Cash held in banks	$	7,500,607	$	22,729,212
Guaranteed investment certificates		394,174		346,501
	$	7,894,781	$	23,075,713

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

4. CASH AND CASH EQUIVALENTS (CONT’D)

On March 27, 2020, the Company purchased a $142,000 guaranteed investment certificate (“GIC”) to secure its credit cards for 1 year at a rate of 0.50% per annum. On March 27, 2021 the Company renewed the GIC for $142,710 for 1 year at a rate of 0.10% per annum. On March 27, 2022 the Company renewed the GIC for $142,852 for 1 year at a rate of 1.00% per annum. On August 23, 2022 the Company redeemed the renewed GIC for $143,436 and purchased a new GIC for $143,436 for 1 year at a rate of 4.5% per annum.

On May 28, 2021, the Company purchased an additional $140,000 GIC to further secure its credit cards. The terms of the GIC are for 1 year at a rate of 0.35% per annum. On May 30, 2022 the Company renewed the GIC for $140,493 for 1 year at a rate of 0.75% per annum. On August 23, 2022 the Company redeemed the renewed GIC for $140,738 and purchased a new GIC for $140,738 for 1 year at a rate of 4.5% per annum.

On December 21, 2021, the Company purchased an additional $50,000 USD GIC to further secure its credit cards. The terms of the GIC are for 1 year at 0.05% per annum. The $50,000 GIC was renewed for $50,018 USD on October 22^nd, 2022 for five months at 0.05% per annum.

All GIC’s must be maintained and renewed upon maturity until such time as the associated credit cards are cancelled. At any time, the Company can redeem the GIC’s and correspondingly cancel the credit cards at its discretion.

XML

RECEIVABLES

12 Months Ended

Dec. 31, 2022

Schedule Of Amounts Receivable

RECEIVABLES

5. RECEIVABLES

	December 31, 2022		December 31, 2021
Trade accounts receivable	$	1,343,795	$	951,314
Corporate taxes receivable		-		182,820
Taxes receivable		745,170		272,993
	$	2,088,965	$	1,407,127

XML

INVENTORY

12 Months Ended

Dec. 31, 2022

INVENTORY

6. INVENTORY

	December 31, 2022		December 31, 2021
Finished goods	$	542,934	$	3,017,363
Parts		513,008		373,459
	$	1,055,942	$	3,390,822

During the year ended December 31, 2022, $6,048,348 (2021 - $3,420,713) of inventory was recognized in cost of sales including an allowance to value its inventory for obsolete and slow-moving inventory of $1,976,514 (2021 - $nil).

Cost of sales consist of the following:

	December 31, 2022		December 31, 2021
Inventory	$	6,048,348	$	3,420,713
Consulting and services		730,170		679,345
Other		35,866		310,719
	$	6,814,384	$	4,410,777

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

XML

NOTES RECEIVABLE

12 Months Ended

Dec. 31, 2022

Notes Receivable

NOTES RECEIVABLE

7. NOTES RECEIVABLE

	Maturity Date	Rate			Principal		Interest		Accretion		(Impairment)/ Recovery			Repayments			Balance December 31, 2022
Note 1(1)	2023-03-31		0	%	$	190,396	$	-	$	12,764	$	-		$	(33,860	)	$	169,300
Note 2(1)	2024-09-22		5	%		1,003,682		48,992		27,971		(1,080,645	)		-			-
Note 3	2022-04-26		8	%		-		37,177		-		771,260			(808,437	)		-
Total					$	1,194,078	$	86,169	$	40,735	$	(309,385	)	$	(842,297	)	$	169,300

	Maturity Date	Rate			Principal		Interest		Accretion		(Impairment)/ Recovery			Repayments		Balance December 31, 2021
Note 1(1)	2022-10-21		0	%	$	180,597	$	-		9,573		-			-		190,170
Note 2(1)	2024-09-22		5	%		943,385		13,156		7,465		-			-		964,006
Note 3	2022-04-26		8	%		750,000		21,260		-		(771,260	)		-		-
Note 4(1)	2023-06-01		8	%		114,833		5,378		-		(120,211	)		-		-
Total					$	1,988,815	$	39,794	$	17,038	$	(891,471	)	$	-	$	1,154,176

(1) These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.

Note 1 was issued on April 4, 2021, is non-interest bearing and is secured by intellectual property. This note is measured at fair value through profit or loss. The parties agreed on an amended maturity date, whereby $34,860 ($25,000 USD) was paid on October 21, 2022, the original maturity date, and the remaining balance will be paid January 21, 2023. Subsequent to the year ended December 31, 2022, the parties mutually agreed to extend the maturity date to March 31, 2023, with a partial repayment of $33,369 ($25,000 USD) due January 30, 2023.

Note 2 was issued on September 9, 2021, bears interest at 5%, is unsecured, and contains a conversion feature upon sale of the recipient. This note is measured at fair value through profit or loss. Management has determined that it is unlikely that the loan will be repaid or the Company will receive some other type of return. Therefore, the loan has been written down to $Nil.

Note 3 was issued on November 17, 2021 pursuant to letter of intent on an acquisition that the Company is no longer pursuing. The loan is interest bearing at 8% and was due April 26, 2022. At December 31, 2021, management determined that it was unlikely that either the loan would be repaid or the Company would receive some other type of return, therefore, the loan was written down to $nil. During the year ended December 31, 2022, the parties agreed on a repayment plan, with $550,000 paid upon execution of the agreement, and $258,437 the remaining balance including interest paid on November 22, 2022.

Note 4 bears interest at 8% and is secured by a general security agreement. At December 31, 2021, management determined that it is unlikely that either the loan will be repaid or the Company will receive some other type of return. Therefore, the loan was written down to $Nil.

XML

PREPAIDS

12 Months Ended

Dec. 31, 2022

PREPAIDS

8. PREPAIDS

	December 31, 2022		December 31, 2021
Insurance	$	1,148,455	$	2,938,246
Prepaid director fees		-		107,763
Prepaid interest		1,889		6,969
Prepaid marketing services		733,417		1,638,179
Prepaid rent		12,485		-
Prepaid subscriptions		29,194		35,687
Deposits(1)		382,284		768,033
	$	2,307,724	$	5,494,877

(1) A deposit in the amount of $228,572 related to the purchase of Vital inventory was written off as there was uncertainty related to whether the Company would recover the value.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

XML

INVESTMENTS

12 Months Ended

Dec. 31, 2022

INVESTMENTS

9. INVESTMENTS

Balance at December 30, 2020	-
Acquisitions		623,706
Change in fair value		(332,640	)
Balance at December 31, 2021		291,066
Change in fair value		(98,483	)
Balance at December 31, 2022	$	192,583

Fair value of investments is comprised of:

Public company shares	$	57,143
Private company shares		135,440
Balance at December 31, 2022	$	192,583

Public company shares	$	142,857
Public company warrants		21,429
Private company shares		126,780
Balance at December 31, 2021	$	291,066

On March 10, 2021, the Company purchased 1,428,571 units of a publicly listed company for $500,000. Each unit is comprised of one common share and one warrant. The warrants have an exercise price of $0.50 each and convert to one common share, and expire on March 17, 2023. The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following assumptions:

	December 31, 2022			December 31, 2021			March 10, 2020
Risk free interest rate		4.07	%		0.91	%		0.28	%
Expected volatility		116.00	%		124.09	%		150.88	%
Expected life		0.21 years			2 years			2 years
Expected dividend yield		0	%		0	%		0	%

On October 27, 2021, the Company purchased 50,000 common shares of a private company for USD$100,000. The Company considers if observable market data exists on a quarterly basis to value the investment. Since inception, the Company has not had any adjustments to the fair value of the investment based on observable market data.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

XML

EQUIPMENT

12 Months Ended

Dec. 31, 2022

EQUIPMENT

10. EQUIPMENT

	Computer Equipment			Furniture and Equipment			Leasehold Improvements			Software			Vehicles			Total
Cost
Balance at December 31, 2020	$	24,397		$	171,606		$	4,352		$	29,967		$	27,652		$	257,974
Additions		29,713			170,866			-			-			12,000			212,579
Revaluation		-			-			-			-			(3,619	)		(3,619	)
Balance at December 31, 2021	$	54,110		$	342,472		$	4,352		$	29,967		$	36,033		$	466,934
Additions		60,240			528,080			-			-			-			588,320
Disposals		(18,688	)		(36,099	)		(4,352	)		(29,967	)		-			(89,106	)
Balance at December 31, 2022	$	95,662		$	834,453		$	-		$	-		$	36,033		$	966,148
Accumulated depreciation
Balance at December 31, 2020	$	12,392		$	59,963		$	3,220		$	22,496		$	6,033		$	104,104
Charge for the year		12,899			42,314			1,132			2,241			7,201			65,787
Balance at December 31, 2021	$	25,291		$	102,277		$	4,352		$	24,737		$	13,234		$	169,891
Charge for the year		32,627			433,855			-			-			3,435			469,917
Disposals		(15,920	)		(33,342	)		(4,352	)		(24,737	)		-			(78,351	)
Balance at December 31, 2022	$	41,998		$	502,790		$	-		$	-		$	16,669		$	561,457
Net book value:
December 31, 2021	$	28,819		$	240,195		$	-		$	5,230		$	22,799		$	297,043
December 31, 2022	$	53,664		$	331,663		$	-		$	-		$	19,364		$	404,691

XML

INTANGIBLE ASSETS AND GOODWILL

12 Months Ended

Dec. 31, 2022

INTANGIBLE ASSETS AND GOODWILL

11. INTANGIBLE ASSETS AND GOODWILL

	Patents		Customer Relationships		Brand			Software (1)			Goodwill			Total
Cost
Balance at December 31, 2020	$	41,931	$	197,000	$	-		$	119,000		$	2,166,563		$	2,524,494
Additions		-		-		23,000			433,000			8,353,609			8,809,609
Impairment		-		-		-			-			(4,579,763	)		(4,579,763	)
Balance at December 31, 2021	$	41,931	$	197,000	$	23,000		$	552,000		$	5,940,409		$	6,754,340
Additions		-		-		-			4,684			-			4,684
Foreign exchange translation		-		-		1,571			29,576			257,782			288,929
Impairment		-		-		(24,571	)		(462,577	)		(6,198,191	)		(6,685,339	)
Balance at December 31, 2022	$	41,931	$	197,000	$	-		$	123,683		$	-		$	362,614
Accumulated amortization
Balance at December 31, 2020	$	41,931	$	26,267	$	-		$	15,866		$	-		$	84,064
Charge for the year		-		34,147		3,450			98,369			-			135,966
Balance at December 31, 2021		41,931		60,414		3,450			114,235			-			220,030
Charge for the year		-		27,317		4,719			147,446			-			179,482
Foreign exchange translation		-		-		431			13,295			-			13,726
Impairment		-		-		(8,600	)		(221,825	)		-			(230,425	)
Balance at December 31, 2022	$	41,931	$	87,731	$	-		$	53,151		$	-		$	182,813
Net book value:
December 31, 2021	$	-	$	136,586	$	19,550		$	437,765		$	5,940,409		$	6,534,310
December 31, 2022	$	-	$	109,269	$	-		$	70,532		$	-		$	179,801

(1) Software acquired via acquisition of Vital and Dronelogics.

Brand

On March 25, 2021, the Company acquired the assets of Vital (note 3) and assigned $23,000 to the fair value of the brand.

Software

On March 25, 2021, the Company acquired the assets of Vital and assigned $433,000 to the fair value of the software.

Goodwill

On April 30, 2020, the Company acquired a 100% interest in Dronelogics, which included goodwill with a value of $2,166,563.

On March 25, 2021, the Company acquired the assets of Vital, which included goodwill. Goodwill was valued at $8,353,609.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

11. INTANGIBLE ASSETS AND GOODWILL (CONT’D)

On December 31, 2022 the Company performed its annual goodwill impairment test on Vital and Dronelogics. The Company determined the recoverable amount based on a value in use calculation using the following key assumptions:

● 5 year post tax cash flow projections expected to be generated based on a financial forecast with a terminal growth rate of 2% (2021 – 2%).

● Budgeted cash flows calculated using a weighted average revenue EBITDA margin of 6.5% (2021 – 14%) for Dronelogics and 0% (2021 – 42%) for Vital respectively were estimated by management based on the past performance and future growth prospects as well as observed trends among comparable companies.

● Cash flows were discounted at the weighted average cost of capital of 19% (2021 – 17%) for Dronelogics and 29% (2021 – 24%) for Vital based on peer group averages and adjusted for the Company’s risk factors.

Based on the annual goodwill impairment test, the Company determined that the goodwill for Dronelogics and Vital required impairment, as such the Company recorded an impairment charge of $2,166,563 (2021 – nil) for Dronelogics and $4,031,628 (2021 - $4,579,763) for Vital. In addition to the goodwill, the Company deemed that the brand and software for Vital required impairment, as such the Company recorded an impairment charge of $15,971 and $240,752 respectively.

The most sensitive inputs to the value in use model are the growth and discount rates. All else being equal:

● A 10% reduction in the Value in use for the discounted cash flow model would result in a reduction of $104,248 for Dronelogics (2021 – $597,100) and $Nil for Vital (2021 - $570,133).

Changing the above assumption would have no impact on the carrying amount for Dronelogics and Vital.

XML

RIGHT OF USE ASSETS

12 Months Ended

Dec. 31, 2022

RIGHT OF USE ASSETS

12. RIGHT OF USE ASSETS

	Total
Cost
Balance at December 31, 2020	$	242,967
Additions		447,242
Lease adjustment		(7,092	)
Balance at December 31, 2021 and 2022	$	683,117
Accumulated depreciation
Balance at December 31, 2020	$	98,548
Charge for the year		109,311
Historical correction		7,152
Balance at December 31, 2021	$	215,011
Charge for the year		123,360
Balance at December 31, 2022	$	338,371
Net book value:
December 31, 2021	$	468,106
December 31, 2022	$	344,746

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

XML

LEASE LIABILITES

12 Months Ended

Dec. 31, 2022

LEASE LIABILITES

13. LEASE LIABILITES

The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 7.5% to 10.5%

	Total
Balance at December 31, 2020	$	158,124
Additions		440,675
Interest expense		26,964
Lease payments		(128,995	)
Lease removal		(7,645	)
Balance at December 31, 2021	$	489,123
Interest expense		39,795
Lease payments		(150,275	)
Balance at December 31, 2022	$	378,643

Which consists of:
	December 31, 2022		December 31, 2021
Current lease liability	$	133,962	$	110,481
Non-current lease liability		244,681		378,642
Ending balance	$	378,643	$	489,123

Maturity analysis	Total
Less than one year	$	147,340
One to three years		209,078
Four to five years		83,850
Total undiscounted lease liabilities		440,268
Amount representing interest		(61,625	)
	$	378,643

XML

TRADE PAYABLES AND ACCRUED LIABILITIES

12 Months Ended

Dec. 31, 2022

TRADE PAYABLES AND ACCRUED LIABILITIES

14. TRADE PAYABLES AND ACCRUED LIABILITIES

	December 31, 2022		December 31, 2021
Trade accounts payable	$	751,422	$	362,890
Accrued liabilities		2,031,545		402,540
Government grant payable		33,709		33,709
	$	2,816,676	$	799,139

XML

DEFERRED INCOME

12 Months Ended

Dec. 31, 2022

DEFERRED INCOME

15. DEFERRED INCOME

At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.

	December 31, 2022		December 31, 2021
Deferred income from customers	$	58,457	$	68,053
Deferred income from government		5,233		5,233
	$	63,690	$	73,286

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

XML

LOANS PAYABLE

12 Months Ended

Dec. 31, 2022

LOANS PAYABLE

16. LOANS PAYABLE

	December 31, 2022			December 31, 2021
Opening balance	$	93,317		$	97,916
Issuance of loans payable		-			60,000
Fair value adjustment		(4,891	)		(24,576	)
Repayment of loans payable		(6,746	)		(44,428	)
Accretion expense		4,891			4,405
Ending balance	$	86,571		$	93,317

	Start Date	Maturity Date	Rate			Carrying Value December 31, 2022		Carrying Value December 31, 2021
CEBA	2020-05-19	2023-12-31		0	%	$	37,383	$	37,384
CEBA	2021-04-23	2023-12-31		0	%		37,383		37,383
Vehicle loan	2019-08-30	2024-09-11		6.99	%		11,805		18,550
Total						$	86,571	$	93,317

On May 19, 2020, Dronelogics received a $40,000 CEBA loan. This loan is currently interest-free and 25% of the loan, up to $10,000, is forgivable if the loan is repaid on or before December 31, 2023. If the loan is not repaid by that date, the loan can be converted to a three-year term loan at an interest rate of 5%. On December 4, 2020, the Government of Canada allowed for an expansion of the CEBA loan by $20,000, of which, an additional $10,000 is forgivable if the entire loan is repaid on or before December 31, 2023.

On April 23, 2021, Draganfly Innovations Inc. received a $60,000 CEBA loan. This loan is currently interest free and up to $20,000 is forgivable if the loan is repaid on or before December 31, 2023. If the loan is not repaid by that date, the loan can be converted to a three-year term loan at an interest rate of 5%.

The CEBA loans are unsecured, and the vehicle loan is secured by the vehicle.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

XML

SHARE CAPITAL

12 Months Ended

Dec. 31, 2022

SHARE CAPITAL

17. SHARE CAPITAL

Authorized share capital

Unlimited number of common shares without par value.

Issued share capital

During the year ended December 31, 2022,

● The Company issued 16,538 common shares for the exercise of warrants for $87,170.

● The Company issued 12,500 common shares for the exercise of stock options for $26,875.

● The Company issued 1,072,595 common shares for the vesting of restricted share units.

During the year ended December 31, 2021,

● The Company issued 1,939,534 common shares for the exercise of warrants for $4,929,790.

● The Company issued 448,660 common shares for the vesting of Restricted Share Units.

● The Company issued 405,499 common shares for the exercise of stock options for $1,014,123.

● The Company issued 371,901 common shares in lieu of cash for services rendered.

● The Company issued 6,488,669 units for the Regulation A+ financing in the United States for proceeds of $18,815,485. Each unit is comprised of one common share and one share purchase warrant. These warrants had a fair value of $0.57 USD allocated to them, have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years. The fair value of $8,261,511 was allocated to warrant derivative liability.

● The Company issued 1,200,000 units for the acquisition of Vital Intelligence. Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.

● The Company issued 5,095,966 common shares in a private placement for $25,538,213.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

17. SHARE CAPITAL (CONT’D)

Stock Options

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.

As at December 31, 2022, the Company had the following options outstanding and exercisable:

Grant Date	Expiry Date	Exercise Price		Remaining Contractual Life (years)		Number of Options Outstanding		Number of Options Exercisable
October 30, 2019	October 30, 2029	$	2.50		6.84		286,665		286,665
November 19, 2019	November 19, 2029	$	2.50		6.89		50,000		50,000
April 30, 2020	April 30, 2030	$	2.50		7.33		85,000		85,000
April 30, 2020	April 30, 2030	$	3.85		7.33		110,000		110,000
July 3, 2020	July 3, 2025	$	3.20		2.51		100,000		100,000
November 24, 2020	November 24, 2030	$	2.50		7.90		32,000		32,000
February 2, 2021	February 2, 2031	$	13.20		8.10		30,000		20,000
March 8, 2021	March 8, 2026	$	13.90		3.19		10,000		10,000
April 27, 2021	April 27, 2031	$	10.15		8.33		147,666		50,326
September 9, 2021	September 9, 2026	$	4.84		3.69		25,826		8,608
							877,157		752,599

	Number of Options			Weighted Average Exercise Price
Outstanding, December 31, 2020		1,193,659		$	2.75
Exercised		(405,494	)		2.50
Granted		247,826			10.12
Outstanding, December 31, 2021		1,035,991		$	4.60
Exercised		(12,500	)		2.15
Forfeited		(146,334	)		4.77
Outstanding, December 31, 2022		877,157		$	4.60

No options were granted by the Company for the year ended December 31, 2022

During the year ended December 31, 2021,

● The Company granted 30,000 options to an employee. Each option is exercisable at $13.20 per share for 10 years.

● The Company granted 10,000 options to a consultant. Each option is exercisable at $13.90 per share for 5 years.

● The Company granted 182,000 options to employees and a consultant. Each option is exercisable at $10.15 per share for 10 years.

● The Company granted 25,826 options to an employee. Each option is exercisable at $4.84 per share for 5 years.

During the year ended December 31, 2022, the Company recorded $502,837 (2021- $1,660,894) in stock-based compensation in relation to the vesting of stock options. The fair values of stock options granted were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

17. SHARE CAPITAL (CONT’D)

Year ended December 31,	2022		2021
Risk free interest rate		-		0.69%-1.40	%
Expected volatility		-		111.87%-113.16	%
Expected life		-		5 years
Expected dividend yield		-		0	%
Exercise price	$	-	$	13.20-13.90

Volatility is calculated using the historical volatility method based on a comparative company’s stock price.

Restricted Share Units

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time.

The aggregate sales price (meaning the sum of all cash, property, notes, cancellation of debt, or other consideration received or to be received by the Company for the sale of the securities) or amount of common shares issued during any consecutive 12-month period will not exceed the greatest of the following: (i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date. At the election of the Board of Directors, upon each vesting date, participants receive (a) the issuance of common shares from treasury equal to the number of RSUs vesting, or (b) a cash payment equal to the number of vested RSUs multiplied by the fair market value of a common share, calculated as the closing price of the common shares on the CSE for the trading day immediately preceding such payment date; or (c) a combination of (a) and (b).

On the grant date of RSUs, the Company determines whether it has a present obligation to settle in cash. If the Company has a present obligation to settle in cash, the RSUs are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and at the date of settlement, with any changes in fair value recognized in profit or loss for the period. The Company has a present obligation to settle in cash if the choice of settlement in shares has no commercial substance, or the Company has a past practice or a stated policy of setting in cash, or generally settles in cash whenever the counterparty asks for cash settlement. If no such obligation exists, RSUs are accounted for as equity settled share-based payments and are valued using the share price on grant date. Upon settlement:

a) If the Company elects to settle in cash, the cash payment is accounted for as the repurchase of an equity interest (i.e. as a deduction from equity), except as noted in (c) below.

b) If the Company elects to settle by issuing shares, the value of RSUs initially recognized in reserves is reclassified to share capital, except as noted in (c) below.

c) If the Company elects the settlement alternative with the higher fair value, as at the date of settlement, the Company recognizes an additional expense for the excess value given (i.e. the difference between the cash paid and the fair value of shares that would otherwise have been issued, or the difference between the fair value of the shares and the amount of cash that would otherwise have been paid, whichever is applicable).

As at December 31, 2022, the Company had the following RSUs outstanding:

	Number of RSUs
Outstanding, December 31, 2020		614,666
Vested		(448,660	)
Issued		348,826
Outstanding, December 31, 2021		514,832
Vested		(1,072,595	)
Issued		1,820,972
Forfeited		(64,334	)
Outstanding, December 31, 2022		1,198,875

During the year ended December 31, 2022, 1,072,595 RSU’s fully vested according to the terms and the Company granted 1,820,972 RSUs to employees and consultants of the Company with each RSU exercisable into one common share of the Company upon the vesting conditions being met for a period of eighteen months from the grant date. In addition, 64,334 RSU’s were forfeited by employees who have left the Company.

During the year ended December 31, 2021, 323,661 RSUs fully vested according to the terms and the Company accelerated the vesting of 124,999 RSUs. The Company issued 348,826 RSUs to employees of the Company with each RSU exercisable into one common share of the Company or the cash equivalent thereof upon the vesting conditions being met for a period of three years from the grant date.

During the year ended December 31, 2022, the Company recorded share-based payment expense of $2,808,187 (2021: $2,291,701) for RSUs, based on the fair values of RSUs granted which were calculated using the closing price of the Company’s stock on the day prior to grant.

Warrants

During the years ended December 31, 2021 and 2020, the Company issued warrants (“USD Warrants”) with a USD exercise price. Being in a foreign currency that is not the Company’s functional currency and these warrants were not issued in exchange for services, these USD Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, these USD Warrants are revalued on a quarterly basis to fair market value with the change in fair value being recorded profit or loss. The initial fair value of these USD Warrants was parsed out from equity and recorded as a financial liability.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

17. SHARE CAPITAL (CONT’D)

To reach a fair value of the USD Warrants, a Black Scholes calculation is used, calculated in USD as the Company also trades on the Nasdaq. The Black Scholes value per USD Warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period from the Bank of Canada.

Warrant Derivative Liability

Balance at December 31, 2020	$	748,634
Warrant issuance		8,261,511
Exercised		(98,048	)
Change in fair value of warrants outstanding		(4,046,325	)
Balance at December 31, 2021	$	4,865,772
Change in fair value of warrants outstanding		(4,865,772	)
Balance at December 31, 2022	$	-

Derivative liability balance at	December 31, 2022		December 31, 2021
Warrants	$	-	$	4,865,772
Contingent consideration (note 3)		57,314		694,230
Ending balance	$	57,314	$	5,560,002

Details of these warrants and their fair values are as follows:

Issue Date	Exercise Price	Number of Warrants Outstanding at December 31, 2022		Fair Value at December 31, 2022		Number of Warrants Outstanding at December 31, 2021		Fair Value at December 31, 2021
November 30, 2020	US$ 3.55		-	$	-		482,425	$	182,262
February 5, 2021(1)	US$ 3.55		1,319,675		-		1,323,275		951,226
March 5, 2021(2)	US$ 3.55		5,142,324		-		5,154,321		3,732,284
July 29, 2021 (3)	US$5.00		250,000		-		250,000		-
September 14, 2021 (4)	US$5.00		4,798		-		4,798		-
			6,716,797	$	-		7,214,819	$	4,865,772

1)	Subsequent to December 31, 2022, the warrants expired on February 5, 2023.
2)	Subsequent to December 31, 2022, the warrants expired on March 5, 2023.
3)	The warrants expire July 29, 2024.
4)	The warrants expire September 14, 2024.

The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

	December 31, 2022			December 31, 2021
Risk free interest rate		4.07	%		0.23%-0.95	%
Expected volatility		91.66%-93.48	%		70.95%-144.59	%
Expected life		0.10-0.18 years			2-3 years
Expected dividend yield		0	%		0	%

Volatility is calculated using the historical volatility method.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

17. SHARE CAPITAL (CONT’D)

	Number of Warrants			Weighted Average Exercise Price
Outstanding, December 31, 2020		2,416,864		$	2.95
Exercised		(1,939,534	)		2.54
Forfeited		(6,000	)		2.50
Issued		7,943,489			5.10
Outstanding, December 31, 2021		8,414,819		$	4.99
Exercised		(16,538	)		4.51
Expired		(481,484	)		4.61
Outstanding December 31, 2022		7,916,797		$	5.08

As at December 31, 2022, the Company had the following warrants outstanding:

Date issued	Expiry date	Exercise price	Number of warrants outstanding
February 5, 2021	February 5, 2023	US$ 3.55		1,319,675
March 5, 2021	March 5, 2023	US$ 3.55		5,142,324
March 22, 2021	March 22, 2023	CDN$ 13.35		1,200,000
July 29, 2021	July 29, 2024	US$ 5.00		250,000
September 14, 2021	September 14, 2024	US$ 5.00		4,798
				7,916,797

The weighted average remaining contractual life of warrants outstanding as of December 31, 2022, was 0.47 years (December 31, 2021 – 1.20 years).

The 1,200,000 warrants issued on March 22, 2021 to acquire Vital, 900,000 of the warrants are currently held in escrow, to be released upon completion of the milestones (note 3).

XML

SEGMENTED INFORMATION

12 Months Ended

Dec. 31, 2022

SEGMENTED INFORMATION

18. SEGMENTED INFORMATION

The Company organizes its three segments based on product lines as well as a Corporate segment. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. The Company aggregates the information for the segments by analyzing the revenue steam and allocating direct costs to that respective segment. The Corporate segment is aggregated by relying on the entity that includes corporate costs (Draganfly Inc.)

December 31, 2022	Drones			Vital		Corporate			Total
Sales of goods		5,388,262			162,170		-			5,550,432
Provision of services		2,054,627			-		-			2,054,627
Total revenue	$	7,442,889		$	162,170	$	-		$	7,605,059
Segment loss	$	9,929,789		$	602,580	$	12,926,884		$	23,459,253
Finance and other costs		(3,529	)		-		(40,816	)		(44,345	)
Depreciation		586,185			-		7,092			593,277
Amortization		179,482			-		-			179,482
Impairment of goodwill and intangibles		2,166,563			4,288,351		-			6,454,914
Change in fair value of derivative liability		-			-		(5,502,688	)		(5,502,688	)
Loss (recovery) on write-off of notes receivable		1,080,645			-		(771,260	)		309,385
Loss on write down of inventory		251,754			1,724,760		-			1,976,514
Write down of deposit		-			228,572		-			228,572
Net loss for the year	$	14,190,889		$	6,844,263	$	6,619,212		$	27,654,364

December 31, 2021	Drones		Vital		Corporate			Total
Sales of goods		4,957,134		146,265		-			5,103,399
Provision of services		1,950,466		-		-			1,950,466
Total revenue	$	6,907,600	$	146,265	$	-		$	7,053,865
Segment loss	$	7,819,739	$	257,656	$	10,498,164		$	18,575,560
Finance and other costs		16,272		-		(21,346	)		(5,074	)
Depreciation		175,098		-		-			175,098
Amortization		135,966		-		-			135,966
Impairment of goodwill and intangibles		-		4,579,763		-			4,579,763
Change in fair value of derivative liability		-		-		(8,149,812	)		(8,149,812	)
Loss on write-off of notes receivable		-		-		891,471			891,471
Net loss for the year	$	8,147,075	$	4,837,419	$	3,218,477		$	16,202,972

Geographic revenue segmentation  is as follows:	For the years ended December 31,
	2022		2021
Canada	$	6,919,038	$	4,982,373
United States		686,021		2,071,492
	$	7,605,059	$	7,053,865

Geographic revenue is measured by aggregating sales based on the country and the entity where the sale was made.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

XML

OFFICE AND MISCELLANEOUS

12 Months Ended

Dec. 31, 2022

OFFICE AND MISCELLANEOUS

19. OFFICE AND MISCELLANEOUS

	For the years ended December 31,
	2022		2021
Advertising, Marketing, and Investor Relations	$	4,431,818	$	5,165,791
Compliance fees		152,826		432,874
Contract Work		441,798		300,975
Other		371,519		556,358
	$	5,397,961	$	6,455,998

XML

RELATED PARTY TRANSACTIONS

12 Months Ended

Dec. 31, 2022

RELATED PARTY TRANSACTIONS

20. RELATED PARTY TRANSACTIONS

On August 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management. The services are provided by a team of consultants and the costs of all charges are based on the fees set in the Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2022, the company incurred fees of $442,485 (December 31, 2021 - $315,643). As at December 31, 2022, the Company was indebted to this company in the amount of $30,804 (December 31, 2021 - $nil).

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the Consultant Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2022, the Company incurred fees of $566,487 (December 31, 2021 - $290,225). As at December 31, 2022, the Company was indebted to this company in the amount of $nil (December 31, 2021 - $nil).

On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. The costs of all charges are based on the fees set in the Executive Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. On May 9, 2022, Scott Larson ceased to be President of the Company and entered into an agreement to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the consulting agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2022, the Company incurred fees of $383,288 (December 31, 2021 - $205,191). As at December 31, 2022, the Company was indebted to this company in the amount of $20,745 (December 31, 2021 - $nil).

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

20. RELATED PARTY TRANSACTIONS (CONT’D)

Trade receivables/payables and accrued receivables/payables:

As at December 31, 2022, the Company had $nil (December 31, 2021 - $155,108) receivable from related parties outstanding that were included in accounts receivable and $51,549 (December 31, 2021 - $nil) payable from related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

Key management compensation

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the year ended December 31, 2022 and 2021 included:

For the years ended December 31,		2022		2021
Director fees	$	522,349	$	370,094
Salaries		843,917		722,068
Share-based payments		2,106,906		2,475,949
	$	3,473,172	$	3,568,111

Other related party transactions

For the years ended December 31,	2022		2021
Management fees paid to a company controlled by CEO and director		566,487		290,225
Management fees paid to a company that the CEO holds an economic interest in		442,485		315,643
Management fees paid to a company controlled by the former President and director		383,288		205,691
	$	1,392,260	$	811,559

XML

FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

12 Months Ended

Dec. 31, 2022

Financial Instruments And Financial Risk Management

FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

Credit risk

Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. The Company’s primary exposure to credit risk is on its cash held in bank accounts and trade receivables. Trade receivables include balances of $920,062 that are past due with no corresponding allowance recorded. The majority of cash is deposited in bank accounts held with major bank in Canada and the United States. As most of the Company’s cash is held by one bank there is a concentration of credit risk. This risk is managed by using major banks that are high credit quality financial institutions as determined by rating agencies. The Company does have past due outstanding receivables however the expected loss rate for undue balance is estimated to be nominal.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company’s normal operating requirements on an ongoing basis. The Company ensures that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations and its holdings of cash and cash equivalents. Historically, the Company’s sole source of funding has been the issuance of equity securities for cash, primarily through private placements. The Company’s access to financing is always uncertain. There can be no assurance of continued access to significant equity funding.

The following is an analysis of the contractual maturities of the Company’s financial liabilities at December 31, 2022:

	1 year		1 – 5 years		More than 5 years
Trade payables and accrued liabilities	$	2,816,676	$	-	$	-
Customer deposits		194,758		-		-
Deferred income		63,690		-		-
Loans payable		81,512		5,059		-
Derivative liability		57,314		-		-
Lease liability		133,962		244,681		-
	$	3,347,912	$	249,740	$	-

Foreign exchange risk

Foreign currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company does not hedge its exposure to fluctuations in foreign exchange rates.

The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net loss upon consolidation as follows:

	December 31, 2022		December 31, 2021
Foreign exchange rate	$	969,977	$	150,715

Interest rate risk

Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its cash equivalents as these instruments have original maturities of three months or less and are therefore exposed to interest rate fluctuations on renewal.

Fair value

A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

Equity securities in investee companies and warrants are measured at fair value. The financial assets and liabilities measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the statements of financial position. These financial assets are measured at fair value through profit and loss.

December 31, 2022	Level 1		Level 2		Level 3		Total
Equity securities in investee companies	$	57,143	$	135,440	$	-	$	192,583
Notes receivable		-		-		169,300		169,300
Derivative liability		-		-		57,314		57,314
Total	$	57,143	$	135,440	$	226,614	$	419,197

December 31, 2021	Level 1		Level 2		Level 3		Total
Equity securities in investee companies	$	164,286	$	126,780	$	-	$	291,066
Notes receivable		-		1,154,176		-		1,154,176
Derivative liability		-		-		5,560,002		5,560,002
Total	$	164,286	$	1,280,956	$	5,560,002	$	7,005,244

Capital Management

The Company manages its capital to maintain its ability to continue as a going concern and to provide returns to shareholders and benefits to other stakeholders. The capital structure of the Company consists of shareholders’ equity

The Company manages its capital structure and makes adjustments to it in light of economic conditions. The Company, upon approval from its board of directors, will balance its overall capital structure through new equity issuances or by undertaking other activities as deemed appropriate under the specific circumstances. The Company is not subject to externally imposed capital requirements and the Company’s overall strategy with respect to capital risk management remains unchanged from the year ended December 31, 2021.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

XML

INCOME TAXES

12 Months Ended

Dec. 31, 2022

INCOME TAXES

22. INCOME TAXES

The following table reconciles the expected income taxes at the Canadian statutory income tax rates to the amounts recognized in the statements of comprehensive loss for the years ended December 31, 2022, 2021:

	December 31, 2022			December 31, 2021
Loss before income taxes	$	27,654,364		$	16,202,972
Canadian statutory rates		27%			27%
Expected income tax recovery		7,338,900			4,196,600
Impact of different foreign statutory tax rates		-			34,900
Non-deductible items		(1,214,400	)		116,400
Share issue costs		1,400			887,600
Adjustments to prior years provision versus statutory tax returns		(742,400	)		376,500
Differences between prior year provision and final tax return		867,500			(206,000	)
Change in deferred tax asset not recognized		(6,251,000	)		(5,406,000	)
Income tax	$	-		$	-

The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:

	December 31, 2022			December 31, 2021
Deferred income tax assets (liabilities):
Share issuance costs	$	568,000		$	728,000
Non-capital losses		14,602,000			7,043,000
Property and equipment		953,000			449,000
Capital gain reserve		-			74,000
Scientific Research and Experimental Development		367,000			291,000
Total deferred income tax assets	$	16,490,000		$	8,585,000
Deferred income tax not recognized		(16,490,000	)		(8,585,000	)
Net deferred tax assets	$	-		$	-

The Company has non-capital loss carry forward of approximately $48,808,245 which may be carried forward to apply against future year income tax for Canadian income tax purposes, subject to the final determination by taxation authorities, expiring in the years 2036 to 2041.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

XML

SUPPLEMENTAL CASH FLOW DISCLOSURES

12 Months Ended

Dec. 31, 2022

Supplemental Cash Flow Disclosures

SUPPLEMENTAL CASH FLOW DISCLOSURES

23. SUPPLEMENTAL CASH FLOW DISCLOSURES

During the year ended December 31, 2022:

- During the year ended December 31, 2022, $508,607 of inventory that was used for rental services was transferred to equipment.

During the year ended December 31, 2021:

- The Company issued 371,901 common shares in lieu of cash for services rendered.

- The Company issued 1,200,000 units for the acquisition of Vital Intelligence. Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.

XML

SUBSEQUENT EVENTS

12 Months Ended

Dec. 31, 2022

SUBSEQUENT EVENTS

24. SUBSEQUENT EVENTS

Subsequent to December 31, 2022, the Company entered into an equity distribution agreement. The agreement will allow the Company from time to time, to distribute in an at-the-market offering (“ATM”) up to $15,000,000 (USD) in common shares. Draganfly intends to use the net proceeds from the ATM for general corporate ‎purposes, including to fund ongoing operations, growth initiatives and/or ‎for working capital requirements ‎including the continuing development and marketing of the Company’s ‎core products, potential acquisitions and ‎research and development‎.

From February 1, 2023 to February 17, 2023, the Company distributed 650,729 ATM shares under the ATM offering at an average price of 2.62 per share for net proceeds of $1,705,013.

XML

BASIS OF PREPARATION (Policies)

12 Months Ended

Dec. 31, 2022

Statement of Compliance

Statement of Compliance

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations issued by the International Reporting Interpretation Committee (“IFRIC”). The principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all years presented, unless otherwise stated.

These consolidated financial statements were authorized for issue by the Board of Directors on March 27, 2023.

Basis of consolidation

Basis of consolidation

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases.

The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

Name of Subsidiary	Place of Incorporation	Ownership Interest
Draganfly Innovations Inc.	Canada	100%
Draganfly Innovations USA, Inc.	US	100%
Dronelogics Systems Inc.	Canada	100%

All intercompany balances and transactions were eliminated on consolidation.

Significant estimates and assumptions

Significant estimates and assumptions

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make estimates and assumptions about reported amounts at the date of the consolidated financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Impairment of Non-financial assets

The CGU’s recoverable amount is evaluated using the higher of the value in use and fair value less costs to sell. In determining the recoverable amount, the Company utilizes discounted cash flow techniques. Management calculates the discounted cash flows based upon its best estimate of a number of economic, operating, engineering, environmental, political and social assumptions. Any changes in the assumptions due to changing circumstances may affect the recoverable amount estimate.

Share-based payments

The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield of the stock option.

Income taxes

Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the company is likely to recognize their recovery from the generation of taxable income.

Inventory

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price less costs to sell. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market- driven changes that may reduce future selling prices.

Contingencies

The assessment of contingencies involves the exercise of significant judgment and estimates of the outcome of future events. In assessing loss contingencies related to legal proceedings that are pending against the Company and that may result in regulatory or government actions that may negatively impact the Company’s business or operations, the Company and its legal counsel evaluate the perceived merits of the legal proceeding or unasserted claim or action as well as the perceived merits of the nature and amount of relief sought or expected to be sought, when determining the amount, if any, to recognize as a contingent liability or when assessing the impact on the carrying value of the Company’s assets. Contingent assets are not recognized in the consolidated financial statements.

Investments in Private companies

Where the fair value of investments in private companies recorded on the statement of financial position cannot be derived from active markets, they are determined using a variety of valuation techniques. The inputs to these models are derived from observable market data where possible, but where observable market data is not available, judgment is required to establish fair value and this value may not be indicative of recoverable value.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Expected credit losses on trade receivables and notes receivable

When determining expected credit losses (“ECLs”), the Company considers the historic credit losses observed by the Company, customer-specific payment history and economic conditions. When determining whether the credit risk of a financial asset has increased significantly since initial recognition and when estimating ECL’s, the Company considers reasonable and supportable information that is relevant and available without undue cost or effort. This includes both quantitative and qualitative information and analysis, based on the Company’s historical experience, informed credit assessment ad forward-looking information

Useful lives of equipment and intangible assets

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

Significant judgments

Significant judgments

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments in applying the Company’s consolidated financial statements include:

Business combinations

The definition of whether a set of assets acquired and liabilities assumed constitute a business may require the Company to make certain judgements taking into account all facts and circumstances. A business is presumed to be an integrated set of activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs, or economic benefits.

Business combination versus asset acquisition

The Company considered the applicability of IFRS 3 – Business Combinations (“IFRS 3”) with respect to acquisitions (Note 3). IFRS 3 defines a business as having a system where inputs enter a process to produce outputs. The Company has determined that the acquisition of Dronelogics Systems Inc. and certain assets of Vital Intelligence Inc. are business combinations and, accordingly, have accounted for as such.

Other significant judgments

−	The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;
−	the classification of financial instruments;
−	the assessment of revenue recognition using the five-step approach under IFRS 15; and
−	the determination of the functional currency of the company.

Foreign currency translation

Foreign currency translation

Transactions in foreign currencies are translated into the functional currency at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Gains and losses resulting from foreign exchange adjustments are included in profit or loss.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

The functional currencies of the parent company and each subsidiary are as follows:

Draganfly Inc.	Canadian Dollar
Draganfly Innovations Inc.	Canadian Dollar
Draganfly Innovations USA, Inc.	US Dollar
Dronelogics Systems Inc.	Canadian Dollar

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all revenue and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translation of foreign operations in other comprehensive loss.

Share-based payments

Share-based payments

The Company operates a stock option plan. Share-based payments to employees are measured at the grant date fair value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of the goods or services received or the fair value of the equity instruments issued, if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The corresponding amount is recorded to the share-based payment reserve. The fair value of options is determined using a Black–Scholes Option Pricing Model. The number of options expected to vest is reviewed and adjusted at the end of each reporting period such that the amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments that eventually vest. Amounts recorded for forfeited or expired unexercised options are transferred to deficit in the year of forfeiture or expiry. Amounts recorded for forfeited unvested options are reversed in the period the forfeiture occurs.

Restricted Share Units

Restricted Share Units

The restricted share units (“RSUs”) entitle employees, directors, or officers to either the issuance of common shares or cash payments payable upon vesting based on vesting terms determined by the Company’s Board of Directors at the time of the grant. On the grant date of RSUs, the Company determines whether it has a present obligation to settle in cash. If the Company has a present obligation to settle in cash, the RSUs are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and at the date of settlement, with any changes in fair value recognized in profit or loss for the period. RSUs settled in common share are measured at the fair value of awards on the grant date using the prior days closing price. Amounts recorded for forfeited unvested RSUs are reversed in the period the forfeiture occurs. The expense is recognized on a graded vesting basis over the vesting period, with a corresponding charge to profit or loss.

Loss per share

Loss per share

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. For all periods presented, the loss attributable to common shareholders equals the reported loss attributable to owners of the Company. Diluted income per share is calculated by the treasury stock method. Under the treasury stock method, the weighted average number of common shares outstanding for the calculation of diluted loss per share assumes that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at the average market price during the period. For the periods presented, the Company incurred a loss and therefore basic loss per share equals diluted loss per share.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Financial Instruments

Financial Instruments

Financial instruments are accounted for in accordance with IFRS 9 Financial Instruments: Classification and Measurement. A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

Financial assets/liabilities	Classification
Cash	Amortized cost
Accounts receivable	Amortized cost
Notes receivable	Amortized cost
Investments	Fair value through other comprehensive income
Accounts payable	Amortized cost
Customer deposits	Amortized cost
Loans payable	Amortized cost
Derivative liability	Fair value through profit or loss

a) Financial assets

Classification and measurement

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the cash flows are not solely principal and interest, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.

Financial assets at FVTPL

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are recorded to profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of financial assets held at FVTPL are included in the profit or loss in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

Financial assets at FVTOCI

Financial assets carried at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income. There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Financial assets at amortized cost

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

Impairment of financial assets at amortized cost

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

Derecognition of financial assets

Financial assets are derecognized when the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recorded to profit or loss. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive loss.

b) Financial liabilities

The Company classifies its financial liabilities into one of two categories as follows:

FVTPL - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans are included in this category.

Derecognition of financial liabilities

Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are recognized in profit or loss.

Impairment of non-financial assets

Impairment of non-financial assets

The carrying amounts of the non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:

● an intangible asset with an indefinite useful life;

● an intangible asset not yet available for use; and

● goodwill recognized in a business combination.

The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest identifiable group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.

An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the units, and then to reduce the carrying amounts of the other assets in the unit (group of units) on a pro rata basis.

In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

Income taxes

Income taxes

Current income tax:

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

Current income taxes relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

Deferred income tax:

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

Inventory

Inventory

Inventory consists of raw materials and finished goods for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Cost is determined using the weighted average cost basis. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Revenue recognition

Revenue recognition

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

Sales of goods

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred, being when the products are delivered to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. Delivery occurs when the products have been shipped to the specific location or picked up by the customer.

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

Some contracts include multiple performance obligations, such as the manufacturing of hardware and support. Support is performed by another party and does not include an integration service. It is therefore accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on stand-alone selling price. Where is the stand-alone selling price is not directly observable, the price is estimated based on expect cost plus margin.

Services

The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized over time as the services are rendered.

Rental equipment

The Company provides rental of equipment which is measured based on rates through contracts or other written agreements with customers. Revenue is recognized in the period when services are performed and only when there is reasonable assurance that the revenue will be collected.

Deferred Revenue

Deferred Revenue

A payment received is included as deferred revenue when products has yet be shipped to customers as of the period end. The amount to be recognized within twelve months following the year-end date is classified as current

Cost of Goods Sold

Cost of Goods Sold

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, or lower of cost and net realizable value adjustments as required.

Intangible Assets and Goodwill

Intangible Assets and Goodwill

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications, brands and software.

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Intangible assets with finite useful lives are amortized on a straight line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.

Class of intangible asset	Useful live
Customer relationship	5 years
Brand	5 years
Software	5 years

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.

Equipment

Equipment

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statement of comprehensive loss during the financial period in which they are incurred.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the statement of comprehensive loss.

Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

Class of equipment	Depreciation rate
Computer equipment	30%
Furniture and equipment	20%
Leasehold improvements	Expected lease term
Vehicles	30%

Research and development expenditures

Research and development expenditures

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following:

(i)	the technical feasibility of completing the intangible asset so that it will be available for use or sale;
(ii)	its intention to complete the intangible asset and use or sell it;
(iii)	its ability to use or sell the intangible asset;
(iv)	how the intangible asset will generate probable future economic benefits. The Company can also demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset;
(v)	the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
(vi)	its ability to measure reliably the expenditure attributable to the intangible asset during its development.

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

Government Assistance

Government Assistance

Government grants are recognized when there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

SR&ED Investment tax credits

SR&ED Investment tax credits

The Company claims federal investment tax credits as a result of incurring scientific research and experimental development (“SR&ED”) expenditures. Federal investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Federal investment tax credits are accounted for as a reduction of research and development expense for items of a period expense nature or as a reduction of property and equipment for items of a capital nature. Management has made a number of estimates and assumptions in determining the expenditures eligible for the federal investment tax credit claim. It is possible that the allowed amount of the federal investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency.

The Company claims provincial investment tax credits as a result of incurring SR&ED expenditures. Provincial investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Management has made a number of estimates and assumptions in determining the expenditures eligible for the provincial investment tax credit claim. The provincial investment tax credits are refundable and have been recorded as a SR&ED tax credit receivable, and as a reduction in research and development expenses on the statement of comprehensive loss. It is possible that the allowed amount of the provincial investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency and the Alberta Tax and Revenue Administration.

Leases

Leases

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset is recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

The lease term is the non-cancellable period of a lease plus periods covered by an optional lease extension option if it is reasonably certain that the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

A lease modification is accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

New accounting standards issued not yet effective

New accounting standards issued not yet effective

Accounting standards or amendments to existing accounting standards that have been issued but have future effective dates are either not applicable or are not expected to have a significant impact on the Company’s consolidated financial statements.

XML

BASIS OF PREPARATION (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF RESULTS OF OPERATIONS

The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

Name of Subsidiary	Place of Incorporation	Ownership Interest
Draganfly Innovations Inc.	Canada	100%
Draganfly Innovations USA, Inc.	US	100%
Dronelogics Systems Inc.	Canada	100%

SCHEDULE OF FUNCTIONAL CURRENCIES

The functional currencies of the parent company and each subsidiary are as follows:

Draganfly Inc.	Canadian Dollar
Draganfly Innovations Inc.	Canadian Dollar
Draganfly Innovations USA, Inc.	US Dollar
Dronelogics Systems Inc.	Canadian Dollar

SCHEDULE OF FINANCIAL INSTRUMENTS

Financial assets/liabilities	Classification
Cash	Amortized cost
Accounts receivable	Amortized cost
Notes receivable	Amortized cost
Investments	Fair value through other comprehensive income
Accounts payable	Amortized cost
Customer deposits	Amortized cost
Loans payable	Amortized cost
Derivative liability	Fair value through profit or loss

SCHEDULE OF INTANGIBLE ASSETS USEFUL LIVES

Class of intangible asset	Useful live
Customer relationship	5 years
Brand	5 years
Software	5 years

SCHEDULE OF DEPRECIATION RATES

Class of equipment	Depreciation rate
Computer equipment	30%
Furniture and equipment	20%
Leasehold improvements	Expected lease term
Vehicles	30%

XML

VITAL INTELLIGENCE ACQUISITION (Tables)

12 Months Ended

Dec. 31, 2022

Vital Intelligence Acquisition

SCHEDULE OF CONTINGENT CONSIDERATION

Contingent consideration
Fair value of contingent consideration	$	4,797,717
Change in fair value of contingent consideration		(4,103,487	)
Contingent consideration at December 31, 2021		694,230
Change in fair value of contingent consideration		(636,916	)
Contingent consideration at December 31, 2022 (note 17)	$	57,314

SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE

The PPA is as follows:

Number of units of Draganfly Inc.		578,248
Fair value of units	$	14.43
Fair value of units of Draganfly Inc.	$	8,342,966
Cash portion of purchase price		466,643
Total	$	8,809,609

Identifiable intangible assets
Brand	$	23,000
Software		433,000
		456,000
Goodwill		8,353,609
Total consideration	$	8,809,609

XML

CASH AND CASH EQUIVALENTS (Tables)

12 Months Ended

Dec. 31, 2022

Cash and cash equivalents [abstract]

SCHEDULE OF CASH AND CASH EQUIVALENTS

	December 31, 2022		December 31, 2021
Cash held in banks	$	7,500,607	$	22,729,212
Guaranteed investment certificates		394,174		346,501
	$	7,894,781	$	23,075,713

XML

RECEIVABLES (Tables)

12 Months Ended

Dec. 31, 2022

Schedule Of Amounts Receivable

SCHEDULE OF AMOUNTS RECEIVABLE

	December 31, 2022		December 31, 2021
Trade accounts receivable	$	1,343,795	$	951,314
Corporate taxes receivable		-		182,820
Taxes receivable		745,170		272,993
	$	2,088,965	$	1,407,127

XML

INVENTORY (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF INVENTORIES

	December 31, 2022		December 31, 2021
Finished goods	$	542,934	$	3,017,363
Parts		513,008		373,459
	$	1,055,942	$	3,390,822

SCHEDULE OF COST OF SALES

Cost of sales consist of the following:

	December 31, 2022		December 31, 2021
Inventory	$	6,048,348	$	3,420,713
Consulting and services		730,170		679,345
Other		35,866		310,719
	$	6,814,384	$	4,410,777

XML

NOTES RECEIVABLE (Tables)

12 Months Ended

Dec. 31, 2022

Notes Receivable

DISCLOSURE OF NOTES RECEIVABLE

	Maturity Date	Rate			Principal		Interest		Accretion		(Impairment)/ Recovery			Repayments			Balance December 31, 2022
Note 1(1)	2023-03-31		0	%	$	190,396	$	-	$	12,764	$	-		$	(33,860	)	$	169,300
Note 2(1)	2024-09-22		5	%		1,003,682		48,992		27,971		(1,080,645	)		-			-
Note 3	2022-04-26		8	%		-		37,177		-		771,260			(808,437	)		-
Total					$	1,194,078	$	86,169	$	40,735	$	(309,385	)	$	(842,297	)	$	169,300

	Maturity Date	Rate			Principal		Interest		Accretion		(Impairment)/ Recovery			Repayments		Balance December 31, 2021
Note 1(1)	2022-10-21		0	%	$	180,597	$	-		9,573		-			-		190,170
Note 2(1)	2024-09-22		5	%		943,385		13,156		7,465		-			-		964,006
Note 3	2022-04-26		8	%		750,000		21,260		-		(771,260	)		-		-
Note 4(1)	2023-06-01		8	%		114,833		5,378		-		(120,211	)		-		-
Total					$	1,988,815	$	39,794	$	17,038	$	(891,471	)	$	-	$	1,154,176

(1) These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.

XML

PREPAIDS (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF PREPAID EXPENSES AND DEPOSITS

	December 31, 2022		December 31, 2021
Insurance	$	1,148,455	$	2,938,246
Prepaid director fees		-		107,763
Prepaid interest		1,889		6,969
Prepaid marketing services		733,417		1,638,179
Prepaid rent		12,485		-
Prepaid subscriptions		29,194		35,687
Deposits(1)		382,284		768,033
	$	2,307,724	$	5,494,877

XML

INVESTMENTS (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF INVESTMENTS

Balance at December 30, 2020	-
Acquisitions		623,706
Change in fair value		(332,640	)
Balance at December 31, 2021		291,066
Change in fair value		(98,483	)
Balance at December 31, 2022	$	192,583

SCHEDULE OF FAIR VALUE OF INVESTMENT

Fair value of investments is comprised of:

Public company shares	$	57,143
Private company shares		135,440
Balance at December 31, 2022	$	192,583

Public company shares	$	142,857
Public company warrants		21,429
Private company shares		126,780
Balance at December 31, 2021	$	291,066

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS

	December 31, 2022			December 31, 2021			March 10, 2020
Risk free interest rate		4.07	%		0.91	%		0.28	%
Expected volatility		116.00	%		124.09	%		150.88	%
Expected life		0.21 years			2 years			2 years
Expected dividend yield		0	%		0	%		0	%

XML

EQUIPMENT (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT

	Computer Equipment			Furniture and Equipment			Leasehold Improvements			Software			Vehicles			Total
Cost
Balance at December 31, 2020	$	24,397		$	171,606		$	4,352		$	29,967		$	27,652		$	257,974
Additions		29,713			170,866			-			-			12,000			212,579
Revaluation		-			-			-			-			(3,619	)		(3,619	)
Balance at December 31, 2021	$	54,110		$	342,472		$	4,352		$	29,967		$	36,033		$	466,934
Additions		60,240			528,080			-			-			-			588,320
Disposals		(18,688	)		(36,099	)		(4,352	)		(29,967	)		-			(89,106	)
Balance at December 31, 2022	$	95,662		$	834,453		$	-		$	-		$	36,033		$	966,148
Accumulated depreciation
Balance at December 31, 2020	$	12,392		$	59,963		$	3,220		$	22,496		$	6,033		$	104,104
Charge for the year		12,899			42,314			1,132			2,241			7,201			65,787
Balance at December 31, 2021	$	25,291		$	102,277		$	4,352		$	24,737		$	13,234		$	169,891
Charge for the year		32,627			433,855			-			-			3,435			469,917
Disposals		(15,920	)		(33,342	)		(4,352	)		(24,737	)		-			(78,351	)
Balance at December 31, 2022	$	41,998		$	502,790		$	-		$	-		$	16,669		$	561,457
Net book value:
December 31, 2021	$	28,819		$	240,195		$	-		$	5,230		$	22,799		$	297,043
December 31, 2022	$	53,664		$	331,663		$	-		$	-		$	19,364		$	404,691

XML

INTANGIBLE ASSETS AND GOODWILL (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF INTELLECTUAL PROPERTY

	Patents		Customer Relationships		Brand			Software (1)			Goodwill			Total
Cost
Balance at December 31, 2020	$	41,931	$	197,000	$	-		$	119,000		$	2,166,563		$	2,524,494
Additions		-		-		23,000			433,000			8,353,609			8,809,609
Impairment		-		-		-			-			(4,579,763	)		(4,579,763	)
Balance at December 31, 2021	$	41,931	$	197,000	$	23,000		$	552,000		$	5,940,409		$	6,754,340
Additions		-		-		-			4,684			-			4,684
Foreign exchange translation		-		-		1,571			29,576			257,782			288,929
Impairment		-		-		(24,571	)		(462,577	)		(6,198,191	)		(6,685,339	)
Balance at December 31, 2022	$	41,931	$	197,000	$	-		$	123,683		$	-		$	362,614
Accumulated amortization
Balance at December 31, 2020	$	41,931	$	26,267	$	-		$	15,866		$	-		$	84,064
Charge for the year		-		34,147		3,450			98,369			-			135,966
Balance at December 31, 2021		41,931		60,414		3,450			114,235			-			220,030
Charge for the year		-		27,317		4,719			147,446			-			179,482
Foreign exchange translation		-		-		431			13,295			-			13,726
Impairment		-		-		(8,600	)		(221,825	)		-			(230,425	)
Balance at December 31, 2022	$	41,931	$	87,731	$	-		$	53,151		$	-		$	182,813
Net book value:
December 31, 2021	$	-	$	136,586	$	19,550		$	437,765		$	5,940,409		$	6,534,310
December 31, 2022	$	-	$	109,269	$	-		$	70,532		$	-		$	179,801

XML

RIGHT OF USE ASSETS (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF RIGHT OF USE ASSETS

	Total
Cost
Balance at December 31, 2020	$	242,967
Additions		447,242
Lease adjustment		(7,092	)
Balance at December 31, 2021 and 2022	$	683,117
Accumulated depreciation
Balance at December 31, 2020	$	98,548
Charge for the year		109,311
Historical correction		7,152
Balance at December 31, 2021	$	215,011
Charge for the year		123,360
Balance at December 31, 2022	$	338,371
Net book value:
December 31, 2021	$	468,106
December 31, 2022	$	344,746

XML

LEASE LIABILITES (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF OPERATING LEASE LIABILITIES

	Total
Balance at December 31, 2020	$	158,124
Additions		440,675
Interest expense		26,964
Lease payments		(128,995	)
Lease removal		(7,645	)
Balance at December 31, 2021	$	489,123
Interest expense		39,795
Lease payments		(150,275	)
Balance at December 31, 2022	$	378,643

Which consists of:
	December 31, 2022		December 31, 2021
Current lease liability	$	133,962	$	110,481
Non-current lease liability		244,681		378,642
Ending balance	$	378,643	$	489,123

SCHEDULE OF OPERATING MATURITY ANALYSIS

Maturity analysis	Total
Less than one year	$	147,340
One to three years		209,078
Four to five years		83,850
Total undiscounted lease liabilities		440,268
Amount representing interest		(61,625	)
	$	378,643

XML

TRADE PAYABLES AND ACCRUED LIABILITIES (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES

	December 31, 2022		December 31, 2021
Trade accounts payable	$	751,422	$	362,890
Accrued liabilities		2,031,545		402,540
Government grant payable		33,709		33,709
	$	2,816,676	$	799,139

XML

DEFERRED INCOME (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF DEFERRED INCOME

	December 31, 2022		December 31, 2021
Deferred income from customers	$	58,457	$	68,053
Deferred income from government		5,233		5,233
	$	63,690	$	73,286

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2022

Expressed in Canadian Dollars

XML

LOANS PAYABLE (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF LOANS PAYABLE

	December 31, 2022			December 31, 2021
Opening balance	$	93,317		$	97,916
Issuance of loans payable		-			60,000
Fair value adjustment		(4,891	)		(24,576	)
Repayment of loans payable		(6,746	)		(44,428	)
Accretion expense		4,891			4,405
Ending balance	$	86,571		$	93,317

SCHEDULE OF LOANS

	Start Date	Maturity Date	Rate			Carrying Value December 31, 2022		Carrying Value December 31, 2021
CEBA	2020-05-19	2023-12-31		0	%	$	37,383	$	37,384
CEBA	2021-04-23	2023-12-31		0	%		37,383		37,383
Vehicle loan	2019-08-30	2024-09-11		6.99	%		11,805		18,550
Total						$	86,571	$	93,317

XML

SHARE CAPITAL (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE

Grant Date	Expiry Date	Exercise Price		Remaining Contractual Life (years)		Number of Options Outstanding		Number of Options Exercisable
October 30, 2019	October 30, 2029	$	2.50		6.84		286,665		286,665
November 19, 2019	November 19, 2029	$	2.50		6.89		50,000		50,000
April 30, 2020	April 30, 2030	$	2.50		7.33		85,000		85,000
April 30, 2020	April 30, 2030	$	3.85		7.33		110,000		110,000
July 3, 2020	July 3, 2025	$	3.20		2.51		100,000		100,000
November 24, 2020	November 24, 2030	$	2.50		7.90		32,000		32,000
February 2, 2021	February 2, 2031	$	13.20		8.10		30,000		20,000
March 8, 2021	March 8, 2026	$	13.90		3.19		10,000		10,000
April 27, 2021	April 27, 2031	$	10.15		8.33		147,666		50,326
September 9, 2021	September 9, 2026	$	4.84		3.69		25,826		8,608
							877,157		752,599

	Number of Options			Weighted Average Exercise Price
Outstanding, December 31, 2020		1,193,659		$	2.75
Exercised		(405,494	)		2.50
Granted		247,826			10.12
Outstanding, December 31, 2021		1,035,991		$	4.60
Exercised		(12,500	)		2.15
Forfeited		(146,334	)		4.77
Outstanding, December 31, 2022		877,157		$	4.60

SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE

	Number of Options			Weighted Average Exercise Price
Outstanding, December 31, 2020		1,193,659		$	2.75
Exercised		(405,494	)		2.50
Granted		247,826			10.12
Outstanding, December 31, 2021		1,035,991		$	4.60
Exercised		(12,500	)		2.15
Forfeited		(146,334	)		4.77
Outstanding, December 31, 2022		877,157		$	4.60

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS

Year ended December 31,	2022		2021
Risk free interest rate		-		0.69%-1.40	%
Expected volatility		-		111.87%-113.16	%
Expected life		-		5 years
Expected dividend yield		-		0	%
Exercise price	$	-	$	13.20-13.90

SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS

As at December 31, 2022, the Company had the following RSUs outstanding:

	Number of RSUs
Outstanding, December 31, 2020		614,666
Vested		(448,660	)
Issued		348,826
Outstanding, December 31, 2021		514,832
Vested		(1,072,595	)
Issued		1,820,972
Forfeited		(64,334	)
Outstanding, December 31, 2022		1,198,875

SCHEDULE OF WARRANT DERIVATIVE LIABILITY

Warrant Derivative Liability

Balance at December 31, 2020	$	748,634
Warrant issuance		8,261,511
Exercised		(98,048	)
Change in fair value of warrants outstanding		(4,046,325	)
Balance at December 31, 2021	$	4,865,772
Change in fair value of warrants outstanding		(4,865,772	)
Balance at December 31, 2022	$	-

Derivative liability balance at	December 31, 2022		December 31, 2021
Warrants	$	-	$	4,865,772
Contingent consideration (note 3)		57,314		694,230
Ending balance	$	57,314	$	5,560,002

SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING

Details of these warrants and their fair values are as follows:

Issue Date	Exercise Price	Number of Warrants Outstanding at December 31, 2022		Fair Value at December 31, 2022		Number of Warrants Outstanding at December 31, 2021		Fair Value at December 31, 2021
November 30, 2020	US$ 3.55		-	$	-		482,425	$	182,262
February 5, 2021(1)	US$ 3.55		1,319,675		-		1,323,275		951,226
March 5, 2021(2)	US$ 3.55		5,142,324		-		5,154,321		3,732,284
July 29, 2021 (3)	US$5.00		250,000		-		250,000		-
September 14, 2021 (4)	US$5.00		4,798		-		4,798		-
			6,716,797	$	-		7,214,819	$	4,865,772

1)	Subsequent to December 31, 2022, the warrants expired on February 5, 2023.
2)	Subsequent to December 31, 2022, the warrants expired on March 5, 2023.
3)	The warrants expire July 29, 2024.
4)	The warrants expire September 14, 2024.

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS

The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

	December 31, 2022			December 31, 2021
Risk free interest rate		4.07	%		0.23%-0.95	%
Expected volatility		91.66%-93.48	%		70.95%-144.59	%
Expected life		0.10-0.18 years			2-3 years
Expected dividend yield		0	%		0	%

SUMMARY OF CHANGES IN WARRANTS

	Number of Warrants			Weighted Average Exercise Price
Outstanding, December 31, 2020		2,416,864		$	2.95
Exercised		(1,939,534	)		2.54
Forfeited		(6,000	)		2.50
Issued		7,943,489			5.10
Outstanding, December 31, 2021		8,414,819		$	4.99
Exercised		(16,538	)		4.51
Expired		(481,484	)		4.61
Outstanding December 31, 2022		7,916,797		$	5.08

SCHEDULE OF WARRANTS OUTSTANDING

As at December 31, 2022, the Company had the following warrants outstanding:

Date issued	Expiry date	Exercise price	Number of warrants outstanding
February 5, 2021	February 5, 2023	US$ 3.55		1,319,675
March 5, 2021	March 5, 2023	US$ 3.55		5,142,324
March 22, 2021	March 22, 2023	CDN$ 13.35		1,200,000
July 29, 2021	July 29, 2024	US$ 5.00		250,000
September 14, 2021	September 14, 2024	US$ 5.00		4,798
				7,916,797

XML

SEGMENTED INFORMATION (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF SEGMENTED INFORMATION

December 31, 2022	Drones			Vital		Corporate			Total
Sales of goods		5,388,262			162,170		-			5,550,432
Provision of services		2,054,627			-		-			2,054,627
Total revenue	$	7,442,889		$	162,170	$	-		$	7,605,059
Segment loss	$	9,929,789		$	602,580	$	12,926,884		$	23,459,253
Finance and other costs		(3,529	)		-		(40,816	)		(44,345	)
Depreciation		586,185			-		7,092			593,277
Amortization		179,482			-		-			179,482
Impairment of goodwill and intangibles		2,166,563			4,288,351		-			6,454,914
Change in fair value of derivative liability		-			-		(5,502,688	)		(5,502,688	)
Loss (recovery) on write-off of notes receivable		1,080,645			-		(771,260	)		309,385
Loss on write down of inventory		251,754			1,724,760		-			1,976,514
Write down of deposit		-			228,572		-			228,572
Net loss for the year	$	14,190,889		$	6,844,263	$	6,619,212		$	27,654,364

December 31, 2021	Drones		Vital		Corporate			Total
Sales of goods		4,957,134		146,265		-			5,103,399
Provision of services		1,950,466		-		-			1,950,466
Total revenue	$	6,907,600	$	146,265	$	-		$	7,053,865
Segment loss	$	7,819,739	$	257,656	$	10,498,164		$	18,575,560
Finance and other costs		16,272		-		(21,346	)		(5,074	)
Depreciation		175,098		-		-			175,098
Amortization		135,966		-		-			135,966
Impairment of goodwill and intangibles		-		4,579,763		-			4,579,763
Change in fair value of derivative liability		-		-		(8,149,812	)		(8,149,812	)
Loss on write-off of notes receivable		-		-		891,471			891,471
Net loss for the year	$	8,147,075	$	4,837,419	$	3,218,477		$	16,202,972

SCHEDULE OF GEOGRAPHIC REVENUE

Geographic revenue segmentation  is as follows:	For the years ended December 31,
	2022		2021
Canada	$	6,919,038	$	4,982,373
United States		686,021		2,071,492
	$	7,605,059	$	7,053,865

XML

OFFICE AND MISCELLANEOUS (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES

	For the years ended December 31,
	2022		2021
Advertising, Marketing, and Investor Relations	$	4,431,818	$	5,165,791
Compliance fees		152,826		432,874
Contract Work		441,798		300,975
Other		371,519		556,358
	$	5,397,961	$	6,455,998

XML

RELATED PARTY TRANSACTIONS (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF KEY COMPENSATION AWARDS

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the year ended December 31, 2022 and 2021 included:

For the years ended December 31,		2022		2021
Director fees	$	522,349	$	370,094
Salaries		843,917		722,068
Share-based payments		2,106,906		2,475,949
	$	3,473,172	$	3,568,111

SCHEDULE OF KEY MANAGEMENT TRANSACTIONS

For the years ended December 31,	2022		2021
Management fees paid to a company controlled by CEO and director		566,487		290,225
Management fees paid to a company that the CEO holds an economic interest in		442,485		315,643
Management fees paid to a company controlled by the former President and director		383,288		205,691
	$	1,392,260	$	811,559

XML

FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables)

12 Months Ended

Dec. 31, 2022

Financial Instruments And Financial Risk Management

SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES

The following is an analysis of the contractual maturities of the Company’s financial liabilities at December 31, 2022:

	1 year		1 – 5 years		More than 5 years
Trade payables and accrued liabilities	$	2,816,676	$	-	$	-
Customer deposits		194,758		-		-
Deferred income		63,690		-		-
Loans payable		81,512		5,059		-
Derivative liability		57,314		-		-
Lease liability		133,962		244,681		-
	$	3,347,912	$	249,740	$	-

SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES

The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net loss upon consolidation as follows:

	December 31, 2022		December 31, 2021
Foreign exchange rate	$	969,977	$	150,715

SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS

December 31, 2022	Level 1		Level 2		Level 3		Total
Equity securities in investee companies	$	57,143	$	135,440	$	-	$	192,583
Notes receivable		-		-		169,300		169,300
Derivative liability		-		-		57,314		57,314
Total	$	57,143	$	135,440	$	226,614	$	419,197

December 31, 2021	Level 1		Level 2		Level 3		Total
Equity securities in investee companies	$	164,286	$	126,780	$	-	$	291,066
Notes receivable		-		1,154,176		-		1,154,176
Derivative liability		-		-		5,560,002		5,560,002
Total	$	164,286	$	1,280,956	$	5,560,002	$	7,005,244

XML

INCOME TAXES (Tables)

12 Months Ended

Dec. 31, 2022

SCHEDULE OF INCOME TAX

	December 31, 2022			December 31, 2021
Loss before income taxes	$	27,654,364		$	16,202,972
Canadian statutory rates		27%			27%
Expected income tax recovery		7,338,900			4,196,600
Impact of different foreign statutory tax rates		-			34,900
Non-deductible items		(1,214,400	)		116,400
Share issue costs		1,400			887,600
Adjustments to prior years provision versus statutory tax returns		(742,400	)		376,500
Differences between prior year provision and final tax return		867,500			(206,000	)
Change in deferred tax asset not recognized		(6,251,000	)		(5,406,000	)
Income tax	$	-		$	-

SCHEDULE OF DEFERRED TAXES

The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:

	December 31, 2022			December 31, 2021
Deferred income tax assets (liabilities):
Share issuance costs	$	568,000		$	728,000
Non-capital losses		14,602,000			7,043,000
Property and equipment		953,000			449,000
Capital gain reserve		-			74,000
Scientific Research and Experimental Development		367,000			291,000
Total deferred income tax assets	$	16,490,000		$	8,585,000
Deferred income tax not recognized		(16,490,000	)		(8,585,000	)
Net deferred tax assets	$	-		$	-

XML

NATURE AND CONTINUANCE OF OPERATIONS (Details Narrative) - CAD ($)	Dec. 31, 2022	Dec. 31, 2021
Nature And Continuance Of Operations
Accumulated deficit	$ 79,976,546	$ 52,322,182

XML

SCHEDULE OF RESULTS OF OPERATIONS (Details)	12 Months Ended
	Dec. 31, 2022
Draganfly innovations inc. [member]
Reserve Quantities [Line Items]
Name of subsidiary	Draganfly Innovations Inc.
Country of incorporation of subsidiary	Canada
Proportion of ownership interest in subsidiary	100.00%
Draganfly innovations usa, inc. [member]
Reserve Quantities [Line Items]
Name of subsidiary	Draganfly Innovations USA, Inc.
Country of incorporation of subsidiary	US
Proportion of ownership interest in subsidiary	100.00%
Dronelogics systems inc. [member]
Reserve Quantities [Line Items]
Name of subsidiary	Dronelogics Systems Inc.
Country of incorporation of subsidiary	Canada
Proportion of ownership interest in subsidiary	100.00%

XML

SCHEDULE OF FUNCTIONAL CURRENCIES (Details)	12 Months Ended
	Dec. 31, 2022
Draganfly inc [member]
Reserve Quantities [Line Items]
Name of company	Draganfly Inc.
Functional currencies	Canadian Dollar
Draganfly innovations inc [member]
Reserve Quantities [Line Items]
Name of company	Draganfly Innovations Inc.
Functional currencies	Canadian Dollar
Draganfly innovations usa inc [member]
Reserve Quantities [Line Items]
Name of company	Draganfly Innovations USA, Inc.
Functional currencies	US Dollar
Dronelogics systems inc. [member]
Reserve Quantities [Line Items]
Name of company	Dronelogics Systems Inc.
Functional currencies	Canadian Dollar

XML

SCHEDULE OF FINANCIAL INSTRUMENTS (Details)	12 Months Ended
	Dec. 31, 2022
Financial cash [member]
IfrsStatementLineItems [Line Items]
Financial classification	Amortized cost
Financial accounts receivable [member]
IfrsStatementLineItems [Line Items]
Financial classification	Amortized cost
Financial notes receivable [member]
IfrsStatementLineItems [Line Items]
Financial classification	Amortized cost
Financial investments [member]
IfrsStatementLineItems [Line Items]
Financial classification	Fair value through other comprehensive income
Financial accounts payable [member]
IfrsStatementLineItems [Line Items]
Financial classification	Amortized cost
Financial customer deposits [member]
IfrsStatementLineItems [Line Items]
Financial classification	Amortized cost
Financial loans payable [member]
IfrsStatementLineItems [Line Items]
Financial classification	Amortized cost
Financial derivative liability [member]
IfrsStatementLineItems [Line Items]
Financial classification	Fair value through profit or loss

XML

SCHEDULE OF INTANGIBLE ASSETS USEFUL LIVES (Details)	12 Months Ended
	Dec. 31, 2022
Customer relationship [member]
IfrsStatementLineItems [Line Items]
Description of intangible assets with indefinite useful life supporting assessment of indefinite useful life	5 years
Brand [Member]
IfrsStatementLineItems [Line Items]
Description of intangible assets with indefinite useful life supporting assessment of indefinite useful life	5 years
Software [member]
IfrsStatementLineItems [Line Items]
Description of intangible assets with indefinite useful life supporting assessment of indefinite useful life	5 years

XML

SCHEDULE OF DEPRECIATION RATES (Details)	12 Months Ended
	Dec. 31, 2022
Computer equipment [member]
IfrsStatementLineItems [Line Items]
Depreciation rate	30.00%
Fixtures and fittings [member]
IfrsStatementLineItems [Line Items]
Depreciation rate	20.00%
Leasehold improvements [member]
IfrsStatementLineItems [Line Items]
Depreciation rate, term	Expected lease term
Vehicles [member]
IfrsStatementLineItems [Line Items]
Depreciation rate	30.00%

XML

SCHEDULE OF CONTINGENT CONSIDERATION (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Vital Intelligence Acquisition
Contingent consideration, beginning balance	$ 694,230	$ 4,797,717
Change in fair value of contingent consideration	(636,916)	(4,103,487)
Contingent consideration, ending balance	$ 57,314	$ 694,230

XML

SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE (Details)	12 Months Ended
	Dec. 31, 2022 CAD ($) $ / shares shares
Vital Intelligence Acquisition
Number of units of Draganfly Inc. | shares	578,248
Fair value of units | $ / shares	$ 14.43
Fair value of units of Draganfly Inc.	$ 8,342,966
Cash portion of purchase price	466,643
Total	8,809,609
Brand	23,000
Software	433,000
Identifiable intangible assets	456,000
Goodwill	8,353,609
Total consideration	$ 8,809,609

XML

VITAL INTELLIGENCE ACQUISITION (Details Narrative)			12 Months Ended
	Aug. 19, 2021 CAD ($) shares	Mar. 25, 2021 CAD ($) $ / shares shares	Dec. 31, 2022 CAD ($)	Dec. 31, 2021 CAD ($) shares
IfrsStatementLineItems [Line Items]
Shares held in escrow	900,000
Derivative financial liabilities | $		$ 4,797,717
Increase (decrease) in credit derivative, fair value | $			$ 57,314	$ 694,230
Vital intelligence inc [member]
IfrsStatementLineItems [Line Items]
Number of shares issued				1,200,000
Vital intelligence inc [member] | Brand [Member]
IfrsStatementLineItems [Line Items]
Royalty Percentage		0.0025
Royalty discount percentage		0.144
Vital intelligence inc [member] | Software [member]
IfrsStatementLineItems [Line Items]
Royalty Percentage		0.050
Royalty discount percentage		0.144
Asset purchase agreement [member] | Vital intelligence inc [member]
IfrsStatementLineItems [Line Items]
Payments to acquire assets | $		$ 500,000
Number of shares issued		1,200,000
Explanation of nature and amount of significant transactions		the holder to acquire one common share for a period of 24 months following closing for $13.35 and the Company will be able to accelerate the expiry date of the warrants after one year in the event the underlying common shares have a value of at least 30% greater than the exercise price of the warrants. The units will be held in escrow with 300,000 units being released at closing with a value of the of $3,545,249 and the remainder to be released upon the Company reaching certain revenue milestones received from the purchased assets
Warrant exercise price per share | $ / shares		$ 13.35
[custom:EscrowDepositUnits-0]		300,000
Description for Number of Shares Issued		The units were issued on March 22, 2021. On August 19, 2021 the parties agreed to reduce the final payment from $250,000 to $227,984 due to certain assets listed in the purchase agreement had not been delivered by Vital
Escrow agreement one [member]
IfrsStatementLineItems [Line Items]
Stock issued, shares	300,000
Escrow agreement two [member]
IfrsStatementLineItems [Line Items]
Stock issued, shares	300,000
Shares issued, amount | $	$ 2,000,000
Escrow agreement three [member]
IfrsStatementLineItems [Line Items]
Stock issued, shares	300,000
Shares issued, amount | $	$ 4,000,000
Escrow agreement four [member]
IfrsStatementLineItems [Line Items]
Stock issued, shares	300,000
Shares issued, amount | $	$ 6,000,000

XML

SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) - CAD ($)	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash and cash equivalents [abstract]
Cash held in banks	$ 7,500,607	$ 22,729,212
Guaranteed investment certificates	394,174	346,501
Cash and Cash Equivalents	$ 7,894,781	$ 23,075,713	$ 1,982,416

XML

CASH AND CASH EQUIVALENTS (Details Narrative) - Guaranteed investment certificate [member]	Oct. 22, 2022 CAD ($)	Oct. 22, 2022 USD ($)	Aug. 23, 2022 CAD ($)	Aug. 23, 2022 CAD ($)	May 30, 2022 CAD ($)	Mar. 27, 2022 CAD ($)	Dec. 21, 2021 CAD ($)	May 28, 2021 CAD ($)	Mar. 27, 2021 CAD ($)	Mar. 27, 2020 CAD ($)
IfrsStatementLineItems [Line Items]
Purchase of financial instrument			$ 140,738	$ 143,436			$ 50,000	$ 140,000		$ 142,000
Financial instrument term			1 year				1 year	1 year		1 year
Average effective Instrument rate			4.50%				0.05%	0.35%		0.50%
Renew of financial instruments	$ 50,000	$ 50,018	$ 140,738	$ 143,436	$ 140,493	$ 142,852			$ 142,710
Renewed financial instrument term	5 months	5 months		1 year	1 year	1 year			1 year
Renewed effective instrument rate	0.05%	0.05%		4.50%	0.75%	1.00%			0.10%

XML

SCHEDULE OF AMOUNTS RECEIVABLE (Details) - CAD ($)	Dec. 31, 2022	Dec. 31, 2021
Schedule Of Amounts Receivable
Trade accounts receivable	$ 1,343,795	$ 951,314
Corporate taxes receivable		182,820
Taxes receivable	745,170	272,993
Trade and other receivables	$ 2,088,965	$ 1,407,127

XML

SCHEDULE OF INVENTORIES (Details) - CAD ($)	Dec. 31, 2022	Dec. 31, 2021
Finished goods	$ 542,934	$ 3,017,363
Parts	513,008	373,459
Inventories	$ 1,055,942	$ 3,390,822

XML

SCHEDULE OF COST OF SALES (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Inventory	$ 6,048,348	$ 3,420,713
Consulting and services	730,170	679,345
Other	35,866	310,719
Cost of sales	$ 6,814,384	$ 4,410,777

XML

INVENTORY (Details Narrative) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Cost of sales	$ 6,814,384	$ 4,410,777
Reserve inventory write down	1,976,514
Inventory [member]
IfrsStatementLineItems [Line Items]
Cost of sales	$ 6,048,348	$ 3,420,713

XML

DISCLOSURE OF NOTES RECEIVABLE (Details) - CAD ($)					12 Months Ended
		Nov. 22, 2022	Nov. 17, 2021	Sep. 09, 2021	Dec. 31, 2022		Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Principal					$ 1,194,078		$ 1,988,815
Interest					86,169		39,794
Accretion					40,735		17,038
(Impairment)/ Recovery					(309,385)		(891,471)
Repayments					(842,297)
Balance					169,300		1,154,176
(Impairment)/ Recovery					309,385		891,471
Note receivable					$ (169,300)		$ (1,154,176)
Note 1 [member]
IfrsStatementLineItems [Line Items]
Maturity date	[1]				Mar. 31, 2023		Oct. 21, 2022
Rate	[1]				0.00%		0.00%
Principal	[1]				$ 190,396		$ 180,597
Interest	[1]
Accretion	[1]				12,764		9,573
(Impairment)/ Recovery	[1]
Repayments	[1]				(33,860)
Balance	[1]				169,300		190,170
(Impairment)/ Recovery	[1]
Note receivable	[1]				$ (169,300)		$ (190,170)
Note 2 [member]
IfrsStatementLineItems [Line Items]
Maturity date	[1]				Sep. 22, 2024		Sep. 22, 2024
Rate				5.00%	5.00%	[1]	5.00%	[1]
Principal	[1]				$ 1,003,682		$ 943,385
Interest	[1]				48,992		13,156
Accretion	[1]				27,971		7,465
(Impairment)/ Recovery	[1]				(1,080,645)
Repayments	[1]
Balance	[1]						964,006
(Impairment)/ Recovery	[1]				1,080,645
Note receivable	[1]						$ (964,006)
Note 3 [member]
IfrsStatementLineItems [Line Items]
Maturity date			Apr. 26, 2022		Apr. 26, 2022		Apr. 26, 2022
Rate			8.00%		8.00%		8.00%
Principal							$ 750,000
Interest		$ 258,437			37,177		21,260
Accretion
(Impairment)/ Recovery					(771,260)		(771,260)
Repayments					(808,437)
Balance
(Impairment)/ Recovery					771,260		771,260
Note receivable
Note 4 [Member]
IfrsStatementLineItems [Line Items]
Maturity date	[1]						Jun. 01, 2023
Rate	[1]						8.00%
Principal	[1]						$ 114,833
Interest	[1]						5,378
Accretion	[1]
(Impairment)/ Recovery	[1]						(120,211)
Repayments	[1]
Balance	[1]
(Impairment)/ Recovery	[1]						120,211
Note receivable	[1]

[1] These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.

XML

NOTES RECEIVABLE (Details Narrative)									12 Months Ended
		Jan. 30, 2023 CAD ($)	Jan. 30, 2023 USD ($)	Nov. 22, 2022 CAD ($)	Oct. 21, 2022 CAD ($)	Oct. 21, 2022 USD ($)	Nov. 17, 2021	Sep. 09, 2021 CAD ($)	Dec. 31, 2022 CAD ($)		Dec. 31, 2021 CAD ($)
IfrsStatementLineItems [Line Items]
Repayments of current borrowings									$ 842,297
Loans written down
Interest									86,169		$ 39,794
Upon execution [member]
IfrsStatementLineItems [Line Items]
Payment from notes receivable									$ 550,000
Note 1 [member]
IfrsStatementLineItems [Line Items]
Maturity date	[1]								Mar. 31, 2023		Oct. 21, 2022
Repayments of current borrowings	[1]								$ 33,860
Interest rate	[1]								0.00%		0.00%
Interest	[1]
Note 2 [member]
IfrsStatementLineItems [Line Items]
Maturity date	[1]								Sep. 22, 2024		Sep. 22, 2024
Repayments of current borrowings	[1]
Interest rate								5.00%	5.00%	[1]	5.00%	[1]
Interest	[1]								$ 48,992		$ 13,156
Note 3 [member]
IfrsStatementLineItems [Line Items]
Maturity date							Apr. 26, 2022		Apr. 26, 2022		Apr. 26, 2022
Repayments of current borrowings									$ 808,437
Interest rate							8.00%		8.00%		8.00%
Loans written down
Interest				$ 258,437					$ 37,177		$ 21,260
Note 4 [Member]
IfrsStatementLineItems [Line Items]
Maturity date	[1]										Jun. 01, 2023
Repayments of current borrowings	[1]
Interest rate	[1]										8.00%
Loans written down
Interest	[1]										$ 5,378
Nonadjusting events related party payment [member]
IfrsStatementLineItems [Line Items]
Payment from notes receivable					$ 34,860	$ 25,000
Nonadjusting events related party payment [member] | Note 1 [member]
IfrsStatementLineItems [Line Items]
Maturity date		Mar. 31, 2023	Mar. 31, 2023
Repayments of current borrowings		$ 33,369	$ 25,000

[1] These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.

XML

SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) - CAD ($)		Dec. 31, 2022	Dec. 31, 2021
Insurance		$ 1,148,455	$ 2,938,246
Prepaid director fees			107,763
Prepaid interest		1,889	6,969
Prepaid marketing services		733,417	1,638,179
Prepaid rent		12,485
Prepaid subscriptions		29,194	35,687
Deposits	[1]	382,284	768,033
Prepaid expenses and deposits		$ 2,307,724	$ 5,494,877

[1] A deposit in the amount of $228,572 related to the purchase of Vital inventory was written off as there was uncertainty related to whether the Company would recover the value.

XML

SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) (Parenthetical) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Deposit written off	$ 228,572

XML

SCHEDULE OF INVESTMENTS (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Balance	$ 291,066
Acquisitions		623,706
Change in fair value	(98,483)	(332,640)
Balance	$ 192,583	$ 291,066

XML

SCHEDULE OF FAIR VALUE OF INVESTMENT (Details) - CAD ($)	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
IfrsStatementLineItems [Line Items]
Fair value of investments	$ 192,583	$ 291,066
Public company shares [member]
IfrsStatementLineItems [Line Items]
Fair value of investments	57,143	142,857
Private Company Shares [Member]
IfrsStatementLineItems [Line Items]
Fair value of investments	$ 135,440	126,780
Public Company Warrants [Member]
IfrsStatementLineItems [Line Items]
Fair value of investments		$ 21,429

XML

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details)		12 Months Ended
	Mar. 10, 2020	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Risk free interest rate
Expected volatility
Expected life			5 years
Expected dividend yield			0.00%
Warrants [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate	0.28%	4.07%	0.91%
Expected volatility	150.88%	116.00%	124.09%
Expected life	2 years	2 months 15 days	2 years
Expected dividend yield	0.00%	0.00%	0.00%

XML

SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Property, plant and equipment, cost, beginning balance	$ 466,934	$ 257,974
Additions	588,320	212,579
Revaluation		(3,619)
Disposals	(89,106)
Property, plant and equipment, cost, ending balance	966,148	466,934
Accumulated depreciation Property, plant and equipment, beginning balance	169,891	104,104
Charge for the year	469,917	65,787
Disposals	(78,351)
Accumulated depreciation Property, plant and equipment, ending balance	561,457	169,891
Property, plant and equipment, net	404,691	297,043
Computer equipment [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment, cost, beginning balance	54,110	24,397
Additions	60,240	29,713
Revaluation
Disposals	(18,688)
Property, plant and equipment, cost, ending balance	95,662	54,110
Accumulated depreciation Property, plant and equipment, beginning balance	25,291	12,392
Charge for the year	32,627	12,899
Disposals	(15,920)
Accumulated depreciation Property, plant and equipment, ending balance	41,998	25,291
Property, plant and equipment, net	53,664	28,819
Furniture and equipment [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment, cost, beginning balance	342,472	171,606
Additions	528,080	170,866
Revaluation
Disposals	(36,099)
Property, plant and equipment, cost, ending balance	834,453	342,472
Accumulated depreciation Property, plant and equipment, beginning balance	102,277	59,963
Charge for the year	433,855	42,314
Disposals	(33,342)
Accumulated depreciation Property, plant and equipment, ending balance	502,790	102,277
Property, plant and equipment, net	331,663	240,195
Leasehold improvements [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment, cost, beginning balance	4,352	4,352
Additions
Revaluation
Disposals	(4,352)
Property, plant and equipment, cost, ending balance		4,352
Accumulated depreciation Property, plant and equipment, beginning balance	4,352	3,220
Charge for the year		1,132
Disposals	(4,352)
Accumulated depreciation Property, plant and equipment, ending balance		4,352
Property, plant and equipment, net
Computer software [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment, cost, beginning balance	29,967	29,967
Additions
Revaluation
Disposals	(29,967)
Property, plant and equipment, cost, ending balance		29,967
Accumulated depreciation Property, plant and equipment, beginning balance	24,737	22,496
Charge for the year		2,241
Disposals	(24,737)
Accumulated depreciation Property, plant and equipment, ending balance		24,737
Property, plant and equipment, net		5,230
Vehicles [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment, cost, beginning balance	36,033	27,652
Additions		12,000
Revaluation		(3,619)
Disposals
Property, plant and equipment, cost, ending balance	36,033	36,033
Accumulated depreciation Property, plant and equipment, beginning balance	13,234	6,033
Charge for the year	3,435	7,201
Disposals
Accumulated depreciation Property, plant and equipment, ending balance	16,669	13,234
Property, plant and equipment, net	$ 19,364	$ 22,799

XML

SCHEDULE OF INTELLECTUAL PROPERTY (Details) - CAD ($)		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Impairment		$ (6,454,914)	$ (4,579,763)
Net book value		179,801	6,534,310
Patent [member]
IfrsStatementLineItems [Line Items]
Net book value
Customer-related intangible assets [member]
IfrsStatementLineItems [Line Items]
Net book value		109,269	136,586
Brand names [member]
IfrsStatementLineItems [Line Items]
Net book value			19,550
Computer software [member]
IfrsStatementLineItems [Line Items]
Net book value	[1]	70,532	437,765
Goodwill [member]
IfrsStatementLineItems [Line Items]
Net book value			5,940,409
Gross carrying amount [member]
IfrsStatementLineItems [Line Items]
Cost, beginning balance		6,754,340	2,524,494
Additions		4,684	8,809,609
Impairment		(6,685,339)	(4,579,763)
Foreign exchange translation		288,929
Cost, ending balance		362,614	6,754,340
Gross carrying amount [member] | Patent [member]
IfrsStatementLineItems [Line Items]
Cost, beginning balance		41,931	41,931
Additions
Impairment
Foreign exchange translation
Cost, ending balance		41,931	41,931
Gross carrying amount [member] | Customer-related intangible assets [member]
IfrsStatementLineItems [Line Items]
Cost, beginning balance		197,000	197,000
Additions
Impairment
Foreign exchange translation
Cost, ending balance		197,000	197,000
Gross carrying amount [member] | Brand names [member]
IfrsStatementLineItems [Line Items]
Cost, beginning balance		23,000
Additions			23,000
Impairment		(24,571)
Foreign exchange translation		1,571
Cost, ending balance			23,000
Gross carrying amount [member] | Computer software [member]
IfrsStatementLineItems [Line Items]
Cost, beginning balance	[1]	552,000	119,000
Additions	[1]	4,684	433,000
Impairment	[1]	(462,577)
Foreign exchange translation	[1]	29,576
Cost, ending balance	[1]	123,683	552,000
Gross carrying amount [member] | Goodwill [member]
IfrsStatementLineItems [Line Items]
Cost, beginning balance		5,940,409	2,166,563
Additions			8,353,609
Impairment		(6,198,191)	(4,579,763)
Foreign exchange translation		257,782
Cost, ending balance			5,940,409
Accumulated depreciation and amortisation [member]
IfrsStatementLineItems [Line Items]
Impairment		(230,425)
Accumulated amortization, beginning balance		220,030	84,064
Accumulated amortization, Change for the period		179,482	135,966
Accumulated amortization, Foreign exchange translation		13,726
Accumulated amortization, ending balance		182,813	220,030
Accumulated depreciation and amortisation [member] | Patent [member]
IfrsStatementLineItems [Line Items]
Impairment
Accumulated amortization, beginning balance		41,931	41,931
Accumulated amortization, Change for the period
Accumulated amortization, Foreign exchange translation
Accumulated amortization, ending balance		41,931	41,931
Accumulated depreciation and amortisation [member] | Customer-related intangible assets [member]
IfrsStatementLineItems [Line Items]
Impairment
Accumulated amortization, beginning balance		60,414	26,267
Accumulated amortization, Change for the period		27,317	34,147
Accumulated amortization, Foreign exchange translation
Accumulated amortization, ending balance		87,731	60,414
Accumulated depreciation and amortisation [member] | Brand names [member]
IfrsStatementLineItems [Line Items]
Impairment		(8,600)
Accumulated amortization, beginning balance		3,450
Accumulated amortization, Change for the period		4,719	3,450
Accumulated amortization, Foreign exchange translation		431
Accumulated amortization, ending balance			3,450
Accumulated depreciation and amortisation [member] | Computer software [member]
IfrsStatementLineItems [Line Items]
Impairment	[1]	(221,825)
Accumulated amortization, beginning balance	[1]	114,235	15,866
Accumulated amortization, Change for the period	[1]	147,446	98,369
Accumulated amortization, Foreign exchange translation	[1]	13,295
Accumulated amortization, ending balance	[1]	53,151	114,235
Accumulated depreciation and amortisation [member] | Goodwill [member]
IfrsStatementLineItems [Line Items]
Impairment
Accumulated amortization, beginning balance
Accumulated amortization, Change for the period
Accumulated amortization, Foreign exchange translation
Accumulated amortization, ending balance

[1] Software acquired via acquisition of Vital and Dronelogics.

XML

INVESTMENTS (Details Narrative)	Oct. 27, 2021 USD ($) shares	Mar. 10, 2021 CAD ($) $ / shares shares
Number of shares purchased | shares	50,000	1,428,571
Number of shares purchased, value	$ 100,000	$ 500,000
Description for common stock and warrants activity		The warrants have an exercise price of $0.50 each and convert to one common share, and expire on March 17, 2023
Warrant, exercise price | $ / shares		$ 0.50
Warrants expiration date		Mar. 17, 2023

XML

INTANGIBLE ASSETS AND GOODWILL (Details Narrative) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Mar. 25, 2021	Apr. 30, 2020
IfrsStatementLineItems [Line Items]
Goodwill		$ 5,940,409
Actuarial assumption of discount rates	10.00%
Vital [member]
IfrsStatementLineItems [Line Items]
[custom:PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization-0]	0.00%	42.00%
[custom:PercentageOfWeightedAverageCostOfCapital-0]	29.00%	24.00%
Impairment loss recognised in profit or loss, goodwill	$ 4,031,628	$ 4,579,763
Impairment loss recognised in profit or loss, intangible assets other than goodwill	15,971	240,752
Reserve of change in value of time value of options		$ 570,133
Dronelogics [member]
IfrsStatementLineItems [Line Items]
[custom:PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization-0]	6.50%	14.00%
[custom:PercentageOfWeightedAverageCostOfCapital-0]	19.00%	17.00%
Impairment loss recognised in profit or loss, goodwill	$ 2,166,563
Reserve of change in value of time value of options	$ 104,248	$ 597,100
Vital and dronelogics [member]
IfrsStatementLineItems [Line Items]
Growth rate used to extrapolate cash flow projections	2.00%	2.00%
Brand [Member]
IfrsStatementLineItems [Line Items]
Customer relationships			$ 23,000
Computer software [member] | Vital [member]
IfrsStatementLineItems [Line Items]
Customer relationships			433,000
Goodwill [member] | Dronelogics [member]
IfrsStatementLineItems [Line Items]
Percentage of voting equity interests acquired				100.00%
Goodwill			$ 8,353,609	$ 2,166,563

XML

SCHEDULE OF RIGHT OF USE ASSETS (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Right of use assets, at cost, beginning	$ 242,967
Additions	447,242
Lease adjustment	(7,092)
Right of use assets, at cost, ending	683,117	$ 242,967
Accumulated amortization, Beginning	215,011	98,548
Charge for the year	123,360	109,311
Historical correction		7,152
Accumulated amortization, Ending	338,371	215,011
Right of use assets	$ 344,746	$ 468,106

XML

SCHEDULE OF OPERATING LEASE LIABILITIES (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Balance - Beginning of period	$ 489,123	$ 158,124
Additions		440,675
Interest expense	39,795	26,964
Lease Payments	(150,275)	(128,995)
Lease removal		(7,645)
Balance - Ending of period	378,643	489,123
Current lease liabilities	133,962	110,481
Non-current lease liabilities	244,681	378,642
Lease liabilities	$ 378,643	$ 489,123

XML

SCHEDULE OF OPERATING MATURITY ANALYSIS (Details) - CAD ($)	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
IfrsStatementLineItems [Line Items]
Total undiscounted lease liabilities	$ 440,268
Amount representing interest	(61,625)
Lease liability	378,643	$ 489,123	$ 158,124
Not later than one year [member]
IfrsStatementLineItems [Line Items]
Total undiscounted lease liabilities	147,340
Later than one year and not later than three years [member]
IfrsStatementLineItems [Line Items]
Total undiscounted lease liabilities	209,078
Later than four years and not later than five years [member]
IfrsStatementLineItems [Line Items]
Total undiscounted lease liabilities	$ 83,850

XML

SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details) - CAD ($)	Dec. 31, 2022	Dec. 31, 2021
Trade accounts payable	$ 751,422	$ 362,890
Accrued liabilities	2,031,545	402,540
Government grant payable	33,709	33,709
Trade payables and accrued liabilities	$ 2,816,676	$ 799,139

XML

SCHEDULE OF DEFERRED INCOME (Details) - CAD ($)	Dec. 31, 2022	Dec. 31, 2021
Deferred income from customers	$ 58,457	$ 68,053
Deferred income from government	5,233	5,233
Deferred Income	$ 63,690	$ 73,286

XML

SCHEDULE OF LOANS PAYABLE (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Opening balance	$ 93,317	$ 97,916
Issuance of loans payable		60,000
Fair value adjustment	(4,891)	(24,576)
Repayment of loans payable	(6,746)	(44,428)
Accretion expense	4,891	4,405
Ending balance	$ 86,571	$ 93,317

XML

SCHEDULE OF LOANS (Details) - CAD ($)			12 Months Ended
	Apr. 23, 2021	May 19, 2020	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Total			$ 86,571	$ 93,317
Rate		25.00%
CEBA [member]
IfrsStatementLineItems [Line Items]
Total			$ 37,383	37,384
Start Date			May 19, 2020
Maturity Date	three-year term	three-year term	Dec. 31, 2023
Rate	5.00%	5.00%	0.00%
CEBA [member]
IfrsStatementLineItems [Line Items]
Total			$ 37,383	37,383
Start Date			Apr. 23, 2021
Maturity Date			Dec. 31, 2023
Rate			0.00%
Vehicle loan [member]
IfrsStatementLineItems [Line Items]
Total			$ 11,805	$ 18,550
Start Date			Aug. 30, 2019
Maturity Date			Sep. 11, 2024
Rate			6.99%

XML

LEASE LIABILITY (Details Narrative)	12 Months Ended
	Dec. 31, 2022
Depreciation lease liability	The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 7.5% to 10.5%

XML

LOANS PAYABLE (Details Narrative) - CAD ($)				12 Months Ended
	Apr. 23, 2021	Dec. 04, 2020	May 19, 2020	Dec. 31, 2022
IfrsStatementLineItems [Line Items]
Interest rate			25.00%
CEBA [member]
IfrsStatementLineItems [Line Items]
Loan received			$ 40,000
Interest rate	5.00%		5.00%	0.00%
Loans forgivable amount	$ 20,000		$ 10,000
Maturity	three-year term		three-year term	Dec. 31, 2023
Proceeds from loan		$ 20,000
Loan forgiveness		$ 10,000
Unsecured loan received	$ 60,000

XML

SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details)	12 Months Ended
	Dec. 31, 2022 shares $ / shares	Dec. 31, 2021 shares $ / shares
IfrsStatementLineItems [Line Items]
Remaining Contractual Life (years)	5 months 19 days	1 year 2 months 12 days
Number of Options Outstanding	877,157	1,035,991
Number of options outstanding, Beginning Balance	1,035,991	1,193,659
Weighted average exercise price, Beginning Balance | $ / shares	$ 4.60	$ 2.75
Number of options outstanding, Exercised	(12,500)	(405,494)
Weighted average exercise price, forfeited | $ / shares	$ 4.77	$ 2.50
Number of options outstanding, Granted		247,826
Weighted average exercise price, Granted | $ / shares		$ 10.12
Weighted average exercise price, Granted | $ / shares	$ 2.15
Number of options outstanding, forfeited	(146,334)
Number of options outstanding, Ending Balance	877,157	1,035,991
Weighted average exercise price, Ending Balance | $ / shares	$ 4.60	$ 4.60
Incentive Share Compensation Plan [Member]
IfrsStatementLineItems [Line Items]
Number of Options Outstanding	877,157
Number of Options Exercisable	752,599
Number of options outstanding, Ending Balance	877,157
Exercise price one [member] | Incentive Share Compensation Plan [Member]
IfrsStatementLineItems [Line Items]
Grant Date	Oct. 30, 2019
Expiry Date	Oct. 30, 2029
Exercise Price | $ / shares	$ 2.50
Remaining Contractual Life (years)	6 years 10 months 2 days
Number of Options Outstanding	286,665
Number of Options Exercisable	286,665
Number of options outstanding, Ending Balance	286,665
Exercise price two [member] | Incentive Share Compensation Plan [Member]
IfrsStatementLineItems [Line Items]
Grant Date	Nov. 19, 2019
Expiry Date	Nov. 19, 2029
Exercise Price | $ / shares	$ 2.50
Remaining Contractual Life (years)	6 years 10 months 20 days
Number of Options Outstanding	50,000
Number of Options Exercisable	50,000
Number of options outstanding, Ending Balance	50,000
Exercise price three [member] | Incentive Share Compensation Plan [Member]
IfrsStatementLineItems [Line Items]
Grant Date	Apr. 30, 2020
Expiry Date	Apr. 30, 2030
Exercise Price | $ / shares	$ 2.50
Remaining Contractual Life (years)	7 years 3 months 29 days
Number of Options Outstanding	85,000
Number of Options Exercisable	85,000
Number of options outstanding, Ending Balance	85,000
Exercise price four [member] | Incentive Share Compensation Plan [Member]
IfrsStatementLineItems [Line Items]
Grant Date	Apr. 30, 2020
Expiry Date	Apr. 30, 2030
Exercise Price | $ / shares	$ 3.85
Remaining Contractual Life (years)	7 years 3 months 29 days
Number of Options Outstanding	110,000
Number of Options Exercisable	110,000
Number of options outstanding, Ending Balance	110,000
Exercise price five [member] | Incentive Share Compensation Plan [Member]
IfrsStatementLineItems [Line Items]
Grant Date	Jul. 03, 2020
Expiry Date	Jul. 03, 2025
Exercise Price | $ / shares	$ 3.20
Remaining Contractual Life (years)	2 years 6 months 3 days
Number of Options Outstanding	100,000
Number of Options Exercisable	100,000
Number of options outstanding, Ending Balance	100,000
Exercise price six [member] | Incentive Share Compensation Plan [Member]
IfrsStatementLineItems [Line Items]
Grant Date	Nov. 24, 2020
Expiry Date	Nov. 24, 2030
Exercise Price | $ / shares	$ 2.50
Remaining Contractual Life (years)	7 years 10 months 24 days
Number of Options Outstanding	32,000
Number of Options Exercisable	32,000
Number of options outstanding, Ending Balance	32,000
Exercise price seven [member] | Incentive Share Compensation Plan [Member]
IfrsStatementLineItems [Line Items]
Grant Date	Feb. 02, 2021
Expiry Date	Feb. 02, 2031
Exercise Price | $ / shares	$ 13.20
Remaining Contractual Life (years)	8 years 1 month 6 days
Number of Options Outstanding	30,000
Number of Options Exercisable	20,000
Number of options outstanding, Ending Balance	30,000
Exercise price eight [member] | Incentive Share Compensation Plan [Member]
IfrsStatementLineItems [Line Items]
Grant Date	Mar. 08, 2021
Expiry Date	Mar. 08, 2026
Exercise Price | $ / shares	$ 13.90
Remaining Contractual Life (years)	3 years 2 months 8 days
Number of Options Outstanding	10,000
Number of Options Exercisable	10,000
Number of options outstanding, Ending Balance	10,000
Exercise price nine [member] | Incentive Share Compensation Plan [Member]
IfrsStatementLineItems [Line Items]
Grant Date	Apr. 27, 2021
Expiry Date	Apr. 27, 2031
Exercise Price | $ / shares	$ 10.15
Remaining Contractual Life (years)	8 years 3 months 29 days
Number of Options Outstanding	147,666
Number of Options Exercisable	50,326
Number of options outstanding, Ending Balance	147,666
Exercise price pen [member] | Incentive Share Compensation Plan [Member]
IfrsStatementLineItems [Line Items]
Grant Date	Sep. 09, 2021
Expiry Date	Sep. 09, 2026
Exercise Price | $ / shares	$ 4.84
Remaining Contractual Life (years)	3 years 8 months 8 days
Number of Options Outstanding	25,826
Number of Options Exercisable	8,608
Number of options outstanding, Ending Balance	25,826

XML

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Risk free interest rate
Expected volatility
Expected life		5 years
Expected dividend yield		0.00%
Exercise price
Bottom of range [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate		0.69%
Expected volatility		111.87%
Exercise price		$ 13.20
Top of range [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate		1.40%
Expected volatility		113.16%
Exercise price		$ 13.90

XML

SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details) - shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Number of RSUs outstanding, Beginning of the period	7,214,819
Number of RSUs outstanding, Ending of the period	6,716,797	7,214,819
Restricted stock units rsu [member]
IfrsStatementLineItems [Line Items]
Number of RSUs outstanding, Beginning of the period	514,832	614,666
Vested	(1,072,595)	(448,660)
Issued	1,820,972	348,826
Forfeited	(64,334)
Number of RSUs outstanding, Ending of the period	1,198,875	514,832

XML

SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details) - Warrants [member]	12 Months Ended
	Dec. 31, 2022 CAD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 CAD ($)	Dec. 31, 2021 USD ($)
IfrsStatementLineItems [Line Items]
Beginning of the period		$ 4,865,772		$ 748,634
Warrants issuance				8,261,511
Exercised				(98,048)
Change in fair value of warrants outstanding		(4,865,772)		(4,046,325)
End of the period				$ 4,865,772
Warrants			$ 4,865,772
Contingent consideration	57,314		694,230
Derivative liability	$ 57,314		$ 5,560,002

XML

SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) shares $ / shares	Dec. 31, 2021 USD ($) shares
IfrsStatementLineItems [Line Items]
Number of Warrants Outstanding | shares	6,716,797	7,214,819
Fair Value of warrants | $		$ 4,865,772
Range 1 [member]
IfrsStatementLineItems [Line Items]
Issue date	Nov. 30, 2020
Exercise price | $ / shares	$ 3.55
Number of Warrants Outstanding | shares		482,425
Fair Value of warrants | $		$ 182,262
Range 2 [member]
IfrsStatementLineItems [Line Items]
Issue date	Feb. 05, 2021
Exercise price | $ / shares	$ 3.55
Number of Warrants Outstanding | shares	1,319,675	1,323,275
Fair Value of warrants | $		$ 951,226
Range 3 [member]
IfrsStatementLineItems [Line Items]
Issue date	Mar. 05, 2021
Exercise price | $ / shares	$ 3.55
Number of Warrants Outstanding | shares	5,142,324	5,154,321
Fair Value of warrants | $		$ 3,732,284
Range 4 [Member]
IfrsStatementLineItems [Line Items]
Issue date	Jul. 29, 2021
Exercise price | $ / shares	$ 5.00
Number of Warrants Outstanding | shares	250,000	250,000
Fair Value of warrants | $
Range 5 [Member]
IfrsStatementLineItems [Line Items]
Issue date	Sep. 14, 2021
Exercise price | $ / shares	$ 5.00
Number of Warrants Outstanding | shares	4,798	4,798
Fair Value of warrants | $

XML

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details)		12 Months Ended
	Mar. 10, 2020	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Risk free interest rate
Expected volatility
Expected life			5 years
Expected dividend yield			0.00%
Bottom of range [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate			0.69%
Expected volatility			111.87%
Top of range [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate			1.40%
Expected volatility			113.16%
Warrants [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate	0.28%	4.07%	0.91%
Expected volatility	150.88%	116.00%	124.09%
Expected life	2 years	2 months 15 days	2 years
Expected dividend yield	0.00%	0.00%	0.00%
Warrants [member] | Bottom of range [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate			0.23%
Expected volatility		91.66%	70.95%
Expected life		1 month 6 days	2 years
Warrants [member] | Top of range [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate			0.95%
Expected volatility		93.48%	144.59%
Expected life		2 months 4 days	3 years

XML

SUMMARY OF CHANGES IN WARRANTS (Details)	12 Months Ended
	Dec. 31, 2022 shares $ / shares	Dec. 31, 2021 shares $ / shares
IfrsStatementLineItems [Line Items]
Number of RSUs outstanding, Beginning of the period | shares	7,214,819
Number of RSUs outstanding, Ending of the period | shares	6,716,797	7,214,819
Weighted Average Exercise Price, Outstanding, Ending Balance
Warrants [member]
IfrsStatementLineItems [Line Items]
Number of RSUs outstanding, Beginning of the period	8,414,819	2,416,864
Weighted Average Exercise Price, Outstanding, Beginning Balance	$ 4.99	$ 2.95
Warrants, Excercised	(16,538)	(1,939,534)
Weighted Average Exercise Price, Exercised	$ 4.51	$ 2.54
Warrants, Forfeited		(6,000)
Weighted Average Exercise Price, Forfeited		$ 2.50
Warrants, Issued		7,943,489
Weighted Average Exercise Price, Issued		$ 5.10
Warrants, Expired	(481,484)
Weighted Average Exercise Price, Expired	$ 4.61
Number of RSUs outstanding, Ending of the period	7,916,797	8,414,819
Weighted Average Exercise Price, Outstanding, Ending Balance	$ 5.08	$ 4.99

XML

SCHEDULE OF WARRANTS OUTSTANDING (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares shares	Dec. 31, 2022 $ / shares shares
Warrant one [member]
IfrsStatementLineItems [Line Items]
Date issued	Feb. 05, 2021
Expiry date	Feb. 05, 2023
Exercise price | $ / shares	$ 3.55
Number of warrants outstanding	1,319,675	1,319,675
Warrant two [member]
IfrsStatementLineItems [Line Items]
Date issued	Mar. 05, 2021
Expiry date	Mar. 05, 2023
Exercise price | $ / shares	$ 3.55
Number of warrants outstanding	5,142,324	5,142,324
Warrant three [member]
IfrsStatementLineItems [Line Items]
Date issued	Mar. 22, 2021
Expiry date	Mar. 22, 2023
Exercise price | $ / shares		$ 13.35
Number of warrants outstanding	1,200,000	1,200,000
Warrant four [member]
IfrsStatementLineItems [Line Items]
Date issued	Jul. 29, 2021
Expiry date	Jul. 29, 2024
Exercise price | $ / shares	$ 5.00
Number of warrants outstanding	250,000	250,000
Warrant five [member]
IfrsStatementLineItems [Line Items]
Date issued	Sep. 14, 2021
Expiry date	Sep. 14, 2024
Exercise price | $ / shares	$ 5.00
Number of warrants outstanding	4,798	4,798
Warrants [member]
IfrsStatementLineItems [Line Items]
Number of warrants outstanding	7,916,797	7,916,797

XML

SHARE CAPITAL (Details Narrative) - CAD ($)		12 Months Ended
	Mar. 22, 2021	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
[custom:StockIssuedDuringPeriodValueExerciseOfWarrants]		$ 87,170	$ 4,929,790
Issued shares			6,488,669
Issued value			$ 18,815,485
Share capital issuance description		(i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date. At the election of the Board of Directors, upon each vesting date, participants receive (a) the issuance of common shares from treasury equal to the number of RSUs vesting, or (b) a cash payment equal to the number of vested RSUs multiplied by the fair market value of a common share, calculated as the closing price of the common shares on the CSE for the trading day immediately preceding such payment date; or (c) a combination of (a) and (b).	Each unit is comprised of one common share and one share purchase warrant. These warrants had a fair value of $0.57 USD allocated to them, have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years. The fair value of $8,261,511 was allocated to warrant derivative liability.
Warrant derivative liability			$ 8,261,511
Number of stock issued for private placement			5,095,966
Value of stock issued for private placement			$ 25,538,213
Number of share options granted in share-based payment arrangement			247,826
Weighted average exercise price of share options granted in share-based payment arrangement			$ 10.12
Adjustments for share-based payments		$ 3,311,024	$ 3,952,595
Weighted average remaining contractual life of outstanding share options		5 months 19 days	1 year 2 months 12 days
Warrants issued	1,200,000
Warrants held in escrow	900,000
Stock options [member]
IfrsStatementLineItems [Line Items]
Adjustments for share-based payments		$ 502,837	$ 1,660,894
Restricted stock units [member]
IfrsStatementLineItems [Line Items]
Number of accelerated vesting shares		1,072,595	323,661
Number of shares vested		1,820,972	124,999
Number of shares forfeited		64,334
Number of shares granted post consolidation			348,826
Share-based payment expense		$ 2,808,187	$ 2,291,701
Employee [member]
IfrsStatementLineItems [Line Items]
Number of share options granted in share-based payment arrangement			30,000
Weighted average exercise price of share options granted in share-based payment arrangement			$ 13.20
Contractual life of exercisable share options			10 years
Consultant [member]
IfrsStatementLineItems [Line Items]
Number of share options granted in share-based payment arrangement			10,000
Weighted average exercise price of share options granted in share-based payment arrangement			$ 13.90
Contractual life of exercisable share options			5 years
Employees and consultant [member]
IfrsStatementLineItems [Line Items]
Number of share options granted in share-based payment arrangement			182,000
Weighted average exercise price of share options granted in share-based payment arrangement			$ 10.15
Contractual life of exercisable share options			10 years
Employee one [member]
IfrsStatementLineItems [Line Items]
Number of share options granted in share-based payment arrangement			25,826
Weighted average exercise price of share options granted in share-based payment arrangement			$ 4.84
Contractual life of exercisable share options			5 years
Vital intelligence inc [member]
IfrsStatementLineItems [Line Items]
Share capital issuance description			Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.
Number of stock units issued for acquisition			1,200,000
Common stock 1 [member]
IfrsStatementLineItems [Line Items]
Number of stock issued for exercise of warrants		16,538	1,939,534
[custom:StockIssuedDuringPeriodValueExerciseOfWarrants]		$ 87,170	$ 4,929,790
Number of stock issued for exercise of options		12,500	405,499
Value of stock issued for exercise of options		$ 26,875	$ 1,014,123
Restricted share units		1,072,595	448,660
Number of shares issued			371,901

XML

SCHEDULE OF SEGMENTED INFORMATION (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Sales of goods	$ 5,550,432	$ 5,103,399
Provision of services	2,054,627	1,950,466
Total revenue	7,605,059	7,053,865
Segment loss	23,459,253	18,575,560
Finance and other costs	(44,345)	(5,074)
Depreciation	593,277	175,098
Amortization	179,482	135,966
Impairment of goodwill and intangibles	6,454,914	4,579,763
Change in fair value of derivative liability	(5,502,688)	(8,149,812)
Loss on write-off of notes receivable	309,385	891,471
Loss on write down of inventory	1,976,514
Write down of deposit	228,572
Net loss for the year	27,654,364	16,202,972
Drones [Member]
IfrsStatementLineItems [Line Items]
Sales of goods	5,388,262	4,957,134
Provision of services	2,054,627	1,950,466
Total revenue	7,442,889	6,907,600
Segment loss	9,929,789	7,819,739
Finance and other costs	(3,529)	16,272
Depreciation	586,185	175,098
Amortization	179,482	135,966
Impairment of goodwill and intangibles	2,166,563
Change in fair value of derivative liability
Loss on write-off of notes receivable	1,080,645
Loss on write down of inventory	251,754
Write down of deposit
Net loss for the year	14,190,889	8,147,075
Vital [member]
IfrsStatementLineItems [Line Items]
Sales of goods	162,170	146,265
Provision of services
Total revenue	162,170	146,265
Segment loss	602,580	257,656
Finance and other costs
Depreciation
Amortization
Impairment of goodwill and intangibles	4,288,351	4,579,763
Change in fair value of derivative liability
Loss on write-off of notes receivable
Loss on write down of inventory	1,724,760
Write down of deposit	228,572
Net loss for the year	6,844,263	4,837,419
Corporate [Member]
IfrsStatementLineItems [Line Items]
Sales of goods
Provision of services
Total revenue
Segment loss	12,926,884	10,498,164
Finance and other costs	(40,816)	(21,346)
Depreciation	7,092
Amortization
Impairment of goodwill and intangibles
Change in fair value of derivative liability	(5,502,688)	(8,149,812)
Loss on write-off of notes receivable	(771,260)	891,471
Loss on write down of inventory
Write down of deposit
Net loss for the year	$ 6,619,212	$ 3,218,477

XML

SCHEDULE OF GEOGRAPHIC REVENUE (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Revenue	$ 7,605,059	$ 7,053,865
CA country [member]
IfrsStatementLineItems [Line Items]
Revenue	6,919,038	4,982,373
United states [member]
IfrsStatementLineItems [Line Items]
Revenue	$ 686,021	$ 2,071,492

XML

SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Advertising, Marketing, and Investor Relations	$ 4,431,818	$ 5,165,791
Compliance fees	152,826	432,874
Contract Work	441,798	300,975
Other	371,519	556,358
Office and Miscellaneous Expenses	$ 5,397,961	$ 6,455,998

XML

SCHEDULE OF KEY COMPENSATION AWARDS (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Director fees	$ 522,349	$ 370,094
Salaries	843,917	722,068
Share-based payments	2,106,906	2,475,949
Total	$ 3,473,172	$ 3,568,111

XML

SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Management fees paid to a company	$ 6,821,583	$ 4,445,949
Total	3,473,172	3,568,111
C E O And Director [Member]
IfrsStatementLineItems [Line Items]
Management fees paid to a company	566,487	290,225
CEO [Member]
IfrsStatementLineItems [Line Items]
Management fees paid to a company	442,485	315,643
President And Director [Member]
IfrsStatementLineItems [Line Items]
Management fees paid to a company	383,288	205,691
Former Director [Member]
IfrsStatementLineItems [Line Items]
Management fees paid to a company	394,039	500,074
Former owner [member]
IfrsStatementLineItems [Line Items]
Salaries
Other related parties [member]
IfrsStatementLineItems [Line Items]
Total	$ 1,392,260	$ 811,559

XML

RELATED PARTY TRANSACTIONS (Details Narrative) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Professional fees expense	$ 6,821,583	$ 4,445,949
Amounts payable, related party transactions	51,549
Amounts receivable, related party transactions		155,108
Business service agreement [member] | Business instincts group [member]
IfrsStatementLineItems [Line Items]
Professional fees expense	442,485	315,643
Amounts payable, related party transactions	30,804
Consultant agreement [member] | Alberta ltd [member]
IfrsStatementLineItems [Line Items]
Professional fees expense	566,487	290,225
Executive agreement [member] | Scott larson [member]
IfrsStatementLineItems [Line Items]
Professional fees expense	383,288	$ 205,191
Amounts payable, related party transactions	$ 20,745

XML

SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES (Details) - CAD ($)	Dec. 31, 2022	Dec. 31, 2021	Mar. 25, 2021	Dec. 31, 2020
IfrsStatementLineItems [Line Items]
Derivative liability			$ 4,797,717
Lease liability	$ 378,643	$ 489,123		$ 158,124
Later than one year [member]
IfrsStatementLineItems [Line Items]
Trade payables and accrued liabilities	2,816,676
Customer deposits	194,758
Deferred income	63,690
Loans payable	81,512
Derivative liability	57,314
Lease liability	133,962
Contractual maturities of financial liabilities	3,347,912
Later than one year and not later than five years [member]
IfrsStatementLineItems [Line Items]
Trade payables and accrued liabilities
Customer deposits
Deferred income
Loans payable	5,059
Derivative liability
Lease liability	244,681
Contractual maturities of financial liabilities	249,740
Later than five years [member]
IfrsStatementLineItems [Line Items]
Trade payables and accrued liabilities
Customer deposits
Deferred income
Loans payable
Derivative liability
Lease liability
Contractual maturities of financial liabilities

XML

SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Financial Instruments And Financial Risk Management
Foreign exchange rate	$ 969,977	$ 150,715

XML

SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS (Details) - CAD ($)	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Equity securities in investee companies	$ 192,583	$ 291,066
Notes receivable	169,300	1,154,176
Derivative liability	57,314	5,560,002
Total	419,197	7,005,244
Level 1 of fair value hierarchy [member]
IfrsStatementLineItems [Line Items]
Equity securities in investee companies	57,143	164,286
Notes receivable
Derivative liability
Total	57,143	164,286
Level 2 of fair value hierarchy [member]
IfrsStatementLineItems [Line Items]
Equity securities in investee companies	135,440	126,780
Notes receivable		1,154,176
Derivative liability
Total	135,440	1,280,956
Level 3 of fair value hierarchy [member]
IfrsStatementLineItems [Line Items]
Equity securities in investee companies
Notes receivable	169,300
Derivative liability	57,314	5,560,002
Total	$ 226,614	$ 5,560,002

XML

FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Details Narrative)	Dec. 31, 2022 CAD ($)
Financial Instruments And Financial Risk Management
Trade receivable	$ 920,062

XML

SCHEDULE OF INCOME TAX (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Loss before income taxes	$ 27,654,364	$ 16,202,972
Canadian statutory rates	27.00%	27.00%
Expected income tax recovery	$ 7,338,900	$ 4,196,600
Impact of different foreign statutory tax rates		34,900
Non-deductible items	(1,214,400)	116,400
Share issue costs	1,400	887,600
Adjustments to prior years provision versus statutory tax returns	(742,400)	376,500
Differences between prior year provision and final tax return	867,500	(206,000)
Change in deferred tax asset not recognized	(6,251,000)	(5,406,000)
Income tax

XML

SCHEDULE OF DEFERRED TAXES (Details) - CAD ($)	Dec. 31, 2022	Dec. 31, 2021
Share issuance costs	$ 568,000	$ 728,000
Non-capital losses	14,602,000	7,043,000
Property and equipment	953,000	449,000
Capital gain reserve		74,000
Scientific Research and Experimental Development	367,000	291,000
Total deferred income tax assets	16,490,000	8,585,000
Deferred income tax not recognized	(16,490,000)	(8,585,000)
Net deferred tax assets

XML

INCOME TAXES (Details Narrative)	12 Months Ended
	Dec. 31, 2022 CAD ($)
Tax effect of tax losses	$ 48,808,245

XML

SUPPLEMENTAL CASH FLOW DISCLOSURES (Details Narrative) - CAD ($)		12 Months Ended
	Mar. 10, 2021	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Description for common stock and warrants activity	The warrants have an exercise price of $0.50 each and convert to one common share, and expire on March 17, 2023
Vital intelligence inc [member]
IfrsStatementLineItems [Line Items]
Number of shares issued			1,200,000
Description for common stock and warrants activity			These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.
Warrant exercise price			$ 13.35
Common shares [member]
IfrsStatementLineItems [Line Items]
Number of shares issued			371,901
Rental Services [Member]
IfrsStatementLineItems [Line Items]
Non - cash transfer of equipment from inventory		$ 508,607

XML

SUBSEQUENT EVENTS (Details Narrative) - Non adjusting event [member]	1 Months Ended
	Feb. 17, 2023 CAD ($) $ / shares shares	Feb. 17, 2023 USD ($) shares
IfrsStatementLineItems [Line Items]
Shares distributed | shares	650,729	650,729
Share price | $ / shares	$ 2.62
Net proceeds from distributed of shares	$ 1,705,013
Equity distribution agreement [member]
IfrsStatementLineItems [Line Items]
Shares distributed		$ 15,000,000